data_2kvv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kvv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.281 0.562 . . . . 74.140000000000001 111.459 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -89.7 128.02 36.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.753 -0.658 . . . . 74.319999999999993 109.926 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.589 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.5 ptp -148.55 149.13 31.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.881 0.372 . . . . 72.540000000000006 111.771 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.85 176.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.249 0.462 . . . . 64.129999999999995 112.249 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.34 -57.61 11.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.547 0.573 . . . . 65.040000000000006 112.547 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.7 -34.41 77.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.419 -0.355 . . . . 72.329999999999998 111.79 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.5 -42.52 74.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.131 0.491 . . . . 75.040000000000006 111.128 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 63' ' ' ILE . 3.3 tm? -60.08 -47.73 84.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.918 -0.583 . . . . 74.349999999999994 111.451 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.504 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.4 ptp -58.76 -32.58 69.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.781 0.324 . . . . 74.310000000000002 111.417 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.39 -41.7 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.1 0.476 . . . . 74.450000000000003 111.391 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.589 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 13.2 mmm180 -71.28 -31.93 68.06 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.259 -0.428 . . . . 72.299999999999997 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.406 ' HG1' HD12 ' A' ' 16' ' ' LEU . 56.2 p -95.58 -30.94 13.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.47 0.544 . . . . 73.340000000000003 112.47 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.14 55.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.398 -0.43 . . . . 72.239999999999995 113.176 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 17' ' ' MET . 8.9 mp -90.11 174.95 7.35 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.194 0.521 . . . . 71.340000000000003 112.035 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.23 161.04 13.08 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.143 -0.48 . . . . 45.5 112.443 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.13 -42.77 63.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.528 0.566 . . . . 74.400000000000006 112.528 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -62.6 -42.78 99.77 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 111.648 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.77 -36.05 77.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.006 0.431 . . . . 71.510000000000005 110.939 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.27 -43.89 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.343 -0.39 . . . . 75.340000000000003 111.404 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.25 -38.93 93.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.787 0.327 . . . . 63.409999999999997 110.489 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -60.38 -40.49 91.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 71.239999999999995 110.713 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 12.3 m-85 -66.12 -34.97 79.26 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.316 -0.402 . . . . 73.510000000000005 111.691 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 23.6 mtm180 -68.42 -21.3 64.67 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.161 0.505 . . . . 73.310000000000002 111.246 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.89 13.47 5.9 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.024 -0.535 . . . . 70.239999999999995 110.738 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.8 -81.89 0.04 OUTLIER Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.229 -0.51 . . . . 64.519999999999996 114.185 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.01 -34.52 43.94 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.145 1.165 . . . . 36.939999999999998 114.145 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.726 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -71.53 104.09 3.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.818 -0.551 . . . . 75.329999999999998 110.861 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -102.03 129.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 64.530000000000001 111.744 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -64.92 132.64 49.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.354 -0.385 . . . . 74.400000000000006 110.802 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.16 -24.86 19.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.271 -0.49 . . . . 52.229999999999997 112.929 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.23 -70.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 122.472 -0.429 . . . . 74.239999999999995 111.892 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -85.66 -12.72 50.6 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.185 0.439 . . . . 74.450000000000003 112.185 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' HE2' ' HB3' ' A' ' 35' ' ' TRP . 52.9 p90 -158.99 169.32 24.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.728 0.27 . . . . 73.549999999999997 111.728 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -141.98 172.1 13.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.782 0.325 . . . . 74.019999999999996 111.158 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -105.39 109.83 21.96 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.281 0.475 . . . . 74.200000000000003 112.281 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 70.420000000000002 111.647 -179.171 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.842 0.353 . . . . 71.200000000000003 111.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -92.69 119.95 32.61 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.067 0.46 . . . . 71.530000000000001 112.144 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -103.78 123.68 47.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 110.578 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.11 150.88 19.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 65.010000000000005 111.927 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -92.42 112.17 24.01 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 111.905 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.556 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 65.4 t80 -56.25 -50.12 89.36 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 112.498 0.555 . . . . 75.219999999999999 112.498 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 50.1 Cg_exo -55.75 -41.56 76.26 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.198 1.932 . . . . 61.25 113.02 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -62.03 -44.99 95.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.48 0.657 . . . . 74.299999999999997 111.628 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 HD13 HD21 ' A' ' 16' ' ' LEU . 87.2 mt -69.1 -47.81 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.683 -0.69 . . . . 71.510000000000005 111.776 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.3 -31.94 69.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.775 0.322 . . . . 73.200000000000003 111.365 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -42.49 91.33 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.101 0.477 . . . . 73.209999999999994 110.011 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.8 -54.99 22.45 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.424 -0.353 . . . . 74.25 111.22 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 73.329999999999998 111.421 178.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 121.205 0.526 . . . . 74.439999999999998 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.468 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 93.7 m95 -93.57 146.09 24.06 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.074 -0.512 . . . . 71.510000000000005 111.241 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.483 ' HE3' ' HB2' ' A' ' 60' ' ' TYR . 17.7 ptp -160.73 159.62 30.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.937 0.399 . . . . 74.349999999999994 112.01 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.14 163.39 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.535 -0.302 . . . . 65.209999999999994 111.478 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -52.48 -47.19 66.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.326 0.491 . . . . 73.340000000000003 112.326 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.82 -32.05 71.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.356 -0.383 . . . . 61.399999999999999 111.31 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.61 24.83 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.034 0.445 . . . . 62.039999999999999 111.36 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.46 HD12 ' HG1' ' A' ' 20' ' ' THR . 3.2 tm? -59.28 -50.61 73.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.892 -0.594 . . . . 65.439999999999998 111.05 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.6 ptp -58.27 -35.53 71.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.081 0.467 . . . . 63.409999999999997 111.481 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.42 -31.35 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 111.941 0.348 . . . . 74.120000000000005 111.941 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.1 -31.9 20.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.38 0.511 . . . . 73.329999999999998 112.38 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.46 ' HG1' HD12 ' A' ' 16' ' ' LEU . 69.9 p -93.36 -30.65 15.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.886 0.699 . . . . 70.5 112.886 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.19 4.93 62.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.887 -0.673 . . . . 53.420000000000002 113.267 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.74 154.47 27.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.101 0.477 . . . . 75.420000000000002 111.31 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.99 165.11 25.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.053 -0.594 . . . . 55.32 112.998 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.79 -47.79 64.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.17 0.433 . . . . 74.549999999999997 112.17 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.95 -27.43 68.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 111.811 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -67.91 -56.89 7.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.197 0.522 . . . . 72.420000000000002 111.099 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.36 -50.76 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 112.112 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 pt-20 -53.63 -39.76 65.23 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.852 0.316 . . . . 64.340000000000003 111.852 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -69.81 -43.45 72.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.927 0.394 . . . . 64.430000000000007 111.249 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -67.17 -28.51 68.17 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.829 0.347 . . . . 73.340000000000003 111.432 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 49.1 mtp180 -58.77 -26.8 64.38 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.192 0.441 . . . . 74.040000000000006 112.192 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -97.14 10.69 38.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.337 0.495 . . . . 64.120000000000005 112.337 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.99 -53.89 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.438 -0.887 . . . . 74.140000000000001 114.454 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.03 -23.22 31.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.311 -0.523 . . . . 73.019999999999996 112.335 -175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.428 ' HE3' ' N ' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.92 139.79 48.9 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.35 0.595 . . . . 74.200000000000003 112.151 -177.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.52 125.98 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.695 -0.684 . . . . 74.120000000000005 110.305 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.21 135.88 56.44 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.0 0.429 . . . . 75.099999999999994 111.701 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -55.84 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.32 -0.4 . . . . 72.299999999999997 113.358 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.99 -46.37 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.533 0.568 . . . . 75.540000000000006 112.533 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -110.71 -18.69 13.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.715 0.635 . . . . 73.439999999999998 112.715 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 44.1 p90 -156.74 160.85 39.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.374 0.509 . . . . 74.420000000000002 112.374 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 22.8 ptmt -148.99 150.86 33.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.847 0.356 . . . . 73.340000000000003 111.444 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -90.64 123.9 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 74.239999999999995 110.811 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 112.121 0.415 . . . . 73.409999999999997 112.121 -178.133 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 75.239999999999995 111.742 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -91.78 124.6 36.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.894 0.378 . . . . 75.239999999999995 111.763 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.12 148.04 25.88 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.317 -0.401 . . . . 71.230000000000004 111.075 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.48 149.51 36.23 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.506 -0.316 . . . . 75.420000000000002 111.801 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.48 114.54 25.21 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.27 0.47 . . . . 74.200000000000003 112.27 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 89.7 t80 -61.64 -48.83 88.98 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.482 0.549 . . . . 74.299999999999997 112.482 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 19.1 Cg_endo -57.59 -33.4 96.52 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.997 1.798 . . . . 63.119999999999997 112.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.44 -49.03 29.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.143 -0.481 . . . . 72.239999999999995 111.235 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.479 ' O ' HG13 ' A' ' 67' ' ' ILE . 72.9 mt -63.41 -32.09 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.354 -0.385 . . . . 72.120000000000005 110.937 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -58.71 -42.76 89.39 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.002 0.429 . . . . 61.509999999999998 110.515 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -60.73 -43.8 97.44 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 64.420000000000002 110.521 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -62.45 -33.21 74.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.315 -0.402 . . . . 73.129999999999995 111.708 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 63' ' ' ILE . 68.7 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.942 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 121.092 0.473 . . . . 71.219999999999999 111.242 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -80.66 120.2 24.27 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.943 -0.571 . . . . 74.329999999999998 110.523 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.0 ptp -141.56 153.32 44.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 75.329999999999998 111.929 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.56 166.45 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 64.209999999999994 111.51 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -51.6 -45.37 63.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.197 0.443 . . . . 75.239999999999995 112.197 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -58.52 -50.7 72.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.831 0.348 . . . . 74.530000000000001 111.084 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -67.11 -38.03 84.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.067 0.461 . . . . 64.099999999999994 111.43 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.504 HD21 HD13 ' A' ' 63' ' ' ILE . 3.3 tm? -60.66 -48.56 81.26 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.974 -0.557 . . . . 72.299999999999997 111.406 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.8 ptp -59.43 -32.36 70.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.932 0.396 . . . . 70.430000000000007 111.529 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.68 -37.52 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.121 0.486 . . . . 75.540000000000006 111.306 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 31.3 mmt180 -76.33 -26.96 56.29 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.384 -0.371 . . . . 75.409999999999997 111.888 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.511 ' HB ' HD12 ' A' ' 22' ' ' LEU . 66.2 p -98.46 -30.85 12.3 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.71 6.58 62.17 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.266 -0.492 . . . . 44.210000000000001 113.125 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.511 HD12 ' HB ' ' A' ' 20' ' ' THR . 9.4 mp -85.92 160.49 19.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.194 0.521 . . . . 75.150000000000006 111.847 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.08 156.75 19.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.27 -0.491 . . . . 75.030000000000001 111.997 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.03 59.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.318 0.488 . . . . 74.420000000000002 112.318 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -21.67 66.86 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.874 0.369 . . . . 74.530000000000001 111.711 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.43 -45.42 12.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.224 0.535 . . . . 75.150000000000006 110.696 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.523 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 51.3 mt -61.11 -49.4 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.152 -0.476 . . . . 73.099999999999994 110.992 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.5 pt-20 -57.43 -29.98 64.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.76 0.281 . . . . 64.329999999999998 111.76 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 t -62.33 -48.1 81.32 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 110.912 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -71.43 -31.03 66.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.022 -0.535 . . . . 74.409999999999997 111.774 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.554 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 27.9 mtp-105 -60.85 -19.32 59.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.067 0.395 . . . . 71.030000000000001 112.067 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.1 mm-40 -80.9 -14.86 57.63 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.501 0.556 . . . . 72.450000000000003 112.501 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.05 -48.44 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.363 -0.922 . . . . 73.409999999999997 114.313 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.25 81.34 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.286 -0.538 . . . . 75.049999999999997 112.059 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.2 104.95 5.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.069 0.461 . . . . 71.349999999999994 110.901 177.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -86.7 135.21 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.298 -0.41 . . . . 62.210000000000001 111.69 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.03 139.18 58.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.966 0.412 . . . . 73.319999999999993 111.613 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.03 -46.49 2.69 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.387 -0.37 . . . . 71.310000000000002 113.225 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.51 -60.1 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.35 0.5 . . . . 74.409999999999997 112.35 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -91.94 -27.37 17.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.96 0.356 . . . . 70.239999999999995 111.96 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 36.1 p90 -152.6 155.92 38.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.693 -0.231 . . . . 72.209999999999994 110.663 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.0 165.8 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.094 0.473 . . . . 74.540000000000006 112.095 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -82.54 122.24 27.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.956 -0.566 . . . . 73.030000000000001 111.525 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.094 0.473 . . . . 73.349999999999994 111.397 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 120.655 0.264 . . . . 71.319999999999993 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -111.67 108.49 17.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.428 0.529 . . . . 73.219999999999999 112.428 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -100.84 136.68 40.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 110.973 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.13 137.46 45.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.297 -0.41 . . . . 71.120000000000005 111.629 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.47 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 60.7 t30 -88.49 112.7 23.27 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.002 0.429 . . . . 74.129999999999995 111.05 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.598 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 68.0 t80 -51.1 -54.25 39.79 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.544 0.942 . . . . 75.439999999999998 113.544 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 78.4 Cg_exo -51.9 -38.07 67.81 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.133 1.888 . . . . 63.439999999999998 113.209 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -65.27 -25.86 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.195 0.442 . . . . 63.520000000000003 112.195 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.504 HD13 HD21 ' A' ' 16' ' ' LEU . 66.0 mt -86.52 -37.49 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.583 -0.28 . . . . 75.439999999999998 111.33 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.76 -39.77 68.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.36 0.6 . . . . 74.219999999999999 110.373 170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -50.63 -44.48 57.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.499 -0.773 . . . . 75.140000000000001 111.016 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.42 -40.63 81.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.783 -0.644 . . . . 75.099999999999994 111.491 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 116.384 -0.371 . . . . 74.140000000000001 111.778 -179.352 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.476 ' HG3' ' HE3' ' A' ' 11' ' ' MET . 9.9 tp10 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.786 0.327 . . . . 74.140000000000001 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -122.52 140.42 52.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.608 0.242 . . . . 74.299999999999997 111.373 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.667 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 pmm? -158.47 174.42 15.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.13 0.49 . . . . 72.099999999999994 111.588 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.35 171.47 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.263 -0.426 . . . . 64.010000000000005 110.926 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -58.33 -41.98 85.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.055 0.391 . . . . 74.230000000000004 112.055 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -55.56 -48.33 74.93 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.957 0.408 . . . . 71.219999999999999 111.055 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.86 -37.53 73.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.941 0.401 . . . . 53.030000000000001 111.075 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 63' ' ' ILE . 3.2 tm? -56.97 -48.99 77.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.3 -0.409 . . . . 72.510000000000005 111.164 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.9 ptp -62.23 -36.26 81.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.658 0.266 . . . . 74.209999999999994 111.236 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 14' ' ' LYS . 64.6 t -69.87 -36.03 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.071 0.462 . . . . 74.319999999999993 111.309 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.444 ' HG3' ' HE2' ' A' ' 11' ' ' MET . 30.5 mmt180 -74.47 -37.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.127 -0.488 . . . . 74.450000000000003 112.008 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.2 p -93.14 -30.86 15.02 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.602 0.593 . . . . 73.530000000000001 112.602 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.02 -3.2 41.04 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.162 -0.542 . . . . 51.219999999999999 113.087 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.24 -175.03 4.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.366 0.603 . . . . 71.439999999999998 112.226 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.37 169.22 23.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.96 -0.564 . . . . 73.129999999999995 112.3 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.31 -49.09 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.557 0.577 . . . . 64.420000000000002 112.557 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -63.33 -23.12 67.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 111.424 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -81.74 -53.92 5.81 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.16 0.505 . . . . 75.099999999999994 111.079 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.54 -43.1 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.022 -0.535 . . . . 74.510000000000005 112.343 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 pt-20 -58.75 -29.27 66.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.997 0.369 . . . . 74.430000000000007 111.997 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -67.86 -36.84 80.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.183 0.516 . . . . 72.109999999999999 110.685 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.97 -31.22 56.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.897 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 55.6 mtp180 -59.96 -25.33 65.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 75.150000000000006 112.061 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -95.33 12.49 28.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 64.510000000000005 111.823 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.54 -85.77 0.06 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.95 -0.643 . . . . 71.510000000000005 114.134 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.58 65.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.8 0.667 . . . . 71.519999999999996 112.8 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.04 104.64 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.531 0.682 . . . . 73.439999999999998 111.691 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -103.61 133.34 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.384 -0.825 . . . . 75.530000000000001 110.335 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.5 142.04 58.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.917 0.389 . . . . 75.439999999999998 110.999 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 -43.62 2.79 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 121.553 -0.356 . . . . 75.439999999999998 113.11 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.13 -50.86 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.579 0.585 . . . . 62.350000000000001 112.579 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -111.49 -18.56 12.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.665 0.616 . . . . 75.030000000000001 112.665 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.63 144.33 20.43 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.441 0.163 . . . . 55.210000000000001 110.602 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -121.09 156.37 32.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.158 0.504 . . . . 74.299999999999997 111.962 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -95.83 143.43 27.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.266 -0.424 . . . . 64.230000000000004 111.017 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.868 0.366 . . . . 64.310000000000002 111.545 178.14 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.92 0.39 . . . . 64.209999999999994 111.434 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -107.3 109.34 21.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.817 0.341 . . . . 72.219999999999999 110.957 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -95.68 133.9 39.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.904 0.383 . . . . 75.430000000000007 111.594 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.7 139.11 33.25 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.076 0.465 . . . . 74.129999999999995 111.591 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.18 95.08 6.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.42 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.667 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 69.4 t80 -55.9 -49.9 90.34 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.65 0.611 . . . . 74.310000000000002 112.65 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.8 Cg_endo -56.82 -23.7 51.9 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.193 1.929 . . . . 63.32 112.782 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.99 -44.73 10.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.794 0.294 . . . . 73.099999999999994 111.794 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 HD11 ' A' ' 16' ' ' LEU . 74.0 mt -66.66 -48.99 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.751 0.31 . . . . 74.239999999999995 111.153 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -56.82 -47.59 79.95 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.256 0.551 . . . . 74.400000000000006 110.39 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.19 -42.2 76.76 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.663 -0.699 . . . . 73.150000000000006 111.908 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -61.51 -47.73 84.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.009 0.433 . . . . 75.340000000000003 111.099 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.462 . . . . 74.510000000000005 111.369 178.609 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 5.0 mm-40 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.191 0.52 . . . . 74.540000000000006 110.79 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 81.9 m95 -99.21 126.53 45.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.849 -0.614 . . . . 74.019999999999996 110.537 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.3 ptp -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.021 0.438 . . . . 74.5 112.021 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.93 163.8 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.255 -0.43 . . . . 75.450000000000003 111.949 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.38 -51.08 28.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.974 0.731 . . . . 75.319999999999993 112.974 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.89 -40.32 92.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.676 0.274 . . . . 74.420000000000002 111.654 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.29 70.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.082 0.467 . . . . 65.109999999999999 111.098 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -60.11 -50.74 72.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.659 -0.7 . . . . 74.409999999999997 111.187 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -59.01 -33.66 70.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.948 0.404 . . . . 74.549999999999997 111.64 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -71.41 -42.44 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.008 0.433 . . . . 63.130000000000003 111.513 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -85.06 -8.5 58.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.018 0.747 . . . . 73.420000000000002 113.018 -176.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.7 p -110.22 -30.34 7.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.207 0.447 . . . . 74.120000000000005 112.207 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.69 -6.69 65.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.202 -0.523 . . . . 52.399999999999999 112.846 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -73.65 157.49 36.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.031 0.443 . . . . 72.420000000000002 111.576 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.56 160.72 20.42 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.125 -0.56 . . . . 62.149999999999999 112.93 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.07 61.43 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.15 0.426 . . . . 75.239999999999995 112.15 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.93 -27.4 67.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.033 0.444 . . . . 75.349999999999994 111.712 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -76.35 -36.91 57.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.125 0.488 . . . . 62.340000000000003 110.631 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 56.6 mt -68.42 -52.53 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.202 -0.454 . . . . 71.230000000000004 111.422 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.567 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.8 pt-20 -54.35 -37.28 64.74 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.914 0.388 . . . . 74.450000000000003 111.405 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -57.69 -53.58 56.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 111.09 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -65.07 -30.99 71.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.325 -0.398 . . . . 75.340000000000003 111.948 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 18.5 mtp-105 -60.47 -23.27 64.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.605 -0.27 . . . . 72.109999999999999 111.658 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -90.76 -9.38 46.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.355 0.872 . . . . 75.219999999999999 113.355 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.49 9.36 0.33 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 119.731 -1.223 . . . . 64.310000000000002 115.666 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.96 -28.79 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.904 0.852 . . . . 64.120000000000005 111.871 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.36 133.21 44.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.591 0.71 . . . . 75.400000000000006 112.493 -177.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 60.6 mt -138.47 126.46 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.419 -0.81 . . . . 73.25 110.329 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.5 139.78 51.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.371 0.605 . . . . 61.450000000000003 110.981 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.39 -15.11 59.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.059 -0.519 . . . . 62.409999999999997 112.593 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -123.89 -73.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 122.57 -0.371 . . . . 74.310000000000002 111.655 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.408 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.5 m80 -86.34 -10.87 53.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.056 0.391 . . . . 74.349999999999994 112.056 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 44.5 p90 -170.51 179.06 3.46 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.858 -0.423 . . . . 75.530000000000001 109.858 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -157.86 149.19 21.42 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.014 0.435 . . . . 74.120000000000005 111.374 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -78.69 103.94 8.97 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.232 0.539 . . . . 72.329999999999998 111.748 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 66.0 t . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 116.117 -0.492 . . . . 74.530000000000001 111.047 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.911 0.386 . . . . 74.049999999999997 110.721 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -86.7 105.76 17.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.09 0.472 . . . . 75.310000000000002 112.009 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 28.7 m95 -91.23 121.75 33.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.08 -0.509 . . . . 72.549999999999997 110.006 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 63' ' ' ILE . 87.5 m-85 -90.32 145.07 25.25 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.918 0.71 . . . . 74.329999999999998 112.918 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 53.2 t-20 -85.36 96.88 9.69 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.735 -0.666 . . . . 73.530000000000001 110.729 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 82.9 t80 -52.4 -53.11 56.69 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 112.543 0.571 . . . . 72.099999999999994 112.543 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 82.5 Cg_exo -51.02 -50.42 13.95 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.376 2.05 . . . . 73.540000000000006 113.588 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.6 mm-40 -71.22 -28.53 64.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.143 0.423 . . . . 75.200000000000003 112.143 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 58' ' ' TYR . 46.7 mt -70.13 -42.14 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.948 -0.47 . . . . 73.340000000000003 110.547 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -34.13 72.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.051 0.453 . . . . 75.140000000000001 110.407 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 5.7 tppp? -59.0 -31.86 69.17 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.939 -0.573 . . . . 73.0 111.279 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -85.51 -32.22 22.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 74.439999999999998 111.232 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.4 mt . . . . . 0 CA--C 1.537 0.47 0 O-C-N 122.206 -0.309 . . . . 72.439999999999998 111.467 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.872 0.367 . . . . 73.209999999999994 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.435 ' HH2' ' HE3' ' A' ' 42' ' ' LYS . 80.9 m95 -93.81 134.31 36.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.429 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 20.4 ptp -157.16 153.85 28.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.987 0.422 . . . . 74.310000000000002 112.035 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.27 170.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.865 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -57.55 -45.59 84.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.22 0.452 . . . . 74.409999999999997 112.22 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -61.54 -38.54 87.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.887 0.375 . . . . 75.430000000000007 111.14 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -72.21 -38.54 68.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.071 0.462 . . . . 74.519999999999996 111.1 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.32 -48.37 81.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.782 -0.645 . . . . 74.340000000000003 110.965 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -61.29 -28.03 68.9 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.808 0.337 . . . . 74.329999999999998 111.901 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.9 t -78.62 -49.19 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.911 0.386 . . . . 75.200000000000003 111.126 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -64.4 -26.88 68.65 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.0 p -99.05 -30.67 12.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.252 0.464 . . . . 65.219999999999999 112.252 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.5 -13.98 56.64 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.117 -0.563 . . . . 74.040000000000006 113.103 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.4 mp -66.99 159.9 27.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.219 0.533 . . . . 75.150000000000006 111.976 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.69 160.63 15.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.039 -0.528 . . . . 37.060000000000002 112.491 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.58 65.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.85 0.357 . . . . 72.230000000000004 111.591 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -59.27 -31.68 69.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.003 -0.544 . . . . 73.049999999999997 111.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' SER . 46.9 tt0 -84.37 -34.28 23.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.398 -0.365 . . . . 73.129999999999995 111.021 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 17' ' ' MET . 60.8 mt -66.24 -50.33 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.598 -0.274 . . . . 64.430000000000007 111.159 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 13.0 pt-20 -58.56 -23.25 58.02 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.986 0.422 . . . . 63.399999999999999 111.193 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 47.9 t -67.18 -56.04 11.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.54 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -65.72 -25.89 67.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.178 0.436 . . . . 65.099999999999994 112.178 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.561 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 78.8 mtp180 -60.37 -10.76 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 111.942 0.349 . . . . 75.409999999999997 111.942 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -63.17 -22.33 66.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.161 0.43 . . . . 73.450000000000003 112.161 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.67 -17.16 0.05 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.488 -0.863 . . . . 71.200000000000003 114.607 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.3 67.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.681 0.741 . . . . 70.0 111.816 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.5 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -71.94 105.07 3.71 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.065 0.46 . . . . 75.310000000000002 111.716 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -87.49 120.24 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.345 -0.389 . . . . 74.150000000000006 111.6 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.61 147.74 40.72 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.905 0.335 . . . . 73.219999999999999 111.905 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.15 -47.18 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.444 -0.344 . . . . 61.210000000000001 113.665 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.3 t -80.44 -63.65 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.468 0.307 . . . . 74.439999999999998 111.732 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.475 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 4.3 m-70 -86.88 -19.93 28.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.127 0.417 . . . . 74.219999999999999 112.127 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 12.3 p90 -165.97 143.48 5.49 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.795 -0.446 . . . . 64.030000000000001 109.795 175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HE3' ' HH2' ' A' ' 10' ' ' TRP . 19.1 ptpt -127.62 161.36 29.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.395 0.617 . . . . 74.299999999999997 112.488 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 43' ' ' ARG . 7.8 ptp180 -74.92 134.62 41.54 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.502 -0.772 . . . . 74.510000000000005 111.032 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 116.657 -0.247 . . . . 63.329999999999998 110.788 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 74.349999999999994 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.1 m -123.12 120.42 33.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.932 0.396 . . . . 75.129999999999995 111.801 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -109.94 140.11 44.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.318 -0.401 . . . . 75.450000000000003 111.108 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -99.34 139.76 34.51 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.827 0.346 . . . . 75.420000000000002 111.524 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 16.7 m120 -87.66 105.49 17.39 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.303 -0.408 . . . . 72.400000000000006 111.317 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.467 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 67.4 t80 -52.06 -52.03 65.82 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.857 0.688 . . . . 71.209999999999994 112.857 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 22.4 Cg_endo -60.01 -29.42 89.27 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.877 1.718 . . . . 62.329999999999998 112.858 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HB3' ' ND1' ' A' ' 40' ' ' HIS . 74.7 mm-40 -79.9 -39.09 31.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 112.063 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -71.69 -35.76 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.768 0.318 . . . . 72.5 110.384 174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.09 -38.24 85.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.759 0.314 . . . . 72.430000000000007 110.382 172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 39.6 ttmt -53.77 -35.46 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.073 0.463 . . . . 74.299999999999997 110.974 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.66 -50.97 10.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 111.163 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 63' ' ' ILE . 54.6 mt . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 112.462 0.541 . . . . 73.109999999999999 112.462 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.0 mm-40 . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 120.901 0.382 . . . . 64.25 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -91.98 135.75 33.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.627 -0.26 . . . . 74.049999999999997 110.526 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.586 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.7 ptp -158.81 142.41 15.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.922 0.391 . . . . 75.120000000000005 112.045 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.09 172.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 111.795 0.295 . . . . 71.439999999999998 111.795 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -46.74 -57.51 4.78 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.896 0.702 . . . . 73.439999999999998 112.896 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -54.69 -37.52 65.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.885 0.374 . . . . 75.310000000000002 111.945 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -76.11 -42.44 47.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.097 0.475 . . . . 53.329999999999998 111.143 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 63' ' ' ILE . 3.2 tm? -58.31 -47.72 82.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.804 -0.635 . . . . 74.299999999999997 111.209 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -58.63 -34.24 70.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.847 0.356 . . . . 65.319999999999993 111.629 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.49 -46.14 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.154 0.502 . . . . 63.310000000000002 111.233 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.586 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 16.8 mmt180 -69.0 -29.57 67.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.131 -0.486 . . . . 74.5 112.247 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.416 ' HG1' HD12 ' A' ' 16' ' ' LEU . 82.3 p -99.96 -30.17 12.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.538 0.57 . . . . 54.509999999999998 112.538 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 -4.64 56.12 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.025 -0.607 . . . . 65.030000000000001 112.824 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.63 -173.11 1.71 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.386 0.612 . . . . 73.010000000000005 111.767 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -146.19 169.14 27.58 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.797 -0.638 . . . . 42.240000000000002 112.266 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.12 -50.69 61.17 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.221 0.452 . . . . 72.230000000000004 112.221 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -60.95 -34.76 75.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.133 0.492 . . . . 75.030000000000001 111.736 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -78.67 -40.37 34.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.349 -0.387 . . . . 75.319999999999993 111.599 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 23' ' ' GLY . 73.8 mt -66.04 -44.07 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.555 0.217 . . . . 72.409999999999997 111.369 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 11.7 pt-20 -56.93 -37.92 72.17 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.812 0.339 . . . . 74.109999999999999 110.905 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 t -60.69 -49.35 77.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 43.409999999999997 110.988 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -63.07 -29.38 70.77 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.805 0.298 . . . . 74.430000000000007 111.805 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.1 mtm180 -69.71 -12.31 61.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.052 0.39 . . . . 74.209999999999994 112.052 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 45.0 mt-30 -88.74 2.76 52.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.625 0.232 . . . . 74.519999999999996 111.625 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.3 -52.29 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.177 -1.011 . . . . 64.409999999999997 114.697 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.08 -38.42 31.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.465 0.913 . . . . 71.310000000000002 113.465 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -71.55 130.67 41.82 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.015 -0.428 . . . . 72.430000000000007 111.68 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.2 mt -130.59 126.31 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 122.522 0.329 . . . . 75.129999999999995 111.094 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG3' ' HA ' ' A' ' 42' ' ' LYS . 38.5 tt0 -68.99 150.92 47.15 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.003 0.43 . . . . 74.140000000000001 110.906 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.45 2.67 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.255 -0.498 . . . . 71.450000000000003 112.841 -174.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.433 HG13 ' HD1' ' A' ' 40' ' ' HIS . 35.0 t -97.76 -64.99 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.249 0.463 . . . . 71.439999999999998 112.249 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.519 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.4 m-70 -92.06 -11.97 34.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.75 0.648 . . . . 61.210000000000001 112.75 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 47.5 p90 -170.78 174.03 5.06 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.0 0.12 . . . . 75.019999999999996 111.012 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 18.7 ptpt -167.74 174.2 7.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.424 0.631 . . . . 75.150000000000006 112.288 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -85.4 120.86 27.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.524 -0.762 . . . . 74.439999999999998 112.002 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 CA--C 1.542 0.65 0 CA-C-N 116.007 -0.542 . . . . 62.340000000000003 110.857 176.109 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.544 0.211 . . . . 73.319999999999993 110.566 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.6 m -89.61 115.25 26.86 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.069 0.461 . . . . 65.109999999999999 112.171 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -102.16 133.54 46.86 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.134 -0.484 . . . . 74.549999999999997 110.848 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.38 143.31 27.54 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.018 0.437 . . . . 73.439999999999998 111.327 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.39 105.53 13.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.322 -0.399 . . . . 71.519999999999996 111.5 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.606 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 90.2 t80 -56.95 -45.15 99.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 111.822 0.305 . . . . 74.549999999999997 111.822 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 9.1 Cg_endo -50.69 -41.78 52.76 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.405 2.07 . . . . 65.319999999999993 113.109 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 40' ' ' HIS . 42.6 mm-40 -65.87 -47.27 75.44 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.136 0.493 . . . . 64.349999999999994 111.815 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.441 HD11 HD22 ' A' ' 16' ' ' LEU . 65.3 mt -71.79 -37.43 62.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.975 0.417 . . . . 75.329999999999998 111.183 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.6 -43.25 99.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.281 0.562 . . . . 65.219999999999999 110.177 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -55.75 -39.49 71.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.593 -0.73 . . . . 72.0 110.81 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -65.03 -48.6 73.29 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.301 -0.409 . . . . 74.510000000000005 111.468 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 121.1 0.476 . . . . 75.510000000000005 111.461 178.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.029 0.442 . . . . 73.030000000000001 111.629 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -77.53 130.53 37.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.033 -0.531 . . . . 72.430000000000007 110.669 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.6 ptp -153.59 142.3 20.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.813 0.339 . . . . 72.129999999999995 111.779 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.81 166.29 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.752 0.31 . . . . 75.519999999999996 111.819 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -52.41 -46.61 66.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.009 0.433 . . . . 70.519999999999996 111.645 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.4 tmmt? -60.13 -37.09 79.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.154 -0.475 . . . . 72.019999999999996 111.483 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.97 55.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.337 0.589 . . . . 74.209999999999994 111.04 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.496 HD12 ' HG1' ' A' ' 20' ' ' THR . 3.3 tm? -65.17 -43.11 92.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.981 -0.554 . . . . 75.209999999999994 111.299 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.1 ptp -61.06 -27.49 68.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.738 0.304 . . . . 72.5 111.35 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 14' ' ' LYS . 47.4 t -67.95 -48.77 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.215 0.531 . . . . 74.219999999999999 110.805 174.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -64.82 -42.76 94.7 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.078 -0.51 . . . . 75.299999999999997 112.289 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.496 ' HG1' HD12 ' A' ' 16' ' ' LEU . 68.3 p -93.5 -30.27 15.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.048 0.758 . . . . 72.239999999999995 113.048 -172.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.84 7.56 64.39 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.055 -0.593 . . . . 72.310000000000002 113.127 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.4 mp -79.76 160.13 26.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 72.209999999999994 111.724 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.02 153.36 16.83 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 71.319999999999993 112.002 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -41.42 62.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.203 0.501 . . . . 73.230000000000004 111.997 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.98 -27.03 69.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.412 -0.358 . . . . 73.239999999999995 111.584 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.406 HE21 ' HE2' ' A' ' 30' ' ' TYR . 48.8 tt0 -84.9 -40.95 16.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.152 0.501 . . . . 74.25 110.755 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.71 -40.0 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.253 -0.43 . . . . 63.310000000000002 112.03 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.477 ' HB3' ' NH2' ' A' ' 31' ' ' ARG . 11.7 pt-20 -62.19 -34.32 76.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.901 0.381 . . . . 74.430000000000007 111.253 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 35.8 t -62.43 -27.6 69.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.245 0.545 . . . . 74.239999999999995 110.773 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HE2' HE21 ' A' ' 26' ' ' GLN . 60.4 m-85 -88.43 -31.61 18.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.274 -0.421 . . . . 74.010000000000005 111.646 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 55.2 mtm180 -64.35 -20.52 66.16 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.296 0.48 . . . . 73.349999999999994 112.296 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' SER . 13.6 pt20 -79.03 -8.11 58.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.435 0.531 . . . . 75.109999999999999 112.435 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.32 -49.08 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.199 -1.0 . . . . 73.25 114.642 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.33 85.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 73.540000000000006 112.463 -176.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.13 106.29 4.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.043 0.449 . . . . 75.209999999999994 111.675 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -96.87 131.71 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.529 -0.305 . . . . 72.319999999999993 111.211 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.83 147.32 53.56 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.044 0.449 . . . . 72.150000000000006 111.4 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.68 -46.03 3.01 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.254 -0.498 . . . . 62.32 112.872 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG11 ' HD1' ' A' ' 40' ' ' HIS . 61.4 t -82.56 -62.79 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.305 0.483 . . . . 74.540000000000006 112.305 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.621 ' HD1' HG11 ' A' ' 39' ' ' VAL . 1.8 m80 -93.91 -21.01 19.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.918 0.71 . . . . 72.349999999999994 112.918 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -153.24 168.22 26.72 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.862 0.301 . . . . 74.510000000000005 111.46 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -136.16 165.29 26.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.21 0.529 . . . . 64.230000000000004 111.424 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -86.79 136.71 32.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.688 -0.687 . . . . 70.439999999999998 110.173 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 78.4 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.216 0.531 . . . . 71.319999999999993 111.656 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.409 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 26.5 m . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.009 0.433 . . . . 71.109999999999999 111.17 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.8 m -91.9 110.2 21.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.718 0.636 . . . . 74.239999999999995 112.718 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -104.35 128.21 52.14 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.514 . . . . 75.230000000000004 111.008 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.531 ' OH ' ' HD3' ' A' ' 31' ' ' ARG . 15.8 m-85 -90.87 157.55 17.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 74.25 112.022 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 40.8 m-80 -94.77 110.19 22.07 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.277 -0.419 . . . . 74.200000000000003 110.406 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.4 t80 -52.65 -49.81 84.16 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.119 0.414 . . . . 74.239999999999995 112.119 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 55.5 Cg_exo -53.63 -41.38 74.31 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.028 1.819 . . . . 74.010000000000005 113.274 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 28.2 mm-40 -70.52 -35.66 73.32 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.735 0.642 . . . . 73.530000000000001 112.735 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.4 -41.57 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.626 0.251 . . . . 75.519999999999996 111.154 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.84 -40.96 90.27 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.26 0.552 . . . . 61.039999999999999 110.279 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -59.88 -44.67 94.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.034 -0.53 . . . . 74.109999999999999 111.118 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.15 -45.7 90.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.199 -0.455 . . . . 72.120000000000005 111.226 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.067 0.46 . . . . 75.530000000000001 111.019 176.206 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 6.8 tp10 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.259 0.552 . . . . 73.230000000000004 109.737 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -94.28 130.48 40.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.864 -0.607 . . . . 62.130000000000003 110.665 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.537 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.4 ptp -144.84 160.51 41.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.074 0.464 . . . . 75.409999999999997 111.823 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.67 170.31 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.133 0.492 . . . . 75.530000000000001 111.632 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.82 -48.69 80.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.237 0.458 . . . . 73.549999999999997 112.237 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -65.33 -29.7 70.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.763 0.316 . . . . 74.120000000000005 111.107 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.47 -41.77 62.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.994 0.426 . . . . 75.239999999999995 111.053 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.513 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -58.04 -45.88 86.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.047 -0.524 . . . . 73.310000000000002 111.207 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.7 ptp -62.28 -35.52 79.25 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.597 0.237 . . . . 74.349999999999994 111.549 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 14' ' ' LYS . 95.8 t -72.77 -40.46 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.07 0.462 . . . . 54.340000000000003 111.433 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 15.0 mmt85 -65.55 -41.59 92.85 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.237 -0.438 . . . . 74.200000000000003 112.051 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.1 p -93.75 -30.21 14.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.97 0.73 . . . . 75.409999999999997 112.97 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.58 -4.62 47.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.198 -0.525 . . . . 75.319999999999993 112.947 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -75.82 -179.1 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 74.519999999999996 111.861 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -132.13 168.44 22.52 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.626 -0.715 . . . . 71.239999999999995 112.26 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.1 71.21 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.673 0.62 . . . . 72.049999999999997 112.673 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 87.2 mtt180 -73.99 -18.64 60.84 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.621 0.6 . . . . 74.230000000000004 112.621 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.437 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 10.3 tt0 -84.57 -37.73 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.898 0.38 . . . . 71.409999999999997 110.701 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.1 mt -63.67 -50.37 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.601 -0.272 . . . . 72.530000000000001 111.126 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.7 pt-20 -59.8 -31.03 69.31 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.141 0.496 . . . . 75.099999999999994 110.935 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 40.8 t -61.5 -50.41 72.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.512 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.14 -23.68 66.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.946 0.35 . . . . 74.329999999999998 111.946 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.669 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 13.6 mtp180 -64.27 -9.79 19.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.797 0.666 . . . . 71.25 112.797 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 29' ' ' SER . 29.0 pt20 -70.9 -22.26 62.29 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.937 0.347 . . . . 74.030000000000001 111.937 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.69 -43.68 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 113.979 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.16 -49.08 78.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.095 0.405 . . . . 74.420000000000002 112.095 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.669 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.95 104.52 5.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.961 0.41 . . . . 73.219999999999999 110.241 175.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.79 127.26 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 72.409999999999997 110.848 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -58.49 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.961 0.41 . . . . 73.430000000000007 111.081 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.11 -50.22 3.35 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 64.230000000000004 113.038 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.1 t -81.35 -61.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.176 0.436 . . . . 73.150000000000006 112.176 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -89.36 -22.12 22.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 111.987 0.366 . . . . 72.310000000000002 111.987 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -160.09 127.34 4.5 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.708 0.29 . . . . 75.530000000000001 110.655 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -122.02 145.07 48.49 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.01 0.433 . . . . 74.340000000000003 111.749 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -73.46 103.21 4.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.03 0.443 . . . . 75.120000000000005 111.09 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.209 0.528 . . . . 74.409999999999997 111.107 -179.884 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 110.503 -0.184 . . . . 74.129999999999995 110.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t -81.12 138.12 35.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.276 0.56 . . . . 72.209999999999994 112.343 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -112.81 136.89 51.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.7 -0.682 . . . . 63.439999999999998 110.371 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -89.93 139.73 30.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.291 0.567 . . . . 73.409999999999997 112.126 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 39.3 t-20 -91.73 101.51 14.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.593 -0.731 . . . . 72.25 110.467 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 87.0 t80 -54.99 -52.13 73.65 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 112.627 0.603 . . . . 70.109999999999999 112.627 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' ' OD1' ' A' ' 59' ' ' ASN . 80.9 Cg_exo -48.51 -49.41 14.63 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.256 1.971 . . . . 72.209999999999994 113.376 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -62.72 -41.53 99.2 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.147 0.425 . . . . 71.239999999999995 112.147 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.24 -49.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.961 0.41 . . . . 72.219999999999999 111.586 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -57.12 -38.32 73.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 64.109999999999999 110.927 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -51.33 70.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.193 -0.458 . . . . 75.549999999999997 110.091 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -55.56 -48.78 74.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.011 -0.541 . . . . 74.010000000000005 111.563 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 111.338 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.834 0.349 . . . . 63.409999999999997 111.335 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -96.12 132.83 41.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.009 0.433 . . . . 74.239999999999995 111.647 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.39 154.45 40.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.439 -0.346 . . . . 71.310000000000002 111.072 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.25 171.33 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.429 -0.351 . . . . 72.319999999999993 111.69 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -51.64 -57.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.211 0.448 . . . . 71.329999999999998 112.211 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.2 tmmt? -53.02 -48.45 67.55 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.295 -0.412 . . . . 61.229999999999997 111.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.22 97.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.015 0.436 . . . . 73.099999999999994 111.558 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.489 HD21 HD13 ' A' ' 63' ' ' ILE . 3.2 tm? -59.65 -51.86 68.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.068 -0.515 . . . . 74.319999999999993 111.496 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -59.5 -39.45 83.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.688 0.28 . . . . 72.540000000000006 111.726 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.38 -42.68 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.829 0.347 . . . . 74.150000000000006 111.375 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -65.55 -35.33 80.55 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.391 0.515 . . . . 74.040000000000006 112.391 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.1 p -93.48 -30.24 15.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.508 0.559 . . . . 73.510000000000005 112.508 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.22 11.29 45.95 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.122 -0.561 . . . . 72.25 112.714 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.3 mp -93.39 173.14 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.137 0.494 . . . . 71.329999999999998 111.172 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.28 162.28 22.01 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.247 -0.502 . . . . 74.540000000000006 112.313 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.25 61.94 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.004 0.372 . . . . 51.43 112.004 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -60.6 -28.64 68.67 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.18 0.437 . . . . 74.019999999999996 112.18 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 9.3 tt0 -84.94 -45.16 12.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.102 0.477 . . . . 75.349999999999994 110.855 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.8 mt -64.14 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.99 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.71 -34.36 69.38 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.857 0.317 . . . . 60.240000000000002 111.857 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 t -64.39 -42.07 96.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.09 0.471 . . . . 74.530000000000001 111.121 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 29.0 m-85 -64.74 -33.5 76.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 75.319999999999993 111.119 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 27.9 mtm180 -62.62 -25.8 68.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.641 0.258 . . . . 70.129999999999995 111.312 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.66 -36.52 80.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.617 0.599 . . . . 74.329999999999998 112.617 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.25 35.89 0.29 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.317 -0.944 . . . . 74.219999999999999 114.506 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.25 -16.85 1.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.103 0.477 . . . . 53.530000000000001 111.917 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.03 111.91 20.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.219 0.533 . . . . 74.209999999999994 112.122 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.89 129.67 64.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.023 -0.535 . . . . 72.450000000000003 110.376 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.18 137.69 53.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.144 0.497 . . . . 73.310000000000002 110.669 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.39 2.93 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.329 -0.462 . . . . 74.519999999999996 112.372 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.25 -64.5 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.094 0.405 . . . . 72.040000000000006 112.094 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -94.24 -37.72 11.39 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.363 0.505 . . . . 73.319999999999993 112.363 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 25.6 p90 -141.74 175.7 9.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 71.209999999999994 111.121 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -144.79 133.05 21.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.897 0.379 . . . . 73.310000000000002 110.98 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -80.75 102.69 10.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.496 0.665 . . . . 74.299999999999997 110.404 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.063 -0.971 . . . . 74.420000000000002 112.175 -174.419 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.823 0.344 . . . . 74.329999999999998 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.2 m -86.15 115.75 23.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.01 0.744 . . . . 75.310000000000002 113.01 -172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -105.19 140.48 38.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.695 -0.684 . . . . 74.129999999999995 110.111 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.42 144.82 32.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.326 0.491 . . . . 70.430000000000007 112.326 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.09 111.78 18.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.379 -0.373 . . . . 70.510000000000005 110.983 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 87.7 t80 -54.85 -53.39 61.38 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 112.342 0.497 . . . . 72.319999999999993 112.342 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 55.6 Cg_endo -67.16 -20.19 50.1 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.154 1.903 . . . . 63.219999999999999 113.786 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -83.29 -38.04 22.66 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.11 -0.369 . . . . 71.109999999999999 111.515 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 HD13 HD21 ' A' ' 16' ' ' LEU . 58.9 mt -70.6 -42.98 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.663 0.268 . . . . 73.430000000000007 110.442 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.25 -38.2 70.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.844 0.354 . . . . 74.150000000000006 111.03 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.44 -49.61 77.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 73.150000000000006 110.798 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -58.81 -41.87 87.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.065 0.459 . . . . 71.329999999999998 111.199 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.7 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 116.276 -0.42 . . . . 64.230000000000004 111.232 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.9 mm-40 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 72.239999999999995 111.59 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -88.62 136.69 32.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.687 0.28 . . . . 75.409999999999997 111.014 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 ptp -157.92 153.55 26.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.949 0.404 . . . . 73.540000000000006 111.814 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.67 174.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.278 -0.419 . . . . 72.040000000000006 111.491 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' HG3' HG21 ' A' ' 27' ' ' ILE . 35.7 tt0 -59.37 -50.66 73.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.42 . . . . 75.129999999999995 112.133 -175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 1.2 tmmt? -61.05 -38.13 85.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.922 0.391 . . . . 74.129999999999995 110.968 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.04 75.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.147 0.499 . . . . 74.25 111.012 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.97 -47.77 83.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.869 -0.605 . . . . 74.420000000000002 111.168 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 23.6 ptp -60.15 -34.99 74.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.82 0.343 . . . . 74.219999999999999 111.311 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 14' ' ' LYS . 59.6 t -76.95 -27.1 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.744 0.307 . . . . 74.019999999999996 111.76 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.0 mmp_? -94.39 -14.69 25.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.672 0.619 . . . . 73.450000000000003 112.672 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.7 p -108.53 -29.86 8.55 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.496 0.554 . . . . 72.239999999999995 112.496 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.58 -0.14 58.06 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.122 -0.561 . . . . 72.129999999999995 112.578 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.1 178.52 7.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.29 0.567 . . . . 72.540000000000006 112.042 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.42 168.74 12.68 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.022 -0.535 . . . . 72.540000000000006 112.578 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 -45.14 91.35 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.602 -0.352 . . . . 71.409999999999997 111.872 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -65.21 -41.2 94.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.151 0.501 . . . . 74.040000000000006 111.123 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.59 -41.77 98.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.278 -0.419 . . . . 73.349999999999994 111.189 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.489 HG21 ' HG3' ' A' ' 13' ' ' GLU . 66.0 mt -62.39 -54.38 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.624 0.25 . . . . 64.040000000000006 111.659 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 11.8 pt-20 -59.65 -29.9 68.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.96 0.41 . . . . 72.519999999999996 111.284 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.3 t -63.04 -46.83 85.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.879 0.371 . . . . 71.510000000000005 111.093 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -68.69 -29.01 67.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.974 0.416 . . . . 64.25 111.029 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.514 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 51.9 mtp180 -61.26 -28.1 68.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.324 -0.398 . . . . 74.510000000000005 111.087 172.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.3 mm100 -73.08 -33.56 65.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.387 0.514 . . . . 73.209999999999994 112.387 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.82 61.19 0.3 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.169 -1.015 . . . . 54.140000000000001 114.737 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.71 -32.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.566 0.698 . . . . 63.219999999999999 110.408 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.404 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.48 130.92 41.78 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.679 -0.691 . . . . 73.510000000000005 111.581 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 70.9 mt -131.93 132.95 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.842 -0.617 . . . . 73.319999999999993 110.898 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.07 142.52 51.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.055 0.455 . . . . 73.109999999999999 111.441 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.31 -48.67 3.43 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.471 -0.395 . . . . 71.150000000000006 113.314 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.35 -60.59 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.941 0.4 . . . . 73.150000000000006 112.031 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.415 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.6 m170 -97.63 -32.19 11.9 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.282 0.475 . . . . 73.340000000000003 112.282 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 23.4 p90 -153.27 169.59 22.67 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.222 -0.299 . . . . 73.209999999999994 111.526 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.59 152.54 27.36 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.782 0.325 . . . . 73.329999999999998 110.851 174.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -78.57 131.0 36.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.237 0.542 . . . . 63.299999999999997 111.796 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 116.034 -0.53 . . . . 75.109999999999999 110.734 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.79 0.329 . . . . 64.420000000000002 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m -94.42 126.23 39.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.292 0.478 . . . . 72.299999999999997 112.292 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -114.64 139.07 49.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.24 -0.437 . . . . 74.200000000000003 110.613 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 63' ' ' ILE . 55.5 m-85 -107.94 148.51 29.57 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.973 0.415 . . . . 72.120000000000005 112.015 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.1 101.36 12.38 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.997 0.427 . . . . 71.109999999999999 111.213 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.755 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 87.0 t80 -53.54 -45.24 98.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.724 0.639 . . . . 73.030000000000001 112.724 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 11.1 Cg_endo -53.65 -47.41 27.41 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.018 1.812 . . . . 75.530000000000001 112.814 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.46 -38.77 84.95 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.253 0.464 . . . . 74.109999999999999 112.253 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 58' ' ' TYR . 64.4 mt -68.06 -43.52 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.876 0.369 . . . . 55.340000000000003 110.884 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.28 -41.25 92.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.039 0.447 . . . . 74.219999999999999 110.269 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -44.43 92.29 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.902 -0.59 . . . . 73.319999999999993 111.323 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -63.35 -46.87 84.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.214 0.531 . . . . 74.140000000000001 111.432 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.3 mt . . . . . 0 CA--C 1.538 0.5 0 CA-C-N 116.253 -0.431 . . . . 73.409999999999997 111.59 179.494 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 11.2 mm-40 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.8 0.333 . . . . 73.430000000000007 111.42 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -99.09 123.89 43.71 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.345 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 19.8 ptp -159.79 156.71 28.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.332 0.493 . . . . 71.049999999999997 112.332 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.3 m -81.58 176.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.319 -0.4 . . . . 74.540000000000006 111.174 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -56.3 -47.05 79.46 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.645 0.609 . . . . 74.099999999999994 112.645 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -39.96 92.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.837 0.351 . . . . 72.209999999999994 111.289 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -74.79 -33.57 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.086 0.47 . . . . 75.209999999999994 111.197 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.96 -47.87 67.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.759 -0.655 . . . . 74.010000000000005 111.326 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.5 ptp -56.12 -33.71 65.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.043 0.449 . . . . 74.030000000000001 111.852 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.38 -33.98 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.102 0.477 . . . . 73.439999999999998 111.457 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HG3' ' HE1' ' A' ' 11' ' ' MET . 30.9 mmm180 -86.81 -15.33 39.57 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.425 0.528 . . . . 72.150000000000006 112.425 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.509 ' HB ' HD11 ' A' ' 22' ' ' LEU . 48.6 p -108.53 -29.1 8.95 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.774 0.657 . . . . 72.120000000000005 112.774 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.98 9.7 65.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.849 -0.691 . . . . 61.229999999999997 112.636 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.0 mp -91.77 163.1 14.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.122 0.487 . . . . 62.210000000000001 111.124 176.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.39 163.2 14.18 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.209 -0.519 . . . . 64.120000000000005 111.811 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -51.2 -41.82 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.137 0.469 . . . . 44.420000000000002 111.501 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -56.6 -37.65 70.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.348 -0.387 . . . . 75.530000000000001 112.025 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -73.92 -46.49 44.05 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 73.319999999999993 111.274 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.56 -46.82 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.462 -0.335 . . . . 73.319999999999993 111.678 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 13.1 pt-20 -59.56 -37.39 78.33 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.824 0.345 . . . . 70.409999999999997 111.027 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -56.92 -39.89 75.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.187 0.518 . . . . 74.099999999999994 110.834 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -80.67 -26.41 37.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 111.61 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 37.9 mtm180 -66.85 -17.95 65.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.798 0.333 . . . . 74.329999999999998 111.139 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.47 -23.09 65.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.311 0.485 . . . . 74.230000000000004 112.311 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.84 -52.05 0.02 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.312 -0.947 . . . . 73.230000000000004 114.276 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.76 -36.92 39.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.634 0.605 . . . . 72.5 112.634 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.33 104.39 3.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.016 0.436 . . . . 65.310000000000002 110.881 176.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -95.2 138.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.183 -0.462 . . . . 72.430000000000007 110.881 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.54 134.39 56.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.068 0.461 . . . . 72.409999999999997 111.899 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -35.85 1.72 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.449 -0.405 . . . . 53.25 113.894 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.5 t -84.64 -53.23 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.333 0.494 . . . . 64.310000000000002 112.333 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.38 -15.13 14.31 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.561 0.578 . . . . 72.530000000000001 112.561 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.78 152.06 35.89 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.469 -0.145 . . . . 73.010000000000005 110.637 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.682 ' HB3' ' HZ2' ' A' ' 42' ' ' LYS . 8.0 mtpm? -125.69 141.29 52.09 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.094 0.473 . . . . 73.409999999999997 111.993 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -84.93 111.86 20.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.879 -0.601 . . . . 73.420000000000002 111.187 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.5 t . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.142 0.496 . . . . 74.150000000000006 111.934 -179.274 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.033 0.444 . . . . 74.129999999999995 111.103 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -97.8 101.16 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.807 0.337 . . . . 73.219999999999999 111.827 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -89.15 138.47 31.39 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.574 -0.285 . . . . 74.140000000000001 110.278 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.13 134.95 43.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.063 0.459 . . . . 74.129999999999995 111.794 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 63' ' ' ILE . 1.4 m-20 -76.93 94.23 3.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.941 -0.572 . . . . 63.109999999999999 111.815 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.604 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 78.6 t80 -52.37 -48.96 87.88 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.214 0.82 . . . . 72.25 113.214 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 13.1 Cg_endo -55.0 -42.15 71.98 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.985 1.79 . . . . 72.209999999999994 112.635 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 60.4 mm-40 -64.73 -41.06 96.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.019 0.438 . . . . 74.109999999999999 111.271 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.0 mt -66.54 -45.34 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.272 -0.422 . . . . 75.209999999999994 111.301 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -58.09 -44.05 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.214 0.53 . . . . 64.019999999999996 110.552 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -54.69 -38.66 67.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.793 -0.64 . . . . 75.010000000000005 111.205 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -71.62 -43.63 65.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 111.024 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 63' ' ' ILE . 77.7 mt . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.394 -0.366 . . . . 72.409999999999997 111.25 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.539 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 4.3 mp0 . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 120.89 0.376 . . . . 71.209999999999994 110.676 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -102.69 129.82 49.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.486 -0.325 . . . . 73.549999999999997 110.968 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.2 pmm? -145.92 162.55 37.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.747 0.308 . . . . 74.099999999999994 111.266 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.4 162.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.425 -0.352 . . . . 74.329999999999998 111.512 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.29 -44.92 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.284 0.476 . . . . 65.219999999999999 112.284 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.1 tmmt? -58.41 -44.54 89.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.4 -0.364 . . . . 73.439999999999998 111.263 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.21 -34.23 65.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.149 0.5 . . . . 71.200000000000003 111.336 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -49.99 75.28 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.966 -0.561 . . . . 74.430000000000007 110.871 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.02 -28.86 69.35 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.753 0.311 . . . . 74.310000000000002 111.699 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 14' ' ' LYS . 62.2 t -73.85 -38.13 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.048 0.452 . . . . 72.409999999999997 111.219 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.1 mmm180 -78.08 -24.41 47.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.986 0.365 . . . . 75.200000000000003 111.986 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.4 ' HB ' HD11 ' A' ' 22' ' ' LEU . 67.1 p -104.67 -30.21 10.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.85 0.685 . . . . 64.519999999999996 112.85 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.78 10.0 60.58 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.258 -0.496 . . . . 62.229999999999997 113.208 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD11 ' HB ' ' A' ' 20' ' ' THR . 9.2 mp -83.73 167.82 16.82 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.197 0.522 . . . . 74.329999999999998 112.147 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.54 159.34 14.55 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.214 -0.448 . . . . 74.230000000000004 112.787 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.1 -46.51 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.851 0.686 . . . . 63.329999999999998 112.851 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 20.8 ttm180 -75.59 -35.34 60.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.796 0.331 . . . . 75.25 111.469 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -61.92 -40.78 96.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.156 0.503 . . . . 75.409999999999997 110.562 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.56 -48.7 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.075 -0.512 . . . . 75.540000000000006 111.593 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.548 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 14.2 pt-20 -63.9 -23.19 67.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.186 -0.321 . . . . 60.229999999999997 111.324 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -67.08 -49.23 65.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.089 0.471 . . . . 72.099999999999994 110.322 172.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.161 0.505 . . . . 74.25 111.092 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.9 mtp180 -61.94 -13.4 24.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.822 -0.627 . . . . 74.299999999999997 111.824 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.53 12.27 37.67 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 111.747 0.277 . . . . 73.5 111.747 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.11 -78.2 0.03 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.461 -0.876 . . . . 61.329999999999998 114.157 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.36 67.47 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.007 0.743 . . . . 73.099999999999994 113.007 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 112.23 7.94 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.472 0.653 . . . . 73.310000000000002 112.066 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 64.8 mt -105.83 134.5 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.457 -0.792 . . . . 75.120000000000005 110.447 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.2 133.01 53.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 74.010000000000005 111.131 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.31 -32.05 3.39 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.536 -0.364 . . . . 73.099999999999994 113.648 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 47.2 t -97.18 -41.09 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.573 0.582 . . . . 75.329999999999998 112.573 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 21.8 m170 -112.18 -5.43 14.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.184 0.438 . . . . 73.430000000000007 112.184 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -170.94 164.59 7.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.606 0.225 . . . . 75.349999999999994 111.606 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -149.47 161.81 41.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.951 0.405 . . . . 75.510000000000005 111.128 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mmm-85 -87.62 118.32 27.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.311 -0.404 . . . . 75.319999999999993 111.463 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.7 t . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 120.768 0.318 . . . . 75.510000000000005 111.158 177.336 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.135 0.493 . . . . 73.5 111.702 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.8 m -83.59 105.43 14.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 111.908 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -89.35 152.69 21.38 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.485 -0.325 . . . . 71.430000000000007 110.462 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -113.4 149.62 33.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.993 0.738 . . . . 74.040000000000006 112.993 -171.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.411 ' O ' HG13 ' A' ' 63' ' ' ILE . 16.3 m120 -77.16 93.66 3.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.696 -0.684 . . . . 75.319999999999993 111.73 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.2 t80 -55.25 -47.03 99.51 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.431 0.53 . . . . 74.230000000000004 112.431 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 7.7 Cg_endo -49.07 -48.57 17.87 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.382 2.055 . . . . 74.319999999999993 113.212 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 29.0 mm-40 -74.22 -34.67 63.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.583 0.586 . . . . 64.530000000000001 112.583 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 59' ' ' ASN . 77.8 mt -67.37 -43.05 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.147 0.499 . . . . 64.230000000000004 110.54 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.78 -41.85 99.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.022 -0.536 . . . . 71.239999999999995 110.358 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -46.81 77.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.793 -0.639 . . . . 71.319999999999993 111.097 174.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.98 -51.84 68.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.056 -0.52 . . . . 73.430000000000007 111.272 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 116.294 -0.412 . . . . 74.310000000000002 111.624 179.299 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.7 mt-10 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.745 0.307 . . . . 55.200000000000003 110.637 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 68.2 m95 -102.26 114.38 28.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.506 -0.315 . . . . 72.120000000000005 110.909 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ptp -135.58 153.13 51.77 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.07 0.396 . . . . 75.319999999999993 112.07 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -80.58 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.321 0.489 . . . . 74.219999999999999 112.321 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -50.32 -57.25 8.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.95 0.722 . . . . 74.329999999999998 112.95 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 1.4 tmmt? -56.34 -40.67 74.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.230000000000004 111.873 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -38.45 68.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 72.340000000000003 111.161 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.44 HD11 ' HG1' ' A' ' 20' ' ' THR . 2.8 tm? -62.78 -46.56 87.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.78 -0.645 . . . . 61.340000000000003 111.512 -176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.508 ' HE1' ' HA ' ' A' ' 14' ' ' LYS . 24.5 ptp -56.99 -36.23 70.12 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.982 0.42 . . . . 71.430000000000007 111.533 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 t -76.01 -40.56 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.123 0.487 . . . . 70.530000000000001 111.273 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.0 mmp_? -74.29 -21.4 59.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.681 0.623 . . . . 72.209999999999994 112.681 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HG1' HD11 ' A' ' 16' ' ' LEU . 70.5 p -108.38 -30.68 8.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.72 0.637 . . . . 73.519999999999996 112.72 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.23 1.12 56.94 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.146 -0.549 . . . . 39.109999999999999 112.858 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.39 172.09 14.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.981 0.42 . . . . 73.530000000000001 111.479 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.0 161.06 12.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.335 -0.46 . . . . 44.43 112.267 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.24 62.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.01 0.374 . . . . 61.439999999999998 112.01 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -63.85 -24.87 67.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.915 0.388 . . . . 73.510000000000005 111.694 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 45.9 tt0 -84.11 -41.2 17.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.905 0.383 . . . . 75.010000000000005 110.763 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.64 -52.32 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.929 0.395 . . . . 74.329999999999998 111.405 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.01 -32.16 67.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.305 -0.407 . . . . 71.439999999999998 111.583 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.07 -43.76 98.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.008 0.432 . . . . 72.329999999999998 110.716 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.463 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 24.9 m-85 -70.9 -27.68 63.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.768 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.7 mtm180 -66.69 -10.3 45.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.798 0.332 . . . . 75.299999999999997 111.868 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -85.34 -9.59 57.42 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.077 0.399 . . . . 74.349999999999994 112.077 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.88 -48.04 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.255 -0.974 . . . . 70.0 114.497 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.409 0.522 . . . . 74.420000000000002 112.409 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 145.8 48.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 111.108 177.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.468 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 78.6 mt -139.45 132.24 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 111.272 -173.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.37 134.06 53.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.1 0.476 . . . . 72.109999999999999 111.926 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.44 -55.42 4.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.464 -0.398 . . . . 51.329999999999998 113.306 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -70.08 -62.94 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.073 0.397 . . . . 72.030000000000001 112.073 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.468 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.7 m80 -95.15 -8.03 37.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.667 0.618 . . . . 74.319999999999993 112.667 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -164.61 155.78 15.18 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.694 0.283 . . . . 74.25 111.493 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -123.53 157.33 33.85 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -104.61 116.18 31.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 111.453 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.992 0.425 . . . . 74.340000000000003 111.615 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 120.717 0.294 . . . . 74.310000000000002 111.045 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -102.41 115.01 29.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.989 0.423 . . . . 73.310000000000002 111.556 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 64.5 m95 -98.7 130.27 45.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.271 -0.422 . . . . 74.340000000000003 110.95 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 5.6 m-85 -88.29 145.01 26.08 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.963 0.411 . . . . 75.420000000000002 111.859 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t-20 -84.44 98.85 10.31 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.048 -0.523 . . . . 55.399999999999999 110.713 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 76.7 t80 -55.37 -51.61 78.43 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 112.596 0.591 . . . . 75.109999999999999 112.596 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 85.5 Cg_exo -48.45 -42.91 34.13 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.372 2.048 . . . . 72.420000000000002 113.437 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.97 -40.28 87.43 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.957 0.408 . . . . 75.219999999999999 111.517 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 58' ' ' TYR . 74.4 mt -65.99 -32.98 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 110.768 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -60.47 -43.45 96.91 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.345 0.593 . . . . 72.030000000000001 110.306 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.8 -25.88 67.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.973 -0.558 . . . . 63.0 111.385 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.98 -52.86 15.04 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 72.099999999999994 110.622 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.472 0.644 0 CA-C-N 116.12 -0.491 . . . . 72.349999999999994 111.147 177.559 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.027 0.441 . . . . 75.510000000000005 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -78.87 123.54 27.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 110.139 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.524 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.2 ptp -151.8 165.53 34.19 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.762 0.653 . . . . 65.340000000000003 112.762 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -82.77 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.088 -0.505 . . . . 75.510000000000005 110.964 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 27.2 tt0 -65.69 -39.22 91.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.839 0.311 . . . . 72.219999999999999 111.839 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' O ' HG21 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -56.54 -45.67 81.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.132 0.492 . . . . 74.519999999999996 110.497 178.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -68.52 -42.21 78.85 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.191 0.519 . . . . 72.530000000000001 111.069 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.28 -47.28 78.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.931 -0.577 . . . . 74.519999999999996 111.36 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 22.8 ptp -64.61 -29.33 70.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.829 0.347 . . . . 63.200000000000003 111.483 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 14' ' ' LYS . 75.6 t -73.54 -40.43 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.015 0.436 . . . . 72.420000000000002 111.494 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.2 mmt85 -71.65 -39.74 70.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.098 0.475 . . . . 73.430000000000007 112.109 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 22' ' ' LEU . 66.6 p -92.98 -30.53 15.29 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.585 0.587 . . . . 74.439999999999998 112.585 -173.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.64 -0.69 70.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.927 -0.654 . . . . 74.310000000000002 112.867 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 20' ' ' THR . 10.6 mp -73.5 156.56 38.06 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.013 0.435 . . . . 74.140000000000001 111.365 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 162.4 16.58 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.299 -0.477 . . . . 72.219999999999999 112.336 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -41.37 82.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.845 0.355 . . . . 64.200000000000003 111.363 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.87 -31.7 65.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.139 0.495 . . . . 75.430000000000007 111.483 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -83.81 -43.25 15.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.102 -0.499 . . . . 74.420000000000002 110.819 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.92 -46.73 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.213 -0.449 . . . . 73.349999999999994 111.667 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.28 -34.11 71.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.911 0.386 . . . . 64.120000000000005 111.298 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -66.67 -33.97 76.82 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.107 0.479 . . . . 74.340000000000003 110.809 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -76.79 -33.82 58.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.077 -0.511 . . . . 75.530000000000001 112.036 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.614 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 20.7 mtt180 -56.06 -34.78 66.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.269 0.557 . . . . 75.5 111.818 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -77.97 0.02 25.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.082 0.771 . . . . 74.25 113.082 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.7 -56.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.525 -0.845 . . . . 70.310000000000002 113.791 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.06 -37.69 78.66 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.81 0.67 . . . . 61.229999999999997 112.81 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.614 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.11 108.83 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.971 0.415 . . . . 75.430000000000007 111.469 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -108.38 123.42 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 110.706 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.02 152.0 44.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.82 0.343 . . . . 71.439999999999998 111.302 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -38.44 1.8 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.109 -0.567 . . . . 75.340000000000003 112.982 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 40.7 t -89.48 -65.91 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 111.87 0.322 . . . . 75.430000000000007 111.87 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.423 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 5.4 m-70 -98.29 -14.63 20.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.094 0.776 . . . . 74.120000000000005 113.094 -174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 34.4 p90 -159.64 171.89 18.78 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.075 -0.39 . . . . 70.230000000000004 111.797 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -150.49 143.97 25.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.343 0.592 . . . . 75.340000000000003 111.556 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.8 139.48 30.41 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 111.569 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.102 0.477 . . . . 74.540000000000006 112.208 -178.424 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.157 0.503 . . . . 73.439999999999998 112.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 m -91.94 118.48 30.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.278 -0.419 . . . . 73.430000000000007 111.136 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -94.27 144.56 25.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.804 0.335 . . . . 74.109999999999999 111.18 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 63' ' ' ILE . 68.5 m-85 -112.13 142.07 45.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.072 0.463 . . . . 75.319999999999993 111.882 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.05 97.85 8.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.701 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.511 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 41.0 t80 -49.91 -50.9 65.58 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 112.788 0.662 . . . . 73.310000000000002 112.788 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 71.3 Cg_exo -51.46 -46.18 33.09 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.244 1.962 . . . . 73.530000000000001 112.948 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 58.4 mm-40 -64.25 -41.18 97.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.091 0.404 . . . . 72.129999999999995 112.091 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -67.93 -45.35 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.606 -0.27 . . . . 64.439999999999998 111.203 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.14 -35.32 75.02 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.287 0.565 . . . . 75.349999999999994 110.576 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.56 -33.65 76.4 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.796 -0.638 . . . . 73.530000000000001 111.277 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.07 -44.13 20.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.345 -0.388 . . . . 73.430000000000007 111.994 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 63' ' ' ILE . 75.5 mt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.235 0.457 . . . . 74.299999999999997 112.235 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 74.150000000000006 111.703 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -94.12 121.85 36.04 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.881 -0.414 . . . . 71.049999999999997 109.881 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.743 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 19.9 ptp -138.9 147.16 41.98 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.31 0.485 . . . . 74.510000000000005 112.31 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.34 165.43 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.943 0.401 . . . . 75.510000000000005 111.972 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.97 -42.73 80.69 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.239 -0.437 . . . . 73.230000000000004 111.724 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.1 tmmt? -59.15 -42.11 89.91 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.214 -0.448 . . . . 74.409999999999997 111.262 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.1 -37.55 66.69 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.191 0.519 . . . . 74.129999999999995 111.279 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 HD12 ' HG1' ' A' ' 20' ' ' THR . 3.2 tm? -63.27 -47.02 84.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.84 -0.618 . . . . 74.409999999999997 111.616 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.9 ptp -59.34 -32.27 69.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.927 0.394 . . . . 64.299999999999997 111.405 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 14' ' ' LYS . 58.5 t -72.71 -32.67 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.073 0.463 . . . . 74.430000000000007 111.267 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.743 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.5 mmt85 -76.55 -43.22 40.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.463 0.542 . . . . 74.439999999999998 112.463 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.47 ' HG1' HD12 ' A' ' 16' ' ' LEU . 69.9 p -93.33 -27.09 16.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.981 0.734 . . . . 73.310000000000002 112.981 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.11 64.58 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.946 -0.645 . . . . 72.519999999999996 113.206 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mp -79.66 166.91 21.35 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.084 0.468 . . . . 72.420000000000002 111.514 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.92 164.18 14.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.212 -0.449 . . . . 63.240000000000002 112.421 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.48 -42.23 70.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.012 0.375 . . . . 74.329999999999998 112.012 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -62.47 -33.69 75.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.057 0.456 . . . . 72.230000000000004 111.231 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.42 -48.25 42.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.425 -0.352 . . . . 70.400000000000006 111.419 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.2 mt -57.14 -50.84 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.86 0.362 . . . . 71.340000000000003 111.313 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.764 0.316 . . . . 64.409999999999997 111.469 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.2 t -63.33 -39.21 93.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.943 0.402 . . . . 74.010000000000005 111.164 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.65 -16.74 55.22 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.976 0.417 . . . . 73.120000000000005 111.51 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.667 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 58.8 mtp180 -68.88 -10.93 59.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.781 0.324 . . . . 75.120000000000005 111.815 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -83.02 2.69 33.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 111.764 0.283 . . . . 62.109999999999999 111.764 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.01 -61.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.66 -0.781 . . . . 71.329999999999998 114.115 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.21 95.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.957 0.725 . . . . 63.130000000000003 112.957 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -71.71 104.43 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.038 -0.414 . . . . 74.409999999999997 111.073 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.89 121.5 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.509 -0.314 . . . . 75.209999999999994 111.23 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -59.86 131.63 51.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.34 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.501 ' HA2' ' HZ2' ' A' ' 42' ' ' LYS . . . 92.12 -31.85 5.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.541 -0.361 . . . . 71.400000000000006 113.201 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.88 -72.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.654 -0.321 . . . . 74.040000000000006 111.391 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -77.42 -7.57 56.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.958 0.355 . . . . 75.409999999999997 111.958 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 33.3 p90 -171.84 167.56 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.617 0.367 . . . . 72.430000000000007 110.773 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.501 ' HZ2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -154.02 136.54 15.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.493 0.663 . . . . 71.319999999999993 111.568 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 61.6 mtp180 -80.62 102.56 9.9 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.264 -0.88 . . . . 73.109999999999999 110.258 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 115.796 -0.638 . . . . 74.510000000000005 112.523 -173.808 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 110.237 -0.283 . . . . 73.340000000000003 110.237 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -84.5 110.32 18.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.383 0.512 . . . . 65.409999999999997 112.383 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -98.59 126.87 44.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.114 -0.494 . . . . 74.439999999999998 110.272 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.415 ' HB3' HD12 ' A' ' 63' ' ' ILE . 84.5 m-85 -93.33 144.75 25.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.919 0.341 . . . . 71.010000000000005 111.919 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 62' ' ' GLU . 59.1 t30 -82.64 94.47 7.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 73.150000000000006 111.049 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.508 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 70.7 t80 -51.38 -53.31 50.9 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 113.299 0.852 . . . . 74.109999999999999 113.299 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -49.66 -36.86 42.47 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.274 1.982 . . . . 74.129999999999995 113.219 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 22.2 mt-10 -81.43 -29.5 33.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.754 0.65 . . . . 73.420000000000002 112.754 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 67' ' ' ILE . 64.7 mt -70.46 -38.78 75.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.956 -0.465 . . . . 73.540000000000006 110.706 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -62.42 -39.08 92.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.191 0.519 . . . . 74.230000000000004 110.495 169.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 59.9 tttp -56.78 -37.16 70.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.883 -0.598 . . . . 70.239999999999995 110.877 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -72.17 -41.25 67.26 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.869 0.366 . . . . 72.230000000000004 111.031 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 63' ' ' ILE . 67.8 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 116.481 -0.327 . . . . 74.409999999999997 111.267 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 60' ' ' TYR . 9.2 tp10 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 110.027 -0.36 . . . . 75.5 110.027 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -119.83 143.2 48.01 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.272 -0.268 . . . . 75.219999999999999 111.093 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.621 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.8 ptp -164.7 171.88 13.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.657 0.614 . . . . 73.019999999999996 112.657 -176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.87 -179.99 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.977 -0.556 . . . . 73.530000000000001 111.335 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.88 -58.08 9.71 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.532 0.568 . . . . 52.43 112.532 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 1.4 tmmt? -61.92 -29.13 70.02 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.49 -0.323 . . . . 63.439999999999998 111.619 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.67 -37.02 42.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.238 0.542 . . . . 72.420000000000002 111.158 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.621 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.5 -49.92 74.82 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.78 -0.646 . . . . 72.310000000000002 111.019 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.539 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 24.0 ptp -55.95 -36.03 67.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.025 0.379 . . . . 74.109999999999999 112.025 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.1 t -65.75 -43.46 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.194 0.442 . . . . 75.439999999999998 112.194 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' HD2' ' HE1' ' A' ' 11' ' ' MET . 86.4 mtt180 -85.23 -18.63 33.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.096 0.406 . . . . 74.340000000000003 112.096 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.432 ' HG1' HD12 ' A' ' 16' ' ' LEU . 77.9 p -100.58 -26.98 13.65 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.331 0.493 . . . . 63.130000000000003 112.331 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.81 24.8 29.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.091 -0.576 . . . . 73.239999999999995 113.176 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.6 mp -102.49 -178.86 3.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.211 0.529 . . . . 75.519999999999996 111.654 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.2 163.41 21.78 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.902 -0.59 . . . . 72.420000000000002 111.987 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.51 -46.1 77.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.096 0.448 . . . . 64.310000000000002 112.162 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.3 tmt_? -64.12 -34.41 77.98 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.115 0.483 . . . . 72.129999999999995 110.749 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.13 -42.4 69.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.918 0.389 . . . . 72.25 110.927 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.36 -50.48 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.357 -0.383 . . . . 74.430000000000007 111.793 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.97 -30.52 66.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.889 0.376 . . . . 75.409999999999997 111.146 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 t -62.44 -38.97 91.84 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.305 -0.407 . . . . 71.310000000000002 111.195 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -75.32 -31.11 60.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.46 -0.336 . . . . 73.430000000000007 111.67 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 21.4 mtm180 -64.88 -11.17 34.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.185 0.439 . . . . 74.510000000000005 112.185 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.23 11.01 24.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.424 -0.353 . . . . 74.140000000000001 111.926 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.53 -50.65 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.329 -0.939 . . . . 63.140000000000001 114.433 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.21 80.09 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.234 0.457 . . . . 74.129999999999995 112.234 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.07 123.49 22.94 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.907 0.384 . . . . 73.230000000000004 111.145 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.84 132.67 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.37 -0.377 . . . . 74.349999999999994 111.125 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.23 146.63 47.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.864 0.364 . . . . 70.200000000000003 111.596 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 -53.66 2.99 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.39 -0.368 . . . . 73.129999999999995 112.638 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.85 -65.8 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.413 0.523 . . . . 73.099999999999994 112.413 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -96.74 -16.96 20.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.932 0.716 . . . . 62.229999999999997 112.932 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 36.5 p90 -161.41 174.81 12.93 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.389 -0.195 . . . . 74.409999999999997 111.154 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.43 154.4 26.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.084 0.469 . . . . 72.510000000000005 112.099 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -79.43 122.9 26.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 112.173 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.204 0.526 . . . . 75.349999999999994 110.872 174.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.94 0.4 . . . . 72.510000000000005 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -96.76 105.52 17.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.254 0.464 . . . . 73.239999999999995 112.254 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -86.0 152.03 23.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.328 -0.396 . . . . 74.200000000000003 110.905 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' A' ' 63' ' ' ILE . 41.3 m-85 -117.14 146.24 43.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.121 0.486 . . . . 75.019999999999996 111.829 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.54 108.78 19.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.986 -0.552 . . . . 63.439999999999998 110.915 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 81.9 t80 -56.79 -48.73 96.79 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.931 0.715 . . . . 65.420000000000002 112.931 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 18.0 Cg_endo -58.33 -33.45 97.74 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.9 1.733 . . . . 64.140000000000001 112.681 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -69.54 -48.2 61.18 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 111.12 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.504 HD12 ' HB3' ' A' ' 58' ' ' TYR . 69.7 mt -65.71 -36.86 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.023 0.44 . . . . 75.319999999999993 111.152 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.66 -37.06 82.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.193 -0.458 . . . . 65.010000000000005 110.585 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.6 -38.65 85.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.094 -0.503 . . . . 75.420000000000002 110.936 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -66.45 -53.53 34.36 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.008 -0.542 . . . . 74.150000000000006 111.062 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 120.884 0.373 . . . . 74.329999999999998 111.451 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.954 0.407 . . . . 75.319999999999993 111.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 95.7 m95 -85.68 136.45 33.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.472 173.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.0 ptp -153.89 154.86 34.64 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.978 0.418 . . . . 75.329999999999998 111.73 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.29 166.27 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.889 0.376 . . . . 73.140000000000001 111.415 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.86 -44.01 86.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.016 0.436 . . . . 75.230000000000004 111.986 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.2 tmmt? -63.71 -32.94 74.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.293 -0.412 . . . . 71.329999999999998 111.527 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.21 -35.94 47.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.041 0.448 . . . . 73.219999999999999 111.149 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.32 -46.21 87.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.838 -0.619 . . . . 74.299999999999997 111.003 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.475 ' HB3' HD13 ' A' ' 27' ' ' ILE . 23.2 ptp -59.87 -34.29 72.95 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.723 0.296 . . . . 72.230000000000004 111.488 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 14' ' ' LYS . 66.9 t -69.18 -40.29 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.881 0.372 . . . . 74.319999999999993 111.209 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.566 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 12.2 mmt85 -66.15 -44.66 83.48 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.996 0.427 . . . . 75.030000000000001 112.099 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 p -93.79 -25.15 17.51 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.034 0.753 . . . . 71.310000000000002 113.034 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.23 64.51 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.211 -0.518 . . . . 74.200000000000003 113.186 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 ' HG ' ' NE2' ' A' ' 26' ' ' GLN . 9.0 mp -74.66 173.41 10.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.367 0.603 . . . . 72.030000000000001 112.167 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.85 170.35 17.73 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.086 -0.506 . . . . 64.209999999999994 112.317 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.8 66.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.212 0.449 . . . . 73.230000000000004 112.212 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -64.82 -29.43 70.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.865 0.365 . . . . 72.530000000000001 111.961 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 47.9 tt0 -76.97 -42.67 38.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.839 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 63.0 mt -63.72 -49.03 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.584 -0.28 . . . . 75.109999999999999 111.683 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.25 -35.03 59.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.771 0.319 . . . . 75.129999999999995 111.38 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 t -63.06 -50.7 69.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 72.109999999999999 110.69 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.72 -35.63 74.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.027 -0.533 . . . . 73.540000000000006 111.412 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 50.1 mtp180 -62.13 -19.98 63.6 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 74.200000000000003 111.44 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.97 -8.54 14.83 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.392 -0.367 . . . . 73.400000000000006 111.989 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.6 41.62 0.97 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.81 -0.71 . . . . 75.409999999999997 114.109 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.33 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.293 0.568 . . . . 71.5 111.377 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.39 141.91 48.71 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.458 0.646 . . . . 72.430000000000007 112.14 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.3 mt -138.65 135.13 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.573 -0.74 . . . . 72.540000000000006 110.236 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.47 130.62 45.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.094 0.473 . . . . 73.150000000000006 112.062 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.67 -26.68 1.64 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.352 -0.385 . . . . 63.399999999999999 113.946 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.2 t -94.91 -40.35 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.292 -0.534 . . . . 74.329999999999998 112.238 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.466 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 48.5 m80 -121.52 -9.72 8.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.425 0.528 . . . . 72.0 112.425 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -165.04 159.25 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.866 0.365 . . . . 75.420000000000002 111.831 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 55.8 pttt -153.82 153.35 31.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.029 0.443 . . . . 65.099999999999994 111.422 174.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.39 141.57 45.09 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.93 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 120.797 0.332 . . . . 75.420000000000002 111.083 177.637 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.35 0.119 . . . . 74.310000000000002 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.1 m -102.93 121.75 43.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.188 0.44 . . . . 73.430000000000007 112.188 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -107.85 146.53 32.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.604 176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 63' ' ' ILE . 23.2 m-85 -106.85 154.06 21.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.791 0.663 . . . . 75.010000000000005 112.791 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.64 101.67 12.34 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.651 -0.704 . . . . 72.400000000000006 111.925 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 80.3 t80 -51.61 -50.85 74.77 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 112.762 0.653 . . . . 74.25 112.762 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.2 Cg_endo -56.13 -53.53 5.28 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.159 1.906 . . . . 74.420000000000002 113.273 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -64.81 -23.62 67.3 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.594 0.59 . . . . 61.130000000000003 112.594 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 58' ' ' TYR . 75.9 mt -82.09 -46.32 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.052 -0.405 . . . . 74.420000000000002 111.379 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.17 -40.95 82.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.512 0.673 . . . . 74.040000000000006 109.973 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -52.81 -48.71 66.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.152 -0.931 . . . . 64.340000000000003 111.39 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.77 -37.77 79.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.457 -0.338 . . . . 73.209999999999994 111.147 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.863 0.364 . . . . 74.409999999999997 111.0 176.054 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HB3' ' HE3' ' A' ' 11' ' ' MET . 7.5 mp0 . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.874 0.368 . . . . 63.439999999999998 111.635 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 82.2 m95 -98.64 118.77 36.1 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.562 -0.29 . . . . 74.099999999999994 110.845 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.1 pmm? -133.26 172.37 12.77 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.533 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.53 162.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.096 -0.502 . . . . 65.030000000000001 111.375 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.54 -42.5 83.03 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.179 0.437 . . . . 73.219999999999999 112.179 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -59.55 -37.87 79.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.994 0.426 . . . . 73.329999999999998 110.968 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.6 45.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.97 0.414 . . . . 72.25 111.328 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -50.61 73.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.603 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.406 ' HB3' HD12 ' A' ' 27' ' ' ILE . 23.6 ptp -58.39 -37.06 74.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.756 0.312 . . . . 72.439999999999998 111.803 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.5 t -69.64 -48.22 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 111.829 0.307 . . . . 75.030000000000001 111.829 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.04 -28.88 66.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.286 0.476 . . . . 73.400000000000006 112.286 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -93.88 -29.25 15.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.489 0.552 . . . . 64.329999999999998 112.489 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.86 56.59 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 52.030000000000001 112.564 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.506 ' HG ' ' HG2' ' A' ' 26' ' ' GLN . 8.3 mp -82.2 -178.17 6.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.399 0.619 . . . . 75.25 111.627 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -133.27 171.09 21.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.981 -0.554 . . . . 64.129999999999995 111.909 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.83 -51.39 66.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.283 0.475 . . . . 73.439999999999998 112.283 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -66.46 -30.01 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.159 0.504 . . . . 73.230000000000004 111.504 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 5.2 tp-100 -66.98 -48.46 68.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.066 0.46 . . . . 75.219999999999999 110.918 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.496 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 64.5 mt -60.79 -52.09 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.343 -0.39 . . . . 71.420000000000002 111.296 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.2 -33.6 69.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.507 0.194 . . . . 74.239999999999995 111.409 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -61.23 -37.51 83.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.929 0.395 . . . . 74.150000000000006 110.981 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -80.26 -30.07 38.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.894 0.378 . . . . 70.450000000000003 111.808 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 67.8 mtp180 -64.13 -15.56 59.99 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.925 0.393 . . . . 75.310000000000002 111.854 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -68.08 -22.65 64.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.537 -0.301 . . . . 74.010000000000005 111.8 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.48 -45.07 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 120.661 -0.781 . . . . 63.32 114.342 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.75 -31.4 71.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.012 0.745 . . . . 73.0 113.012 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.18 104.69 3.72 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.455 0.645 . . . . 75.129999999999995 111.829 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.92 123.58 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.565 -0.743 . . . . 74.219999999999999 111.279 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.22 147.19 48.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.112 0.482 . . . . 72.0 111.395 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.53 -58.92 3.75 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.121 -0.49 . . . . 61.329999999999998 113.164 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.81 -56.11 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.439 0.533 . . . . 73.109999999999999 112.439 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 52.9 m80 -92.24 -23.54 19.3 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.501 0.556 . . . . 75.019999999999996 112.501 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 15.4 p90 -163.68 149.58 11.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.536 -0.172 . . . . 65.120000000000005 110.536 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -147.76 147.57 30.02 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.092 0.472 . . . . 74.129999999999995 112.264 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -79.7 117.87 21.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.853 -0.612 . . . . 74.150000000000006 111.775 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 120.774 0.321 . . . . 73.430000000000007 111.051 176.321 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.859 0.361 . . . . 73.140000000000001 111.543 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -91.96 114.88 27.54 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.709 0.29 . . . . 74.25 111.418 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -100.3 144.3 29.47 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.734 -0.212 . . . . 74.409999999999997 110.856 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 94.0 m-85 -110.27 144.46 38.94 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.254 0.549 . . . . 75.530000000000001 112.135 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 40.6 t-20 -87.86 92.07 8.99 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.801 -0.636 . . . . 74.230000000000004 110.943 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.568 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 66.0 t80 -46.98 -53.04 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.972 0.73 . . . . 73.400000000000006 112.972 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -52.29 -39.19 73.06 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.171 1.914 . . . . 71.349999999999994 113.399 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 52.9 mm-40 -72.03 -34.12 68.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.3 0.481 . . . . 74.510000000000005 112.3 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.54 -49.94 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 75.319999999999993 110.464 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -54.1 -46.83 72.21 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.151 0.501 . . . . 63.200000000000003 110.662 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.87 -46.13 67.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.661 . . . . 65.439999999999998 111.536 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -57.2 -50.6 72.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 111.478 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.861 0.363 . . . . 74.010000000000005 111.586 177.179 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.182 0.515 . . . . 73.299999999999997 112.355 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 76.3 m95 -94.49 149.44 21.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.778 -0.646 . . . . 65.120000000000005 110.606 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.6 ptp -159.05 151.58 21.59 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.032 0.444 . . . . 75.340000000000003 111.778 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.33 167.71 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.155 0.428 . . . . 73.439999999999998 112.155 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.21 -54.5 46.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.461 0.541 . . . . 74.409999999999997 112.461 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -35.48 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.424 -0.353 . . . . 71.450000000000003 111.551 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.81 60.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.115 0.484 . . . . 73.109999999999999 111.289 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.9 -53.59 56.53 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.812 -0.631 . . . . 44.409999999999997 111.046 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.439 ' HB3' HD13 ' A' ' 27' ' ' ILE . 23.7 ptp -54.24 -40.34 67.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.846 0.313 . . . . 70.349999999999994 111.846 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -70.4 -42.49 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.95 0.405 . . . . 74.209999999999994 112.077 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.627 0.603 . . . . 75.299999999999997 112.627 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -107.17 -28.45 9.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.929 0.395 . . . . 71.329999999999998 111.893 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.88 5.22 59.91 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.233 -0.508 . . . . 72.310000000000002 112.715 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.3 mp -82.29 160.9 22.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.197 0.522 . . . . 70.439999999999998 111.428 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.89 160.9 13.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.091 -0.576 . . . . 55.130000000000003 112.447 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.82 -41.17 61.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.938 0.369 . . . . 74.040000000000006 111.861 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 25' ' ' ARG . 8.1 ptp180 -62.56 -32.19 73.12 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.135 0.493 . . . . 73.299999999999997 111.612 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.51 -37.8 35.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.003 0.43 . . . . 73.129999999999995 111.017 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 17' ' ' MET . 59.3 mt -63.99 -49.36 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.39 -0.368 . . . . 70.439999999999998 111.095 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.75 -35.63 76.86 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.858 0.361 . . . . 74.129999999999995 110.985 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.6 t -60.75 -37.61 82.4 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 64.329999999999998 111.278 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -72.83 -37.82 67.32 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.96 0.41 . . . . 74.109999999999999 111.504 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 24.7 mtm180 -65.46 -10.41 33.88 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.228 0.455 . . . . 74.200000000000003 112.228 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -59.95 -30.95 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.759 0.281 . . . . 75.400000000000006 111.759 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.99 31.94 0.05 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.308 -0.949 . . . . 73.109999999999999 114.721 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.12 -24.86 4.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.412 0.606 . . . . 54.229999999999997 111.428 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -83.28 129.32 35.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.029 -0.532 . . . . 75.340000000000003 111.731 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.9 mt -130.87 137.27 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.697 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.69 153.17 43.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 111.157 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.26 -49.95 3.89 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.487 -0.387 . . . . 64.310000000000002 112.496 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.36 -57.49 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 74.409999999999997 112.043 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -101.67 -23.76 14.2 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.094 0.776 . . . . 74.409999999999997 113.094 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -161.92 172.48 15.95 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.315 -0.24 . . . . 62.399999999999999 111.484 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -154.74 160.66 41.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.911 0.386 . . . . 74.0 111.786 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -87.48 137.09 32.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.026 0.441 . . . . 74.510000000000005 111.443 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 120.986 0.422 . . . . 73.340000000000003 111.777 179.475 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 73.530000000000001 110.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -90.44 127.25 36.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.093 0.473 . . . . 64.129999999999995 111.952 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 29.0 m95 -104.4 132.8 50.24 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.156 -0.474 . . . . 75.209999999999994 110.657 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HB3' HD12 ' A' ' 63' ' ' ILE . 52.2 m-85 -104.36 147.01 28.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.336 -0.393 . . . . 73.450000000000003 111.88 -176.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -78.78 106.59 10.89 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.837 0.351 . . . . 63.219999999999999 111.422 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.508 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.1 t80 -53.49 -50.21 84.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 112.701 0.63 . . . . 54.409999999999997 112.701 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 21.0 Cg_endo -59.15 -42.82 47.01 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.11 1.873 . . . . 70.209999999999994 113.254 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -66.55 -40.12 88.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 111.892 0.33 . . . . 75.430000000000007 111.892 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 58' ' ' TYR . 67.5 mt -67.87 -41.8 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.707 0.289 . . . . 72.129999999999995 110.786 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -60.39 -41.26 93.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.901 0.381 . . . . 72.019999999999996 110.744 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.38 -42.59 92.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.075 0.464 . . . . 72.409999999999997 110.75 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.0 -38.13 89.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 110.984 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' ILE . 80.7 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 116.541 -0.299 . . . . 74.239999999999995 110.728 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.697 0.284 . . . . 60.43 110.982 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.8 -54.09 5.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.986 0.422 . . . . 75.409999999999997 111.03 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -165.91 135.6 3.35 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 110.829 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.7 mm -72.25 90.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.228 0.537 . . . . 73.439999999999998 111.096 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.05 139.56 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.062 -0.517 . . . . 74.219999999999999 110.742 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -109.93 143.52 39.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.94 0.4 . . . . 73.200000000000003 111.885 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.68 93.99 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.935 0.397 . . . . 71.439999999999998 110.323 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -94.24 27.75 2.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.047 0.451 . . . . 64.120000000000005 112.177 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -78.14 55.09 1.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.281 0.562 . . . . 74.140000000000001 111.459 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -89.7 128.02 36.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.753 -0.658 . . . . 74.319999999999993 109.926 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.589 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.5 ptp -148.55 149.13 31.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.881 0.372 . . . . 72.540000000000006 111.771 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.85 176.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.249 0.462 . . . . 64.129999999999995 112.249 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.34 -57.61 11.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.547 0.573 . . . . 65.040000000000006 112.547 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.7 -34.41 77.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.419 -0.355 . . . . 72.329999999999998 111.79 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.5 -42.52 74.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.131 0.491 . . . . 75.040000000000006 111.128 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 63' ' ' ILE . 3.3 tm? -60.08 -47.73 84.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.918 -0.583 . . . . 74.349999999999994 111.451 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.504 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.4 ptp -58.76 -32.58 69.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.781 0.324 . . . . 74.310000000000002 111.417 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.39 -41.7 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.1 0.476 . . . . 74.450000000000003 111.391 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.589 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 13.2 mmm180 -71.28 -31.93 68.06 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.259 -0.428 . . . . 72.299999999999997 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.406 ' HG1' HD12 ' A' ' 16' ' ' LEU . 56.2 p -95.58 -30.94 13.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.47 0.544 . . . . 73.340000000000003 112.47 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.14 55.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.398 -0.43 . . . . 72.239999999999995 113.176 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 17' ' ' MET . 8.9 mp -90.11 174.95 7.35 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.194 0.521 . . . . 71.340000000000003 112.035 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.23 161.04 13.08 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.143 -0.48 . . . . 45.5 112.443 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.13 -42.77 63.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.528 0.566 . . . . 74.400000000000006 112.528 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -62.6 -42.78 99.77 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 111.648 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.77 -36.05 77.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.006 0.431 . . . . 71.510000000000005 110.939 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.27 -43.89 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.343 -0.39 . . . . 75.340000000000003 111.404 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.25 -38.93 93.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.787 0.327 . . . . 63.409999999999997 110.489 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -60.38 -40.49 91.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 71.239999999999995 110.713 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 12.3 m-85 -66.12 -34.97 79.26 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.316 -0.402 . . . . 73.510000000000005 111.691 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 23.6 mtm180 -68.42 -21.3 64.67 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.161 0.505 . . . . 73.310000000000002 111.246 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.89 13.47 5.9 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.024 -0.535 . . . . 70.239999999999995 110.738 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.8 -81.89 0.04 OUTLIER Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.229 -0.51 . . . . 64.519999999999996 114.185 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.01 -34.52 43.94 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.145 1.165 . . . . 36.939999999999998 114.145 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.726 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -71.53 104.09 3.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.818 -0.551 . . . . 75.329999999999998 110.861 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -102.03 129.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 64.530000000000001 111.744 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -64.92 132.64 49.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.354 -0.385 . . . . 74.400000000000006 110.802 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.16 -24.86 19.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.271 -0.49 . . . . 52.229999999999997 112.929 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.23 -70.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 122.472 -0.429 . . . . 74.239999999999995 111.892 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -85.66 -12.72 50.6 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.185 0.439 . . . . 74.450000000000003 112.185 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' HE2' ' HB3' ' A' ' 35' ' ' TRP . 52.9 p90 -158.99 169.32 24.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.728 0.27 . . . . 73.549999999999997 111.728 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -141.98 172.1 13.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.782 0.325 . . . . 74.019999999999996 111.158 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -105.39 109.83 21.96 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.281 0.475 . . . . 74.200000000000003 112.281 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.73 107.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 70.420000000000002 111.647 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.627 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 53.9 m -89.36 149.81 43.43 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.128 -0.487 . . . . 70.140000000000001 111.539 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.06 26.04 0.18 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.019 2.48 . . . . 72.310000000000002 113.136 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 45' ' ' SER . 42.9 t -158.64 -179.6 8.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.355 0.662 . . . . 61.200000000000003 109.849 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.11 -21.71 34.82 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.787 -0.721 . . . . 74.140000000000001 113.437 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -92.06 179.01 5.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.656 0.741 . . . . 75.340000000000003 112.839 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.42 111.84 10.0 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.38 -0.827 . . . . 74.140000000000001 112.012 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 p -134.48 142.69 47.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.471 -0.332 . . . . 72.230000000000004 110.964 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.7 mm? -80.19 -6.42 57.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.287 0.565 . . . . 72.219999999999999 110.968 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -82.15 8.65 10.35 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.058 -0.519 . . . . 75.519999999999996 111.341 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 45' ' ' SER . . . -66.08 114.13 6.31 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.445 -0.343 . . . . 73.519999999999996 113.593 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 m -66.83 135.8 54.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.842 0.353 . . . . 71.200000000000003 111.482 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -92.69 119.95 32.61 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.067 0.46 . . . . 71.530000000000001 112.144 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -103.78 123.68 47.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 110.578 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.11 150.88 19.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 65.010000000000005 111.927 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -92.42 112.17 24.01 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 111.905 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.556 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 65.4 t80 -56.25 -50.12 89.36 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 112.498 0.555 . . . . 75.219999999999999 112.498 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 50.1 Cg_exo -55.75 -41.56 76.26 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.198 1.932 . . . . 61.25 113.02 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -62.03 -44.99 95.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.48 0.657 . . . . 74.299999999999997 111.628 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 HD13 HD21 ' A' ' 16' ' ' LEU . 87.2 mt -69.1 -47.81 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.683 -0.69 . . . . 71.510000000000005 111.776 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.3 -31.94 69.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.775 0.322 . . . . 73.200000000000003 111.365 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -42.49 91.33 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.101 0.477 . . . . 73.209999999999994 110.011 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.8 -54.99 22.45 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.424 -0.353 . . . . 74.25 111.22 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -53.39 -34.13 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 73.329999999999998 111.421 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -50.71 -31.47 16.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.844 -0.616 . . . . 74.219999999999999 111.922 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.89 -41.72 92.23 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.912 0.387 . . . . 71.040000000000006 111.479 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.562 -0.29 . . . . 73.230000000000004 111.487 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.53 -43.81 88.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.344 0.592 . . . . 74.439999999999998 110.685 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -79.97 61.19 3.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.889 -0.596 . . . . 55.409999999999997 109.927 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -48.38 106.89 0.11 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.89 -0.595 . . . . 74.219999999999999 112.497 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -133.44 131.02 39.44 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.039 0.447 . . . . 73.530000000000001 111.292 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.71 90.33 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.125 -0.489 . . . . 64.040000000000006 111.141 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -91.53 -25.03 19.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.097 -0.501 . . . . 75.200000000000003 112.124 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -107.4 117.53 34.32 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.297 -0.252 . . . . 65.430000000000007 110.91 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.3 p80 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.66 -0.686 . . . . 74.109999999999999 112.596 -178.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.06 0.457 . . . . 74.150000000000006 112.038 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.1 139.37 34.02 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.213 -0.448 . . . . 75.510000000000005 110.527 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -119.7 124.35 46.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.941 0.401 . . . . 73.010000000000005 111.484 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.684 HG23 ' HB3' ' A' ' 7' ' ' ASN . 46.7 mm -71.64 90.59 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.288 0.566 . . . . 71.150000000000006 112.024 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -97.81 92.9 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.364 -0.38 . . . . 75.420000000000002 110.839 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 54.8 25.09 6.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.21 0.529 . . . . 61.310000000000002 111.665 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 4' ' ' ILE . 4.1 t-20 -71.25 -33.64 70.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.949 -0.568 . . . . 65.450000000000003 111.486 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -78.05 87.75 4.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 111.552 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -89.45 84.95 6.43 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.932 -0.576 . . . . 74.439999999999998 110.856 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.468 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 93.7 m95 -93.57 146.09 24.06 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.074 -0.512 . . . . 71.510000000000005 111.241 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.483 ' HE3' ' HB2' ' A' ' 60' ' ' TYR . 17.7 ptp -160.73 159.62 30.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.937 0.399 . . . . 74.349999999999994 112.01 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.14 163.39 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.535 -0.302 . . . . 65.209999999999994 111.478 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -52.48 -47.19 66.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.326 0.491 . . . . 73.340000000000003 112.326 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.82 -32.05 71.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.356 -0.383 . . . . 61.399999999999999 111.31 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.61 24.83 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.034 0.445 . . . . 62.039999999999999 111.36 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.46 HD12 ' HG1' ' A' ' 20' ' ' THR . 3.2 tm? -59.28 -50.61 73.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.892 -0.594 . . . . 65.439999999999998 111.05 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.6 ptp -58.27 -35.53 71.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.081 0.467 . . . . 63.409999999999997 111.481 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.42 -31.35 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 111.941 0.348 . . . . 74.120000000000005 111.941 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.1 -31.9 20.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.38 0.511 . . . . 73.329999999999998 112.38 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.46 ' HG1' HD12 ' A' ' 16' ' ' LEU . 69.9 p -93.36 -30.65 15.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.886 0.699 . . . . 70.5 112.886 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.19 4.93 62.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.887 -0.673 . . . . 53.420000000000002 113.267 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.74 154.47 27.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.101 0.477 . . . . 75.420000000000002 111.31 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.99 165.11 25.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.053 -0.594 . . . . 55.32 112.998 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.79 -47.79 64.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.17 0.433 . . . . 74.549999999999997 112.17 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.95 -27.43 68.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 111.811 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -67.91 -56.89 7.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.197 0.522 . . . . 72.420000000000002 111.099 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.36 -50.76 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 112.112 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 pt-20 -53.63 -39.76 65.23 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.852 0.316 . . . . 64.340000000000003 111.852 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -69.81 -43.45 72.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.927 0.394 . . . . 64.430000000000007 111.249 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -67.17 -28.51 68.17 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.829 0.347 . . . . 73.340000000000003 111.432 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 49.1 mtp180 -58.77 -26.8 64.38 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.192 0.441 . . . . 74.040000000000006 112.192 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -97.14 10.69 38.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.337 0.495 . . . . 64.120000000000005 112.337 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.99 -53.89 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.438 -0.887 . . . . 74.140000000000001 114.454 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.03 -23.22 31.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.311 -0.523 . . . . 73.019999999999996 112.335 -175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.428 ' HE3' ' N ' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.92 139.79 48.9 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.35 0.595 . . . . 74.200000000000003 112.151 -177.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.52 125.98 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.695 -0.684 . . . . 74.120000000000005 110.305 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.21 135.88 56.44 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.0 0.429 . . . . 75.099999999999994 111.701 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -55.84 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.32 -0.4 . . . . 72.299999999999997 113.358 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.99 -46.37 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.533 0.568 . . . . 75.540000000000006 112.533 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -110.71 -18.69 13.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.715 0.635 . . . . 73.439999999999998 112.715 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 44.1 p90 -156.74 160.85 39.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.374 0.509 . . . . 74.420000000000002 112.374 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 22.8 ptmt -148.99 150.86 33.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.847 0.356 . . . . 73.340000000000003 111.444 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -90.64 123.9 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 74.239999999999995 110.811 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -121.07 118.13 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.121 0.415 . . . . 73.409999999999997 112.121 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.8 t -88.87 132.45 38.27 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.459 -0.337 . . . . 72.319999999999993 110.785 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.55 -75.9 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.759 2.306 . . . . 71.420000000000002 113.425 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -118.37 96.88 5.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.831 0.348 . . . . 70.420000000000002 111.44 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' O ' HG22 ' A' ' 51' ' ' THR . . . 81.57 134.17 1.67 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.218 -0.515 . . . . 73.150000000000006 112.998 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.6 11.53 2.49 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.003 -0.704 . . . . 53.43 111.936 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -82.95 -3.97 57.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.427 -0.351 . . . . 72.430000000000007 111.42 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 48' ' ' GLY . 30.2 p -79.83 164.7 23.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 55.549999999999997 112.495 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.0 mm? -101.82 3.35 39.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.009 -0.541 . . . . 73.540000000000006 110.679 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -105.22 82.63 1.86 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.13 0.49 . . . . 74.519999999999996 111.258 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.57 79.91 1.15 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.105 -0.569 . . . . 51.399999999999999 112.917 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.4 m -63.68 118.04 7.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 75.239999999999995 111.742 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -91.78 124.6 36.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.894 0.378 . . . . 75.239999999999995 111.763 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.12 148.04 25.88 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.317 -0.401 . . . . 71.230000000000004 111.075 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.48 149.51 36.23 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.506 -0.316 . . . . 75.420000000000002 111.801 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.48 114.54 25.21 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.27 0.47 . . . . 74.200000000000003 112.27 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 89.7 t80 -61.64 -48.83 88.98 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.482 0.549 . . . . 74.299999999999997 112.482 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 19.1 Cg_endo -57.59 -33.4 96.52 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.997 1.798 . . . . 63.119999999999997 112.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.44 -49.03 29.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.143 -0.481 . . . . 72.239999999999995 111.235 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.479 ' O ' HG13 ' A' ' 67' ' ' ILE . 72.9 mt -63.41 -32.09 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.354 -0.385 . . . . 72.120000000000005 110.937 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -58.71 -42.76 89.39 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.002 0.429 . . . . 61.509999999999998 110.515 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -60.73 -43.8 97.44 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 64.420000000000002 110.521 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -62.45 -33.21 74.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.315 -0.402 . . . . 73.129999999999995 111.708 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 63' ' ' ILE . 68.7 mt -55.39 -38.03 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.942 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -62.24 -32.82 73.55 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.25 0.547 . . . . 74.099999999999994 110.807 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.95 -40.62 27.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.911 -0.586 . . . . 75.319999999999993 111.279 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.6 t -70.66 -22.68 62.46 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.101 -0.499 . . . . 74.209999999999994 110.862 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 2.0 tm? -63.68 -41.57 98.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 72.420000000000002 109.938 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.72 138.9 44.95 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.925 -0.58 . . . . 74.450000000000003 110.189 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -127.62 115.27 18.52 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.397 0.517 . . . . 72.310000000000002 112.397 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -134.22 22.02 3.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.864 0.364 . . . . 62.119999999999997 111.631 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -160.58 102.1 1.35 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.976 0.417 . . . . 74.019999999999996 110.864 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -87.45 -1.5 57.97 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.409 0.522 . . . . 73.150000000000006 112.409 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -124.54 -62.31 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.996 -0.44 . . . . 73.140000000000001 111.469 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--O 1.257 1.468 0 CA-C-O 118.671 -0.681 . . . . 74.340000000000003 111.081 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.642 0.258 . . . . 70.209999999999994 111.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.16 97.64 8.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.842 0.353 . . . . 70.129999999999995 111.755 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -127.59 147.31 50.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.921 0.391 . . . . 74.540000000000006 111.521 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.49 86.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.452 0.644 . . . . 71.530000000000001 111.424 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.59 128.67 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.833 -0.621 . . . . 72.140000000000001 110.908 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -88.76 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 74.219999999999999 110.515 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -173.8 142.15 0.88 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.864 -0.607 . . . . 75.310000000000002 110.556 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.03 99.93 3.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.599 0.714 . . . . 62.140000000000001 110.934 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -99.32 89.77 4.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.507 . . . . 71.219999999999999 111.242 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -80.66 120.2 24.27 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.943 -0.571 . . . . 74.329999999999998 110.523 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.0 ptp -141.56 153.32 44.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 75.329999999999998 111.929 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.56 166.45 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 64.209999999999994 111.51 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -51.6 -45.37 63.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.197 0.443 . . . . 75.239999999999995 112.197 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -58.52 -50.7 72.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.831 0.348 . . . . 74.530000000000001 111.084 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -67.11 -38.03 84.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.067 0.461 . . . . 64.099999999999994 111.43 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.504 HD21 HD13 ' A' ' 63' ' ' ILE . 3.3 tm? -60.66 -48.56 81.26 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.974 -0.557 . . . . 72.299999999999997 111.406 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.8 ptp -59.43 -32.36 70.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.932 0.396 . . . . 70.430000000000007 111.529 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.68 -37.52 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.121 0.486 . . . . 75.540000000000006 111.306 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 31.3 mmt180 -76.33 -26.96 56.29 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.384 -0.371 . . . . 75.409999999999997 111.888 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.511 ' HB ' HD12 ' A' ' 22' ' ' LEU . 66.2 p -98.46 -30.85 12.3 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.71 6.58 62.17 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.266 -0.492 . . . . 44.210000000000001 113.125 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.511 HD12 ' HB ' ' A' ' 20' ' ' THR . 9.4 mp -85.92 160.49 19.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.194 0.521 . . . . 75.150000000000006 111.847 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.08 156.75 19.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.27 -0.491 . . . . 75.030000000000001 111.997 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.03 59.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.318 0.488 . . . . 74.420000000000002 112.318 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -21.67 66.86 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.874 0.369 . . . . 74.530000000000001 111.711 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.43 -45.42 12.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.224 0.535 . . . . 75.150000000000006 110.696 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.523 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 51.3 mt -61.11 -49.4 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.152 -0.476 . . . . 73.099999999999994 110.992 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.5 pt-20 -57.43 -29.98 64.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.76 0.281 . . . . 64.329999999999998 111.76 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 t -62.33 -48.1 81.32 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 110.912 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -71.43 -31.03 66.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.022 -0.535 . . . . 74.409999999999997 111.774 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.554 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 27.9 mtp-105 -60.85 -19.32 59.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.067 0.395 . . . . 71.030000000000001 112.067 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.1 mm-40 -80.9 -14.86 57.63 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.501 0.556 . . . . 72.450000000000003 112.501 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.05 -48.44 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.363 -0.922 . . . . 73.409999999999997 114.313 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.25 81.34 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.286 -0.538 . . . . 75.049999999999997 112.059 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.2 104.95 5.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.069 0.461 . . . . 71.349999999999994 110.901 177.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -86.7 135.21 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.298 -0.41 . . . . 62.210000000000001 111.69 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.03 139.18 58.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.966 0.412 . . . . 73.319999999999993 111.613 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.03 -46.49 2.69 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.387 -0.37 . . . . 71.310000000000002 113.225 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.51 -60.1 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.35 0.5 . . . . 74.409999999999997 112.35 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -91.94 -27.37 17.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.96 0.356 . . . . 70.239999999999995 111.96 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 36.1 p90 -152.6 155.92 38.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.693 -0.231 . . . . 72.209999999999994 110.663 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.0 165.8 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.094 0.473 . . . . 74.540000000000006 112.095 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -82.54 122.24 27.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.956 -0.566 . . . . 73.030000000000001 111.525 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.19 119.29 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.094 0.473 . . . . 73.349999999999994 111.397 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.6 p -90.03 140.81 27.58 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.382 -0.372 . . . . 75.219999999999999 110.955 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.04 24.62 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.485 2.123 . . . . 63.32 113.02 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -169.5 170.78 8.05 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.235 -0.29 . . . . 74.310000000000002 111.018 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.88 -18.83 74.69 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.059 -0.591 . . . . 71.209999999999994 111.929 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.69 160.66 22.34 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.44 0.638 . . . . 74.25 111.783 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HD3' ' N ' ' A' ' 50' ' ' LYS . 2.6 mppt? -104.0 73.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.715 -0.675 . . . . 72.230000000000004 111.047 -173.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -72.54 154.71 40.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.163 -0.472 . . . . 71.329999999999998 111.232 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.7 mm? -67.82 -9.66 46.34 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.033 0.383 . . . . 71.230000000000004 112.033 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -96.05 92.54 6.49 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.598 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.5 107.71 3.57 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.171 -0.538 . . . . 74.530000000000001 113.099 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 m -65.86 140.42 58.37 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.696 -0.296 . . . . 71.319999999999993 110.714 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -111.67 108.49 17.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.428 0.529 . . . . 73.219999999999999 112.428 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -100.84 136.68 40.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 110.973 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.13 137.46 45.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.297 -0.41 . . . . 71.120000000000005 111.629 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.47 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 60.7 t30 -88.49 112.7 23.27 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.002 0.429 . . . . 74.129999999999995 111.05 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.598 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 68.0 t80 -51.1 -54.25 39.79 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.544 0.942 . . . . 75.439999999999998 113.544 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 78.4 Cg_exo -51.9 -38.07 67.81 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.133 1.888 . . . . 63.439999999999998 113.209 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -65.27 -25.86 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.195 0.442 . . . . 63.520000000000003 112.195 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD13 HD21 ' A' ' 16' ' ' LEU . 66.0 mt -86.52 -37.49 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.583 -0.28 . . . . 75.439999999999998 111.33 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.76 -39.77 68.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.36 0.6 . . . . 74.219999999999999 110.373 170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -50.63 -44.48 57.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.499 -0.773 . . . . 75.140000000000001 111.016 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.42 -40.63 81.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.783 -0.644 . . . . 75.099999999999994 111.491 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 71' ' ' LEU . 62.3 mt -57.21 -36.83 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.384 -0.371 . . . . 74.140000000000001 111.778 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -82.35 -36.45 26.84 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.15 -0.344 . . . . 73.150000000000006 111.248 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.6 -56.1 26.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.214 0.45 . . . . 74.299999999999997 112.214 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.5 m -62.97 -36.21 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.642 0.608 . . . . 71.329999999999998 112.642 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 67' ' ' ILE . 8.5 mp -85.37 -24.11 27.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.145 0.424 . . . . 65.239999999999995 112.145 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 74' ' ' HIS . 48.3 mt-10 59.47 -80.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.058 0.543 . . . . 73.140000000000001 112.432 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.9 p80 45.79 -71.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.418 1.087 . . . . 73.120000000000005 113.557 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 72' ' ' GLU . 73.5 t60 -118.62 102.17 8.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.954 -0.466 . . . . 75.409999999999997 110.469 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -67.72 92.81 0.35 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.538 0.685 . . . . 63.5 111.442 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -68.95 101.14 1.32 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.53 -0.759 . . . . 74.019999999999996 112.223 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -120.48 18.22 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.255 0.55 . . . . 74.209999999999994 110.951 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 . . . . . 0 C--O 1.253 1.262 0 CA-C-N 115.995 -0.548 . . . . 74.150000000000006 110.809 171.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.538 0.209 . . . . 63.409999999999997 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.23 37.41 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.278 0.844 . . . . 74.319999999999993 113.278 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -165.39 135.62 3.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.785 -0.643 . . . . 75.409999999999997 110.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.93 97.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.294 0.568 . . . . 74.109999999999999 111.874 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 6' ' ' PHE . 41.5 mm -131.02 143.41 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.836 -0.62 . . . . 71.349999999999994 110.457 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 5' ' ' ILE . 51.6 m-85 65.21 26.32 12.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.917 0.487 . . . . 74.530000000000001 112.146 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.1 12.74 23.43 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.25 0.548 . . . . 72.120000000000005 110.8 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.22 104.84 15.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.053 0.454 . . . . 64.430000000000007 111.772 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.476 ' HG3' ' HE3' ' A' ' 11' ' ' MET . 9.9 tp10 -101.45 121.53 42.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.262 -0.426 . . . . 74.140000000000001 110.882 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -122.52 140.42 52.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.608 0.242 . . . . 74.299999999999997 111.373 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.667 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 pmm? -158.47 174.42 15.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.13 0.49 . . . . 72.099999999999994 111.588 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.35 171.47 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.263 -0.426 . . . . 64.010000000000005 110.926 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -58.33 -41.98 85.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.055 0.391 . . . . 74.230000000000004 112.055 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -55.56 -48.33 74.93 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.957 0.408 . . . . 71.219999999999999 111.055 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.86 -37.53 73.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.941 0.401 . . . . 53.030000000000001 111.075 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 63' ' ' ILE . 3.2 tm? -56.97 -48.99 77.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.3 -0.409 . . . . 72.510000000000005 111.164 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.9 ptp -62.23 -36.26 81.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.658 0.266 . . . . 74.209999999999994 111.236 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 14' ' ' LYS . 64.6 t -69.87 -36.03 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.071 0.462 . . . . 74.319999999999993 111.309 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.444 ' HG3' ' HE2' ' A' ' 11' ' ' MET . 30.5 mmt180 -74.47 -37.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.127 -0.488 . . . . 74.450000000000003 112.008 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.2 p -93.14 -30.86 15.02 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.602 0.593 . . . . 73.530000000000001 112.602 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.02 -3.2 41.04 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.162 -0.542 . . . . 51.219999999999999 113.087 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.24 -175.03 4.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.366 0.603 . . . . 71.439999999999998 112.226 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.37 169.22 23.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.96 -0.564 . . . . 73.129999999999995 112.3 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.31 -49.09 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.557 0.577 . . . . 64.420000000000002 112.557 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -63.33 -23.12 67.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 111.424 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -81.74 -53.92 5.81 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.16 0.505 . . . . 75.099999999999994 111.079 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.54 -43.1 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.022 -0.535 . . . . 74.510000000000005 112.343 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 pt-20 -58.75 -29.27 66.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.997 0.369 . . . . 74.430000000000007 111.997 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -67.86 -36.84 80.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.183 0.516 . . . . 72.109999999999999 110.685 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.97 -31.22 56.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.897 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 55.6 mtp180 -59.96 -25.33 65.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 75.150000000000006 112.061 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -95.33 12.49 28.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 64.510000000000005 111.823 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.54 -85.77 0.06 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.95 -0.643 . . . . 71.510000000000005 114.134 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.58 65.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.8 0.667 . . . . 71.519999999999996 112.8 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.04 104.64 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.531 0.682 . . . . 73.439999999999998 111.691 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -103.61 133.34 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.384 -0.825 . . . . 75.530000000000001 110.335 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.5 142.04 58.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.917 0.389 . . . . 75.439999999999998 110.999 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 -43.62 2.79 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 121.553 -0.356 . . . . 75.439999999999998 113.11 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.13 -50.86 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.579 0.585 . . . . 62.350000000000001 112.579 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -111.49 -18.56 12.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.665 0.616 . . . . 75.030000000000001 112.665 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.63 144.33 20.43 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.441 0.163 . . . . 55.210000000000001 110.602 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -121.09 156.37 32.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.158 0.504 . . . . 74.299999999999997 111.962 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -95.83 143.43 27.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.266 -0.424 . . . . 64.230000000000004 111.017 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.82 100.62 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.868 0.366 . . . . 64.310000000000002 111.545 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 91.9 p -90.42 110.65 42.38 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.541 -0.3 . . . . 74.129999999999995 110.943 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.42 -30.52 91.04 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.796 2.33 . . . . 72.340000000000003 113.099 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.4 p -82.75 -13.7 55.83 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.434 -0.348 . . . . 72.329999999999998 111.705 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.352 -0.451 . . . . 74.319999999999993 113.395 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.48 10.43 8.92 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.598 0.592 . . . . 74.310000000000002 112.598 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 73.47 -35.02 0.3 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 112.981 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -63.03 160.56 14.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.522 -0.308 . . . . 74.049999999999997 110.583 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.467 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.9 mm? -73.59 21.27 0.09 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.95 0.722 . . . . 74.209999999999994 112.95 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -77.16 81.42 3.67 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.976 -0.452 . . . . 71.140000000000001 110.741 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 45' ' ' SER . . . -177.9 -167.93 36.69 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.985 -1.102 . . . . 74.040000000000006 114.926 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.3 m -91.26 145.88 24.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.899 0.48 . . . . 64.209999999999994 111.434 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -107.3 109.34 21.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.817 0.341 . . . . 72.219999999999999 110.957 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -95.68 133.9 39.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.904 0.383 . . . . 75.430000000000007 111.594 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.7 139.11 33.25 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.076 0.465 . . . . 74.129999999999995 111.591 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.18 95.08 6.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.42 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.667 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 69.4 t80 -55.9 -49.9 90.34 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.65 0.611 . . . . 74.310000000000002 112.65 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.8 Cg_endo -56.82 -23.7 51.9 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.193 1.929 . . . . 63.32 112.782 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.99 -44.73 10.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.794 0.294 . . . . 73.099999999999994 111.794 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 HD11 ' A' ' 16' ' ' LEU . 74.0 mt -66.66 -48.99 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.751 0.31 . . . . 74.239999999999995 111.153 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 53.8 t30 -56.82 -47.59 79.95 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.256 0.551 . . . . 74.400000000000006 110.39 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.19 -42.2 76.76 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.663 -0.699 . . . . 73.150000000000006 111.908 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -61.51 -47.73 84.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.009 0.433 . . . . 75.340000000000003 111.099 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.97 -52.25 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.462 . . . . 74.510000000000005 111.369 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 25.4 mmt85 -66.41 -25.3 66.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.355 -0.384 . . . . 74.120000000000005 111.686 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.16 -52.54 54.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.791 0.329 . . . . 75.120000000000005 111.633 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -83.47 -53.79 5.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.55 . . . . 74.319999999999993 112.484 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.34 -47.2 77.29 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.102 0.408 . . . . 74.129999999999995 112.102 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 61.28 16.59 7.46 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.834 0.679 . . . . 74.349999999999994 112.834 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.49 141.21 46.8 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.116 -0.365 . . . . 64.200000000000003 110.395 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -50.03 160.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.825 0.676 . . . . 75.409999999999997 112.825 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -56.79 137.14 55.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.696 -0.683 . . . . 64.329999999999998 111.721 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -95.29 146.54 24.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.848 0.356 . . . . 75.540000000000006 111.608 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -100.14 137.92 37.92 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.723 0.296 . . . . 64.25 111.551 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.884 -0.579 . . . . 64.030000000000001 111.41 177.611 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.828 0.347 . . . . 74.010000000000005 110.407 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.88 115.56 29.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.576 0.954 . . . . 74.040000000000006 113.576 -169.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -108.34 131.64 54.54 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.087 -0.708 . . . . 72.109999999999999 109.087 166.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.63 113.43 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.351 0.5 . . . . 75.519999999999996 112.351 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.75 107.54 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.884 0.373 . . . . 71.430000000000007 110.299 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -73.15 134.59 44.48 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.04 0.447 . . . . 75.540000000000006 111.594 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.427 ' HB2' ' HG2' ' A' ' 9' ' ' GLU . 15.5 m120 -75.37 9.58 2.06 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.103 0.408 . . . . 74.510000000000005 112.103 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 58.57 33.84 23.41 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.174 0.435 . . . . 73.129999999999995 112.174 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 5.0 mm-40 -75.02 70.05 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.191 0.52 . . . . 74.540000000000006 110.79 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 81.9 m95 -99.21 126.53 45.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.849 -0.614 . . . . 74.019999999999996 110.537 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.3 ptp -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.021 0.438 . . . . 74.5 112.021 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.93 163.8 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.255 -0.43 . . . . 75.450000000000003 111.949 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.38 -51.08 28.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.974 0.731 . . . . 75.319999999999993 112.974 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.89 -40.32 92.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.676 0.274 . . . . 74.420000000000002 111.654 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.29 70.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.082 0.467 . . . . 65.109999999999999 111.098 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -60.11 -50.74 72.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.659 -0.7 . . . . 74.409999999999997 111.187 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -59.01 -33.66 70.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.948 0.404 . . . . 74.549999999999997 111.64 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -71.41 -42.44 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.008 0.433 . . . . 63.130000000000003 111.513 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -85.06 -8.5 58.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.018 0.747 . . . . 73.420000000000002 113.018 -176.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.7 p -110.22 -30.34 7.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.207 0.447 . . . . 74.120000000000005 112.207 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.69 -6.69 65.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.202 -0.523 . . . . 52.399999999999999 112.846 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -73.65 157.49 36.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.031 0.443 . . . . 72.420000000000002 111.576 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.56 160.72 20.42 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.125 -0.56 . . . . 62.149999999999999 112.93 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.07 61.43 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.15 0.426 . . . . 75.239999999999995 112.15 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.93 -27.4 67.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.033 0.444 . . . . 75.349999999999994 111.712 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -76.35 -36.91 57.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.125 0.488 . . . . 62.340000000000003 110.631 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 56.6 mt -68.42 -52.53 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.202 -0.454 . . . . 71.230000000000004 111.422 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.567 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.8 pt-20 -54.35 -37.28 64.74 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.914 0.388 . . . . 74.450000000000003 111.405 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -57.69 -53.58 56.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 111.09 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -65.07 -30.99 71.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.325 -0.398 . . . . 75.340000000000003 111.948 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 18.5 mtp-105 -60.47 -23.27 64.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.605 -0.27 . . . . 72.109999999999999 111.658 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -90.76 -9.38 46.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.355 0.872 . . . . 75.219999999999999 113.355 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.49 9.36 0.33 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 119.731 -1.223 . . . . 64.310000000000002 115.666 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.96 -28.79 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.904 0.852 . . . . 64.120000000000005 111.871 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.36 133.21 44.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.591 0.71 . . . . 75.400000000000006 112.493 -177.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 60.6 mt -138.47 126.46 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.419 -0.81 . . . . 73.25 110.329 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.5 139.78 51.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.371 0.605 . . . . 61.450000000000003 110.981 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.39 -15.11 59.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.059 -0.519 . . . . 62.409999999999997 112.593 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -123.89 -73.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 122.57 -0.371 . . . . 74.310000000000002 111.655 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.408 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.5 m80 -86.34 -10.87 53.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.056 0.391 . . . . 74.349999999999994 112.056 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 44.5 p90 -170.51 179.06 3.46 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.858 -0.423 . . . . 75.530000000000001 109.858 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -157.86 149.19 21.42 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.014 0.435 . . . . 74.120000000000005 111.374 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -78.69 103.94 8.97 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.232 0.539 . . . . 72.329999999999998 111.748 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 66.0 t -100.24 144.08 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.117 -0.492 . . . . 74.530000000000001 111.047 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -74.58 143.09 78.45 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.741 0.305 . . . . 72.120000000000005 111.552 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.95 -178.18 2.47 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.752 2.302 . . . . 74.329999999999998 112.101 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -68.39 83.25 0.26 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.254 0.55 . . . . 70.540000000000006 110.737 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.62 -177.92 47.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.007 -0.542 . . . . 60.009999999999998 112.489 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.33 40.89 0.66 Allowed 'General case' 0 CA--C 1.544 0.744 0 O-C-N 122.346 -0.502 . . . . 74.209999999999994 111.487 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.03 2.48 30.82 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.455 0.539 . . . . 71.439999999999998 112.455 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.9 m -145.91 151.4 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.149 -0.344 . . . . 74.109999999999999 111.121 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' N ' HD21 ' A' ' 52' ' ' LEU . 2.8 mm? -74.79 -60.24 2.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.948 0.404 . . . . 75.420000000000002 111.62 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -87.01 0.78 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.898 0.38 . . . . 63.420000000000002 111.574 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.82 -126.9 7.62 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.272 -0.422 . . . . 51.210000000000001 113.303 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 84.8 m -140.61 119.68 12.79 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 122.442 -0.446 . . . . 74.049999999999997 110.721 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -86.7 105.76 17.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.09 0.472 . . . . 75.310000000000002 112.009 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 28.7 m95 -91.23 121.75 33.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.08 -0.509 . . . . 72.549999999999997 110.006 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 63' ' ' ILE . 87.5 m-85 -90.32 145.07 25.25 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.918 0.71 . . . . 74.329999999999998 112.918 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 53.2 t-20 -85.36 96.88 9.69 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.735 -0.666 . . . . 73.530000000000001 110.729 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 82.9 t80 -52.4 -53.11 56.69 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 112.543 0.571 . . . . 72.099999999999994 112.543 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 82.5 Cg_exo -51.02 -50.42 13.95 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.376 2.05 . . . . 73.540000000000006 113.588 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.6 mm-40 -71.22 -28.53 64.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.143 0.423 . . . . 75.200000000000003 112.143 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 58' ' ' TYR . 46.7 mt -70.13 -42.14 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.948 -0.47 . . . . 73.340000000000003 110.547 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -34.13 72.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.051 0.453 . . . . 75.140000000000001 110.407 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.7 tppp? -59.0 -31.86 69.17 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.939 -0.573 . . . . 73.0 111.279 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -85.51 -32.22 22.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 74.439999999999998 111.232 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.4 mt -60.69 -37.39 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 122.206 -0.309 . . . . 72.439999999999998 111.467 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 65' ' ' LYS . 1.7 ppt_? -57.27 -33.49 67.68 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.71 0.29 . . . . 74.340000000000003 110.976 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.21 -44.22 89.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.365 0.603 . . . . 75.310000000000002 110.105 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -60.64 -23.79 65.04 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.632 -0.713 . . . . 62.329999999999998 112.162 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.26 -21.99 35.99 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -72.9 -174.69 1.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.389 0.614 . . . . 75.129999999999995 112.359 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -79.24 115.99 19.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.109 -0.496 . . . . 73.200000000000003 111.501 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -132.99 146.2 51.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.238 -0.437 . . . . 74.540000000000006 111.625 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -125.05 86.94 2.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.38 0.609 . . . . 55.210000000000001 112.07 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -135.14 -51.91 0.77 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.473 -0.785 . . . . 62.140000000000001 109.408 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -148.21 131.29 16.32 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.324 -0.853 . . . . 73.140000000000001 110.17 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.618 -0.706 . . . . 74.109999999999999 111.535 176.737 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 111.535 0.198 . . . . 74.319999999999993 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.79 124.77 25.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.945 0.402 . . . . 73.239999999999995 111.489 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 111.833 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.9 mm -77.92 85.82 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.274 0.559 . . . . 73.530000000000001 110.228 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.62 139.77 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.947 -0.569 . . . . 73.540000000000006 111.739 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.86 131.15 55.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.522 -0.308 . . . . 74.409999999999997 110.874 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -171.74 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.796 0.331 . . . . 74.519999999999996 111.848 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 116.74 1.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.462 0.912 . . . . 63.530000000000001 113.462 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.26 94.08 4.88 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.922 -0.581 . . . . 73.209999999999994 110.819 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.435 ' HH2' ' HE3' ' A' ' 42' ' ' LYS . 80.9 m95 -93.81 134.31 36.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.429 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 20.4 ptp -157.16 153.85 28.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.987 0.422 . . . . 74.310000000000002 112.035 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.27 170.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.865 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -57.55 -45.59 84.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.22 0.452 . . . . 74.409999999999997 112.22 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -61.54 -38.54 87.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.887 0.375 . . . . 75.430000000000007 111.14 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -72.21 -38.54 68.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.071 0.462 . . . . 74.519999999999996 111.1 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.32 -48.37 81.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.782 -0.645 . . . . 74.340000000000003 110.965 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -61.29 -28.03 68.9 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.808 0.337 . . . . 74.329999999999998 111.901 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.9 t -78.62 -49.19 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.911 0.386 . . . . 75.200000000000003 111.126 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -64.4 -26.88 68.65 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.0 p -99.05 -30.67 12.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.252 0.464 . . . . 65.219999999999999 112.252 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.5 -13.98 56.64 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.117 -0.563 . . . . 74.040000000000006 113.103 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.4 mp -66.99 159.9 27.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.219 0.533 . . . . 75.150000000000006 111.976 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.69 160.63 15.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.039 -0.528 . . . . 37.060000000000002 112.491 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.58 65.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.85 0.357 . . . . 72.230000000000004 111.591 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -59.27 -31.68 69.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.003 -0.544 . . . . 73.049999999999997 111.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' SER . 46.9 tt0 -84.37 -34.28 23.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.398 -0.365 . . . . 73.129999999999995 111.021 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 17' ' ' MET . 60.8 mt -66.24 -50.33 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.598 -0.274 . . . . 64.430000000000007 111.159 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 13.0 pt-20 -58.56 -23.25 58.02 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.986 0.422 . . . . 63.399999999999999 111.193 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 47.9 t -67.18 -56.04 11.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.54 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -65.72 -25.89 67.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.178 0.436 . . . . 65.099999999999994 112.178 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.561 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 78.8 mtp180 -60.37 -10.76 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 111.942 0.349 . . . . 75.409999999999997 111.942 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -63.17 -22.33 66.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.161 0.43 . . . . 73.450000000000003 112.161 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.67 -17.16 0.05 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.488 -0.863 . . . . 71.200000000000003 114.607 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.3 67.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.681 0.741 . . . . 70.0 111.816 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.5 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -71.94 105.07 3.71 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.065 0.46 . . . . 75.310000000000002 111.716 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -87.49 120.24 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.345 -0.389 . . . . 74.150000000000006 111.6 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.61 147.74 40.72 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.905 0.335 . . . . 73.219999999999999 111.905 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.15 -47.18 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.444 -0.344 . . . . 61.210000000000001 113.665 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.3 t -80.44 -63.65 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.468 0.307 . . . . 74.439999999999998 111.732 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.475 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 4.3 m-70 -86.88 -19.93 28.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.127 0.417 . . . . 74.219999999999999 112.127 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 12.3 p90 -165.97 143.48 5.49 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.795 -0.446 . . . . 64.030000000000001 109.795 175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HE3' ' HH2' ' A' ' 10' ' ' TRP . 19.1 ptpt -127.62 161.36 29.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.395 0.617 . . . . 74.299999999999997 112.488 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 43' ' ' ARG . 7.8 ptp180 -74.92 134.62 41.54 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.502 -0.772 . . . . 74.510000000000005 111.032 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.07 149.16 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.657 -0.247 . . . . 63.329999999999998 110.788 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -49.77 139.8 15.91 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 111.929 0.344 . . . . 74.219999999999999 111.929 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 53.2 Cg_exo -52.65 130.43 36.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.739 2.293 . . . . 71.329999999999998 113.357 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.1 m -55.73 -40.66 72.78 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.031 0.443 . . . . 74.409999999999997 110.996 174.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 170.11 32.47 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.385 -0.436 . . . . 74.209999999999994 112.072 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.31 -30.63 71.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.304 0.552 . . . . 64.319999999999993 112.19 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -140.73 39.54 1.84 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.422 0.527 . . . . 75.200000000000003 112.422 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 46' ' ' PRO . 9.4 m -68.19 144.19 55.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.686 0.279 . . . . 73.420000000000002 110.289 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.494 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.0 mm? -69.99 -61.47 1.76 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.34 0.496 . . . . 74.310000000000002 112.34 -173.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -90.94 9.59 29.91 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.342 0.497 . . . . 75.409999999999997 112.342 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.21 -134.99 34.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.035 -0.602 . . . . 37.060000000000002 113.37 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -134.22 137.74 44.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 74.349999999999994 110.791 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.1 m -123.12 120.42 33.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.932 0.396 . . . . 75.129999999999995 111.801 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -109.94 140.11 44.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.318 -0.401 . . . . 75.450000000000003 111.108 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -99.34 139.76 34.51 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.827 0.346 . . . . 75.420000000000002 111.524 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 16.7 m120 -87.66 105.49 17.39 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.303 -0.408 . . . . 72.400000000000006 111.317 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.467 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 67.4 t80 -52.06 -52.03 65.82 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.857 0.688 . . . . 71.209999999999994 112.857 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 22.4 Cg_endo -60.01 -29.42 89.27 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.877 1.718 . . . . 62.329999999999998 112.858 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HB3' ' ND1' ' A' ' 40' ' ' HIS . 74.7 mm-40 -79.9 -39.09 31.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 112.063 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -71.69 -35.76 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.768 0.318 . . . . 72.5 110.384 174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.09 -38.24 85.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.759 0.314 . . . . 72.430000000000007 110.382 172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 39.6 ttmt -53.77 -35.46 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.073 0.463 . . . . 74.299999999999997 110.974 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.66 -50.97 10.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 111.163 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 63' ' ' ILE . 54.6 mt -67.85 -22.08 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.462 0.541 . . . . 73.109999999999999 112.462 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -53.11 -32.83 49.42 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.963 0.411 . . . . 72.519999999999996 111.428 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.77 -33.61 76.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.093 0.473 . . . . 75.409999999999997 110.922 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -76.33 -24.93 54.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 111.386 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.02 -34.74 77.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.636 0.255 . . . . 62.32 110.523 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 53.93 37.96 27.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.926 0.393 . . . . 63.310000000000002 110.581 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -44.62 124.22 4.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.015 0.746 . . . . 73.310000000000002 113.015 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -55.95 127.77 31.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.08 -0.964 . . . . 74.120000000000005 112.265 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 77' ' ' HIS . 30.6 m-70 -72.8 106.37 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.147 -0.479 . . . . 72.400000000000006 111.28 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -69.71 -29.31 66.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.654 0.74 . . . . 71.120000000000005 109.61 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 26.2 p-80 -132.74 165.52 24.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.005 -0.998 . . . . 75.319999999999993 109.687 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.61 -0.709 . . . . 74.510000000000005 112.125 -179.194 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 112.202 0.445 . . . . 74.239999999999995 112.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.34 140.2 12.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 111.671 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.493 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 24.9 tm0? -84.64 102.48 12.97 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 64.510000000000005 110.543 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.5 mm -113.23 68.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.613 0.721 . . . . 72.129999999999995 111.068 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' HB ' ' NE2' ' A' ' 3' ' ' GLN . 4.4 mp -132.75 115.75 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.828 -0.624 . . . . 65.549999999999997 110.723 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -168.51 150.12 4.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.453 -0.34 . . . . 74.239999999999995 111.18 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 61' ' ' PRO . 3.8 t-20 -162.43 159.3 24.96 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.98 0.419 . . . . 74.439999999999998 111.26 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.468 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -136.85 27.69 2.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.451 0.538 . . . . 62.420000000000002 112.451 -175.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.0 mm-40 -73.87 99.18 3.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.901 0.382 . . . . 64.25 111.98 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -91.98 135.75 33.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.627 -0.26 . . . . 74.049999999999997 110.526 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.586 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.7 ptp -158.81 142.41 15.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.922 0.391 . . . . 75.120000000000005 112.045 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.09 172.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 111.795 0.295 . . . . 71.439999999999998 111.795 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -46.74 -57.51 4.78 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.896 0.702 . . . . 73.439999999999998 112.896 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -54.69 -37.52 65.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.885 0.374 . . . . 75.310000000000002 111.945 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -76.11 -42.44 47.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.097 0.475 . . . . 53.329999999999998 111.143 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 63' ' ' ILE . 3.2 tm? -58.31 -47.72 82.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.804 -0.635 . . . . 74.299999999999997 111.209 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -58.63 -34.24 70.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.847 0.356 . . . . 65.319999999999993 111.629 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.49 -46.14 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.154 0.502 . . . . 63.310000000000002 111.233 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.586 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 16.8 mmt180 -69.0 -29.57 67.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.131 -0.486 . . . . 74.5 112.247 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.416 ' HG1' HD12 ' A' ' 16' ' ' LEU . 82.3 p -99.96 -30.17 12.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.538 0.57 . . . . 54.509999999999998 112.538 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 -4.64 56.12 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.025 -0.607 . . . . 65.030000000000001 112.824 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.63 -173.11 1.71 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.386 0.612 . . . . 73.010000000000005 111.767 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -146.19 169.14 27.58 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.797 -0.638 . . . . 42.240000000000002 112.266 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.12 -50.69 61.17 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.221 0.452 . . . . 72.230000000000004 112.221 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -60.95 -34.76 75.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.133 0.492 . . . . 75.030000000000001 111.736 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -78.67 -40.37 34.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.349 -0.387 . . . . 75.319999999999993 111.599 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 23' ' ' GLY . 73.8 mt -66.04 -44.07 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.555 0.217 . . . . 72.409999999999997 111.369 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 11.7 pt-20 -56.93 -37.92 72.17 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.812 0.339 . . . . 74.109999999999999 110.905 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 t -60.69 -49.35 77.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 43.409999999999997 110.988 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -63.07 -29.38 70.77 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.805 0.298 . . . . 74.430000000000007 111.805 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.1 mtm180 -69.71 -12.31 61.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.052 0.39 . . . . 74.209999999999994 112.052 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 45.0 mt-30 -88.74 2.76 52.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.625 0.232 . . . . 74.519999999999996 111.625 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.3 -52.29 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.177 -1.011 . . . . 64.409999999999997 114.697 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.08 -38.42 31.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.465 0.913 . . . . 71.310000000000002 113.465 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -71.55 130.67 41.82 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.015 -0.428 . . . . 72.430000000000007 111.68 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.2 mt -130.59 126.31 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 122.522 0.329 . . . . 75.129999999999995 111.094 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG3' ' HA ' ' A' ' 42' ' ' LYS . 38.5 tt0 -68.99 150.92 47.15 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.003 0.43 . . . . 74.140000000000001 110.906 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.45 2.67 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.255 -0.498 . . . . 71.450000000000003 112.841 -174.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG13 ' HD1' ' A' ' 40' ' ' HIS . 35.0 t -97.76 -64.99 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.249 0.463 . . . . 71.439999999999998 112.249 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.519 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.4 m-70 -92.06 -11.97 34.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.75 0.648 . . . . 61.210000000000001 112.75 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 47.5 p90 -170.78 174.03 5.06 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.0 0.12 . . . . 75.019999999999996 111.012 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 18.7 ptpt -167.74 174.2 7.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.424 0.631 . . . . 75.150000000000006 112.288 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -85.4 120.86 27.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.524 -0.762 . . . . 74.439999999999998 112.002 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.8 149.98 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.007 -0.542 . . . . 62.340000000000003 110.857 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 49.5 m -58.04 141.41 81.41 Favored Pre-proline 0 N--CA 1.473 0.706 0 N-CA-C 112.318 0.488 . . . . 74.340000000000003 112.318 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.534 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 8.7 Cg_exo -72.38 163.77 37.63 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.873 2.382 . . . . 62.130000000000003 112.371 175.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.2 p -79.31 -64.29 1.22 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.403 0.52 . . . . 44.350000000000001 112.403 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.85 -58.93 3.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.22 -0.514 . . . . 72.319999999999993 114.257 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.86 147.35 50.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.285 0.564 . . . . 72.329999999999998 112.115 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.51 114.62 20.36 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.778 -0.646 . . . . 65.150000000000006 111.256 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.9 p -118.6 168.79 10.36 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.106 0.479 . . . . 73.129999999999995 111.91 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 52' ' ' LEU . 2.9 mm? -80.54 -9.86 59.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.24 0.543 . . . . 75.239999999999995 110.372 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -85.92 -47.06 9.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.758 -0.655 . . . . 71.209999999999994 111.651 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' HA2' ' HG3' ' A' ' 46' ' ' PRO . . . 69.69 -168.04 47.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.284 -0.484 . . . . 41.350000000000001 113.443 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 m -127.61 116.7 20.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.614 -0.345 . . . . 73.319999999999993 110.566 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.6 m -89.61 115.25 26.86 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.069 0.461 . . . . 65.109999999999999 112.171 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -102.16 133.54 46.86 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.134 -0.484 . . . . 74.549999999999997 110.848 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.38 143.31 27.54 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.018 0.437 . . . . 73.439999999999998 111.327 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.39 105.53 13.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.322 -0.399 . . . . 71.519999999999996 111.5 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.606 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 90.2 t80 -56.95 -45.15 99.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 111.822 0.305 . . . . 74.549999999999997 111.822 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.791 ' HB3' ' HB3' ' A' ' 7' ' ' ASN . 9.1 Cg_endo -50.69 -41.78 52.76 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.405 2.07 . . . . 65.319999999999993 113.109 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG3' ' HA ' ' A' ' 40' ' ' HIS . 42.6 mm-40 -65.87 -47.27 75.44 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.136 0.493 . . . . 64.349999999999994 111.815 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.441 HD11 HD22 ' A' ' 16' ' ' LEU . 65.3 mt -71.79 -37.43 62.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.975 0.417 . . . . 75.329999999999998 111.183 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.6 -43.25 99.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.281 0.562 . . . . 65.219999999999999 110.177 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -55.75 -39.49 71.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.593 -0.73 . . . . 72.0 110.81 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -65.03 -48.6 73.29 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.301 -0.409 . . . . 74.510000000000005 111.468 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.4 -45.36 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.1 0.476 . . . . 75.510000000000005 111.461 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 41.3 mtp-105 -64.89 -56.75 11.47 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 111.241 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.68 -37.86 76.97 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.574 0.583 . . . . 75.319999999999993 112.574 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.4 p -82.45 -64.21 1.22 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.171 0.434 . . . . 71.340000000000003 112.171 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -74.42 -43.7 55.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.138 0.421 . . . . 71.010000000000005 112.138 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 1.5 mm-40 55.22 76.91 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.358 0.873 . . . . 72.439999999999998 113.358 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -79.33 106.07 11.1 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.742 -0.836 . . . . 71.400000000000006 108.742 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -57.76 89.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.028 -0.533 . . . . 72.420000000000002 112.08 -169.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -67.4 -17.17 64.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.849 0.685 . . . . 75.510000000000005 112.849 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -68.76 -3.8 13.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.018 0.437 . . . . 75.010000000000005 111.08 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -125.05 -55.46 1.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 110.473 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.255 1.383 0 CA-C-O 118.799 -0.619 . . . . 74.540000000000006 112.042 -178.239 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.4 0.143 . . . . 74.120000000000005 110.753 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.07 141.92 2.72 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.212 0.449 . . . . 64.230000000000004 112.212 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -99.4 111.27 23.67 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.075 0.464 . . . . 73.129999999999995 111.063 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -71.07 93.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.979 0.419 . . . . 74.409999999999997 110.727 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mm -94.94 102.08 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.002 0.43 . . . . 73.349999999999994 111.777 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -132.97 132.55 42.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.197 -0.456 . . . . 61.140000000000001 110.762 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -73.36 79.02 1.36 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.426 0.631 . . . . 73.409999999999997 110.794 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -78.02 82.05 4.39 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.758 0.79 . . . . 73.400000000000006 111.405 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -75.46 85.33 2.57 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.848 -0.614 . . . . 73.030000000000001 111.629 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -77.53 130.53 37.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.033 -0.531 . . . . 72.430000000000007 110.669 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.6 ptp -153.59 142.3 20.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.813 0.339 . . . . 72.129999999999995 111.779 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.81 166.29 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.752 0.31 . . . . 75.519999999999996 111.819 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -52.41 -46.61 66.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.009 0.433 . . . . 70.519999999999996 111.645 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.534 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.4 tmmt? -60.13 -37.09 79.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.154 -0.475 . . . . 72.019999999999996 111.483 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.21 -38.97 55.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.337 0.589 . . . . 74.209999999999994 111.04 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.496 HD12 ' HG1' ' A' ' 20' ' ' THR . 3.3 tm? -65.17 -43.11 92.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.981 -0.554 . . . . 75.209999999999994 111.299 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.1 ptp -61.06 -27.49 68.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.738 0.304 . . . . 72.5 111.35 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 14' ' ' LYS . 47.4 t -67.95 -48.77 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.215 0.531 . . . . 74.219999999999999 110.805 174.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -64.82 -42.76 94.7 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.078 -0.51 . . . . 75.299999999999997 112.289 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.496 ' HG1' HD12 ' A' ' 16' ' ' LEU . 68.3 p -93.5 -30.27 15.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.048 0.758 . . . . 72.239999999999995 113.048 -172.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.84 7.56 64.39 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.055 -0.593 . . . . 72.310000000000002 113.127 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.4 mp -79.76 160.13 26.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 72.209999999999994 111.724 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.02 153.36 16.83 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 71.319999999999993 112.002 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -41.42 62.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.203 0.501 . . . . 73.230000000000004 111.997 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.98 -27.03 69.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.412 -0.358 . . . . 73.239999999999995 111.584 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.406 HE21 ' HE2' ' A' ' 30' ' ' TYR . 48.8 tt0 -84.9 -40.95 16.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.152 0.501 . . . . 74.25 110.755 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.71 -40.0 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.253 -0.43 . . . . 63.310000000000002 112.03 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.477 ' HB3' ' NH2' ' A' ' 31' ' ' ARG . 11.7 pt-20 -62.19 -34.32 76.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.901 0.381 . . . . 74.430000000000007 111.253 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 35.8 t -62.43 -27.6 69.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.245 0.545 . . . . 74.239999999999995 110.773 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HE2' HE21 ' A' ' 26' ' ' GLN . 60.4 m-85 -88.43 -31.61 18.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.274 -0.421 . . . . 74.010000000000005 111.646 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 55.2 mtm180 -64.35 -20.52 66.16 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.296 0.48 . . . . 73.349999999999994 112.296 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' SER . 13.6 pt20 -79.03 -8.11 58.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.435 0.531 . . . . 75.109999999999999 112.435 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.32 -49.08 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.199 -1.0 . . . . 73.25 114.642 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.33 85.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 73.540000000000006 112.463 -176.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.13 106.29 4.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.043 0.449 . . . . 75.209999999999994 111.675 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -96.87 131.71 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.529 -0.305 . . . . 72.319999999999993 111.211 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.83 147.32 53.56 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.044 0.449 . . . . 72.150000000000006 111.4 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.68 -46.03 3.01 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.254 -0.498 . . . . 62.32 112.872 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG11 ' HD1' ' A' ' 40' ' ' HIS . 61.4 t -82.56 -62.79 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.305 0.483 . . . . 74.540000000000006 112.305 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.621 ' HD1' HG11 ' A' ' 39' ' ' VAL . 1.8 m80 -93.91 -21.01 19.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.918 0.71 . . . . 72.349999999999994 112.918 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -153.24 168.22 26.72 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.862 0.301 . . . . 74.510000000000005 111.46 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -136.16 165.29 26.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.21 0.529 . . . . 64.230000000000004 111.424 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -86.79 136.71 32.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.688 -0.687 . . . . 70.439999999999998 110.173 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 78.4 t -125.14 147.77 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.216 0.531 . . . . 71.319999999999993 111.656 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 t -66.9 141.57 96.83 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.035 -0.53 . . . . 63.140000000000001 112.122 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.06 22.95 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.732 2.288 . . . . 73.109999999999999 113.123 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.0 m 66.02 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.811 0.671 . . . . 72.129999999999995 112.811 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.93 1.3 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.173 -0.537 . . . . 62.140000000000001 113.537 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' O ' HG21 ' A' ' 51' ' ' THR . 39.6 mt-10 -90.28 102.82 15.54 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.346 -0.503 . . . . 71.239999999999995 111.204 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.08 97.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.968 0.413 . . . . 74.349999999999994 111.716 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 49' ' ' GLU . 63.6 p -110.35 162.5 14.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.36 0.6 . . . . 74.209999999999994 111.968 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.8 mm? -96.26 14.69 23.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.823 -0.626 . . . . 74.430000000000007 110.204 173.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -122.66 102.38 8.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.606 -0.725 . . . . 72.120000000000005 110.702 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.65 113.77 6.18 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 72.209999999999994 113.048 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.409 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 26.5 m -51.45 115.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.009 0.433 . . . . 71.109999999999999 111.17 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.8 m -91.9 110.2 21.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.718 0.636 . . . . 74.239999999999995 112.718 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -104.35 128.21 52.14 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.514 . . . . 75.230000000000004 111.008 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' OH ' ' HD3' ' A' ' 31' ' ' ARG . 15.8 m-85 -90.87 157.55 17.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 74.25 112.022 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 40.8 m-80 -94.77 110.19 22.07 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.277 -0.419 . . . . 74.200000000000003 110.406 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.4 t80 -52.65 -49.81 84.16 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.119 0.414 . . . . 74.239999999999995 112.119 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 55.5 Cg_exo -53.63 -41.38 74.31 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.028 1.819 . . . . 74.010000000000005 113.274 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 28.2 mm-40 -70.52 -35.66 73.32 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.735 0.642 . . . . 73.530000000000001 112.735 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.4 -41.57 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.626 0.251 . . . . 75.519999999999996 111.154 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.84 -40.96 90.27 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.26 0.552 . . . . 61.039999999999999 110.279 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -59.88 -44.67 94.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.034 -0.53 . . . . 74.109999999999999 111.118 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.15 -45.7 90.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.199 -0.455 . . . . 72.120000000000005 111.226 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.462 ' O ' HD23 ' A' ' 71' ' ' LEU . 75.0 mt -59.49 -48.49 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.067 0.46 . . . . 75.530000000000001 111.019 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -54.59 -51.9 63.85 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.278 -0.419 . . . . 75.140000000000001 111.094 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.36 -39.75 81.7 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.242 -0.435 . . . . 61.539999999999999 111.506 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -63.65 -49.96 71.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.835 0.35 . . . . 54.439999999999998 111.397 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 67' ' ' ILE . 4.5 mm? -61.49 -43.6 98.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 73.329999999999998 111.378 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.0 pt-20 -161.17 108.09 1.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.623 0.725 . . . . 74.430000000000007 112.295 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.76 52.68 2.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.473 0.654 . . . . 74.319999999999993 110.755 173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.46 ' ND1' ' HB2' ' A' ' 72' ' ' GLU . 33.1 m170 -88.75 146.26 25.13 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.229 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 91.1 3.28 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.462 0.649 . . . . 73.310000000000002 111.586 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -81.72 83.03 7.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.407 0.622 . . . . 63.520000000000003 111.483 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 178.99 -42.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.06 -0.973 . . . . 74.519999999999996 109.389 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.446 -0.788 . . . . 74.400000000000006 109.953 171.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.453 0.168 . . . . 74.420000000000002 111.218 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.23 130.9 0.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.245 0.461 . . . . 61.439999999999998 112.245 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -144.97 120.44 10.34 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.007 0.432 . . . . 74.239999999999995 110.277 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.02 101.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.972 0.415 . . . . 63.030000000000001 111.147 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -99.22 104.92 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.922 0.391 . . . . 74.099999999999994 111.853 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -110.92 12.12 22.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.278 0.561 . . . . 74.209999999999994 110.744 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -78.59 62.26 3.12 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.26 0.552 . . . . 75.329999999999998 111.049 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.43 118.75 23.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.156 0.503 . . . . 74.450000000000003 111.501 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 6.8 tp10 -131.83 91.01 2.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.971 -0.559 . . . . 73.230000000000004 109.737 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -94.28 130.48 40.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.864 -0.607 . . . . 62.130000000000003 110.665 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.537 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.4 ptp -144.84 160.51 41.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.074 0.464 . . . . 75.409999999999997 111.823 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.67 170.31 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.133 0.492 . . . . 75.530000000000001 111.632 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.82 -48.69 80.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.237 0.458 . . . . 73.549999999999997 112.237 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -65.33 -29.7 70.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.763 0.316 . . . . 74.120000000000005 111.107 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.47 -41.77 62.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.994 0.426 . . . . 75.239999999999995 111.053 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.513 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -58.04 -45.88 86.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.047 -0.524 . . . . 73.310000000000002 111.207 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.7 ptp -62.28 -35.52 79.25 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.597 0.237 . . . . 74.349999999999994 111.549 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 14' ' ' LYS . 95.8 t -72.77 -40.46 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.07 0.462 . . . . 54.340000000000003 111.433 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 15.0 mmt85 -65.55 -41.59 92.85 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.237 -0.438 . . . . 74.200000000000003 112.051 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.1 p -93.75 -30.21 14.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.97 0.73 . . . . 75.409999999999997 112.97 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.58 -4.62 47.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.198 -0.525 . . . . 75.319999999999993 112.947 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -75.82 -179.1 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 74.519999999999996 111.861 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -132.13 168.44 22.52 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.626 -0.715 . . . . 71.239999999999995 112.26 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.1 71.21 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.673 0.62 . . . . 72.049999999999997 112.673 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 87.2 mtt180 -73.99 -18.64 60.84 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.621 0.6 . . . . 74.230000000000004 112.621 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.437 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 10.3 tt0 -84.57 -37.73 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.898 0.38 . . . . 71.409999999999997 110.701 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.1 mt -63.67 -50.37 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.601 -0.272 . . . . 72.530000000000001 111.126 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.7 pt-20 -59.8 -31.03 69.31 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.141 0.496 . . . . 75.099999999999994 110.935 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 40.8 t -61.5 -50.41 72.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.512 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.14 -23.68 66.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.946 0.35 . . . . 74.329999999999998 111.946 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.669 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 13.6 mtp180 -64.27 -9.79 19.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.797 0.666 . . . . 71.25 112.797 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 29' ' ' SER . 29.0 pt20 -70.9 -22.26 62.29 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.937 0.347 . . . . 74.030000000000001 111.937 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.69 -43.68 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 113.979 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.16 -49.08 78.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.095 0.405 . . . . 74.420000000000002 112.095 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.669 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.95 104.52 5.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.961 0.41 . . . . 73.219999999999999 110.241 175.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.79 127.26 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 72.409999999999997 110.848 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -58.49 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.961 0.41 . . . . 73.430000000000007 111.081 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.11 -50.22 3.35 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 64.230000000000004 113.038 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.1 t -81.35 -61.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.176 0.436 . . . . 73.150000000000006 112.176 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -89.36 -22.12 22.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 111.987 0.366 . . . . 72.310000000000002 111.987 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -160.09 127.34 4.5 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.708 0.29 . . . . 75.530000000000001 110.655 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -122.02 145.07 48.49 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.01 0.433 . . . . 74.340000000000003 111.749 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -73.46 103.21 4.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.03 0.443 . . . . 75.120000000000005 111.09 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.4 100.43 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.209 0.528 . . . . 74.409999999999997 111.107 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.3 p -86.93 132.22 42.61 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.318 -0.401 . . . . 71.439999999999998 110.79 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.01 -8.13 21.79 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.685 2.256 . . . . 74.319999999999993 113.093 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.1 t -127.27 158.9 35.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.118 0.485 . . . . 74.049999999999997 111.596 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.71 2.31 69.77 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.055 -0.521 . . . . 54.109999999999999 112.309 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.08 152.07 25.49 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.079 0.466 . . . . 73.450000000000003 111.911 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.74 86.17 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 74.219999999999999 111.221 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.0 p -131.91 154.29 49.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.217 -0.447 . . . . 71.030000000000001 111.489 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.4 mm? -88.88 14.9 9.35 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.014 0.435 . . . . 70.349999999999994 111.287 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -86.9 28.39 0.9 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.959 0.409 . . . . 72.219999999999999 111.98 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.12 80.25 0.2 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.147 -0.549 . . . . 65.239999999999995 113.202 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.2 m -72.97 116.7 13.8 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.579 -0.365 . . . . 74.129999999999995 110.503 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t -81.12 138.12 35.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.276 0.56 . . . . 72.209999999999994 112.343 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -112.81 136.89 51.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.7 -0.682 . . . . 63.439999999999998 110.371 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -89.93 139.73 30.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.291 0.567 . . . . 73.409999999999997 112.126 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 39.3 t-20 -91.73 101.51 14.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.593 -0.731 . . . . 72.25 110.467 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 87.0 t80 -54.99 -52.13 73.65 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 112.627 0.603 . . . . 70.109999999999999 112.627 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' ' OD1' ' A' ' 59' ' ' ASN . 80.9 Cg_exo -48.51 -49.41 14.63 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.256 1.971 . . . . 72.209999999999994 113.376 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -62.72 -41.53 99.2 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.147 0.425 . . . . 71.239999999999995 112.147 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.24 -49.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.961 0.41 . . . . 72.219999999999999 111.586 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -57.12 -38.32 73.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 64.109999999999999 110.927 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -51.33 70.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.193 -0.458 . . . . 75.549999999999997 110.091 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -55.56 -48.78 74.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.011 -0.541 . . . . 74.010000000000005 111.563 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.74 -40.86 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 111.338 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -59.08 -32.76 70.09 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.309 0.485 . . . . 75.239999999999995 112.309 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -61.75 -49.08 77.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.937 0.399 . . . . 65.540000000000006 111.895 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.3 t -83.85 -44.68 14.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.117 0.414 . . . . 72.439999999999998 112.117 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.83 -43.68 78.97 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.924 0.342 . . . . 72.400000000000006 111.924 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 68.3 -69.56 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.168 0.587 . . . . 72.109999999999999 112.275 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -97.27 137.39 36.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.046 -0.524 . . . . 72.219999999999999 112.366 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -80.87 116.39 20.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.968 0.413 . . . . 61.399999999999999 111.45 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.3 133.33 54.97 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.381 -0.372 . . . . 71.319999999999993 111.247 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -80.15 126.81 31.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.392 . . . . 63.310000000000002 111.489 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -93.41 137.1 33.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.239 -0.437 . . . . 72.450000000000003 110.636 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.33 -0.843 . . . . 74.25 110.913 178.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.768 0.318 . . . . 65.120000000000005 111.294 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 90.64 2.06 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.39 0.515 . . . . 73.439999999999998 112.39 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -84.95 137.8 32.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.356 -0.383 . . . . 74.510000000000005 110.264 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.3 mm -70.46 78.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 121.166 0.508 . . . . 73.340000000000003 111.493 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -140.37 90.17 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.282 -0.417 . . . . 74.349999999999994 110.972 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -173.87 127.88 0.39 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.408 -0.36 . . . . 74.129999999999995 110.9 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -155.11 115.74 3.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.266 0.555 . . . . 64.230000000000004 111.915 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.568 ' HB3' ' NE1' ' A' ' 10' ' ' TRP . 50.7 mt-10 -96.14 99.96 11.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 111.065 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -88.78 88.09 7.48 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.834 0.349 . . . . 63.409999999999997 111.335 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.568 ' NE1' ' HB3' ' A' ' 8' ' ' GLU . 87.9 m95 -96.12 132.83 41.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.009 0.433 . . . . 74.239999999999995 111.647 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.39 154.45 40.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.439 -0.346 . . . . 71.310000000000002 111.072 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.25 171.33 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.429 -0.351 . . . . 72.319999999999993 111.69 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -51.64 -57.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.211 0.448 . . . . 71.329999999999998 112.211 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.2 tmmt? -53.02 -48.45 67.55 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.295 -0.412 . . . . 61.229999999999997 111.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.22 97.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.015 0.436 . . . . 73.099999999999994 111.558 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.489 HD21 HD13 ' A' ' 63' ' ' ILE . 3.2 tm? -59.65 -51.86 68.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.068 -0.515 . . . . 74.319999999999993 111.496 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -59.5 -39.45 83.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.688 0.28 . . . . 72.540000000000006 111.726 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.38 -42.68 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.829 0.347 . . . . 74.150000000000006 111.375 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -65.55 -35.33 80.55 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.391 0.515 . . . . 74.040000000000006 112.391 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.1 p -93.48 -30.24 15.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.508 0.559 . . . . 73.510000000000005 112.508 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.22 11.29 45.95 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.122 -0.561 . . . . 72.25 112.714 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.3 mp -93.39 173.14 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.137 0.494 . . . . 71.329999999999998 111.172 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.28 162.28 22.01 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.247 -0.502 . . . . 74.540000000000006 112.313 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.25 61.94 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.004 0.372 . . . . 51.43 112.004 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -60.6 -28.64 68.67 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.18 0.437 . . . . 74.019999999999996 112.18 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 9.3 tt0 -84.94 -45.16 12.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.102 0.477 . . . . 75.349999999999994 110.855 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.8 mt -64.14 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.99 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.71 -34.36 69.38 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.857 0.317 . . . . 60.240000000000002 111.857 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 t -64.39 -42.07 96.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.09 0.471 . . . . 74.530000000000001 111.121 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 29.0 m-85 -64.74 -33.5 76.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 75.319999999999993 111.119 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 27.9 mtm180 -62.62 -25.8 68.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.641 0.258 . . . . 70.129999999999995 111.312 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.66 -36.52 80.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.617 0.599 . . . . 74.329999999999998 112.617 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.25 35.89 0.29 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.317 -0.944 . . . . 74.219999999999999 114.506 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.25 -16.85 1.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.103 0.477 . . . . 53.530000000000001 111.917 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.03 111.91 20.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.219 0.533 . . . . 74.209999999999994 112.122 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.89 129.67 64.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.023 -0.535 . . . . 72.450000000000003 110.376 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.18 137.69 53.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.144 0.497 . . . . 73.310000000000002 110.669 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.39 2.93 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.329 -0.462 . . . . 74.519999999999996 112.372 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.25 -64.5 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.094 0.405 . . . . 72.040000000000006 112.094 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -94.24 -37.72 11.39 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.363 0.505 . . . . 73.319999999999993 112.363 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 25.6 p90 -141.74 175.7 9.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 71.209999999999994 111.121 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -144.79 133.05 21.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.897 0.379 . . . . 73.310000000000002 110.98 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -80.75 102.69 10.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.496 0.665 . . . . 74.299999999999997 110.404 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.39 125.36 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.063 -0.971 . . . . 74.420000000000002 112.175 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 75.5 m -82.79 126.35 73.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.021 -0.536 . . . . 75.140000000000001 110.704 174.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.89 -21.6 58.42 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.522 2.148 . . . . 74.329999999999998 112.859 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.7 t -136.85 105.91 5.97 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.755 0.312 . . . . 64.329999999999998 111.318 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.24 -110.13 3.24 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.159 -0.543 . . . . 64.430000000000007 113.46 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.49 169.7 17.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.029 0.442 . . . . 54.520000000000003 112.137 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 52.55 26.75 4.51 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.772 1.027 . . . . 74.230000000000004 113.772 172.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 22.8 m -71.88 160.78 31.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.122 -0.361 . . . . 73.109999999999999 110.598 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.471 HD21 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -82.18 20.79 0.98 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.08 0.467 . . . . 64.400000000000006 111.348 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -137.52 79.51 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.923 0.489 . . . . 74.219999999999999 110.82 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.39 82.81 0.9 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.053 -0.594 . . . . 51.130000000000003 112.985 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -69.82 113.49 7.11 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.61 -0.347 . . . . 74.329999999999998 110.679 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.2 m -86.15 115.75 23.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.01 0.744 . . . . 75.310000000000002 113.01 -172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -105.19 140.48 38.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.695 -0.684 . . . . 74.129999999999995 110.111 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.42 144.82 32.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.326 0.491 . . . . 70.430000000000007 112.326 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.09 111.78 18.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.379 -0.373 . . . . 70.510000000000005 110.983 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 87.7 t80 -54.85 -53.39 61.38 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 112.342 0.497 . . . . 72.319999999999993 112.342 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 55.6 Cg_endo -67.16 -20.19 50.1 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.154 1.903 . . . . 63.219999999999999 113.786 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -83.29 -38.04 22.66 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.11 -0.369 . . . . 71.109999999999999 111.515 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 HD13 HD21 ' A' ' 16' ' ' LEU . 58.9 mt -70.6 -42.98 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.663 0.268 . . . . 73.430000000000007 110.442 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.25 -38.2 70.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.844 0.354 . . . . 74.150000000000006 111.03 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.44 -49.61 77.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 73.150000000000006 110.798 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -58.81 -41.87 87.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.065 0.459 . . . . 71.329999999999998 111.199 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.7 mt -62.15 -53.82 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.276 -0.42 . . . . 64.230000000000004 111.232 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -66.81 -28.31 68.27 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.7 0.286 . . . . 72.030000000000001 111.675 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.32 -41.38 80.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 60.009999999999998 110.586 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -71.0 -32.06 68.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.045 0.45 . . . . 74.120000000000005 111.28 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -80.46 -56.34 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.596 0.591 . . . . 73.329999999999998 112.596 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 70.42 -35.24 0.32 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.186 0.81 . . . . 72.510000000000005 113.186 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -52.2 133.43 33.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.226 0.454 . . . . 74.420000000000002 112.226 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 77.26 12.29 2.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.914 0.886 . . . . 74.209999999999994 112.462 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -79.46 88.82 5.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.113 -0.329 . . . . 70.439999999999998 110.113 169.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -77.75 128.23 33.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.037 0.446 . . . . 74.120000000000005 111.265 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -110.22 148.98 30.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.792 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 . . . . . 0 C--O 1.249 1.051 0 O-C-N 122.29 -0.256 . . . . 74.349999999999994 111.278 175.283 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.716 0.293 . . . . 71.450000000000003 111.662 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.41 159.7 14.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.431 0.53 . . . . 73.109999999999999 112.431 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -143.89 122.28 12.37 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.005 0.431 . . . . 71.140000000000001 111.313 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.13 119.93 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.775 0.322 . . . . 64.439999999999998 111.192 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -102.46 106.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.901 0.382 . . . . 74.0 111.162 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -163.46 103.41 0.95 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.51 -0.314 . . . . 74.209999999999994 110.731 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -167.9 97.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.75 0.648 . . . . 71.439999999999998 112.75 -175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.67 132.85 49.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.021 0.438 . . . . 73.230000000000004 110.336 170.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.9 mm-40 -84.88 105.78 15.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 72.239999999999995 111.59 -176.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -88.62 136.69 32.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.687 0.28 . . . . 75.409999999999997 111.014 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 ptp -157.92 153.55 26.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.949 0.404 . . . . 73.540000000000006 111.814 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.67 174.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.278 -0.419 . . . . 72.040000000000006 111.491 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' HG3' HG21 ' A' ' 27' ' ' ILE . 35.7 tt0 -59.37 -50.66 73.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.42 . . . . 75.129999999999995 112.133 -175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 1.2 tmmt? -61.05 -38.13 85.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.922 0.391 . . . . 74.129999999999995 110.968 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.04 75.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.147 0.499 . . . . 74.25 111.012 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.97 -47.77 83.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.869 -0.605 . . . . 74.420000000000002 111.168 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 23.6 ptp -60.15 -34.99 74.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.82 0.343 . . . . 74.219999999999999 111.311 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 14' ' ' LYS . 59.6 t -76.95 -27.1 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.744 0.307 . . . . 74.019999999999996 111.76 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.0 mmp_? -94.39 -14.69 25.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.672 0.619 . . . . 73.450000000000003 112.672 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.7 p -108.53 -29.86 8.55 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.496 0.554 . . . . 72.239999999999995 112.496 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.58 -0.14 58.06 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.122 -0.561 . . . . 72.129999999999995 112.578 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.1 178.52 7.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.29 0.567 . . . . 72.540000000000006 112.042 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.42 168.74 12.68 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.022 -0.535 . . . . 72.540000000000006 112.578 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 -45.14 91.35 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.602 -0.352 . . . . 71.409999999999997 111.872 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -65.21 -41.2 94.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.151 0.501 . . . . 74.040000000000006 111.123 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.59 -41.77 98.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.278 -0.419 . . . . 73.349999999999994 111.189 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.489 HG21 ' HG3' ' A' ' 13' ' ' GLU . 66.0 mt -62.39 -54.38 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.624 0.25 . . . . 64.040000000000006 111.659 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 11.8 pt-20 -59.65 -29.9 68.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.96 0.41 . . . . 72.519999999999996 111.284 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.3 t -63.04 -46.83 85.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.879 0.371 . . . . 71.510000000000005 111.093 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -68.69 -29.01 67.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.974 0.416 . . . . 64.25 111.029 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.514 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 51.9 mtp180 -61.26 -28.1 68.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.324 -0.398 . . . . 74.510000000000005 111.087 172.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.3 mm100 -73.08 -33.56 65.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.387 0.514 . . . . 73.209999999999994 112.387 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.82 61.19 0.3 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.169 -1.015 . . . . 54.140000000000001 114.737 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.71 -32.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.566 0.698 . . . . 63.219999999999999 110.408 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.404 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.48 130.92 41.78 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.679 -0.691 . . . . 73.510000000000005 111.581 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 70.9 mt -131.93 132.95 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.842 -0.617 . . . . 73.319999999999993 110.898 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.07 142.52 51.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.055 0.455 . . . . 73.109999999999999 111.441 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.31 -48.67 3.43 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.471 -0.395 . . . . 71.150000000000006 113.314 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.35 -60.59 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.941 0.4 . . . . 73.150000000000006 112.031 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.415 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.6 m170 -97.63 -32.19 11.9 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.282 0.475 . . . . 73.340000000000003 112.282 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 23.4 p90 -153.27 169.59 22.67 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.222 -0.299 . . . . 73.209999999999994 111.526 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.59 152.54 27.36 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.782 0.325 . . . . 73.329999999999998 110.851 174.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -78.57 131.0 36.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.237 0.542 . . . . 63.299999999999997 111.796 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.66 159.66 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.034 -0.53 . . . . 75.109999999999999 110.734 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 m -51.38 131.17 33.98 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.356 -0.384 . . . . 73.549999999999997 111.713 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.21 114.25 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.235 1.957 . . . . 74.200000000000003 112.361 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -82.89 9.29 10.29 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.143 0.423 . . . . 72.219999999999999 112.143 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.07 -104.51 0.21 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.255 -0.498 . . . . 64.239999999999995 112.516 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.77 122.46 19.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.016 0.436 . . . . 71.340000000000003 111.327 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -78.05 100.18 6.41 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.253 -0.431 . . . . 75.200000000000003 110.41 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -129.69 156.1 44.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.5 -0.318 . . . . 72.049999999999997 110.873 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.1 mm? -62.66 -15.21 51.14 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.837 0.68 . . . . 65.519999999999996 112.837 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.41 -31.1 37.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.227 -0.296 . . . . 63.539999999999999 111.591 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.99 -174.45 43.49 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.33 -0.462 . . . . 54.310000000000002 113.214 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -101.04 114.68 28.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.248 -0.56 . . . . 64.420000000000002 110.325 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m -94.42 126.23 39.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.292 0.478 . . . . 72.299999999999997 112.292 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -114.64 139.07 49.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.24 -0.437 . . . . 74.200000000000003 110.613 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 63' ' ' ILE . 55.5 m-85 -107.94 148.51 29.57 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.973 0.415 . . . . 72.120000000000005 112.015 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.1 101.36 12.38 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.997 0.427 . . . . 71.109999999999999 111.213 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.755 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 87.0 t80 -53.54 -45.24 98.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.724 0.639 . . . . 73.030000000000001 112.724 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 11.1 Cg_endo -53.65 -47.41 27.41 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.018 1.812 . . . . 75.530000000000001 112.814 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.46 -38.77 84.95 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.253 0.464 . . . . 74.109999999999999 112.253 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 58' ' ' TYR . 64.4 mt -68.06 -43.52 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.876 0.369 . . . . 55.340000000000003 110.884 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 53.1 t30 -60.28 -41.25 92.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.039 0.447 . . . . 74.219999999999999 110.269 173.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -44.43 92.29 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.902 -0.59 . . . . 73.319999999999993 111.323 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -63.35 -46.87 84.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.214 0.531 . . . . 74.140000000000001 111.432 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.27 -47.41 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.253 -0.431 . . . . 73.409999999999997 111.59 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 6.8 tpp180 -61.27 -34.61 75.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.297 -0.41 . . . . 72.099999999999994 111.164 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -28.02 65.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 111.49 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.1 t -72.95 -24.23 60.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.197 -0.456 . . . . 72.230000000000004 111.408 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.34 -40.71 15.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.402 -0.363 . . . . 64.120000000000005 111.904 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.79 16.57 3.63 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.043 0.757 . . . . 70.450000000000003 113.043 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.58 104.31 16.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.536 0.569 . . . . 72.120000000000005 112.536 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 31.11 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.902 1.445 . . . . 73.25 114.902 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -68.81 99.14 0.99 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.883 -0.599 . . . . 72.420000000000002 110.315 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -94.92 132.51 39.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.703 0.287 . . . . 72.200000000000003 111.694 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -176.36 114.93 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.997 0.427 . . . . 62.539999999999999 111.379 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.5 p80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 119.327 -0.368 . . . . 73.120000000000005 111.39 177.738 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 111.631 0.234 . . . . 75.400000000000006 111.631 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.81 -65.15 1.04 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.467 0.543 . . . . 62.219999999999999 112.467 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 59.46 55.62 4.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.416 0.627 . . . . 72.450000000000003 111.583 -175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.94 85.63 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.39 0.614 . . . . 74.329999999999998 109.848 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.6 mm -71.03 104.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 113.101 0.778 . . . . 73.010000000000005 113.101 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -134.91 107.91 7.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.869 -0.605 . . . . 75.109999999999999 110.095 170.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -153.48 43.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.782 0.801 . . . . 74.310000000000002 110.23 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 5.2 mp0 -75.35 96.26 3.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.424 -0.807 . . . . 74.329999999999998 111.705 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 11.2 mm-40 -76.43 117.0 17.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 73.430000000000007 111.42 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -99.09 123.89 43.71 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.345 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 19.8 ptp -159.79 156.71 28.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.332 0.493 . . . . 71.049999999999997 112.332 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.3 m -81.58 176.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.319 -0.4 . . . . 74.540000000000006 111.174 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -56.3 -47.05 79.46 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.645 0.609 . . . . 74.099999999999994 112.645 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -39.96 92.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.837 0.351 . . . . 72.209999999999994 111.289 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -74.79 -33.57 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.086 0.47 . . . . 75.209999999999994 111.197 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.96 -47.87 67.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.759 -0.655 . . . . 74.010000000000005 111.326 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.5 ptp -56.12 -33.71 65.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.043 0.449 . . . . 74.030000000000001 111.852 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.38 -33.98 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.102 0.477 . . . . 73.439999999999998 111.457 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HG3' ' HE1' ' A' ' 11' ' ' MET . 30.9 mmm180 -86.81 -15.33 39.57 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.425 0.528 . . . . 72.150000000000006 112.425 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.509 ' HB ' HD11 ' A' ' 22' ' ' LEU . 48.6 p -108.53 -29.1 8.95 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.774 0.657 . . . . 72.120000000000005 112.774 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.98 9.7 65.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.849 -0.691 . . . . 61.229999999999997 112.636 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.0 mp -91.77 163.1 14.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.122 0.487 . . . . 62.210000000000001 111.124 176.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.39 163.2 14.18 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.209 -0.519 . . . . 64.120000000000005 111.811 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -51.2 -41.82 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.137 0.469 . . . . 44.420000000000002 111.501 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -56.6 -37.65 70.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.348 -0.387 . . . . 75.530000000000001 112.025 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -73.92 -46.49 44.05 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 73.319999999999993 111.274 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.56 -46.82 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.462 -0.335 . . . . 73.319999999999993 111.678 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 13.1 pt-20 -59.56 -37.39 78.33 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.824 0.345 . . . . 70.409999999999997 111.027 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -56.92 -39.89 75.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.187 0.518 . . . . 74.099999999999994 110.834 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -80.67 -26.41 37.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 111.61 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 37.9 mtm180 -66.85 -17.95 65.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.798 0.333 . . . . 74.329999999999998 111.139 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.47 -23.09 65.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.311 0.485 . . . . 74.230000000000004 112.311 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.84 -52.05 0.02 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.312 -0.947 . . . . 73.230000000000004 114.276 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.76 -36.92 39.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.634 0.605 . . . . 72.5 112.634 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.33 104.39 3.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.016 0.436 . . . . 65.310000000000002 110.881 176.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -95.2 138.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.183 -0.462 . . . . 72.430000000000007 110.881 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.54 134.39 56.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.068 0.461 . . . . 72.409999999999997 111.899 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -35.85 1.72 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.449 -0.405 . . . . 53.25 113.894 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.5 t -84.64 -53.23 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.333 0.494 . . . . 64.310000000000002 112.333 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.38 -15.13 14.31 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.561 0.578 . . . . 72.530000000000001 112.561 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.78 152.06 35.89 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.469 -0.145 . . . . 73.010000000000005 110.637 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.682 ' HB3' ' HZ2' ' A' ' 42' ' ' LYS . 8.0 mtpm? -125.69 141.29 52.09 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.094 0.473 . . . . 73.409999999999997 111.993 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -84.93 111.86 20.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.879 -0.601 . . . . 73.420000000000002 111.187 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.5 t -107.46 119.79 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.142 0.496 . . . . 74.150000000000006 111.934 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -84.32 141.56 39.83 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.089 -0.505 . . . . 63.439999999999998 111.35 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.97 -7.17 20.45 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.674 2.249 . . . . 75.109999999999999 113.149 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.5 t -136.24 -59.7 0.73 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.637 0.256 . . . . 72.430000000000007 111.323 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.01 -42.1 0.19 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.627 -0.797 . . . . 45.229999999999997 113.838 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 -177.93 6.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.207 0.527 . . . . 72.540000000000006 111.908 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -64.31 120.67 12.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.037 0.446 . . . . 74.510000000000005 111.067 -178.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -120.64 157.38 29.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.827 -0.624 . . . . 72.030000000000001 111.423 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD21 ' N ' ' A' ' 52' ' ' LEU . 2.7 mm? -82.25 -51.5 7.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.388 0.613 . . . . 74.239999999999995 110.027 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -81.25 72.9 8.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.306 0.574 . . . . 74.400000000000006 111.181 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.16 126.53 8.0 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.845 -0.616 . . . . 72.510000000000005 112.488 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.8 m -76.69 116.39 17.33 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 122.429 -0.453 . . . . 74.129999999999995 111.103 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -97.8 101.16 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.807 0.337 . . . . 73.219999999999999 111.827 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -89.15 138.47 31.39 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.574 -0.285 . . . . 74.140000000000001 110.278 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.13 134.95 43.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.063 0.459 . . . . 74.129999999999995 111.794 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 63' ' ' ILE . 1.4 m-20 -76.93 94.23 3.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.941 -0.572 . . . . 63.109999999999999 111.815 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 78.6 t80 -52.37 -48.96 87.88 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.214 0.82 . . . . 72.25 113.214 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.623 ' HG3' ' HA ' ' A' ' 8' ' ' GLU . 13.1 Cg_endo -55.0 -42.15 71.98 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.985 1.79 . . . . 72.209999999999994 112.635 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 60.4 mm-40 -64.73 -41.06 96.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.019 0.438 . . . . 74.109999999999999 111.271 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.0 mt -66.54 -45.34 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.272 -0.422 . . . . 75.209999999999994 111.301 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -58.09 -44.05 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.214 0.53 . . . . 64.019999999999996 110.552 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -54.69 -38.66 67.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.793 -0.64 . . . . 75.010000000000005 111.205 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -71.62 -43.63 65.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 111.024 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 63' ' ' ILE . 77.7 mt -55.29 -46.88 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.394 -0.366 . . . . 72.409999999999997 111.25 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -50.59 -54.7 20.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.75 0.31 . . . . 62.340000000000003 111.618 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.33 -48.25 79.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.011 0.434 . . . . 73.200000000000003 111.312 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.7 t -71.38 -24.58 62.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.527 0.565 . . . . 60.210000000000001 112.527 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp -86.01 -52.25 5.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.68 0.622 . . . . 75.510000000000005 112.68 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -25.39 49.03 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.679 0.622 . . . . 74.109999999999999 112.679 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -67.14 142.13 57.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.812 0.339 . . . . 74.400000000000006 111.046 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -72.45 71.81 0.95 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.651 0.739 . . . . 74.329999999999998 112.43 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -149.82 95.7 2.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.485 -0.78 . . . . 74.540000000000006 109.789 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -97.66 124.91 42.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.874 0.369 . . . . 75.310000000000002 111.81 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -61.06 121.69 13.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.451 -0.341 . . . . 75.120000000000005 110.463 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.679 -0.677 . . . . 71.349999999999994 111.553 177.806 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 112.088 0.403 . . . . 75.420000000000002 112.088 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.33 -59.36 5.46 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.056 0.455 . . . . 64.030000000000001 111.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -129.55 141.88 50.88 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.395 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -80.7 94.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.001 0.429 . . . . 74.209999999999994 111.217 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.1 114.16 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.055 0.455 . . . . 74.450000000000003 110.002 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 91.5 m-85 -68.82 -52.12 33.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.935 0.717 . . . . 74.430000000000007 112.935 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 65.72 21.82 11.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.877 0.37 . . . . 72.319999999999993 111.816 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -104.22 23.67 12.7 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.415 0.626 . . . . 75.420000000000002 110.917 177.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.539 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 4.3 mp0 -72.06 82.58 0.97 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.668 -0.697 . . . . 71.209999999999994 110.676 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -102.69 129.82 49.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.486 -0.325 . . . . 73.549999999999997 110.968 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.2 pmm? -145.92 162.55 37.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.747 0.308 . . . . 74.099999999999994 111.266 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.4 162.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.425 -0.352 . . . . 74.329999999999998 111.512 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.29 -44.92 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.284 0.476 . . . . 65.219999999999999 112.284 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.1 tmmt? -58.41 -44.54 89.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.4 -0.364 . . . . 73.439999999999998 111.263 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.21 -34.23 65.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.149 0.5 . . . . 71.200000000000003 111.336 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -49.99 75.28 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.966 -0.561 . . . . 74.430000000000007 110.871 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.02 -28.86 69.35 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.753 0.311 . . . . 74.310000000000002 111.699 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 14' ' ' LYS . 62.2 t -73.85 -38.13 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.048 0.452 . . . . 72.409999999999997 111.219 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.1 mmm180 -78.08 -24.41 47.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.986 0.365 . . . . 75.200000000000003 111.986 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.4 ' HB ' HD11 ' A' ' 22' ' ' LEU . 67.1 p -104.67 -30.21 10.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.85 0.685 . . . . 64.519999999999996 112.85 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.78 10.0 60.58 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.258 -0.496 . . . . 62.229999999999997 113.208 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD11 ' HB ' ' A' ' 20' ' ' THR . 9.2 mp -83.73 167.82 16.82 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.197 0.522 . . . . 74.329999999999998 112.147 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.54 159.34 14.55 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.214 -0.448 . . . . 74.230000000000004 112.787 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.1 -46.51 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.851 0.686 . . . . 63.329999999999998 112.851 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 20.8 ttm180 -75.59 -35.34 60.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.796 0.331 . . . . 75.25 111.469 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -61.92 -40.78 96.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.156 0.503 . . . . 75.409999999999997 110.562 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.56 -48.7 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.075 -0.512 . . . . 75.540000000000006 111.593 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.548 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 14.2 pt-20 -63.9 -23.19 67.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.186 -0.321 . . . . 60.229999999999997 111.324 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -67.08 -49.23 65.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.089 0.471 . . . . 72.099999999999994 110.322 172.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.161 0.505 . . . . 74.25 111.092 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.9 mtp180 -61.94 -13.4 24.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.822 -0.627 . . . . 74.299999999999997 111.824 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.53 12.27 37.67 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 111.747 0.277 . . . . 73.5 111.747 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.11 -78.2 0.03 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.461 -0.876 . . . . 61.329999999999998 114.157 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.36 67.47 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.007 0.743 . . . . 73.099999999999994 113.007 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 112.23 7.94 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.472 0.653 . . . . 73.310000000000002 112.066 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 64.8 mt -105.83 134.5 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.457 -0.792 . . . . 75.120000000000005 110.447 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.2 133.01 53.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 74.010000000000005 111.131 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.31 -32.05 3.39 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.536 -0.364 . . . . 73.099999999999994 113.648 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 47.2 t -97.18 -41.09 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.573 0.582 . . . . 75.329999999999998 112.573 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 21.8 m170 -112.18 -5.43 14.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.184 0.438 . . . . 73.430000000000007 112.184 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -170.94 164.59 7.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.606 0.225 . . . . 75.349999999999994 111.606 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -149.47 161.81 41.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.951 0.405 . . . . 75.510000000000005 111.128 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mmm-85 -87.62 118.32 27.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.311 -0.404 . . . . 75.319999999999993 111.463 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.7 t -94.24 134.52 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.768 0.318 . . . . 75.510000000000005 111.158 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -77.26 118.89 74.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 112.126 0.417 . . . . 75.430000000000007 112.126 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.499 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 70.5 Cg_endo -75.22 106.61 2.31 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.458 2.105 . . . . 71.049999999999997 111.657 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.9 t -50.41 -38.15 41.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.777 0.658 . . . . 74.219999999999999 112.777 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.29 -83.98 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.077 -0.582 . . . . 63.509999999999998 113.301 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.67 87.92 6.27 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.319 -0.518 . . . . 74.310000000000002 110.874 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -71.57 81.26 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 111.662 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 p -117.64 -173.02 2.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.165 -0.47 . . . . 74.200000000000003 110.61 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.2 mm? -86.45 3.69 42.81 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.188 0.518 . . . . 74.530000000000001 111.004 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -85.63 21.58 1.8 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.309 -0.405 . . . . 74.430000000000007 111.102 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.499 ' HA2' ' HD3' ' A' ' 46' ' ' PRO . . . -45.73 127.29 8.68 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.4 -0.364 . . . . 63.439999999999998 113.86 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -54.52 117.36 3.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.135 0.493 . . . . 73.5 111.702 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.8 m -83.59 105.43 14.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 111.908 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -89.35 152.69 21.38 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.485 -0.325 . . . . 71.430000000000007 110.462 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -113.4 149.62 33.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.993 0.738 . . . . 74.040000000000006 112.993 -171.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' O ' HG13 ' A' ' 63' ' ' ILE . 16.3 m120 -77.16 93.66 3.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.696 -0.684 . . . . 75.319999999999993 111.73 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.2 t80 -55.25 -47.03 99.51 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.431 0.53 . . . . 74.230000000000004 112.431 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 7.7 Cg_endo -49.07 -48.57 17.87 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.382 2.055 . . . . 74.319999999999993 113.212 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 29.0 mm-40 -74.22 -34.67 63.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.583 0.586 . . . . 64.530000000000001 112.583 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 59' ' ' ASN . 77.8 mt -67.37 -43.05 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.147 0.499 . . . . 64.230000000000004 110.54 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.78 -41.85 99.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.022 -0.536 . . . . 71.239999999999995 110.358 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -46.81 77.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.793 -0.639 . . . . 71.319999999999993 111.097 174.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.98 -51.84 68.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.056 -0.52 . . . . 73.430000000000007 111.272 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.99 -29.86 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.294 -0.412 . . . . 74.310000000000002 111.624 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.52 -49.96 75.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.823 0.344 . . . . 73.329999999999998 111.402 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.38 57.5 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.772 0.32 . . . . 74.430000000000007 111.601 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -71.5 -41.57 69.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.028 0.442 . . . . 53.25 111.752 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -56.1 6.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.968 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.28 -71.33 0.09 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.909 0.707 . . . . 71.109999999999999 112.909 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.26 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.706 0.403 . . . . 74.409999999999997 111.325 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -47.58 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.209 0.818 . . . . 55.420000000000002 113.209 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -97.18 129.77 44.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.709 -0.678 . . . . 75.519999999999996 111.255 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -84.6 178.02 7.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.409 0.623 . . . . 72.239999999999995 112.38 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -64.34 152.72 40.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.726 -0.67 . . . . 64.540000000000006 112.318 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.9 p80 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.486 -0.768 . . . . 74.420000000000002 111.677 176.377 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.83 0.347 . . . . 75.540000000000006 111.277 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.29 154.72 41.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.455 -0.338 . . . . 73.010000000000005 111.097 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -154.11 119.45 5.12 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 72.209999999999994 111.673 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.41 105.57 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.352 -0.386 . . . . 73.120000000000005 110.816 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 5' ' ' ILE . 3.1 mp -90.97 96.53 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.463 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -149.03 152.34 36.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 111.327 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.87 124.09 16.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.953 0.406 . . . . 71.409999999999997 111.133 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -122.78 140.92 52.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.158 0.504 . . . . 71.349999999999994 111.278 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.7 mt-10 -132.28 96.56 3.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.193 -0.458 . . . . 55.200000000000003 110.637 176.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 68.2 m95 -102.26 114.38 28.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.506 -0.315 . . . . 72.120000000000005 110.909 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ptp -135.58 153.13 51.77 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.07 0.396 . . . . 75.319999999999993 112.07 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -80.58 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.321 0.489 . . . . 74.219999999999999 112.321 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -50.32 -57.25 8.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.95 0.722 . . . . 74.329999999999998 112.95 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 1.4 tmmt? -56.34 -40.67 74.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.230000000000004 111.873 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -38.45 68.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 72.340000000000003 111.161 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.44 HD11 ' HG1' ' A' ' 20' ' ' THR . 2.8 tm? -62.78 -46.56 87.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.78 -0.645 . . . . 61.340000000000003 111.512 -176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.508 ' HE1' ' HA ' ' A' ' 14' ' ' LYS . 24.5 ptp -56.99 -36.23 70.12 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.982 0.42 . . . . 71.430000000000007 111.533 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 t -76.01 -40.56 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.123 0.487 . . . . 70.530000000000001 111.273 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.0 mmp_? -74.29 -21.4 59.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.681 0.623 . . . . 72.209999999999994 112.681 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HG1' HD11 ' A' ' 16' ' ' LEU . 70.5 p -108.38 -30.68 8.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.72 0.637 . . . . 73.519999999999996 112.72 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.23 1.12 56.94 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.146 -0.549 . . . . 39.109999999999999 112.858 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.39 172.09 14.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.981 0.42 . . . . 73.530000000000001 111.479 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.0 161.06 12.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.335 -0.46 . . . . 44.43 112.267 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.24 62.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.01 0.374 . . . . 61.439999999999998 112.01 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -63.85 -24.87 67.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.915 0.388 . . . . 73.510000000000005 111.694 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 45.9 tt0 -84.11 -41.2 17.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.905 0.383 . . . . 75.010000000000005 110.763 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.64 -52.32 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.929 0.395 . . . . 74.329999999999998 111.405 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.01 -32.16 67.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.305 -0.407 . . . . 71.439999999999998 111.583 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.07 -43.76 98.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.008 0.432 . . . . 72.329999999999998 110.716 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.463 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 24.9 m-85 -70.9 -27.68 63.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.768 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.7 mtm180 -66.69 -10.3 45.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.798 0.332 . . . . 75.299999999999997 111.868 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -85.34 -9.59 57.42 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.077 0.399 . . . . 74.349999999999994 112.077 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.88 -48.04 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.255 -0.974 . . . . 70.0 114.497 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.409 0.522 . . . . 74.420000000000002 112.409 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 145.8 48.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 111.108 177.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.468 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 78.6 mt -139.45 132.24 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 111.272 -173.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.37 134.06 53.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.1 0.476 . . . . 72.109999999999999 111.926 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.44 -55.42 4.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.464 -0.398 . . . . 51.329999999999998 113.306 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -70.08 -62.94 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.073 0.397 . . . . 72.030000000000001 112.073 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.468 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.7 m80 -95.15 -8.03 37.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.667 0.618 . . . . 74.319999999999993 112.667 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -164.61 155.78 15.18 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.694 0.283 . . . . 74.25 111.493 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -123.53 157.33 33.85 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -104.61 116.18 31.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 111.453 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -116.04 134.59 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.992 0.425 . . . . 74.340000000000003 111.615 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.3 p -83.64 154.74 65.45 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.255 -0.429 . . . . 63.420000000000002 111.347 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.17 160.9 17.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.484 2.122 . . . . 74.400000000000006 113.012 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -68.79 113.35 6.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 64.230000000000004 111.243 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.72 -69.3 2.11 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 116.31 -0.405 . . . . 43.210000000000001 113.535 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.6 110.39 6.14 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 111.711 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -78.6 82.7 4.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.578 0.704 . . . . 63.520000000000003 112.186 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -94.03 155.64 17.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.697 -0.683 . . . . 72.349999999999994 110.445 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.472 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.7 mm? -63.62 -32.46 73.95 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 111.704 0.261 . . . . 64.310000000000002 111.704 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -64.09 82.14 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.298 0.57 . . . . 75.239999999999995 111.772 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.95 134.66 13.08 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.701 -0.681 . . . . 52.119999999999997 113.033 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 m -77.55 120.17 22.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.717 0.294 . . . . 74.310000000000002 111.045 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -102.41 115.01 29.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.989 0.423 . . . . 73.310000000000002 111.556 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 64.5 m95 -98.7 130.27 45.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.271 -0.422 . . . . 74.340000000000003 110.95 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 5.6 m-85 -88.29 145.01 26.08 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.963 0.411 . . . . 75.420000000000002 111.859 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t-20 -84.44 98.85 10.31 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.048 -0.523 . . . . 55.399999999999999 110.713 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 76.7 t80 -55.37 -51.61 78.43 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 112.596 0.591 . . . . 75.109999999999999 112.596 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 85.5 Cg_exo -48.45 -42.91 34.13 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.372 2.048 . . . . 72.420000000000002 113.437 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.97 -40.28 87.43 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.957 0.408 . . . . 75.219999999999999 111.517 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 58' ' ' TYR . 74.4 mt -65.99 -32.98 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 110.768 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -60.47 -43.45 96.91 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.345 0.593 . . . . 72.030000000000001 110.306 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.8 -25.88 67.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.973 -0.558 . . . . 63.0 111.385 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.98 -52.86 15.04 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 72.099999999999994 110.622 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.78 -28.45 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.12 -0.491 . . . . 72.349999999999994 111.147 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 1.8 tpm_? -47.72 -57.37 5.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.964 -0.562 . . . . 71.349999999999994 111.263 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.1 -48.45 67.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.047 0.451 . . . . 75.349999999999994 111.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 66.7 m -62.28 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 74.510000000000005 111.731 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.27 -35.1 69.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.866 0.691 . . . . 74.329999999999998 112.866 -173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 16.1 mm-40 -66.57 -58.19 5.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.344 0.498 . . . . 75.129999999999995 112.344 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -97.12 18.11 15.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.371 0.508 . . . . 73.120000000000005 112.371 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' SER . 93.3 m-70 -128.3 176.67 7.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.507 -0.553 . . . . 64.219999999999999 109.507 166.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -132.38 96.68 3.91 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.221 0.534 . . . . 75.519999999999996 111.341 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -79.23 77.69 5.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.904 -0.589 . . . . 74.150000000000006 110.895 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -73.48 95.58 2.27 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.916 -0.583 . . . . 75.010000000000005 111.338 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.61 -0.71 . . . . 71.530000000000001 112.705 177.678 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.855 0.317 . . . . 74.010000000000005 111.855 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.46 35.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 111.91 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -162.05 132.34 4.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.445 -0.343 . . . . 74.329999999999998 111.34 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -85.72 135.87 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.894 0.378 . . . . 74.430000000000007 111.743 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 5' ' ' ILE . 2.9 mp -107.73 113.59 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.021 0.439 . . . . 75.209999999999994 111.585 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -113.42 90.17 3.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.162 0.505 . . . . 63.109999999999999 111.323 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -78.7 63.72 3.53 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.803 0.811 . . . . 65.420000000000002 110.678 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -75.28 79.43 2.38 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.397 -0.82 . . . . 73.099999999999994 112.216 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.78 78.02 9.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.027 0.441 . . . . 75.510000000000005 111.072 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -78.87 123.54 27.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 110.139 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.524 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.2 ptp -151.8 165.53 34.19 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.762 0.653 . . . . 65.340000000000003 112.762 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -82.77 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.088 -0.505 . . . . 75.510000000000005 110.964 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 27.2 tt0 -65.69 -39.22 91.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.839 0.311 . . . . 72.219999999999999 111.839 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' O ' HG21 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -56.54 -45.67 81.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.132 0.492 . . . . 74.519999999999996 110.497 178.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -68.52 -42.21 78.85 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.191 0.519 . . . . 72.530000000000001 111.069 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.28 -47.28 78.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.931 -0.577 . . . . 74.519999999999996 111.36 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 22.8 ptp -64.61 -29.33 70.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.829 0.347 . . . . 63.200000000000003 111.483 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 14' ' ' LYS . 75.6 t -73.54 -40.43 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.015 0.436 . . . . 72.420000000000002 111.494 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.2 mmt85 -71.65 -39.74 70.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.098 0.475 . . . . 73.430000000000007 112.109 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 22' ' ' LEU . 66.6 p -92.98 -30.53 15.29 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.585 0.587 . . . . 74.439999999999998 112.585 -173.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.64 -0.69 70.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.927 -0.654 . . . . 74.310000000000002 112.867 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 20' ' ' THR . 10.6 mp -73.5 156.56 38.06 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.013 0.435 . . . . 74.140000000000001 111.365 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 162.4 16.58 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.299 -0.477 . . . . 72.219999999999999 112.336 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -41.37 82.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.845 0.355 . . . . 64.200000000000003 111.363 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.87 -31.7 65.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.139 0.495 . . . . 75.430000000000007 111.483 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -83.81 -43.25 15.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.102 -0.499 . . . . 74.420000000000002 110.819 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.92 -46.73 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.213 -0.449 . . . . 73.349999999999994 111.667 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.28 -34.11 71.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.911 0.386 . . . . 64.120000000000005 111.298 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -66.67 -33.97 76.82 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.107 0.479 . . . . 74.340000000000003 110.809 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -76.79 -33.82 58.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.077 -0.511 . . . . 75.530000000000001 112.036 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 20.7 mtt180 -56.06 -34.78 66.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.269 0.557 . . . . 75.5 111.818 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -77.97 0.02 25.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.082 0.771 . . . . 74.25 113.082 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.7 -56.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.525 -0.845 . . . . 70.310000000000002 113.791 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.06 -37.69 78.66 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.81 0.67 . . . . 61.229999999999997 112.81 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.614 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.11 108.83 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.971 0.415 . . . . 75.430000000000007 111.469 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -108.38 123.42 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 110.706 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.02 152.0 44.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.82 0.343 . . . . 71.439999999999998 111.302 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -38.44 1.8 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.109 -0.567 . . . . 75.340000000000003 112.982 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 40.7 t -89.48 -65.91 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 111.87 0.322 . . . . 75.430000000000007 111.87 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.423 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 5.4 m-70 -98.29 -14.63 20.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.094 0.776 . . . . 74.120000000000005 113.094 -174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 34.4 p90 -159.64 171.89 18.78 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.075 -0.39 . . . . 70.230000000000004 111.797 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -150.49 143.97 25.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.343 0.592 . . . . 75.340000000000003 111.556 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.8 139.48 30.41 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 111.569 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.74 118.3 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.102 0.477 . . . . 74.540000000000006 112.208 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -91.94 148.98 38.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 CA-C-N 116.156 -0.475 . . . . 55.140000000000001 111.354 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.39 0.88 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.468 2.112 . . . . 73.430000000000007 112.251 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 50' ' ' LYS . 89.7 p -135.14 -165.58 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.891 -0.595 . . . . 74.209999999999994 110.542 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.14 -115.91 0.07 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.141 -0.552 . . . . 55.439999999999998 113.505 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -91.13 20.67 4.82 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.461 -0.434 . . . . 74.439999999999998 111.937 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 55.6 mtpt -78.7 -172.24 2.89 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.538 0.208 . . . . 71.430000000000007 110.682 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.2 m -61.77 149.94 38.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.967 -0.458 . . . . 75.340000000000003 111.312 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.494 ' N ' HD21 ' A' ' 52' ' ' LEU . 2.9 mm? -69.3 -81.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.227 -0.442 . . . . 73.230000000000004 112.064 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 61.85 13.89 5.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.03 0.381 . . . . 75.129999999999995 112.03 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -142.43 6.08 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.392 -0.367 . . . . 71.540000000000006 113.454 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 m -110.94 136.28 50.19 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.336 -0.508 . . . . 73.439999999999998 112.304 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 m -91.94 118.48 30.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.278 -0.419 . . . . 73.430000000000007 111.136 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -94.27 144.56 25.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.804 0.335 . . . . 74.109999999999999 111.18 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 63' ' ' ILE . 68.5 m-85 -112.13 142.07 45.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.072 0.463 . . . . 75.319999999999993 111.882 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.05 97.85 8.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.701 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.511 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 41.0 t80 -49.91 -50.9 65.58 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 112.788 0.662 . . . . 73.310000000000002 112.788 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 71.3 Cg_exo -51.46 -46.18 33.09 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.244 1.962 . . . . 73.530000000000001 112.948 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 58.4 mm-40 -64.25 -41.18 97.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.091 0.404 . . . . 72.129999999999995 112.091 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -67.93 -45.35 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.606 -0.27 . . . . 64.439999999999998 111.203 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.14 -35.32 75.02 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.287 0.565 . . . . 75.349999999999994 110.576 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.56 -33.65 76.4 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.796 -0.638 . . . . 73.530000000000001 111.277 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.07 -44.13 20.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.345 -0.388 . . . . 73.430000000000007 111.994 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 63' ' ' ILE . 75.5 mt -47.56 -40.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.235 0.457 . . . . 74.299999999999997 112.235 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -51.82 -48.56 63.85 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.989 0.423 . . . . 73.109999999999999 111.738 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 37.3 t70 -60.0 -33.31 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.259 -0.428 . . . . 73.019999999999996 111.219 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -55.24 -27.15 44.3 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.951 0.352 . . . . 74.319999999999993 111.951 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 71' ' ' LEU . 3.5 mm? -86.21 -40.57 15.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.248 0.462 . . . . 73.439999999999998 112.248 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.6 6.17 19.83 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.359 0.874 . . . . 70.099999999999994 113.359 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 69' ' ' ASP . 67.5 t60 -53.56 118.79 4.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.817 0.303 . . . . 73.099999999999994 111.817 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -63.28 167.79 4.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.207 0.527 . . . . 44.240000000000002 112.184 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -66.82 109.65 2.99 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.395 0.617 . . . . 74.340000000000003 112.091 -176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -95.44 99.89 11.73 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 110.839 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -146.89 119.58 8.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.809 0.338 . . . . 72.400000000000006 111.852 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 118.617 -0.706 . . . . 71.439999999999998 110.599 175.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 111.735 0.272 . . . . 53.119999999999997 111.735 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.17 -65.55 0.68 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.331 0.493 . . . . 63.32 112.331 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -77.3 116.72 18.14 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.302 0.572 . . . . 65.530000000000001 111.69 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -101.51 101.01 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.997 0.427 . . . . 74.340000000000003 111.139 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -94.12 102.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.816 0.341 . . . . 72.409999999999997 110.609 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -164.4 9.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.331 -0.395 . . . . 72.329999999999998 111.818 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -80.87 56.62 2.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.775 0.798 . . . . 74.329999999999998 110.444 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.29 137.25 14.55 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.578 -0.737 . . . . 74.0 111.134 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.65 109.83 17.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 74.150000000000006 111.703 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -94.12 121.85 36.04 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.881 -0.414 . . . . 71.049999999999997 109.881 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.743 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 19.9 ptp -138.9 147.16 41.98 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.31 0.485 . . . . 74.510000000000005 112.31 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.34 165.43 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.943 0.401 . . . . 75.510000000000005 111.972 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.97 -42.73 80.69 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.239 -0.437 . . . . 73.230000000000004 111.724 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.1 tmmt? -59.15 -42.11 89.91 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.214 -0.448 . . . . 74.409999999999997 111.262 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.1 -37.55 66.69 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.191 0.519 . . . . 74.129999999999995 111.279 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 HD12 ' HG1' ' A' ' 20' ' ' THR . 3.2 tm? -63.27 -47.02 84.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.84 -0.618 . . . . 74.409999999999997 111.616 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.9 ptp -59.34 -32.27 69.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.927 0.394 . . . . 64.299999999999997 111.405 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 14' ' ' LYS . 58.5 t -72.71 -32.67 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.073 0.463 . . . . 74.430000000000007 111.267 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.743 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.5 mmt85 -76.55 -43.22 40.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.463 0.542 . . . . 74.439999999999998 112.463 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.47 ' HG1' HD12 ' A' ' 16' ' ' LEU . 69.9 p -93.33 -27.09 16.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.981 0.734 . . . . 73.310000000000002 112.981 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.11 64.58 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.946 -0.645 . . . . 72.519999999999996 113.206 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mp -79.66 166.91 21.35 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.084 0.468 . . . . 72.420000000000002 111.514 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.92 164.18 14.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.212 -0.449 . . . . 63.240000000000002 112.421 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.48 -42.23 70.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.012 0.375 . . . . 74.329999999999998 112.012 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -62.47 -33.69 75.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.057 0.456 . . . . 72.230000000000004 111.231 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.42 -48.25 42.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.425 -0.352 . . . . 70.400000000000006 111.419 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.2 mt -57.14 -50.84 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.86 0.362 . . . . 71.340000000000003 111.313 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.764 0.316 . . . . 64.409999999999997 111.469 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.2 t -63.33 -39.21 93.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.943 0.402 . . . . 74.010000000000005 111.164 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.65 -16.74 55.22 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.976 0.417 . . . . 73.120000000000005 111.51 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.667 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 58.8 mtp180 -68.88 -10.93 59.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.781 0.324 . . . . 75.120000000000005 111.815 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -83.02 2.69 33.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 111.764 0.283 . . . . 62.109999999999999 111.764 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.01 -61.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.66 -0.781 . . . . 71.329999999999998 114.115 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.21 95.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.957 0.725 . . . . 63.130000000000003 112.957 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -71.71 104.43 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.038 -0.414 . . . . 74.409999999999997 111.073 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.89 121.5 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.509 -0.314 . . . . 75.209999999999994 111.23 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -59.86 131.63 51.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.34 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.501 ' HA2' ' HZ2' ' A' ' 42' ' ' LYS . . . 92.12 -31.85 5.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.541 -0.361 . . . . 71.400000000000006 113.201 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.88 -72.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.654 -0.321 . . . . 74.040000000000006 111.391 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -77.42 -7.57 56.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.958 0.355 . . . . 75.409999999999997 111.958 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 33.3 p90 -171.84 167.56 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.617 0.367 . . . . 72.430000000000007 110.773 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.501 ' HZ2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -154.02 136.54 15.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.493 0.663 . . . . 71.319999999999993 111.568 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 61.6 mtp180 -80.62 102.56 9.9 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.264 -0.88 . . . . 73.109999999999999 110.258 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.11 143.1 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.796 -0.638 . . . . 74.510000000000005 112.523 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -80.46 140.6 52.13 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 116.014 -0.539 . . . . 74.239999999999995 111.391 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.97 -35.55 76.52 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.489 2.126 . . . . 73.299999999999997 112.416 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -97.71 -46.92 5.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.225 -0.443 . . . . 65.519999999999996 111.666 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.24 -43.48 0.85 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.083 -0.579 . . . . 37.32 112.555 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 137.55 44.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 110.81 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -51.56 111.7 0.63 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.734 . . . . 64.420000000000002 112.983 -171.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.4 m -83.82 155.28 23.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.487 -0.779 . . . . 74.540000000000006 110.705 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 52' ' ' LEU . 2.6 mm? -65.2 -44.85 87.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.876 0.369 . . . . 74.319999999999993 111.478 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -86.82 -66.63 0.89 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.589 -0.278 . . . . 75.030000000000001 111.525 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.52 119.88 1.63 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.262 -0.494 . . . . 54.409999999999997 113.442 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.1 m -66.55 113.93 5.13 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.602 -0.352 . . . . 73.340000000000003 110.237 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -84.5 110.32 18.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.383 0.512 . . . . 65.409999999999997 112.383 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -98.59 126.87 44.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.114 -0.494 . . . . 74.439999999999998 110.272 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.415 ' HB3' HD12 ' A' ' 63' ' ' ILE . 84.5 m-85 -93.33 144.75 25.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.919 0.341 . . . . 71.010000000000005 111.919 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 62' ' ' GLU . 59.1 t30 -82.64 94.47 7.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 73.150000000000006 111.049 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.508 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 70.7 t80 -51.38 -53.31 50.9 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 113.299 0.852 . . . . 74.109999999999999 113.299 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -49.66 -36.86 42.47 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.274 1.982 . . . . 74.129999999999995 113.219 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 22.2 mt-10 -81.43 -29.5 33.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.754 0.65 . . . . 73.420000000000002 112.754 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 67' ' ' ILE . 64.7 mt -70.46 -38.78 75.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.956 -0.465 . . . . 73.540000000000006 110.706 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -62.42 -39.08 92.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.191 0.519 . . . . 74.230000000000004 110.495 169.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 59.9 tttp -56.78 -37.16 70.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.883 -0.598 . . . . 70.239999999999995 110.877 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -72.17 -41.25 67.26 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.869 0.366 . . . . 72.230000000000004 111.031 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 63' ' ' ILE . 67.8 mt -53.29 -39.18 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.481 -0.327 . . . . 74.409999999999997 111.267 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -53.64 -36.68 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.729 0.3 . . . . 75.099999999999994 111.611 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.25 -25.77 27.07 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.04 0.448 . . . . 73.140000000000001 110.998 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.0 t -59.49 -36.35 75.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.821 0.343 . . . . 61.329999999999998 111.901 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.32 -21.28 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.018 0.377 . . . . 74.140000000000001 112.018 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -61.24 105.59 0.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.144 0.497 . . . . 74.310000000000002 111.983 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -59.38 133.0 55.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.152 -0.476 . . . . 63.399999999999999 111.518 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -74.51 -67.22 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.15 0.5 . . . . 71.230000000000004 110.867 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -142.55 111.18 6.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.131 -0.486 . . . . 74.340000000000003 110.646 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -71.81 93.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.151 0.5 . . . . 73.400000000000006 111.102 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -77.79 2.16 17.95 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.831 1.048 . . . . 62.119999999999997 113.831 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 66.6 m80 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.918 -0.563 . . . . 74.319999999999993 111.951 176.304 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.99 0.424 . . . . 70.349999999999994 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.92 101.68 12.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.969 0.414 . . . . 64.340000000000003 111.208 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -129.81 160.27 34.01 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.884 0.373 . . . . 74.530000000000001 111.365 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' A' ' 7' ' ' ASN . 47.7 mm -86.91 92.71 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.923 0.392 . . . . 72.349999999999994 111.769 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -99.27 112.44 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.931 0.396 . . . . 74.200000000000003 111.392 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.2 t80 60.05 7.77 1.28 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.629 0.974 . . . . 61.219999999999999 113.629 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.454 ' HB3' HG21 ' A' ' 4' ' ' ILE . 5.5 t30 -72.8 71.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.54 -0.725 . . . . 72.540000000000006 109.742 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.77 -170.99 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.646 -0.707 . . . . 72.439999999999998 111.386 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 60' ' ' TYR . 9.2 tp10 -151.39 111.38 4.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.027 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -119.83 143.2 48.01 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.272 -0.268 . . . . 75.219999999999999 111.093 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.621 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.8 ptp -164.7 171.88 13.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.657 0.614 . . . . 73.019999999999996 112.657 -176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.87 -179.99 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.977 -0.556 . . . . 73.530000000000001 111.335 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.88 -58.08 9.71 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.532 0.568 . . . . 52.43 112.532 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 1.4 tmmt? -61.92 -29.13 70.02 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.49 -0.323 . . . . 63.439999999999998 111.619 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.67 -37.02 42.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.238 0.542 . . . . 72.420000000000002 111.158 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.621 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.5 -49.92 74.82 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.78 -0.646 . . . . 72.310000000000002 111.019 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.539 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 24.0 ptp -55.95 -36.03 67.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.025 0.379 . . . . 74.109999999999999 112.025 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.1 t -65.75 -43.46 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.194 0.442 . . . . 75.439999999999998 112.194 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' HD2' ' HE1' ' A' ' 11' ' ' MET . 86.4 mtt180 -85.23 -18.63 33.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.096 0.406 . . . . 74.340000000000003 112.096 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.432 ' HG1' HD12 ' A' ' 16' ' ' LEU . 77.9 p -100.58 -26.98 13.65 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.331 0.493 . . . . 63.130000000000003 112.331 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.81 24.8 29.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.091 -0.576 . . . . 73.239999999999995 113.176 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.6 mp -102.49 -178.86 3.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.211 0.529 . . . . 75.519999999999996 111.654 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.2 163.41 21.78 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.902 -0.59 . . . . 72.420000000000002 111.987 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.51 -46.1 77.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.096 0.448 . . . . 64.310000000000002 112.162 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.3 tmt_? -64.12 -34.41 77.98 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.115 0.483 . . . . 72.129999999999995 110.749 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.13 -42.4 69.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.918 0.389 . . . . 72.25 110.927 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.36 -50.48 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.357 -0.383 . . . . 74.430000000000007 111.793 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.97 -30.52 66.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.889 0.376 . . . . 75.409999999999997 111.146 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 t -62.44 -38.97 91.84 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.305 -0.407 . . . . 71.310000000000002 111.195 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -75.32 -31.11 60.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.46 -0.336 . . . . 73.430000000000007 111.67 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 21.4 mtm180 -64.88 -11.17 34.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.185 0.439 . . . . 74.510000000000005 112.185 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.23 11.01 24.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.424 -0.353 . . . . 74.140000000000001 111.926 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.53 -50.65 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.329 -0.939 . . . . 63.140000000000001 114.433 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.21 80.09 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.234 0.457 . . . . 74.129999999999995 112.234 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.07 123.49 22.94 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.907 0.384 . . . . 73.230000000000004 111.145 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.84 132.67 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.37 -0.377 . . . . 74.349999999999994 111.125 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.23 146.63 47.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.864 0.364 . . . . 70.200000000000003 111.596 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 -53.66 2.99 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.39 -0.368 . . . . 73.129999999999995 112.638 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.85 -65.8 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.413 0.523 . . . . 73.099999999999994 112.413 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -96.74 -16.96 20.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.932 0.716 . . . . 62.229999999999997 112.932 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 36.5 p90 -161.41 174.81 12.93 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.389 -0.195 . . . . 74.409999999999997 111.154 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.43 154.4 26.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.084 0.469 . . . . 72.510000000000005 112.099 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -79.43 122.9 26.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 112.173 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.37 104.15 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.204 0.526 . . . . 75.349999999999994 110.872 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.1 p -87.25 155.93 54.45 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.097 -0.501 . . . . 71.549999999999997 110.947 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.55 -49.42 6.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.205 2.604 . . . . 73.040000000000006 114.257 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -105.72 12.75 30.64 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.625 0.602 . . . . 62.5 112.625 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.08 30.78 78.82 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.639 -0.791 . . . . 70.209999999999994 112.057 -173.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.12 3.78 37.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.482 0.713 . . . . 72.040000000000006 112.029 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 65.74 2.57 2.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.122 0.786 . . . . 75.340000000000003 113.122 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.5 m -64.27 151.34 43.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.002 -0.436 . . . . 65.140000000000001 110.969 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.597 ' H ' HD21 ' A' ' 52' ' ' LEU . 2.6 mm? -59.87 -34.24 72.89 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.487 0.551 . . . . 74.540000000000006 112.487 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -78.27 86.18 4.38 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.204 0.526 . . . . 74.549999999999997 110.973 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.43 37.08 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.785 -0.643 . . . . 73.329999999999998 112.933 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 135.99 35.45 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.94 0.4 . . . . 72.510000000000005 111.688 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -96.76 105.52 17.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.254 0.464 . . . . 73.239999999999995 112.254 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -86.0 152.03 23.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.328 -0.396 . . . . 74.200000000000003 110.905 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' A' ' 63' ' ' ILE . 41.3 m-85 -117.14 146.24 43.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.121 0.486 . . . . 75.019999999999996 111.829 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.54 108.78 19.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.986 -0.552 . . . . 63.439999999999998 110.915 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 81.9 t80 -56.79 -48.73 96.79 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.931 0.715 . . . . 65.420000000000002 112.931 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 18.0 Cg_endo -58.33 -33.45 97.74 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.9 1.733 . . . . 64.140000000000001 112.681 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -69.54 -48.2 61.18 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 111.12 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD12 ' HB3' ' A' ' 58' ' ' TYR . 69.7 mt -65.71 -36.86 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.023 0.44 . . . . 75.319999999999993 111.152 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.66 -37.06 82.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.193 -0.458 . . . . 65.010000000000005 110.585 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.6 -38.65 85.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.094 -0.503 . . . . 75.420000000000002 110.936 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -66.45 -53.53 34.36 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.008 -0.542 . . . . 74.150000000000006 111.062 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.69 -38.47 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.884 0.373 . . . . 74.329999999999998 111.451 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -57.93 -35.41 71.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.001 0.429 . . . . 73.420000000000002 111.186 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.69 -43.48 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.333 -0.394 . . . . 63.329999999999998 111.724 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.0 m -74.33 -54.13 8.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.286 0.476 . . . . 75.349999999999994 112.286 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.9 tp -75.78 -43.0 48.64 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.042 0.386 . . . . 63.329999999999998 112.042 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 70.09 -52.05 0.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.05 0.759 . . . . 75.25 113.05 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -52.47 109.47 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.272 0.558 . . . . 73.040000000000006 112.287 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -67.15 139.94 57.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.049 -0.523 . . . . 75.030000000000001 110.769 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -153.53 151.99 30.43 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.079 0.4 . . . . 53.350000000000001 112.079 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -129.42 146.88 51.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 111.194 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -78.83 -33.71 45.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 73.420000000000002 110.726 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.94 -0.552 . . . . 72.519999999999996 111.459 179.5 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.699 0.285 . . . . 74.409999999999997 111.07 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.94 157.93 36.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.664 0.269 . . . . 75.400000000000006 111.417 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -152.76 148.91 27.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.308 0.485 . . . . 65.510000000000005 112.308 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.8 mm -113.86 90.68 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.223 0.535 . . . . 74.420000000000002 109.816 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.8 mt -133.09 103.11 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.056 0.455 . . . . 74.420000000000002 111.606 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -160.84 99.69 1.25 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.941 -0.572 . . . . 72.129999999999995 110.171 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -132.63 111.84 11.53 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.999 0.428 . . . . 70.519999999999996 111.442 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.55 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 4.6 mp0 -74.49 81.26 1.95 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.176 0.512 . . . . 62.109999999999999 110.525 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.06 109.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.73 -0.668 . . . . 75.319999999999993 111.882 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 95.7 m95 -85.68 136.45 33.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.472 173.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.0 ptp -153.89 154.86 34.64 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.978 0.418 . . . . 75.329999999999998 111.73 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.29 166.27 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.889 0.376 . . . . 73.140000000000001 111.415 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.86 -44.01 86.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.016 0.436 . . . . 75.230000000000004 111.986 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.2 tmmt? -63.71 -32.94 74.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.293 -0.412 . . . . 71.329999999999998 111.527 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.21 -35.94 47.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.041 0.448 . . . . 73.219999999999999 111.149 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.32 -46.21 87.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.838 -0.619 . . . . 74.299999999999997 111.003 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.475 ' HB3' HD13 ' A' ' 27' ' ' ILE . 23.2 ptp -59.87 -34.29 72.95 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.723 0.296 . . . . 72.230000000000004 111.488 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 14' ' ' LYS . 66.9 t -69.18 -40.29 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.881 0.372 . . . . 74.319999999999993 111.209 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.566 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 12.2 mmt85 -66.15 -44.66 83.48 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.996 0.427 . . . . 75.030000000000001 112.099 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 p -93.79 -25.15 17.51 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.034 0.753 . . . . 71.310000000000002 113.034 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.23 64.51 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.211 -0.518 . . . . 74.200000000000003 113.186 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 ' HG ' ' NE2' ' A' ' 26' ' ' GLN . 9.0 mp -74.66 173.41 10.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.367 0.603 . . . . 72.030000000000001 112.167 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.85 170.35 17.73 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.086 -0.506 . . . . 64.209999999999994 112.317 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.8 66.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.212 0.449 . . . . 73.230000000000004 112.212 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -64.82 -29.43 70.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.865 0.365 . . . . 72.530000000000001 111.961 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 47.9 tt0 -76.97 -42.67 38.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.839 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 63.0 mt -63.72 -49.03 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.584 -0.28 . . . . 75.109999999999999 111.683 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.25 -35.03 59.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.771 0.319 . . . . 75.129999999999995 111.38 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 t -63.06 -50.7 69.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 72.109999999999999 110.69 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.72 -35.63 74.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.027 -0.533 . . . . 73.540000000000006 111.412 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 50.1 mtp180 -62.13 -19.98 63.6 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 74.200000000000003 111.44 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.97 -8.54 14.83 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.392 -0.367 . . . . 73.400000000000006 111.989 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.6 41.62 0.97 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.81 -0.71 . . . . 75.409999999999997 114.109 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.33 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.293 0.568 . . . . 71.5 111.377 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.39 141.91 48.71 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.458 0.646 . . . . 72.430000000000007 112.14 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.3 mt -138.65 135.13 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.573 -0.74 . . . . 72.540000000000006 110.236 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.47 130.62 45.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.094 0.473 . . . . 73.150000000000006 112.062 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.67 -26.68 1.64 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.352 -0.385 . . . . 63.399999999999999 113.946 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.2 t -94.91 -40.35 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.292 -0.534 . . . . 74.329999999999998 112.238 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.466 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 48.5 m80 -121.52 -9.72 8.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.425 0.528 . . . . 72.0 112.425 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -165.04 159.25 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.866 0.365 . . . . 75.420000000000002 111.831 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 55.8 pttt -153.82 153.35 31.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.029 0.443 . . . . 65.099999999999994 111.422 174.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.39 141.57 45.09 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.93 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t -107.93 145.06 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.797 0.332 . . . . 75.420000000000002 111.083 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -52.1 129.78 40.24 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.855 -0.611 . . . . 64.140000000000001 112.396 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.91 -32.99 49.68 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.849 2.366 . . . . 72.150000000000006 113.277 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.6 m 68.33 -5.2 0.95 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.833 1.049 . . . . 75.450000000000003 113.833 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.26 -119.07 0.86 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.639 -0.791 . . . . 61.43 114.183 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.08 -12.81 54.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.922 0.712 . . . . 64.400000000000006 112.922 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -60.54 133.74 56.39 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.9 0.381 . . . . 75.140000000000001 111.187 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -73.25 -172.06 1.05 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.129 0.49 . . . . 74.450000000000003 111.785 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.417 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.9 mm? -62.9 -13.94 40.46 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.002 0.371 . . . . 71.109999999999999 112.002 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -60.04 -47.17 86.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.062 0.458 . . . . 73.540000000000006 111.566 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.67 -151.13 45.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.263 -0.494 . . . . 62.219999999999999 112.947 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -148.25 133.18 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 122.545 -0.385 . . . . 74.310000000000002 110.692 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.1 m -102.93 121.75 43.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.188 0.44 . . . . 73.430000000000007 112.188 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -107.85 146.53 32.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.604 176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 63' ' ' ILE . 23.2 m-85 -106.85 154.06 21.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.791 0.663 . . . . 75.010000000000005 112.791 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.64 101.67 12.34 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.651 -0.704 . . . . 72.400000000000006 111.925 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 80.3 t80 -51.61 -50.85 74.77 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 112.762 0.653 . . . . 74.25 112.762 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.55 ' HG3' ' HA ' ' A' ' 8' ' ' GLU . 17.2 Cg_endo -56.13 -53.53 5.28 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.159 1.906 . . . . 74.420000000000002 113.273 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -64.81 -23.62 67.3 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.594 0.59 . . . . 61.130000000000003 112.594 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 58' ' ' TYR . 75.9 mt -82.09 -46.32 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.052 -0.405 . . . . 74.420000000000002 111.379 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.17 -40.95 82.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.512 0.673 . . . . 74.040000000000006 109.973 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -52.81 -48.71 66.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.152 -0.931 . . . . 64.340000000000003 111.39 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.77 -37.77 79.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.457 -0.338 . . . . 73.209999999999994 111.147 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.71 -40.51 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.863 0.364 . . . . 74.409999999999997 111.0 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -57.08 -58.96 5.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.176 0.512 . . . . 74.219999999999999 110.166 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.45 -18.36 65.31 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.088 -0.505 . . . . 73.409999999999997 111.941 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.0 t -79.89 -23.08 42.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.174 0.512 . . . . 54.329999999999998 110.846 172.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.53 -61.3 1.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 111.5 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -71.86 85.44 0.95 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.648 0.261 . . . . 72.310000000000002 111.168 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -60.33 98.71 0.06 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.756 0.65 . . . . 75.530000000000001 112.756 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -148.59 -24.37 0.32 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.759 -0.655 . . . . 73.219999999999999 111.023 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -93.14 123.16 36.21 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.448 -0.342 . . . . 64.239999999999995 110.828 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -82.93 145.84 29.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.125 0.488 . . . . 74.430000000000007 111.832 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -68.6 112.36 5.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.975 -0.557 . . . . 74.409999999999997 111.762 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.2 t60 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.636 -0.697 . . . . 73.430000000000007 110.951 174.446 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.672 0.272 . . . . 72.430000000000007 111.686 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 87.88 0.73 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.385 0.513 . . . . 73.409999999999997 112.385 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -90.14 121.46 32.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.112 0.482 . . . . 73.140000000000001 110.573 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.63 88.79 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.219 0.533 . . . . 74.299999999999997 111.662 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.7 mm -87.9 64.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.94 0.876 . . . . 73.409999999999997 110.101 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -148.68 132.73 17.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 74.120000000000005 110.373 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -122.3 -177.74 3.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.882 0.372 . . . . 74.409999999999997 110.817 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 61' ' ' PRO . 50.5 mt-10 -113.75 91.15 3.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.889 0.376 . . . . 65.340000000000003 110.312 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HB3' ' HE3' ' A' ' 11' ' ' MET . 7.5 mp0 -70.44 104.37 2.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 63.439999999999998 111.635 175.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 82.2 m95 -98.64 118.77 36.1 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.562 -0.29 . . . . 74.099999999999994 110.845 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.1 pmm? -133.26 172.37 12.77 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.533 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.53 162.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.096 -0.502 . . . . 65.030000000000001 111.375 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.54 -42.5 83.03 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.179 0.437 . . . . 73.219999999999999 112.179 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -59.55 -37.87 79.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.994 0.426 . . . . 73.329999999999998 110.968 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.6 45.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.97 0.414 . . . . 72.25 111.328 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -50.61 73.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.603 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.406 ' HB3' HD12 ' A' ' 27' ' ' ILE . 23.6 ptp -58.39 -37.06 74.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.756 0.312 . . . . 72.439999999999998 111.803 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.5 t -69.64 -48.22 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 111.829 0.307 . . . . 75.030000000000001 111.829 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.04 -28.88 66.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.286 0.476 . . . . 73.400000000000006 112.286 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -93.88 -29.25 15.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.489 0.552 . . . . 64.329999999999998 112.489 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.86 56.59 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 52.030000000000001 112.564 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' HG ' ' HG2' ' A' ' 26' ' ' GLN . 8.3 mp -82.2 -178.17 6.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.399 0.619 . . . . 75.25 111.627 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -133.27 171.09 21.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.981 -0.554 . . . . 64.129999999999995 111.909 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.83 -51.39 66.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.283 0.475 . . . . 73.439999999999998 112.283 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -66.46 -30.01 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.159 0.504 . . . . 73.230000000000004 111.504 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 5.2 tp-100 -66.98 -48.46 68.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.066 0.46 . . . . 75.219999999999999 110.918 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.496 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 64.5 mt -60.79 -52.09 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.343 -0.39 . . . . 71.420000000000002 111.296 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.2 -33.6 69.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.507 0.194 . . . . 74.239999999999995 111.409 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -61.23 -37.51 83.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.929 0.395 . . . . 74.150000000000006 110.981 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -80.26 -30.07 38.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.894 0.378 . . . . 70.450000000000003 111.808 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 67.8 mtp180 -64.13 -15.56 59.99 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.925 0.393 . . . . 75.310000000000002 111.854 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -68.08 -22.65 64.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.537 -0.301 . . . . 74.010000000000005 111.8 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.48 -45.07 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 120.661 -0.781 . . . . 63.32 114.342 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.75 -31.4 71.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.012 0.745 . . . . 73.0 113.012 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.18 104.69 3.72 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.455 0.645 . . . . 75.129999999999995 111.829 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.92 123.58 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.565 -0.743 . . . . 74.219999999999999 111.279 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.22 147.19 48.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.112 0.482 . . . . 72.0 111.395 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.53 -58.92 3.75 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.121 -0.49 . . . . 61.329999999999998 113.164 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.81 -56.11 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.439 0.533 . . . . 73.109999999999999 112.439 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 52.9 m80 -92.24 -23.54 19.3 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.501 0.556 . . . . 75.019999999999996 112.501 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 15.4 p90 -163.68 149.58 11.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.536 -0.172 . . . . 65.120000000000005 110.536 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -147.76 147.57 30.02 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.092 0.472 . . . . 74.129999999999995 112.264 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -79.7 117.87 21.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.853 -0.612 . . . . 74.150000000000006 111.775 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.57 128.8 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.774 0.321 . . . . 73.430000000000007 111.051 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.9 p -67.81 154.58 93.3 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 112.38 0.511 . . . . 63.340000000000003 112.38 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -58.08 -44.84 35.99 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.419 2.08 . . . . 75.439999999999998 112.517 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 t -163.97 123.14 1.98 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.08 0.4 . . . . 73.030000000000001 112.08 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.73 -94.22 0.28 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 115.151 0.82 . . . . 65.239999999999995 115.151 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -67.7 158.79 31.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.519 0.933 . . . . 75.230000000000004 113.519 -171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -76.92 86.89 3.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.431 -0.804 . . . . 74.5 111.429 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.3 m -92.59 148.04 22.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.974 0.416 . . . . 75.109999999999999 111.477 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.8 mm? -70.91 -14.03 62.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.897 0.703 . . . . 71.439999999999998 112.897 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.77 107.28 11.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.775 0.321 . . . . 75.510000000000005 110.671 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.6 -168.96 15.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.116 -0.564 . . . . 54.030000000000001 113.606 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 m -86.36 123.7 31.9 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.859 0.361 . . . . 73.140000000000001 111.543 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -91.96 114.88 27.54 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.709 0.29 . . . . 74.25 111.418 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -100.3 144.3 29.47 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.734 -0.212 . . . . 74.409999999999997 110.856 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 94.0 m-85 -110.27 144.46 38.94 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.254 0.549 . . . . 75.530000000000001 112.135 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 40.6 t-20 -87.86 92.07 8.99 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.801 -0.636 . . . . 74.230000000000004 110.943 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.568 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 66.0 t80 -46.98 -53.04 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.972 0.73 . . . . 73.400000000000006 112.972 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.711 ' HG2' ' HA ' ' A' ' 8' ' ' GLU . 75.6 Cg_exo -52.29 -39.19 73.06 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.171 1.914 . . . . 71.349999999999994 113.399 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 52.9 mm-40 -72.03 -34.12 68.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.3 0.481 . . . . 74.510000000000005 112.3 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.54 -49.94 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 75.319999999999993 110.464 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 58.5 t30 -54.1 -46.83 72.21 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.151 0.501 . . . . 63.200000000000003 110.662 176.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.87 -46.13 67.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.661 . . . . 65.439999999999998 111.536 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -57.2 -50.6 72.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 111.478 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 -57.22 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.861 0.363 . . . . 74.010000000000005 111.586 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 16.0 mmt180 -54.32 -46.16 72.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.304 0.483 . . . . 75.329999999999998 112.304 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -23.24 66.99 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 64.219999999999999 111.443 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.3 m -75.22 -30.25 60.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.522 -0.308 . . . . 74.530000000000001 111.17 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.71 -41.27 75.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.799 0.333 . . . . 65.310000000000002 110.957 175.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.6 108.66 2.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.919 0.39 . . . . 74.209999999999994 111.148 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -61.71 -35.01 76.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.401 0.62 . . . . 74.340000000000003 110.148 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -142.54 112.31 6.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.402 -0.817 . . . . 64.129999999999995 109.676 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -47.78 101.57 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.219 0.608 . . . . 73.420000000000002 112.292 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -81.85 -29.61 32.45 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.238 -0.437 . . . . 70.209999999999994 112.027 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -73.15 109.05 6.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.279 0.474 . . . . 74.310000000000002 112.279 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.226 0 N-CA-C 112.052 0.39 . . . . 72.140000000000001 112.052 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.652 0.263 . . . . 73.329999999999998 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.54 94.04 4.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.034 0.445 . . . . 62.340000000000003 112.194 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -133.51 149.51 51.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.37 -0.377 . . . . 73.239999999999995 110.983 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.02 105.0 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.511 -0.313 . . . . 74.150000000000006 110.686 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -76.42 115.65 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.475 -0.33 . . . . 75.409999999999997 110.382 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -67.85 92.8 0.37 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.309 0.576 . . . . 74.239999999999995 111.674 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.3 147.2 25.62 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.349 0.595 . . . . 74.25 111.722 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.55 110.55 11.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.464 0.649 . . . . 74.239999999999995 110.497 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -92.38 82.21 4.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.182 0.515 . . . . 73.299999999999997 112.355 -171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 76.3 m95 -94.49 149.44 21.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.778 -0.646 . . . . 65.120000000000005 110.606 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.6 ptp -159.05 151.58 21.59 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.032 0.444 . . . . 75.340000000000003 111.778 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.33 167.71 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.155 0.428 . . . . 73.439999999999998 112.155 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.21 -54.5 46.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.461 0.541 . . . . 74.409999999999997 112.461 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -35.48 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.424 -0.353 . . . . 71.450000000000003 111.551 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.81 60.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.115 0.484 . . . . 73.109999999999999 111.289 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.9 -53.59 56.53 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.812 -0.631 . . . . 44.409999999999997 111.046 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.439 ' HB3' HD13 ' A' ' 27' ' ' ILE . 23.7 ptp -54.24 -40.34 67.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.846 0.313 . . . . 70.349999999999994 111.846 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -70.4 -42.49 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.95 0.405 . . . . 74.209999999999994 112.077 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.627 0.603 . . . . 75.299999999999997 112.627 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -107.17 -28.45 9.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.929 0.395 . . . . 71.329999999999998 111.893 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.88 5.22 59.91 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.233 -0.508 . . . . 72.310000000000002 112.715 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.3 mp -82.29 160.9 22.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.197 0.522 . . . . 70.439999999999998 111.428 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.89 160.9 13.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.091 -0.576 . . . . 55.130000000000003 112.447 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.82 -41.17 61.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.938 0.369 . . . . 74.040000000000006 111.861 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 25' ' ' ARG . 8.1 ptp180 -62.56 -32.19 73.12 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.135 0.493 . . . . 73.299999999999997 111.612 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.51 -37.8 35.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.003 0.43 . . . . 73.129999999999995 111.017 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 17' ' ' MET . 59.3 mt -63.99 -49.36 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.39 -0.368 . . . . 70.439999999999998 111.095 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.75 -35.63 76.86 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.858 0.361 . . . . 74.129999999999995 110.985 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.6 t -60.75 -37.61 82.4 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 64.329999999999998 111.278 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -72.83 -37.82 67.32 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.96 0.41 . . . . 74.109999999999999 111.504 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 24.7 mtm180 -65.46 -10.41 33.88 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.228 0.455 . . . . 74.200000000000003 112.228 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -59.95 -30.95 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.759 0.281 . . . . 75.400000000000006 111.759 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.99 31.94 0.05 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.308 -0.949 . . . . 73.109999999999999 114.721 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.12 -24.86 4.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.412 0.606 . . . . 54.229999999999997 111.428 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -83.28 129.32 35.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.029 -0.532 . . . . 75.340000000000003 111.731 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.9 mt -130.87 137.27 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.697 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.69 153.17 43.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 111.157 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.26 -49.95 3.89 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.487 -0.387 . . . . 64.310000000000002 112.496 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.36 -57.49 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 74.409999999999997 112.043 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -101.67 -23.76 14.2 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.094 0.776 . . . . 74.409999999999997 113.094 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -161.92 172.48 15.95 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.315 -0.24 . . . . 62.399999999999999 111.484 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -154.74 160.66 41.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.911 0.386 . . . . 74.0 111.786 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -87.48 137.09 32.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.026 0.441 . . . . 74.510000000000005 111.443 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.3 t -108.26 127.79 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.986 0.422 . . . . 73.340000000000003 111.777 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.567 ' HG ' ' HG3' ' A' ' 49' ' ' GLU . 43.2 t -90.35 115.18 63.49 Favored Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 116.23 -0.441 . . . . 61.420000000000002 111.259 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 6.4 Cg_exo -73.72 80.82 1.97 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.679 2.252 . . . . 73.430000000000007 112.516 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.7 m 55.59 33.52 21.33 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.122 0.487 . . . . 74.319999999999993 111.359 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.16 123.77 4.46 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.558 -0.617 . . . . 73.519999999999996 111.558 -173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HG3' ' HG ' ' A' ' 45' ' ' SER . 46.5 mt-10 -72.39 81.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.124 0.488 . . . . 71.450000000000003 112.109 -174.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 50' ' ' LYS . 8.2 mmpt? -111.53 11.89 21.32 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.222 0.534 . . . . 63.109999999999999 110.984 171.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 p -112.15 144.92 40.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.825 -0.625 . . . . 73.099999999999994 110.562 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.84 3.71 52.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.941 0.401 . . . . 71.049999999999997 111.076 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -119.99 80.95 1.66 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.863 0.364 . . . . 72.010000000000005 111.187 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.54 131.94 12.66 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.98 -0.628 . . . . 62.539999999999999 113.16 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 m -84.16 114.74 22.0 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.63 -0.335 . . . . 73.530000000000001 110.744 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -90.44 127.25 36.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.093 0.473 . . . . 64.129999999999995 111.952 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 29.0 m95 -104.4 132.8 50.24 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.156 -0.474 . . . . 75.209999999999994 110.657 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HB3' HD12 ' A' ' 63' ' ' ILE . 52.2 m-85 -104.36 147.01 28.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.336 -0.393 . . . . 73.450000000000003 111.88 -176.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -78.78 106.59 10.89 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.837 0.351 . . . . 63.219999999999999 111.422 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.508 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.1 t80 -53.49 -50.21 84.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 112.701 0.63 . . . . 54.409999999999997 112.701 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 21.0 Cg_endo -59.15 -42.82 47.01 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.11 1.873 . . . . 70.209999999999994 113.254 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -66.55 -40.12 88.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 111.892 0.33 . . . . 75.430000000000007 111.892 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 58' ' ' TYR . 67.5 mt -67.87 -41.8 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.707 0.289 . . . . 72.129999999999995 110.786 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -60.39 -41.26 93.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.901 0.381 . . . . 72.019999999999996 110.744 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.38 -42.59 92.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.075 0.464 . . . . 72.409999999999997 110.75 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.0 -38.13 89.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 110.984 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' ILE . 80.7 mt -59.26 -44.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.541 -0.299 . . . . 74.239999999999995 110.728 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 68' ' ' ARG . 27.8 mmt180 -57.27 -51.13 70.6 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.238 0.542 . . . . 74.349999999999994 110.561 175.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -56.85 -34.88 68.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.385 -0.825 . . . . 64.439999999999998 111.832 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -84.14 -46.16 12.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.832 0.678 . . . . 74.219999999999999 112.832 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.5 tp -75.83 -37.65 58.84 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.02 0.748 . . . . 72.430000000000007 113.02 -170.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -57.26 99.99 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.054 0.454 . . . . 75.230000000000004 111.221 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -79.17 80.07 5.55 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.9 0.333 . . . . 73.430000000000007 111.9 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -111.22 1.04 16.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.741 0.305 . . . . 73.540000000000006 111.599 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -164.92 118.0 1.25 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.734 0.302 . . . . 71.219999999999999 111.001 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.07 132.46 45.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.37 . . . . 73.319999999999993 111.9 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -113.58 3.3 15.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.497 0.665 . . . . 75.310000000000002 109.736 170.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.46 -0.791 . . . . 72.209999999999994 110.822 175.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.281 0.562 . . . . 74.14 111.459 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -89.7 128.02 36.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.753 -0.658 . . . . 74.32 109.926 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.591 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.5 ptp -148.55 149.13 31.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.881 0.372 . . . . 53.04 111.771 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.85 176.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.249 0.462 . . . . 64.13 112.249 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.34 -57.61 11.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.547 0.573 . . . . 65.04 112.547 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.9 tmmt? -63.7 -34.41 77.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.419 -0.355 . . . . 72.33 111.79 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.5 -42.52 74.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.131 0.491 . . . . 75.04 111.128 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.08 -47.73 84.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.918 -0.583 . . . . 64.25 111.451 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.4 ptp -58.76 -32.58 69.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.781 0.324 . . . . 74.31 111.417 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' LYS . 61.4 t -74.39 -41.7 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.1 0.476 . . . . 74.45 111.391 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.591 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 13.2 mmm180 -71.28 -31.93 68.06 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.259 -0.428 . . . . 72.3 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.2 p -95.58 -30.94 13.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.47 0.544 . . . . 73.34 112.47 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.14 55.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.398 -0.43 . . . . 54.13 113.176 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' MET . 8.9 mp -90.11 174.95 7.35 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.194 0.521 . . . . 71.34 112.035 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.23 161.04 13.08 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.143 -0.48 . . . . 45.5 112.443 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.13 -42.77 63.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.528 0.566 . . . . 74.4 112.528 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -62.6 -42.78 99.77 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.098 0.475 . . . . 73.2 111.648 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.77 -36.05 77.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.006 0.431 . . . . 71.51 110.939 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.27 -43.89 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.343 -0.39 . . . . 75.34 111.404 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.25 -38.93 93.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.787 0.327 . . . . 63.41 110.489 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -60.38 -40.49 91.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 71.24 110.713 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 12.3 m-85 -66.12 -34.97 79.26 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.316 -0.402 . . . . 63.12 111.691 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.766 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 23.6 mtm180 -68.42 -21.3 64.67 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.161 0.505 . . . . 73.31 111.246 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.89 13.47 5.9 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.024 -0.535 . . . . 70.24 110.738 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.8 -81.89 0.04 OUTLIER Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.229 -0.51 . . . . 64.52 114.185 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.01 -34.52 43.94 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.145 1.165 . . . . 31.04 114.145 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.766 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -71.53 104.09 3.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.818 -0.551 . . . . 75.33 110.861 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -102.03 129.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 60.45 111.744 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -64.92 132.64 49.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.354 -0.385 . . . . 74.4 110.802 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.16 -24.86 19.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.271 -0.49 . . . . 52.23 112.929 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.23 -70.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 122.472 -0.429 . . . . 74.24 111.892 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -85.66 -12.72 50.6 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.185 0.439 . . . . 74.45 112.185 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 35' ' ' TRP . 52.9 p90 -158.99 169.32 24.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.728 0.27 . . . . 73.55 111.728 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -141.98 172.1 13.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.782 0.325 . . . . 73.23 111.158 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -105.39 109.83 21.96 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.281 0.475 . . . . 74.2 112.281 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 91.7 t . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 51.1 111.647 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.842 0.353 . . . . 71.2 111.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -92.69 119.95 32.61 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.067 0.46 . . . . 71.53 112.144 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 44' ' ' VAL . 37.2 m95 -103.78 123.68 47.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.578 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.11 150.88 19.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 65.01 111.927 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -92.42 112.17 24.01 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.195 -0.457 . . . . 75.1 111.905 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 65.4 t80 -56.25 -50.12 89.36 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 112.498 0.555 . . . . 75.22 112.498 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 50.1 Cg_exo -55.75 -41.56 76.26 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.198 1.932 . . . . 61.25 113.02 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -62.03 -44.99 95.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.48 0.657 . . . . 74.3 111.628 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.486 HD12 HD21 ' A' ' 16' ' ' LEU . 87.2 mt -69.1 -47.81 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.683 -0.69 . . . . 71.51 111.776 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.3 -31.94 69.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.775 0.322 . . . . 71.53 111.365 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -42.49 91.33 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.101 0.477 . . . . 60.24 110.011 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.8 -54.99 22.45 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.424 -0.353 . . . . 74.25 111.22 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 63.41 111.421 178.767 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 8.8 tp10 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 121.205 0.526 . . . . 74.44 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.466 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 93.7 m95 -93.57 146.09 24.06 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.074 -0.512 . . . . 71.51 111.241 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.7 ptp -160.73 159.62 30.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.937 0.399 . . . . 74.35 112.01 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.14 163.39 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.535 -0.302 . . . . 64.53 111.478 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -52.48 -47.19 66.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.326 0.491 . . . . 73.34 112.326 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -60.82 -32.05 71.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.356 -0.383 . . . . 61.4 111.31 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.61 24.83 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.034 0.445 . . . . 55.01 111.36 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -59.28 -50.61 73.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.892 -0.594 . . . . 65.44 111.05 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.6 ptp -58.27 -35.53 71.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.081 0.467 . . . . 63.41 111.481 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.4 t -72.42 -31.35 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 111.941 0.348 . . . . 65.24 111.941 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.1 -31.9 20.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.38 0.511 . . . . 73.33 112.38 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.36 -30.65 15.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.886 0.699 . . . . 70.42 112.886 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.19 4.93 62.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.887 -0.673 . . . . 53.42 113.267 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' MET . 11.0 mp -80.74 154.47 27.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.101 0.477 . . . . 75.42 111.31 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.99 165.11 25.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.053 -0.594 . . . . 55.32 112.998 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.79 -47.79 64.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.17 0.433 . . . . 74.55 112.17 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.95 -27.43 68.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.773 0.32 . . . . 70.54 111.811 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -67.91 -56.89 7.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.197 0.522 . . . . 72.42 111.099 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.36 -50.76 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.85 -0.614 . . . . 64.12 112.112 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 pt-20 -53.63 -39.76 65.23 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.852 0.316 . . . . 64.34 111.852 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -69.81 -43.45 72.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.927 0.394 . . . . 51.24 111.249 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -67.17 -28.51 68.17 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.829 0.347 . . . . 73.34 111.432 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 49.1 mtp180 -58.77 -26.8 64.38 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.192 0.441 . . . . 74.04 112.192 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -97.14 10.69 38.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.337 0.495 . . . . 52.13 112.337 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.99 -53.89 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.438 -0.887 . . . . 72.14 114.454 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.03 -23.22 31.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.311 -0.523 . . . . 73.02 112.335 -175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.436 ' HE3' ' N ' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.92 139.79 48.9 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.35 0.595 . . . . 74.2 112.151 -177.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.5 mt -134.52 125.98 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.695 -0.684 . . . . 61.3 110.305 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.21 135.88 56.44 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.0 0.429 . . . . 64.21 111.701 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -55.84 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.32 -0.4 . . . . 72.3 113.358 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.99 -46.37 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.533 0.568 . . . . 71.13 112.533 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 1.7 m-70 -110.71 -18.69 13.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.715 0.635 . . . . 70.22 112.715 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 44.1 p90 -156.74 160.85 39.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.374 0.509 . . . . 61.51 112.374 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 22.8 ptmt -148.99 150.86 33.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.847 0.356 . . . . 73.2 111.444 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -90.64 123.9 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 53.43 110.811 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 112.121 0.415 . . . . 50.45 112.121 -178.133 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 73.55 111.742 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -91.78 124.6 36.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.894 0.378 . . . . 73.25 111.763 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.12 148.04 25.88 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.317 -0.401 . . . . 71.23 111.075 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.48 149.51 36.23 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.506 -0.316 . . . . 75.42 111.801 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.48 114.54 25.21 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.27 0.47 . . . . 71.14 112.27 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 89.7 t80 -61.64 -48.83 88.98 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.482 0.549 . . . . 74.02 112.482 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 19.1 Cg_endo -57.59 -33.4 96.52 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.997 1.798 . . . . 63.12 112.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.44 -49.03 29.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.143 -0.481 . . . . 72.24 111.235 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 67' ' ' ILE . 72.9 mt -63.41 -32.09 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.354 -0.385 . . . . 72.12 110.937 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -58.71 -42.76 89.39 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.002 0.429 . . . . 61.51 110.515 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -60.73 -43.8 97.44 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 60.2 110.521 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -62.45 -33.21 74.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.315 -0.402 . . . . 73.13 111.708 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 63' ' ' ILE . 68.7 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.898 0.38 . . . . 64.5 110.942 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 121.092 0.473 . . . . 71.22 111.242 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -80.66 120.2 24.27 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.943 -0.571 . . . . 74.33 110.523 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.0 ptp -141.56 153.32 44.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 62.13 111.929 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.56 166.45 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 61.53 111.51 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -51.6 -45.37 63.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.197 0.443 . . . . 75.24 112.197 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -58.52 -50.7 72.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.831 0.348 . . . . 62.42 111.084 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -67.11 -38.03 84.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.067 0.461 . . . . 55.41 111.43 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.542 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.66 -48.56 81.26 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.974 -0.557 . . . . 72.3 111.406 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.8 ptp -59.43 -32.36 70.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.932 0.396 . . . . 53.03 111.529 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.68 -37.52 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.121 0.486 . . . . 73.24 111.306 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 31.3 mmt180 -76.33 -26.96 56.29 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.888 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.2 p -98.46 -30.85 12.3 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.305 0.483 . . . . 73.04 112.305 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.71 6.58 62.17 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.266 -0.492 . . . . 43.23 113.125 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.4 mp -85.92 160.49 19.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.194 0.521 . . . . 75.15 111.847 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.08 156.75 19.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.27 -0.491 . . . . 71.11 111.997 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.03 59.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.318 0.488 . . . . 74.42 112.318 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -21.67 66.86 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.874 0.369 . . . . 73.43 111.711 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.43 -45.42 12.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.224 0.535 . . . . 75.15 110.696 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 51.3 mt -61.11 -49.4 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.992 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.5 pt-20 -57.43 -29.98 64.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.76 0.281 . . . . 61.45 111.76 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 t -62.33 -48.1 81.32 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.182 0.515 . . . . 73.42 110.912 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -71.43 -31.03 66.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.022 -0.535 . . . . 74.41 111.774 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 27.9 mtp-105 -60.85 -19.32 59.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.067 0.395 . . . . 71.03 112.067 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.1 mm-40 -80.9 -14.86 57.63 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.501 0.556 . . . . 72.45 112.501 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.05 -48.44 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.363 -0.922 . . . . 70.41 114.313 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.25 81.34 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.286 -0.538 . . . . 75.05 112.059 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.2 104.95 5.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.069 0.461 . . . . 71.23 110.901 177.098 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -86.7 135.21 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.298 -0.41 . . . . 61.13 111.69 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.03 139.18 58.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.966 0.412 . . . . 73.32 111.613 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.03 -46.49 2.69 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.387 -0.37 . . . . 71.31 113.225 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.51 -60.1 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.35 0.5 . . . . 74.41 112.35 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -91.94 -27.37 17.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.96 0.356 . . . . 70.24 111.96 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 36.1 p90 -152.6 155.92 38.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.693 -0.231 . . . . 72.21 110.663 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.0 165.8 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.094 0.473 . . . . 74.04 112.095 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -82.54 122.24 27.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.956 -0.566 . . . . 73.03 111.525 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.094 0.473 . . . . 73.35 111.397 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 120.655 0.264 . . . . 71.32 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -111.67 108.49 17.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.428 0.529 . . . . 73.22 112.428 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -100.84 136.68 40.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.254 -0.43 . . . . 73.44 110.973 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.13 137.46 45.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.297 -0.41 . . . . 70.34 111.629 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 60.7 t30 -88.49 112.7 23.27 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.002 0.429 . . . . 74.13 111.05 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 68.0 t80 -51.1 -54.25 39.79 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.544 0.942 . . . . 75.44 113.544 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 78.4 Cg_exo -51.9 -38.07 67.81 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.133 1.888 . . . . 61.44 113.209 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -65.27 -25.86 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.195 0.442 . . . . 63.52 112.195 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.542 HD12 HD21 ' A' ' 16' ' ' LEU . 66.0 mt -86.52 -37.49 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.583 -0.28 . . . . 73.34 111.33 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.76 -39.77 68.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.36 0.6 . . . . 73.53 110.373 170.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -50.63 -44.48 57.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.499 -0.773 . . . . 75.14 111.016 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.42 -40.63 81.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.783 -0.644 . . . . 73.04 111.491 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 116.384 -0.371 . . . . 74.14 111.778 -179.352 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 9.9 tp10 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.786 0.327 . . . . 74.14 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -122.52 140.42 52.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.608 0.242 . . . . 71.41 111.373 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 pmm? -158.47 174.42 15.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.13 0.49 . . . . 72.1 111.588 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.35 171.47 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.263 -0.426 . . . . 43.43 110.926 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -58.33 -41.98 85.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.055 0.391 . . . . 74.23 112.055 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -55.56 -48.33 74.93 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.957 0.408 . . . . 61.35 111.055 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.86 -37.53 73.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.941 0.401 . . . . 52.21 111.075 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 63' ' ' ILE . 3.2 tm? -56.97 -48.99 77.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.3 -0.409 . . . . 62.32 111.164 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.9 ptp -62.23 -36.26 81.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.658 0.266 . . . . 74.21 111.236 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' LYS . 64.6 t -69.87 -36.03 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.071 0.462 . . . . 51.34 111.309 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.5 mmt180 -74.47 -37.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.127 -0.488 . . . . 74.45 112.008 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.2 p -93.14 -30.86 15.02 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.602 0.593 . . . . 63.53 112.602 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.02 -3.2 41.04 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.162 -0.542 . . . . 51.22 113.087 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.24 -175.03 4.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.366 0.603 . . . . 64.23 112.226 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.37 169.22 23.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.96 -0.564 . . . . 73.13 112.3 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.31 -49.09 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.557 0.577 . . . . 62.41 112.557 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -63.33 -23.12 67.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.992 0.425 . . . . 74.24 111.424 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -81.74 -53.92 5.81 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.16 0.505 . . . . 75.1 111.079 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.54 -43.1 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.022 -0.535 . . . . 72.51 112.343 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 pt-20 -58.75 -29.27 66.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.997 0.369 . . . . 74.43 111.997 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -67.86 -36.84 80.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.183 0.516 . . . . 72.11 110.685 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.97 -31.22 56.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.165 -0.47 . . . . 74.23 110.897 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 55.6 mtp180 -59.96 -25.33 65.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 75.15 112.061 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -95.33 12.49 28.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 64.51 111.823 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.54 -85.77 0.06 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.95 -0.643 . . . . 71.51 114.134 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.58 65.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.8 0.667 . . . . 71.52 112.8 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.04 104.64 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.531 0.682 . . . . 73.44 111.691 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -103.61 133.34 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.384 -0.825 . . . . 75.53 110.335 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.5 142.04 58.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.917 0.389 . . . . 75.44 110.999 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 -43.62 2.79 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 121.553 -0.356 . . . . 75.44 113.11 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.13 -50.86 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.579 0.585 . . . . 62.35 112.579 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -111.49 -18.56 12.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.665 0.616 . . . . 75.03 112.665 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.63 144.33 20.43 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.441 0.163 . . . . 55.21 110.602 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -121.09 156.37 32.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.158 0.504 . . . . 74.3 111.962 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -95.83 143.43 27.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.266 -0.424 . . . . 53.34 111.017 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.868 0.366 . . . . 63.41 111.545 178.14 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.92 0.39 . . . . 63.35 111.434 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -107.3 109.34 21.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.817 0.341 . . . . 64.32 110.957 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -95.68 133.9 39.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.904 0.383 . . . . 73.43 111.594 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.7 139.11 33.25 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.076 0.465 . . . . 74.13 111.591 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.18 95.08 6.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.176 -0.465 . . . . 53.15 111.42 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.679 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 69.4 t80 -55.9 -49.9 90.34 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.65 0.611 . . . . 74.31 112.65 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.8 Cg_endo -56.82 -23.7 51.9 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.193 1.929 . . . . 63.32 112.782 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.99 -44.73 10.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.794 0.294 . . . . 73.1 111.794 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 16' ' ' LEU . 74.0 mt -66.66 -48.99 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.751 0.31 . . . . 74.24 111.153 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -56.82 -47.59 79.95 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.256 0.551 . . . . 45.23 110.39 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.19 -42.2 76.76 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.663 -0.699 . . . . 73.15 111.908 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -61.51 -47.73 84.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.009 0.433 . . . . 75.34 111.099 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.462 . . . . 74.51 111.369 178.609 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 5.0 mm-40 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.191 0.52 . . . . 74.23 110.79 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 81.9 m95 -99.21 126.53 45.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.849 -0.614 . . . . 74.02 110.537 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.502 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.3 ptp -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.021 0.438 . . . . 74.5 112.021 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.93 163.8 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.255 -0.43 . . . . 70.43 111.949 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.38 -51.08 28.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.974 0.731 . . . . 75.32 112.974 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -60.89 -40.32 92.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.676 0.274 . . . . 74.12 111.654 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.29 70.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.082 0.467 . . . . 53.43 111.098 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -60.11 -50.74 72.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.659 -0.7 . . . . 74.41 111.187 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -59.01 -33.66 70.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.948 0.404 . . . . 74.55 111.64 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' LYS . 65.2 t -71.41 -42.44 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.008 0.433 . . . . 51.12 111.513 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -85.06 -8.5 58.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.018 0.747 . . . . 73.01 113.018 -176.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.7 p -110.22 -30.34 7.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.207 0.447 . . . . 74.12 112.207 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.69 -6.69 65.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.202 -0.523 . . . . 52.4 112.846 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -73.65 157.49 36.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.031 0.443 . . . . 72.42 111.576 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.56 160.72 20.42 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.125 -0.56 . . . . 62.15 112.93 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.07 61.43 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.15 0.426 . . . . 63.22 112.15 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.93 -27.4 67.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.033 0.444 . . . . 75.35 111.712 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -76.35 -36.91 57.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.125 0.488 . . . . 62.34 110.631 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 56.6 mt -68.42 -52.53 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.422 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.8 pt-20 -54.35 -37.28 64.74 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.914 0.388 . . . . 74.45 111.405 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -57.69 -53.58 56.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.09 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -65.07 -30.99 71.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.325 -0.398 . . . . 75.34 111.948 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 18.5 mtp-105 -60.47 -23.27 64.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.605 -0.27 . . . . 72.11 111.658 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -90.76 -9.38 46.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.355 0.872 . . . . 53.31 113.355 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.49 9.36 0.33 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 119.731 -1.223 . . . . 64.31 115.666 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.96 -28.79 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.904 0.852 . . . . 52.24 111.871 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.36 133.21 44.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.591 0.71 . . . . 75.4 112.493 -177.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 60.6 mt -138.47 126.46 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.419 -0.81 . . . . 71.24 110.329 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.5 139.78 51.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.371 0.605 . . . . 43.32 110.981 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.39 -15.11 59.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.059 -0.519 . . . . 53.51 112.593 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -123.89 -73.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 122.57 -0.371 . . . . 71.11 111.655 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.447 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.5 m80 -86.34 -10.87 53.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.056 0.391 . . . . 74.35 112.056 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 44.5 p90 -170.51 179.06 3.46 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.858 -0.423 . . . . 75.53 109.858 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -157.86 149.19 21.42 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.014 0.435 . . . . 74.12 111.374 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -78.69 103.94 8.97 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.232 0.539 . . . . 72.33 111.748 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 66.0 t . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 116.117 -0.492 . . . . 74.53 111.047 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.911 0.386 . . . . 74.05 110.721 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -86.7 105.76 17.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.09 0.472 . . . . 75.31 112.009 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 28.7 m95 -91.23 121.75 33.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.08 -0.509 . . . . 72.55 110.006 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' ILE . 87.5 m-85 -90.32 145.07 25.25 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.918 0.71 . . . . 72.35 112.918 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.479 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 53.2 t-20 -85.36 96.88 9.69 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.735 -0.666 . . . . 73.53 110.729 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 82.9 t80 -52.4 -53.11 56.69 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 112.543 0.571 . . . . 72.1 112.543 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 82.5 Cg_exo -51.02 -50.42 13.95 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.376 2.05 . . . . 73.54 113.588 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.6 mm-40 -71.22 -28.53 64.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.143 0.423 . . . . 75.2 112.143 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 58' ' ' TYR . 46.7 mt -70.13 -42.14 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.948 -0.47 . . . . 73.0 110.547 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -34.13 72.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.051 0.453 . . . . 75.14 110.407 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 5.7 tppp? -59.0 -31.86 69.17 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.939 -0.573 . . . . 64.32 111.279 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -85.51 -32.22 22.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 72.24 111.232 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.4 mt . . . . . 0 CA--C 1.537 0.47 0 O-C-N 122.206 -0.309 . . . . 72.44 111.467 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 70.6 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.872 0.367 . . . . 60.34 110.819 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.431 ' HH2' ' HE3' ' A' ' 42' ' ' LYS . 80.9 m95 -93.81 134.31 36.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.148 -0.478 . . . . 73.11 110.429 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 20.4 ptp -157.16 153.85 28.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.987 0.422 . . . . 74.31 112.035 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.27 170.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.203 -0.453 . . . . 71.45 110.865 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -57.55 -45.59 84.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.22 0.452 . . . . 74.41 112.22 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.1 tmmt? -61.54 -38.54 87.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.887 0.375 . . . . 75.43 111.14 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -72.21 -38.54 68.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.071 0.462 . . . . 74.52 111.1 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.32 -48.37 81.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.782 -0.645 . . . . 53.2 110.965 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -61.29 -28.03 68.9 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.808 0.337 . . . . 74.33 111.901 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.9 t -78.62 -49.19 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.911 0.386 . . . . 61.11 111.126 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -64.4 -26.88 68.65 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.0 p -99.05 -30.67 12.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.252 0.464 . . . . 65.22 112.252 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.5 -13.98 56.64 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.117 -0.563 . . . . 64.3 113.103 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.4 mp -66.99 159.9 27.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.219 0.533 . . . . 61.43 111.976 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.69 160.63 15.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.039 -0.528 . . . . 24.52 112.491 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.58 65.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.85 0.357 . . . . 71.53 111.591 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -59.27 -31.68 69.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.003 -0.544 . . . . 72.33 111.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' SER . 46.9 tt0 -84.37 -34.28 23.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.398 -0.365 . . . . 70.21 111.021 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 17' ' ' MET . 60.8 mt -66.24 -50.33 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.598 -0.274 . . . . 64.43 111.159 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 13.0 pt-20 -58.56 -23.25 58.02 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.986 0.422 . . . . 63.4 111.193 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 47.9 t -67.18 -56.04 11.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.224 -0.444 . . . . 73.11 110.54 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -65.72 -25.89 67.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.178 0.436 . . . . 65.1 112.178 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 78.8 mtp180 -60.37 -10.76 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 111.942 0.349 . . . . 73.23 111.942 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.17 -22.33 66.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.161 0.43 . . . . 73.45 112.161 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.67 -17.16 0.05 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.488 -0.863 . . . . 71.2 114.607 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.3 67.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.681 0.741 . . . . 55.55 111.816 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -71.94 105.07 3.71 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.065 0.46 . . . . 75.31 111.716 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -87.49 120.24 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.345 -0.389 . . . . 74.15 111.6 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.61 147.74 40.72 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.905 0.335 . . . . 73.22 111.905 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.15 -47.18 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.444 -0.344 . . . . 61.15 113.665 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.3 t -80.44 -63.65 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.468 0.307 . . . . 74.44 111.732 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.477 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 4.3 m-70 -86.88 -19.93 28.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.127 0.417 . . . . 74.22 112.127 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 12.3 p90 -165.97 143.48 5.49 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.795 -0.446 . . . . 64.03 109.795 175.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.431 ' HE3' ' HH2' ' A' ' 10' ' ' TRP . 19.1 ptpt -127.62 161.36 29.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.395 0.617 . . . . 73.55 112.488 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 43' ' ' ARG . 7.8 ptp180 -74.92 134.62 41.54 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.502 -0.772 . . . . 62.13 111.032 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 116.657 -0.247 . . . . 51.21 110.788 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 74.35 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.1 m -123.12 120.42 33.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.932 0.396 . . . . 75.13 111.801 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -109.94 140.11 44.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.318 -0.401 . . . . 74.11 111.108 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -99.34 139.76 34.51 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.827 0.346 . . . . 74.3 111.524 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 16.7 m120 -87.66 105.49 17.39 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.303 -0.408 . . . . 72.4 111.317 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 67.4 t80 -52.06 -52.03 65.82 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.857 0.688 . . . . 71.21 112.857 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 22.4 Cg_endo -60.01 -29.42 89.27 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.877 1.718 . . . . 60.24 112.858 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HB3' ' ND1' ' A' ' 40' ' ' HIS . 74.7 mm-40 -79.9 -39.09 31.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.194 -0.457 . . . . 71.14 112.063 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -71.69 -35.76 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.768 0.318 . . . . 64.33 110.384 174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.09 -38.24 85.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.759 0.314 . . . . 72.43 110.382 172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 39.6 ttmt -53.77 -35.46 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.073 0.463 . . . . 55.41 110.974 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.66 -50.97 10.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.149 -0.478 . . . . 42.45 111.163 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 63' ' ' ILE . 54.6 mt . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 112.462 0.541 . . . . 72.52 112.462 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.0 mm-40 . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 120.901 0.382 . . . . 64.25 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -91.98 135.75 33.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.627 -0.26 . . . . 74.05 110.526 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.7 ptp -158.81 142.41 15.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.922 0.391 . . . . 54.34 112.045 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.09 172.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 111.795 0.295 . . . . 61.04 111.795 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -46.74 -57.51 4.78 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.896 0.702 . . . . 73.44 112.896 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -54.69 -37.52 65.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.885 0.374 . . . . 73.34 111.945 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -76.11 -42.44 47.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.097 0.475 . . . . 53.33 111.143 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -58.31 -47.72 82.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.804 -0.635 . . . . 62.31 111.209 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -58.63 -34.24 70.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.847 0.356 . . . . 63.14 111.629 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.9 t -73.49 -46.14 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.154 0.502 . . . . 52.41 111.233 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.596 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 16.8 mmt180 -69.0 -29.57 67.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.131 -0.486 . . . . 74.5 112.247 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -99.96 -30.17 12.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.538 0.57 . . . . 54.33 112.538 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 -4.64 56.12 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.025 -0.607 . . . . 41.23 112.824 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.63 -173.11 1.71 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.386 0.612 . . . . 73.01 111.767 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -146.19 169.14 27.58 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.797 -0.638 . . . . 42.24 112.266 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.12 -50.69 61.17 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.221 0.452 . . . . 72.23 112.221 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -60.95 -34.76 75.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.133 0.492 . . . . 72.15 111.736 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.67 -40.37 34.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.349 -0.387 . . . . 71.44 111.599 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 23' ' ' GLY . 73.8 mt -66.04 -44.07 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.555 0.217 . . . . 54.12 111.369 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 11.7 pt-20 -56.93 -37.92 72.17 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.812 0.339 . . . . 74.11 110.905 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 t -60.69 -49.35 77.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 43.41 110.988 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -63.07 -29.38 70.77 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.805 0.298 . . . . 74.43 111.805 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.1 mtm180 -69.71 -12.31 61.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.052 0.39 . . . . 73.13 112.052 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 45.0 mt-30 -88.74 2.76 52.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.625 0.232 . . . . 74.52 111.625 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.3 -52.29 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.177 -1.011 . . . . 64.41 114.697 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.08 -38.42 31.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.465 0.913 . . . . 71.31 113.465 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -71.55 130.67 41.82 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.015 -0.428 . . . . 72.43 111.68 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.2 mt -130.59 126.31 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 122.522 0.329 . . . . 75.13 111.094 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 42' ' ' LYS . 38.5 tt0 -68.99 150.92 47.15 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.003 0.43 . . . . 44.13 110.906 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.45 2.67 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.255 -0.498 . . . . 71.45 112.841 -174.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -97.76 -64.99 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.249 0.463 . . . . 71.44 112.249 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.4 m-70 -92.06 -11.97 34.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.75 0.648 . . . . 53.13 112.75 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 47.5 p90 -170.78 174.03 5.06 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.0 0.12 . . . . 75.02 111.012 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 18.7 ptpt -167.74 174.2 7.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.424 0.631 . . . . 75.15 112.288 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -85.4 120.86 27.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.524 -0.762 . . . . 74.44 112.002 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 CA--C 1.542 0.65 0 CA-C-N 116.007 -0.542 . . . . 62.34 110.857 176.109 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.544 0.211 . . . . 73.32 110.566 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.6 m -89.61 115.25 26.86 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.069 0.461 . . . . 65.11 112.171 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -102.16 133.54 46.86 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.134 -0.484 . . . . 74.55 110.848 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.38 143.31 27.54 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.018 0.437 . . . . 73.44 111.327 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.39 105.53 13.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.322 -0.399 . . . . 71.52 111.5 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 90.2 t80 -56.95 -45.15 99.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 111.822 0.305 . . . . 74.12 111.822 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 9.1 Cg_endo -50.69 -41.78 52.76 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.405 2.07 . . . . 65.32 113.109 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 40' ' ' HIS . 42.6 mm-40 -65.87 -47.27 75.44 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.136 0.493 . . . . 64.03 111.815 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 HD21 ' A' ' 16' ' ' LEU . 65.3 mt -71.79 -37.43 62.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.975 0.417 . . . . 74.23 111.183 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.6 -43.25 99.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.281 0.562 . . . . 65.22 110.177 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -55.75 -39.49 71.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.593 -0.73 . . . . 72.0 110.81 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -65.03 -48.6 73.29 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.301 -0.409 . . . . 74.51 111.468 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 121.1 0.476 . . . . 71.55 111.461 178.828 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.029 0.442 . . . . 71.03 111.629 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -77.53 130.53 37.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.669 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.6 ptp -153.59 142.3 20.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.813 0.339 . . . . 70.33 111.779 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 15' ' ' ALA . 35.8 m -64.81 166.29 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.752 0.31 . . . . 75.52 111.819 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -52.41 -46.61 66.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.009 0.433 . . . . 70.52 111.645 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -60.13 -37.09 79.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.154 -0.475 . . . . 72.02 111.483 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -76.21 -38.97 55.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.337 0.589 . . . . 74.21 111.04 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.17 -43.11 92.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.981 -0.554 . . . . 74.43 111.299 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.519 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.1 ptp -61.06 -27.49 68.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.738 0.304 . . . . 70.35 111.35 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.4 t -67.95 -48.77 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.215 0.531 . . . . 74.22 110.805 174.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -64.82 -42.76 94.7 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.078 -0.51 . . . . 75.3 112.289 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -93.5 -30.27 15.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.048 0.758 . . . . 72.24 113.048 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.84 7.56 64.39 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.055 -0.593 . . . . 72.31 113.127 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.4 mp -79.76 160.13 26.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 63.21 111.724 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.02 153.36 16.83 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 71.32 112.002 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -41.42 62.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.203 0.501 . . . . 45.12 111.997 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.98 -27.03 69.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.412 -0.358 . . . . 72.51 111.584 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -84.9 -40.95 16.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.152 0.501 . . . . 72.14 110.755 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.71 -40.0 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.253 -0.43 . . . . 61.24 112.03 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.487 ' HB3' ' NH2' ' A' ' 31' ' ' ARG . 11.7 pt-20 -62.19 -34.32 76.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.901 0.381 . . . . 74.43 111.253 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 35.8 t -62.43 -27.6 69.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.245 0.545 . . . . 74.24 110.773 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -88.43 -31.61 18.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.274 -0.421 . . . . 72.2 111.646 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 55.2 mtm180 -64.35 -20.52 66.16 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.296 0.48 . . . . 73.35 112.296 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 29' ' ' SER . 13.6 pt20 -79.03 -8.11 58.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.435 0.531 . . . . 75.11 112.435 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.32 -49.08 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.199 -1.0 . . . . 73.25 114.642 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.33 85.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 73.54 112.463 -176.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.13 106.29 4.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.043 0.449 . . . . 75.21 111.675 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -96.87 131.71 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.529 -0.305 . . . . 72.32 111.211 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.83 147.32 53.56 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.044 0.449 . . . . 72.15 111.4 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.68 -46.03 3.01 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.254 -0.498 . . . . 62.32 112.872 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.56 -62.79 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.305 0.483 . . . . 71.14 112.305 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -93.91 -21.01 19.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.918 0.71 . . . . 50.01 112.918 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -153.24 168.22 26.72 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.862 0.301 . . . . 74.51 111.46 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -136.16 165.29 26.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.21 0.529 . . . . 64.0 111.424 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -86.79 136.71 32.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.688 -0.687 . . . . 62.03 110.173 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 78.4 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.216 0.531 . . . . 25.23 111.656 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 26.5 m . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.009 0.433 . . . . 71.11 111.17 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.8 m -91.9 110.2 21.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.718 0.636 . . . . 74.24 112.718 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -104.35 128.21 52.14 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.514 . . . . 74.24 111.008 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' OH ' ' HD3' ' A' ' 31' ' ' ARG . 15.8 m-85 -90.87 157.55 17.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 74.25 112.022 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 19.1 m120 -94.77 110.19 22.07 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.277 -0.419 . . . . 74.2 110.406 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.4 t80 -52.65 -49.81 84.16 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.119 0.414 . . . . 72.25 112.119 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 55.5 Cg_exo -53.63 -41.38 74.31 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.028 1.819 . . . . 74.01 113.274 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 28.2 mm-40 -70.52 -35.66 73.32 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.735 0.642 . . . . 71.11 112.735 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.4 -41.57 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.626 0.251 . . . . 75.52 111.154 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.84 -40.96 90.27 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.26 0.552 . . . . 61.04 110.279 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -59.88 -44.67 94.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.034 -0.53 . . . . 72.42 111.118 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.15 -45.7 90.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.199 -0.455 . . . . 72.12 111.226 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.067 0.46 . . . . 72.34 111.019 176.206 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.559 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 6.8 tp10 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.259 0.552 . . . . 52.55 109.737 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -94.28 130.48 40.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.864 -0.607 . . . . 60.22 110.665 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.547 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.4 ptp -144.84 160.51 41.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.074 0.464 . . . . 75.41 111.823 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 15' ' ' ALA . 33.0 m -73.67 170.31 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.133 0.492 . . . . 75.53 111.632 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.82 -48.69 80.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.237 0.458 . . . . 73.55 112.237 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . 0.8 OUTLIER -65.33 -29.7 70.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.763 0.316 . . . . 62.22 111.107 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -73.47 -41.77 62.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.994 0.426 . . . . 75.24 111.053 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -58.04 -45.88 86.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.047 -0.524 . . . . 50.33 111.207 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.7 ptp -62.28 -35.52 79.25 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.597 0.237 . . . . 74.01 111.549 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 95.8 t -72.77 -40.46 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.07 0.462 . . . . 54.34 111.433 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.547 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 15.0 mmt85 -65.55 -41.59 92.85 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.237 -0.438 . . . . 73.25 112.051 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.1 p -93.75 -30.21 14.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.97 0.73 . . . . 75.41 112.97 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.58 -4.62 47.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.198 -0.525 . . . . 75.32 112.947 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -75.82 -179.1 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 74.52 111.861 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -132.13 168.44 22.52 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.626 -0.715 . . . . 71.24 112.26 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.1 71.21 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.673 0.62 . . . . 72.05 112.673 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 87.2 mtt180 -73.99 -18.64 60.84 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.621 0.6 . . . . 54.51 112.621 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -84.57 -37.73 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.898 0.38 . . . . 71.41 110.701 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.1 mt -63.67 -50.37 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.601 -0.272 . . . . 72.53 111.126 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.7 pt-20 -59.8 -31.03 69.31 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.141 0.496 . . . . 75.1 110.935 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 40.8 t -61.5 -50.41 72.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.512 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.14 -23.68 66.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.946 0.35 . . . . 74.14 111.946 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.702 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 13.6 mtp180 -64.27 -9.79 19.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.797 0.666 . . . . 71.04 112.797 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 29' ' ' SER . 29.0 pt20 -70.9 -22.26 62.29 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.937 0.347 . . . . 74.03 111.937 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.69 -43.68 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.753 -0.737 . . . . 71.45 113.979 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.16 -49.08 78.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.095 0.405 . . . . 63.01 112.095 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.95 104.52 5.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.961 0.41 . . . . 73.22 110.241 175.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.79 127.26 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 72.41 110.848 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -58.49 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.961 0.41 . . . . 73.43 111.081 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.11 -50.22 3.35 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 64.23 113.038 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.1 t -81.35 -61.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.176 0.436 . . . . 73.15 112.176 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -89.36 -22.12 22.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 111.987 0.366 . . . . 72.31 111.987 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -160.09 127.34 4.5 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.708 0.29 . . . . 75.53 110.655 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -122.02 145.07 48.49 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.01 0.433 . . . . 71.42 111.749 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 45.3 mtm180 -73.46 103.21 4.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.03 0.443 . . . . 71.35 111.09 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.209 0.528 . . . . 72.43 111.107 -179.884 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 110.503 -0.184 . . . . 74.13 110.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 6.9 t -81.12 138.12 35.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.276 0.56 . . . . 72.21 112.343 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -112.81 136.89 51.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.7 -0.682 . . . . 55.02 110.371 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -89.93 139.73 30.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.291 0.567 . . . . 72.42 112.126 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.547 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 39.3 t-20 -91.73 101.51 14.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.593 -0.731 . . . . 70.31 110.467 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 87.0 t80 -54.99 -52.13 73.65 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 112.627 0.603 . . . . 70.11 112.627 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 9' ' ' GLU . 80.9 Cg_exo -48.51 -49.41 14.63 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.256 1.971 . . . . 72.21 113.376 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -62.72 -41.53 99.2 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.147 0.425 . . . . 71.24 112.147 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.24 -49.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.961 0.41 . . . . 72.22 111.586 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -57.12 -38.32 73.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 61.45 110.927 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -51.33 70.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.193 -0.458 . . . . 75.55 110.091 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -55.56 -48.78 74.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.011 -0.541 . . . . 73.4 111.563 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.17 -0.468 . . . . 62.32 111.338 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.834 0.349 . . . . 62.55 111.335 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -96.12 132.83 41.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.009 0.433 . . . . 74.24 111.647 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.39 154.45 40.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.439 -0.346 . . . . 71.31 111.072 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.25 171.33 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.429 -0.351 . . . . 72.32 111.69 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -51.64 -57.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.211 0.448 . . . . 70.44 112.211 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.2 tmmt? -53.02 -48.45 67.55 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.295 -0.412 . . . . 61.23 111.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.22 97.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.015 0.436 . . . . 70.53 111.558 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -59.65 -51.86 68.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.068 -0.515 . . . . 65.0 111.496 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -59.5 -39.45 83.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.688 0.28 . . . . 72.14 111.726 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.38 -42.68 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.829 0.347 . . . . 50.33 111.375 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -65.55 -35.33 80.55 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.391 0.515 . . . . 74.04 112.391 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.1 p -93.48 -30.24 15.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.508 0.559 . . . . 73.13 112.508 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.22 11.29 45.95 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.122 -0.561 . . . . 70.31 112.714 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.3 mp -93.39 173.14 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.137 0.494 . . . . 71.33 111.172 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.28 162.28 22.01 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.247 -0.502 . . . . 74.54 112.313 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.25 61.94 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.004 0.372 . . . . 51.43 112.004 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -60.6 -28.64 68.67 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.18 0.437 . . . . 74.02 112.18 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 9.3 tt0 -84.94 -45.16 12.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.102 0.477 . . . . 75.14 110.855 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.8 mt -64.14 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.24 -0.436 . . . . 74.42 111.99 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.71 -34.36 69.38 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.857 0.317 . . . . 60.24 111.857 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 t -64.39 -42.07 96.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.09 0.471 . . . . 61.41 111.121 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 29.0 m-85 -64.74 -33.5 76.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 75.32 111.119 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 27.9 mtm180 -62.62 -25.8 68.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.641 0.258 . . . . 70.13 111.312 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.66 -36.52 80.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.617 0.599 . . . . 70.34 112.617 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.25 35.89 0.29 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.317 -0.944 . . . . 74.22 114.506 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.25 -16.85 1.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.103 0.477 . . . . 53.53 111.917 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.499 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.03 111.91 20.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.219 0.533 . . . . 64.12 112.122 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.89 129.67 64.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.023 -0.535 . . . . 71.12 110.376 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.18 137.69 53.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.144 0.497 . . . . 43.43 110.669 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.39 2.93 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.329 -0.462 . . . . 74.52 112.372 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.25 -64.5 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.094 0.405 . . . . 72.04 112.094 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 47.4 m170 -94.24 -37.72 11.39 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.363 0.505 . . . . 73.32 112.363 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 25.6 p90 -141.74 175.7 9.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 63.24 111.121 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -144.79 133.05 21.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.897 0.379 . . . . 73.31 110.98 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -80.75 102.69 10.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.496 0.665 . . . . 74.3 110.404 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.063 -0.971 . . . . 55.15 112.175 -174.419 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.823 0.344 . . . . 63.32 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.432 HG23 ' CD2' ' A' ' 41' ' ' PHE . 52.2 m -86.15 115.75 23.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.01 0.744 . . . . 42.54 113.01 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -105.19 140.48 38.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.695 -0.684 . . . . 73.35 110.111 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.42 144.82 32.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.326 0.491 . . . . 70.43 112.326 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.09 111.78 18.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.379 -0.373 . . . . 64.14 110.983 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 87.7 t80 -54.85 -53.39 61.38 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 112.342 0.497 . . . . 72.32 112.342 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 55.6 Cg_endo -67.16 -20.19 50.1 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.154 1.903 . . . . 53.11 113.786 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 40' ' ' HIS . 47.1 mm-40 -83.29 -38.04 22.66 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.11 -0.369 . . . . 71.11 111.515 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 16' ' ' LEU . 58.9 mt -70.6 -42.98 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.663 0.268 . . . . 73.43 110.442 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.25 -38.2 70.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.844 0.354 . . . . 74.15 111.03 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.44 -49.61 77.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 73.15 110.798 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -58.81 -41.87 87.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.065 0.459 . . . . 71.33 111.199 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.7 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 116.276 -0.42 . . . . 61.11 111.232 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.9 mm-40 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 72.24 111.59 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -88.62 136.69 32.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.687 0.28 . . . . 75.41 111.014 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 ptp -157.92 153.55 26.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.949 0.404 . . . . 64.43 111.814 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.67 174.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.278 -0.419 . . . . 72.04 111.491 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 27' ' ' ILE . 35.7 tt0 -59.37 -50.66 73.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.42 . . . . 75.13 112.133 -175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -61.05 -38.13 85.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.922 0.391 . . . . 74.13 110.968 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.04 75.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.147 0.499 . . . . 74.25 111.012 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.97 -47.77 83.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.869 -0.605 . . . . 74.42 111.168 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.6 ptp -60.15 -34.99 74.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.82 0.343 . . . . 74.22 111.311 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.6 t -76.95 -27.1 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.744 0.307 . . . . 61.25 111.76 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.0 mmp_? -94.39 -14.69 25.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.672 0.619 . . . . 64.23 112.672 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.7 p -108.53 -29.86 8.55 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.496 0.554 . . . . 41.41 112.496 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.58 -0.14 58.06 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.122 -0.561 . . . . 72.13 112.578 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.1 178.52 7.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.29 0.567 . . . . 61.34 112.042 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.42 168.74 12.68 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.022 -0.535 . . . . 72.54 112.578 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 -45.14 91.35 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.602 -0.352 . . . . 60.21 111.872 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -65.21 -41.2 94.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.151 0.501 . . . . 74.04 111.123 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.59 -41.77 98.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.278 -0.419 . . . . 73.35 111.189 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG21 ' HG3' ' A' ' 13' ' ' GLU . 66.0 mt -62.39 -54.38 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.624 0.25 . . . . 42.31 111.659 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 11.8 pt-20 -59.65 -29.9 68.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.96 0.41 . . . . 72.52 111.284 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.3 t -63.04 -46.83 85.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.879 0.371 . . . . 71.51 111.093 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -68.69 -29.01 67.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.974 0.416 . . . . 61.31 111.029 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 51.9 mtp180 -61.26 -28.1 68.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.087 172.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.3 mm100 -73.08 -33.56 65.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.387 0.514 . . . . 73.21 112.387 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.82 61.19 0.3 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.169 -1.015 . . . . 54.12 114.737 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.71 -32.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.566 0.698 . . . . 63.22 110.408 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.48 130.92 41.78 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.679 -0.691 . . . . 72.24 111.581 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.458 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 70.9 mt -131.93 132.95 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.842 -0.617 . . . . 62.31 110.898 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.07 142.52 51.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.055 0.455 . . . . 71.21 111.441 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.31 -48.67 3.43 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.471 -0.395 . . . . 71.15 113.314 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.35 -60.59 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.941 0.4 . . . . 54.41 112.031 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.458 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.6 m170 -97.63 -32.19 11.9 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.282 0.475 . . . . 73.34 112.282 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 23.4 p90 -153.27 169.59 22.67 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.222 -0.299 . . . . 73.21 111.526 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.59 152.54 27.36 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.782 0.325 . . . . 73.33 110.851 174.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -78.57 131.0 36.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.237 0.542 . . . . 63.3 111.796 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 116.034 -0.53 . . . . 75.11 110.734 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.79 0.329 . . . . 64.42 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m -94.42 126.23 39.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.292 0.478 . . . . 72.3 112.292 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -114.64 139.07 49.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.24 -0.437 . . . . 74.2 110.613 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 63' ' ' ILE . 55.5 m-85 -107.94 148.51 29.57 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.973 0.415 . . . . 72.12 112.015 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.1 101.36 12.38 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.997 0.427 . . . . 64.12 111.213 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.783 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 87.0 t80 -53.54 -45.24 98.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.724 0.639 . . . . 73.03 112.724 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 11.1 Cg_endo -53.65 -47.41 27.41 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.018 1.812 . . . . 75.53 112.814 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.46 -38.77 84.95 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.253 0.464 . . . . 74.11 112.253 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 58' ' ' TYR . 64.4 mt -68.06 -43.52 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.876 0.369 . . . . 55.34 110.884 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.28 -41.25 92.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.039 0.447 . . . . 63.25 110.269 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -44.43 92.29 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.902 -0.59 . . . . 55.42 111.323 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -63.35 -46.87 84.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.214 0.531 . . . . 74.14 111.432 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.3 mt . . . . . 0 CA--C 1.538 0.5 0 CA-C-N 116.253 -0.431 . . . . 73.21 111.59 179.494 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 11.2 mm-40 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.8 0.333 . . . . 70.11 111.42 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -99.09 123.89 43.71 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.345 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 19.8 ptp -159.79 156.71 28.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.332 0.493 . . . . 54.05 112.332 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.3 m -81.58 176.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.319 -0.4 . . . . 42.33 111.174 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -56.3 -47.05 79.46 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.645 0.609 . . . . 74.1 112.645 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -39.96 92.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.837 0.351 . . . . 72.21 111.289 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -74.79 -33.57 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.086 0.47 . . . . 62.21 111.197 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.96 -47.87 67.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.759 -0.655 . . . . 73.05 111.326 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.5 ptp -56.12 -33.71 65.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.043 0.449 . . . . 74.03 111.852 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.38 -33.98 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.102 0.477 . . . . 73.44 111.457 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -86.81 -15.33 39.57 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.425 0.528 . . . . 72.15 112.425 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' HD13 ' A' ' 22' ' ' LEU . 48.6 p -108.53 -29.1 8.95 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.774 0.657 . . . . 72.12 112.774 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.98 9.7 65.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.849 -0.691 . . . . 61.23 112.636 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.0 mp -91.77 163.1 14.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.122 0.487 . . . . 62.21 111.124 176.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.39 163.2 14.18 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.209 -0.519 . . . . 64.12 111.811 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -51.2 -41.82 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.137 0.469 . . . . 44.42 111.501 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -56.6 -37.65 70.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.348 -0.387 . . . . 72.14 112.025 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -73.92 -46.49 44.05 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 70.1 111.274 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.56 -46.82 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.462 -0.335 . . . . 72.12 111.678 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 13.1 pt-20 -59.56 -37.39 78.33 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.824 0.345 . . . . 70.41 111.027 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -56.92 -39.89 75.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.187 0.518 . . . . 74.1 110.834 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -80.67 -26.41 37.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.249 -0.432 . . . . 72.4 111.61 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 37.9 mtm180 -66.85 -17.95 65.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.798 0.333 . . . . 74.33 111.139 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.47 -23.09 65.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.311 0.485 . . . . 74.23 112.311 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.84 -52.05 0.02 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.312 -0.947 . . . . 73.23 114.276 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.76 -36.92 39.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.634 0.605 . . . . 72.5 112.634 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.33 104.39 3.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.016 0.436 . . . . 65.31 110.881 176.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -95.2 138.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.881 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.54 134.39 56.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.068 0.461 . . . . 72.41 111.899 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -35.85 1.72 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.449 -0.405 . . . . 53.25 113.894 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.5 t -84.64 -53.23 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.333 0.494 . . . . 63.21 112.333 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.38 -15.13 14.31 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.561 0.578 . . . . 72.53 112.561 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.78 152.06 35.89 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.469 -0.145 . . . . 73.01 110.637 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 8.0 mtpm? -125.69 141.29 52.09 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.094 0.473 . . . . 70.5 111.993 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -84.93 111.86 20.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.879 -0.601 . . . . 73.42 111.187 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.5 t . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.142 0.496 . . . . 70.13 111.934 -179.274 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.033 0.444 . . . . 74.13 111.103 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -97.8 101.16 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.807 0.337 . . . . 73.22 111.827 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -89.15 138.47 31.39 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.574 -0.285 . . . . 72.4 110.278 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.13 134.95 43.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.063 0.459 . . . . 72.1 111.794 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 63' ' ' ILE . 1.4 m-20 -76.93 94.23 3.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.941 -0.572 . . . . 44.21 111.815 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 78.6 t80 -52.37 -48.96 87.88 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.214 0.82 . . . . 65.12 113.214 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 13.1 Cg_endo -55.0 -42.15 71.98 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.985 1.79 . . . . 72.21 112.635 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 60.4 mm-40 -64.73 -41.06 96.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.019 0.438 . . . . 74.11 111.271 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.0 mt -66.54 -45.34 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.272 -0.422 . . . . 53.22 111.301 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -58.09 -44.05 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.214 0.53 . . . . 64.02 110.552 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -54.69 -38.66 67.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.793 -0.64 . . . . 75.01 111.205 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -71.62 -43.63 65.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.172 -0.467 . . . . 72.53 111.024 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 63' ' ' ILE . 77.7 mt . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.394 -0.366 . . . . 72.41 111.25 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 4.3 mp0 . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 120.89 0.376 . . . . 71.21 110.676 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -102.69 129.82 49.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.486 -0.325 . . . . 73.55 110.968 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.2 pmm? -145.92 162.55 37.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.747 0.308 . . . . 74.1 111.266 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.4 162.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.425 -0.352 . . . . 61.13 111.512 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 42.9 tt0 -50.29 -44.92 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.284 0.476 . . . . 65.22 112.284 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -58.41 -44.54 89.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.4 -0.364 . . . . 54.35 111.263 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.21 -34.23 65.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.149 0.5 . . . . 71.2 111.336 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -49.99 75.28 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.966 -0.561 . . . . 74.43 110.871 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.02 -28.86 69.35 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.753 0.311 . . . . 74.31 111.699 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 14' ' ' LYS . 62.2 t -73.85 -38.13 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.048 0.452 . . . . 72.22 111.219 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.1 mmm180 -78.08 -24.41 47.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.986 0.365 . . . . 75.2 111.986 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 22' ' ' LEU . 67.1 p -104.67 -30.21 10.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.85 0.685 . . . . 52.25 112.85 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.78 10.0 60.58 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.258 -0.496 . . . . 62.23 113.208 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.2 mp -83.73 167.82 16.82 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.197 0.522 . . . . 70.1 112.147 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.54 159.34 14.55 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.214 -0.448 . . . . 74.23 112.787 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.1 -46.51 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.851 0.686 . . . . 63.33 112.851 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 20.8 ttm180 -75.59 -35.34 60.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.796 0.331 . . . . 75.25 111.469 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -61.92 -40.78 96.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.156 0.503 . . . . 75.41 110.562 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.56 -48.7 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.075 -0.512 . . . . 75.54 111.593 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 14.2 pt-20 -63.9 -23.19 67.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.186 -0.321 . . . . 60.23 111.324 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -67.08 -49.23 65.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.089 0.471 . . . . 72.1 110.322 172.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.161 0.505 . . . . 74.25 111.092 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 48.9 mtp180 -61.94 -13.4 24.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.822 -0.627 . . . . 70.23 111.824 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -100.53 12.27 37.67 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 111.747 0.277 . . . . 71.41 111.747 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.11 -78.2 0.03 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.461 -0.876 . . . . 61.33 114.157 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.36 67.47 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.007 0.743 . . . . 43.05 113.007 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.562 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 112.23 7.94 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.472 0.653 . . . . 73.31 112.066 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 64.8 mt -105.83 134.5 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.457 -0.792 . . . . 73.02 110.447 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.2 133.01 53.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 74.01 111.131 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.31 -32.05 3.39 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.536 -0.364 . . . . 73.1 113.648 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 47.2 t -97.18 -41.09 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.573 0.582 . . . . 62.13 112.573 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 21.8 m170 -112.18 -5.43 14.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.184 0.438 . . . . 63.51 112.184 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -170.94 164.59 7.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.606 0.225 . . . . 73.44 111.606 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -149.47 161.81 41.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.951 0.405 . . . . 72.21 111.128 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mmm-85 -87.62 118.32 27.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.311 -0.404 . . . . 75.32 111.463 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.7 t . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 120.768 0.318 . . . . 72.21 111.158 177.336 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.135 0.493 . . . . 73.5 111.702 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.8 m -83.59 105.43 14.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.191 -0.459 . . . . 62.35 111.908 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -89.35 152.69 21.38 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.485 -0.325 . . . . 71.43 110.462 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.403 ' HE2' ' HB2' ' A' ' 13' ' ' GLU . 85.5 m-85 -113.4 149.62 33.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.993 0.738 . . . . 72.31 112.993 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 63' ' ' ILE . 16.3 m120 -77.16 93.66 3.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.696 -0.684 . . . . 70.43 111.73 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.584 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.2 t80 -55.25 -47.03 99.51 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.431 0.53 . . . . 74.23 112.431 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 7.7 Cg_endo -49.07 -48.57 17.87 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.382 2.055 . . . . 63.34 113.212 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 29.0 mm-40 -74.22 -34.67 63.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.583 0.586 . . . . 64.53 112.583 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 59' ' ' ASN . 77.8 mt -67.37 -43.05 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.147 0.499 . . . . 63.14 110.54 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.78 -41.85 99.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.022 -0.536 . . . . 55.42 110.358 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -46.81 77.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.793 -0.639 . . . . 71.32 111.097 174.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.98 -51.84 68.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.056 -0.52 . . . . 65.22 111.272 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 116.294 -0.412 . . . . 73.11 111.624 179.299 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.7 mt-10 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.745 0.307 . . . . 55.2 110.637 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.469 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 68.2 m95 -102.26 114.38 28.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.506 -0.315 . . . . 72.12 110.909 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ptp -135.58 153.13 51.77 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.07 0.396 . . . . 53.21 112.07 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -80.58 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.321 0.489 . . . . 74.22 112.321 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -50.32 -57.25 8.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.95 0.722 . . . . 74.33 112.95 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.4 tmmt? -56.34 -40.67 74.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -38.45 68.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 64.1 111.161 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.78 -46.56 87.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.78 -0.645 . . . . 61.34 111.512 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 24.5 ptp -56.99 -36.23 70.12 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.982 0.42 . . . . 71.43 111.533 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 t -76.01 -40.56 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.123 0.487 . . . . 52.2 111.273 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.0 mmp_? -74.29 -21.4 59.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.681 0.623 . . . . 52.35 112.681 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.5 p -108.38 -30.68 8.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.72 0.637 . . . . 73.52 112.72 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.23 1.12 56.94 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.146 -0.549 . . . . 30.23 112.858 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.39 172.09 14.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.981 0.42 . . . . 73.53 111.479 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.0 161.06 12.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.335 -0.46 . . . . 44.43 112.267 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.24 62.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.01 0.374 . . . . 61.44 112.01 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -63.85 -24.87 67.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.915 0.388 . . . . 64.25 111.694 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 45.9 tt0 -84.11 -41.2 17.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.905 0.383 . . . . 75.01 110.763 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.64 -52.32 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.929 0.395 . . . . 74.33 111.405 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.01 -32.16 67.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.583 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.07 -43.76 98.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.008 0.432 . . . . 72.33 110.716 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 24.9 m-85 -70.9 -27.68 63.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.439 -0.346 . . . . 74.14 111.768 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.7 mtm180 -66.69 -10.3 45.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.798 0.332 . . . . 75.3 111.868 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -85.34 -9.59 57.42 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.077 0.399 . . . . 74.35 112.077 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.88 -48.04 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.255 -0.974 . . . . 70.0 114.497 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.409 0.522 . . . . 74.42 112.409 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 145.8 48.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.037 0.446 . . . . 73.43 111.108 177.252 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.56 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 78.6 mt -139.45 132.24 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 116.265 -0.425 . . . . 73.3 111.272 -173.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.37 134.06 53.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.1 0.476 . . . . 72.11 111.926 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.44 -55.42 4.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.464 -0.398 . . . . 51.33 113.306 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -70.08 -62.94 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.073 0.397 . . . . 72.03 112.073 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.56 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.7 m80 -95.15 -8.03 37.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.667 0.618 . . . . 74.32 112.667 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -164.61 155.78 15.18 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.694 0.283 . . . . 74.25 111.493 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -123.53 157.33 33.85 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.95 0.405 . . . . 74.11 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -104.61 116.18 31.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.986 0.422 . . . . 75.21 111.453 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.992 0.425 . . . . 54.31 111.615 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 120.717 0.294 . . . . 72.44 111.045 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -102.41 115.01 29.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.989 0.423 . . . . 73.31 111.556 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 64.5 m95 -98.7 130.27 45.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.271 -0.422 . . . . 61.35 110.95 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 5.6 m-85 -88.29 145.01 26.08 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.963 0.411 . . . . 75.42 111.859 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t-20 -84.44 98.85 10.31 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.048 -0.523 . . . . 55.4 110.713 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 76.7 t80 -55.37 -51.61 78.43 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 112.596 0.591 . . . . 75.11 112.596 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 85.5 Cg_exo -48.45 -42.91 34.13 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.372 2.048 . . . . 52.45 113.437 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.97 -40.28 87.43 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.957 0.408 . . . . 75.22 111.517 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 58' ' ' TYR . 74.4 mt -65.99 -32.98 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.91 0.386 . . . . 71.34 110.768 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -60.47 -43.45 96.91 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.345 0.593 . . . . 64.41 110.306 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.8 -25.88 67.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.973 -0.558 . . . . 63.0 111.385 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.98 -52.86 15.04 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 72.1 110.622 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.472 0.644 0 CA-C-N 116.12 -0.491 . . . . 70.33 111.147 177.559 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.027 0.441 . . . . 75.51 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -78.87 123.54 27.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.139 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.543 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.2 ptp -151.8 165.53 34.19 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.762 0.653 . . . . 44.41 112.762 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -82.77 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.088 -0.505 . . . . 75.51 110.964 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 27.2 tt0 -65.69 -39.22 91.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.839 0.311 . . . . 72.22 111.839 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -56.54 -45.67 81.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.132 0.492 . . . . 70.45 110.497 178.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -68.52 -42.21 78.85 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.191 0.519 . . . . 72.53 111.069 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.28 -47.28 78.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.931 -0.577 . . . . 64.21 111.36 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 22.8 ptp -64.61 -29.33 70.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.829 0.347 . . . . 63.2 111.483 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 14' ' ' LYS . 75.6 t -73.54 -40.43 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.015 0.436 . . . . 71.51 111.494 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.543 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.2 mmt85 -71.65 -39.74 70.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.098 0.475 . . . . 71.41 112.109 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.6 p -92.98 -30.53 15.29 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.585 0.587 . . . . 74.11 112.585 -173.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.64 -0.69 70.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.927 -0.654 . . . . 74.31 112.867 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 20' ' ' THR . 10.6 mp -73.5 156.56 38.06 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.013 0.435 . . . . 74.14 111.365 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 162.4 16.58 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.299 -0.477 . . . . 72.22 112.336 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -41.37 82.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.845 0.355 . . . . 64.2 111.363 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.87 -31.7 65.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.139 0.495 . . . . 64.52 111.483 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -83.81 -43.25 15.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.102 -0.499 . . . . 71.0 110.819 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.92 -46.73 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.213 -0.449 . . . . 64.41 111.667 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.28 -34.11 71.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.911 0.386 . . . . 63.44 111.298 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -66.67 -33.97 76.82 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.107 0.479 . . . . 74.34 110.809 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -76.79 -33.82 58.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.077 -0.511 . . . . 75.53 112.036 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.632 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 20.7 mtt180 -56.06 -34.78 66.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.269 0.557 . . . . 73.43 111.818 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -77.97 0.02 25.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.082 0.771 . . . . 74.25 113.082 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.7 -56.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.525 -0.845 . . . . 70.31 113.791 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.06 -37.69 78.66 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.81 0.67 . . . . 50.01 112.81 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.632 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.11 108.83 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.971 0.415 . . . . 75.43 111.469 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -108.38 123.42 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.138 -0.483 . . . . 75.41 110.706 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.02 152.0 44.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.82 0.343 . . . . 71.44 111.302 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -38.44 1.8 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.109 -0.567 . . . . 75.34 112.982 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 40.7 t -89.48 -65.91 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 111.87 0.322 . . . . 74.31 111.87 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.424 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 5.4 m-70 -98.29 -14.63 20.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.094 0.776 . . . . 74.12 113.094 -174.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 34.4 p90 -159.64 171.89 18.78 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.075 -0.39 . . . . 70.23 111.797 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -150.49 143.97 25.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.343 0.592 . . . . 75.01 111.556 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.8 139.48 30.41 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 70.45 111.569 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.102 0.477 . . . . 74.54 112.208 -178.424 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.157 0.503 . . . . 73.44 112.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 m -91.94 118.48 30.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.278 -0.419 . . . . 73.43 111.136 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -94.27 144.56 25.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.804 0.335 . . . . 74.11 111.18 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 63' ' ' ILE . 68.5 m-85 -112.13 142.07 45.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.072 0.463 . . . . 75.2 111.882 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.05 97.85 8.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.701 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 41.0 t80 -49.91 -50.9 65.58 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 112.788 0.662 . . . . 73.31 112.788 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 71.3 Cg_exo -51.46 -46.18 33.09 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.244 1.962 . . . . 72.11 112.948 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 58.4 mm-40 -64.25 -41.18 97.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.091 0.404 . . . . 72.13 112.091 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -67.93 -45.35 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.606 -0.27 . . . . 63.14 111.203 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -60.14 -35.32 75.02 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.287 0.565 . . . . 75.35 110.576 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.56 -33.65 76.4 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.796 -0.638 . . . . 73.14 111.277 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.07 -44.13 20.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.345 -0.388 . . . . 73.43 111.994 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' ILE . 75.5 mt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.235 0.457 . . . . 74.3 112.235 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 74.15 111.703 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -94.12 121.85 36.04 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.881 -0.414 . . . . 71.05 109.881 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.76 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 19.9 ptp -138.9 147.16 41.98 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.31 0.485 . . . . 74.51 112.31 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.34 165.43 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.943 0.401 . . . . 74.14 111.972 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.97 -42.73 80.69 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.239 -0.437 . . . . 73.23 111.724 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -59.15 -42.11 89.91 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.214 -0.448 . . . . 70.54 111.262 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.1 -37.55 66.69 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.191 0.519 . . . . 74.13 111.279 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.27 -47.02 84.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.84 -0.618 . . . . 72.41 111.616 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.9 ptp -59.34 -32.27 69.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.927 0.394 . . . . 64.3 111.405 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 14' ' ' LYS . 58.5 t -72.71 -32.67 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.073 0.463 . . . . 54.04 111.267 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.5 mmt85 -76.55 -43.22 40.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.463 0.542 . . . . 70.51 112.463 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.33 -27.09 16.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.981 0.734 . . . . 73.31 112.981 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.11 64.58 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.946 -0.645 . . . . 72.52 113.206 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mp -79.66 166.91 21.35 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.084 0.468 . . . . 72.42 111.514 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.92 164.18 14.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.212 -0.449 . . . . 63.24 112.421 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.48 -42.23 70.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.012 0.375 . . . . 74.33 112.012 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -62.47 -33.69 75.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.057 0.456 . . . . 72.23 111.231 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.42 -48.25 42.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.425 -0.352 . . . . 70.4 111.419 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.2 mt -57.14 -50.84 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.86 0.362 . . . . 71.34 111.313 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.764 0.316 . . . . 64.41 111.469 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.2 t -63.33 -39.21 93.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.943 0.402 . . . . 74.01 111.164 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.65 -16.74 55.22 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.976 0.417 . . . . 73.12 111.51 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.695 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 58.8 mtp180 -68.88 -10.93 59.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.781 0.324 . . . . 75.12 111.815 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -83.02 2.69 33.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 111.764 0.283 . . . . 62.11 111.764 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.01 -61.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.66 -0.781 . . . . 71.33 114.115 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.21 95.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.957 0.725 . . . . 63.13 112.957 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.695 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -71.71 104.43 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.038 -0.414 . . . . 74.41 111.073 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 62.2 mt -89.89 121.5 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.509 -0.314 . . . . 75.21 111.23 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -59.86 131.63 51.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.904 0.383 . . . . 61.42 110.34 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.752 ' HA2' ' HZ1' ' A' ' 42' ' ' LYS . . . 92.12 -31.85 5.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.541 -0.361 . . . . 43.51 113.201 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 46.4 t -101.88 -72.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.654 -0.321 . . . . 71.24 111.391 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -77.42 -7.57 56.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.958 0.355 . . . . 71.2 111.958 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 33.3 p90 -171.84 167.56 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.617 0.367 . . . . 72.01 110.773 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.752 ' HZ1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -154.02 136.54 15.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.493 0.663 . . . . 71.32 111.568 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 61.6 mtp180 -80.62 102.56 9.9 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.264 -0.88 . . . . 62.44 110.258 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 115.796 -0.638 . . . . 74.51 112.523 -173.808 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 110.237 -0.283 . . . . 73.25 110.237 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -84.5 110.32 18.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.383 0.512 . . . . 65.41 112.383 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -98.59 126.87 44.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.114 -0.494 . . . . 73.44 110.272 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HB3' HD11 ' A' ' 63' ' ' ILE . 84.5 m-85 -93.33 144.75 25.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.919 0.341 . . . . 51.04 111.919 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 62' ' ' GLU . 59.1 t30 -82.64 94.47 7.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 71.04 111.049 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.523 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 70.7 t80 -51.38 -53.31 50.9 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 113.299 0.852 . . . . 73.45 113.299 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -49.66 -36.86 42.47 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.274 1.982 . . . . 74.13 113.219 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 22.2 mt-10 -81.43 -29.5 33.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.754 0.65 . . . . 73.42 112.754 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.492 ' O ' HG13 ' A' ' 67' ' ' ILE . 64.7 mt -70.46 -38.78 75.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.956 -0.465 . . . . 73.54 110.706 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -62.42 -39.08 92.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.191 0.519 . . . . 74.23 110.495 169.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 59.9 tttp -56.78 -37.16 70.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.883 -0.598 . . . . 61.31 110.877 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -72.17 -41.25 67.26 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.869 0.366 . . . . 71.25 111.031 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 63' ' ' ILE . 67.8 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 116.481 -0.327 . . . . 74.41 111.267 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 60' ' ' TYR . 9.2 tp10 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 110.027 -0.36 . . . . 70.53 110.027 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -119.83 143.2 48.01 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.272 -0.268 . . . . 75.22 111.093 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.604 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.8 ptp -164.7 171.88 13.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.657 0.614 . . . . 73.02 112.657 -176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.87 -179.99 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.977 -0.556 . . . . 34.33 111.335 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.88 -58.08 9.71 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.532 0.568 . . . . 52.43 112.532 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -61.92 -29.13 70.02 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.49 -0.323 . . . . 60.24 111.619 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.67 -37.02 42.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.238 0.542 . . . . 54.14 111.158 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.5 -49.92 74.82 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.78 -0.646 . . . . 72.31 111.019 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -55.95 -36.03 67.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.025 0.379 . . . . 74.11 112.025 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.1 t -65.75 -43.46 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.194 0.442 . . . . 75.44 112.194 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -85.23 -18.63 33.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.096 0.406 . . . . 70.24 112.096 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.9 p -100.58 -26.98 13.65 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.331 0.493 . . . . 63.13 112.331 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.81 24.8 29.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.091 -0.576 . . . . 72.13 113.176 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.6 mp -102.49 -178.86 3.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.211 0.529 . . . . 75.52 111.654 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.2 163.41 21.78 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.902 -0.59 . . . . 72.42 111.987 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.51 -46.1 77.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.096 0.448 . . . . 64.31 112.162 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 2.3 tmt_? -64.12 -34.41 77.98 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.115 0.483 . . . . 72.13 110.749 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.13 -42.4 69.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.918 0.389 . . . . 72.25 110.927 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.36 -50.48 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.357 -0.383 . . . . 74.43 111.793 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.97 -30.52 66.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.889 0.376 . . . . 74.41 111.146 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 t -62.44 -38.97 91.84 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.305 -0.407 . . . . 71.31 111.195 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -75.32 -31.11 60.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.46 -0.336 . . . . 61.45 111.67 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 21.4 mtm180 -64.88 -11.17 34.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.185 0.439 . . . . 74.31 112.185 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.23 11.01 24.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.424 -0.353 . . . . 74.14 111.926 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.53 -50.65 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.329 -0.939 . . . . 63.14 114.433 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.21 80.09 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.605 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.07 123.49 22.94 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.907 0.384 . . . . 62.03 111.145 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.84 132.67 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.37 -0.377 . . . . 74.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.23 146.63 47.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.864 0.364 . . . . 53.11 111.596 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 -53.66 2.99 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.39 -0.368 . . . . 73.13 112.638 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG12 ' ND1' ' A' ' 40' ' ' HIS . 46.3 t -70.85 -65.8 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.413 0.523 . . . . 43.41 112.413 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.412 ' ND1' HG12 ' A' ' 39' ' ' VAL . 3.1 m-70 -96.74 -16.96 20.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.932 0.716 . . . . 62.22 112.932 -175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 36.5 p90 -161.41 174.81 12.93 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.389 -0.195 . . . . 74.41 111.154 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.43 154.4 26.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.084 0.469 . . . . 72.51 112.099 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -79.43 122.9 26.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.217 -0.447 . . . . 74.13 112.173 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.204 0.526 . . . . 75.35 110.872 174.984 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.94 0.4 . . . . 55.24 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -96.76 105.52 17.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.254 0.464 . . . . 73.24 112.254 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -86.0 152.03 23.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.328 -0.396 . . . . 74.2 110.905 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 41.3 m-85 -117.14 146.24 43.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.121 0.486 . . . . 75.02 111.829 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.54 108.78 19.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.986 -0.552 . . . . 54.55 110.915 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 81.9 t80 -56.79 -48.73 96.79 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.931 0.715 . . . . 65.31 112.931 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 18.0 Cg_endo -58.33 -33.45 97.74 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.9 1.733 . . . . 64.14 112.681 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -69.54 -48.2 61.18 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.155 -0.475 . . . . 62.44 111.12 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 69.7 mt -65.71 -36.86 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.023 0.44 . . . . 65.01 111.152 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.66 -37.06 82.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.585 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.6 -38.65 85.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.094 -0.503 . . . . 72.42 110.936 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -66.45 -53.53 34.36 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.008 -0.542 . . . . 74.15 111.062 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 120.884 0.373 . . . . 65.4 111.451 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.954 0.407 . . . . 75.32 111.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.495 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 95.7 m95 -85.68 136.45 33.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.296 -0.411 . . . . 74.24 110.472 173.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.581 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.0 ptp -153.89 154.86 34.64 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.978 0.418 . . . . 75.33 111.73 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 15' ' ' ALA . 34.4 m -71.29 166.27 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.889 0.376 . . . . 73.14 111.415 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.86 -44.01 86.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.016 0.436 . . . . 75.23 111.986 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -63.71 -32.94 74.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.293 -0.412 . . . . 71.33 111.527 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -78.21 -35.94 47.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.041 0.448 . . . . 73.22 111.149 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.32 -46.21 87.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.838 -0.619 . . . . 53.24 111.003 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.501 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.2 ptp -59.87 -34.29 72.95 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.723 0.296 . . . . 72.23 111.488 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 14' ' ' LYS . 66.9 t -69.18 -40.29 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.881 0.372 . . . . 74.32 111.209 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 12.2 mmt85 -66.15 -44.66 83.48 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.996 0.427 . . . . 75.03 112.099 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 p -93.79 -25.15 17.51 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.034 0.753 . . . . 71.31 113.034 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.23 64.51 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.211 -0.518 . . . . 74.2 113.186 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' HG ' ' NE2' ' A' ' 26' ' ' GLN . 9.0 mp -74.66 173.41 10.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.367 0.603 . . . . 54.52 112.167 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.85 170.35 17.73 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.086 -0.506 . . . . 42.41 112.317 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.8 66.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.212 0.449 . . . . 50.05 112.212 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -64.82 -29.43 70.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.865 0.365 . . . . 72.53 111.961 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 47.9 tt0 -76.97 -42.67 38.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.972 0.415 . . . . 72.12 110.839 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 63.0 mt -63.72 -49.03 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.584 -0.28 . . . . 74.03 111.683 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.25 -35.03 59.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.771 0.319 . . . . 75.13 111.38 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 t -63.06 -50.7 69.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 54.41 110.69 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.72 -35.63 74.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.027 -0.533 . . . . 73.54 111.412 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 50.1 mtp180 -62.13 -19.98 63.6 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 74.2 111.44 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.97 -8.54 14.83 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.392 -0.367 . . . . 70.2 111.989 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.6 41.62 0.97 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.81 -0.71 . . . . 65.1 114.109 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.33 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.293 0.568 . . . . 71.5 111.377 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.39 141.91 48.71 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.458 0.646 . . . . 72.43 112.14 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.3 mt -138.65 135.13 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.573 -0.74 . . . . 72.54 110.236 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.47 130.62 45.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.094 0.473 . . . . 73.15 112.062 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.67 -26.68 1.64 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.352 -0.385 . . . . 63.4 113.946 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.2 t -94.91 -40.35 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.292 -0.534 . . . . 74.33 112.238 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.507 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 48.5 m80 -121.52 -9.72 8.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.425 0.528 . . . . 72.0 112.425 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -165.04 159.25 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.866 0.365 . . . . 73.21 111.831 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 55.8 pttt -153.82 153.35 31.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.029 0.443 . . . . 63.51 111.422 174.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.39 141.57 45.09 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.93 170.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 120.797 0.332 . . . . 74.53 111.083 177.637 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.35 0.119 . . . . 74.31 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.1 m -102.93 121.75 43.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.188 0.44 . . . . 73.43 112.188 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -107.85 146.53 32.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.604 176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 23.2 m-85 -106.85 154.06 21.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.791 0.663 . . . . 75.01 112.791 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.64 101.67 12.34 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.651 -0.704 . . . . 63.02 111.925 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 80.3 t80 -51.61 -50.85 74.77 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 112.762 0.653 . . . . 70.21 112.762 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.2 Cg_endo -56.13 -53.53 5.28 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.159 1.906 . . . . 74.42 113.273 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -64.81 -23.62 67.3 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.594 0.59 . . . . 61.13 112.594 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 75.9 mt -82.09 -46.32 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.052 -0.405 . . . . 63.41 111.379 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -58.17 -40.95 82.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.512 0.673 . . . . 65.51 109.973 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -52.81 -48.71 66.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.152 -0.931 . . . . 63.23 111.39 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.77 -37.77 79.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.457 -0.338 . . . . 65.25 111.147 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.863 0.364 . . . . 60.13 111.0 176.054 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.874 0.368 . . . . 51.43 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 82.2 m95 -98.64 118.77 36.1 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.562 -0.29 . . . . 74.1 110.845 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.1 pmm? -133.26 172.37 12.77 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.118 0.485 . . . . 70.14 111.533 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.53 162.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.096 -0.502 . . . . 61.31 111.375 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.54 -42.5 83.03 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.179 0.437 . . . . 73.22 112.179 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -59.55 -37.87 79.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.994 0.426 . . . . 73.33 110.968 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.6 45.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.97 0.414 . . . . 72.02 111.328 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -50.61 73.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.172 -0.467 . . . . 70.34 110.603 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.404 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.6 ptp -58.39 -37.06 74.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.756 0.312 . . . . 71.41 111.803 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.5 t -69.64 -48.22 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 111.829 0.307 . . . . 75.03 111.829 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 19' ' ' ARG . 29.0 mmt180 -69.04 -28.88 66.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.286 0.476 . . . . 73.4 112.286 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.415 HG21 HG21 ' A' ' 63' ' ' ILE . 80.5 p -93.88 -29.25 15.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.489 0.552 . . . . 64.33 112.489 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.86 56.59 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 52.03 112.564 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 26' ' ' GLN . 8.3 mp -82.2 -178.17 6.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.399 0.619 . . . . 75.25 111.627 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' GLN . . . -133.27 171.09 21.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.981 -0.554 . . . . 64.13 111.909 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.83 -51.39 66.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.283 0.475 . . . . 53.51 112.283 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -66.46 -30.01 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.159 0.504 . . . . 63.3 111.504 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.542 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 5.2 tp-100 -66.98 -48.46 68.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.066 0.46 . . . . 75.22 110.918 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 64.5 mt -60.79 -52.09 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.343 -0.39 . . . . 71.42 111.296 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.2 -33.6 69.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.507 0.194 . . . . 74.24 111.409 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -61.23 -37.51 83.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.929 0.395 . . . . 50.32 110.981 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -80.26 -30.07 38.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.894 0.378 . . . . 70.45 111.808 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 67.8 mtp180 -64.13 -15.56 59.99 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.925 0.393 . . . . 75.31 111.854 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.08 -22.65 64.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.537 -0.301 . . . . 74.01 111.8 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.48 -45.07 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 120.661 -0.781 . . . . 63.32 114.342 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.75 -31.4 71.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.012 0.745 . . . . 50.25 113.012 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.513 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.18 104.69 3.72 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.455 0.645 . . . . 74.22 111.829 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.92 123.58 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.565 -0.743 . . . . 74.22 111.279 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.22 147.19 48.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.112 0.482 . . . . 72.0 111.395 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.53 -58.92 3.75 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.121 -0.49 . . . . 61.33 113.164 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.81 -56.11 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.439 0.533 . . . . 72.4 112.439 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.461 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 52.9 m80 -92.24 -23.54 19.3 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.501 0.556 . . . . 73.31 112.501 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 15.4 p90 -163.68 149.58 11.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.536 -0.172 . . . . 64.02 110.536 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -147.76 147.57 30.02 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.092 0.472 . . . . 71.22 112.264 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -79.7 117.87 21.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.853 -0.612 . . . . 74.15 111.775 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 120.774 0.321 . . . . 73.43 111.051 176.321 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.859 0.361 . . . . 73.14 111.543 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -91.96 114.88 27.54 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.709 0.29 . . . . 60.43 111.418 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -100.3 144.3 29.47 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.734 -0.212 . . . . 74.41 110.856 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 94.0 m-85 -110.27 144.46 38.94 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.254 0.549 . . . . 64.55 112.135 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 40.6 t-20 -87.86 92.07 8.99 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.801 -0.636 . . . . 74.23 110.943 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 66.0 t80 -46.98 -53.04 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.972 0.73 . . . . 71.51 112.972 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -52.29 -39.19 73.06 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.171 1.914 . . . . 53.32 113.399 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 52.9 mm-40 -72.03 -34.12 68.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.3 0.481 . . . . 74.51 112.3 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 20' ' ' THR . 1.8 mp -71.54 -49.94 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 75.32 110.464 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -54.1 -46.83 72.21 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.151 0.501 . . . . 63.2 110.662 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.87 -46.13 67.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.661 . . . . 53.05 111.536 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -57.2 -50.6 72.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.227 -0.442 . . . . 73.55 111.478 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.861 0.363 . . . . 71.3 111.586 177.179 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 33.2 mt-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.182 0.515 . . . . 73.3 112.355 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 76.3 m95 -94.49 149.44 21.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.778 -0.646 . . . . 65.12 110.606 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.6 ptp -159.05 151.58 21.59 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.032 0.444 . . . . 75.34 111.778 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.33 167.71 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.155 0.428 . . . . 73.44 112.155 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.21 -54.5 46.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.461 0.541 . . . . 74.41 112.461 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -35.48 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.424 -0.353 . . . . 71.45 111.551 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.81 60.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.115 0.484 . . . . 54.14 111.289 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.9 -53.59 56.53 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.812 -0.631 . . . . 44.41 111.046 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.437 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.7 ptp -54.24 -40.34 67.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.846 0.313 . . . . 62.45 111.846 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -70.4 -42.49 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.95 0.405 . . . . 73.44 112.077 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.627 0.603 . . . . 75.3 112.627 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -107.17 -28.45 9.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.929 0.395 . . . . 64.2 111.893 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.88 5.22 59.91 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.233 -0.508 . . . . 72.31 112.715 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.3 mp -82.29 160.9 22.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.197 0.522 . . . . 70.43 111.428 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.89 160.9 13.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.091 -0.576 . . . . 55.13 112.447 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.82 -41.17 61.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.938 0.369 . . . . 71.22 111.861 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 25' ' ' ARG . 8.1 ptp180 -62.56 -32.19 73.12 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.135 0.493 . . . . 73.3 111.612 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.51 -37.8 35.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.003 0.43 . . . . 72.55 111.017 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 17' ' ' MET . 59.3 mt -63.99 -49.36 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.39 -0.368 . . . . 61.33 111.095 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.75 -35.63 76.86 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.858 0.361 . . . . 74.13 110.985 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.6 t -60.75 -37.61 82.4 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 60.24 111.278 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -72.83 -37.82 67.32 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.96 0.41 . . . . 74.11 111.504 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 24.7 mtm180 -65.46 -10.41 33.88 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.228 0.455 . . . . 72.35 112.228 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -59.95 -30.95 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.759 0.281 . . . . 73.52 111.759 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.99 31.94 0.05 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.308 -0.949 . . . . 61.25 114.721 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.12 -24.86 4.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.412 0.606 . . . . 54.23 111.428 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -83.28 129.32 35.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.029 -0.532 . . . . 75.34 111.731 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.9 mt -130.87 137.27 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.697 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.69 153.17 43.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.781 0.324 . . . . 75.04 111.157 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.26 -49.95 3.89 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.487 -0.387 . . . . 53.41 112.496 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.36 -57.49 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 74.41 112.043 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -101.67 -23.76 14.2 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.094 0.776 . . . . 63.24 113.094 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -161.92 172.48 15.95 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.315 -0.24 . . . . 62.4 111.484 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -154.74 160.66 41.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.911 0.386 . . . . 74.0 111.786 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -87.48 137.09 32.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.026 0.441 . . . . 74.11 111.443 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 120.986 0.422 . . . . 73.34 111.777 179.475 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 73.53 110.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -90.44 127.25 36.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.093 0.473 . . . . 44.41 111.952 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 29.0 m95 -104.4 132.8 50.24 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.156 -0.474 . . . . 75.21 110.657 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.525 ' HB3' HD11 ' A' ' 63' ' ' ILE . 52.2 m-85 -104.36 147.01 28.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.88 -176.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -78.78 106.59 10.89 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.837 0.351 . . . . 53.15 111.422 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.1 t80 -53.49 -50.21 84.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 112.701 0.63 . . . . 53.53 112.701 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 21.0 Cg_endo -59.15 -42.82 47.01 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.11 1.873 . . . . 70.21 113.254 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -66.55 -40.12 88.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 111.892 0.33 . . . . 75.43 111.892 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' A' ' 58' ' ' TYR . 67.5 mt -67.87 -41.8 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.707 0.289 . . . . 72.13 110.786 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -60.39 -41.26 93.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.901 0.381 . . . . 72.02 110.744 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.38 -42.59 92.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.075 0.464 . . . . 72.41 110.75 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.0 -38.13 89.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.984 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' ILE . 80.7 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 116.541 -0.299 . . . . 74.24 110.728 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.697 0.284 . . . . 44.14 110.982 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.8 -54.09 5.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.986 0.422 . . . . 65.22 111.03 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -165.91 135.6 3.35 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.056 -0.52 . . . . 73.11 110.829 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.7 mm -72.25 90.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.228 0.537 . . . . 62.31 111.096 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.05 139.56 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.062 -0.517 . . . . 74.22 110.742 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -109.93 143.52 39.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.94 0.4 . . . . 71.55 111.885 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.68 93.99 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.935 0.397 . . . . 71.44 110.323 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -94.24 27.75 2.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.047 0.451 . . . . 64.12 112.177 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -78.14 55.09 1.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.281 0.562 . . . . 74.14 111.459 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -89.7 128.02 36.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.753 -0.658 . . . . 74.32 109.926 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.591 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.5 ptp -148.55 149.13 31.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.881 0.372 . . . . 53.04 111.771 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.85 176.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.249 0.462 . . . . 64.13 112.249 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.34 -57.61 11.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.547 0.573 . . . . 65.04 112.547 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.9 tmmt? -63.7 -34.41 77.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.419 -0.355 . . . . 72.33 111.79 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.5 -42.52 74.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.131 0.491 . . . . 75.04 111.128 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.08 -47.73 84.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.918 -0.583 . . . . 64.25 111.451 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.4 ptp -58.76 -32.58 69.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.781 0.324 . . . . 74.31 111.417 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' LYS . 61.4 t -74.39 -41.7 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.1 0.476 . . . . 74.45 111.391 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.591 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 13.2 mmm180 -71.28 -31.93 68.06 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.259 -0.428 . . . . 72.3 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.2 p -95.58 -30.94 13.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.47 0.544 . . . . 73.34 112.47 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.14 55.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.398 -0.43 . . . . 54.13 113.176 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' MET . 8.9 mp -90.11 174.95 7.35 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.194 0.521 . . . . 71.34 112.035 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.23 161.04 13.08 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.143 -0.48 . . . . 45.5 112.443 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.13 -42.77 63.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.528 0.566 . . . . 74.4 112.528 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -62.6 -42.78 99.77 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.098 0.475 . . . . 73.2 111.648 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.77 -36.05 77.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.006 0.431 . . . . 71.51 110.939 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.27 -43.89 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.343 -0.39 . . . . 75.34 111.404 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.25 -38.93 93.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.787 0.327 . . . . 63.41 110.489 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -60.38 -40.49 91.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 71.24 110.713 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 12.3 m-85 -66.12 -34.97 79.26 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.316 -0.402 . . . . 63.12 111.691 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.766 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 23.6 mtm180 -68.42 -21.3 64.67 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.161 0.505 . . . . 73.31 111.246 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.89 13.47 5.9 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.024 -0.535 . . . . 70.24 110.738 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.8 -81.89 0.04 OUTLIER Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.229 -0.51 . . . . 64.52 114.185 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.01 -34.52 43.94 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.145 1.165 . . . . 31.04 114.145 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.766 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -71.53 104.09 3.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.818 -0.551 . . . . 75.33 110.861 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -102.03 129.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 60.45 111.744 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -64.92 132.64 49.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.354 -0.385 . . . . 74.4 110.802 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.16 -24.86 19.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.271 -0.49 . . . . 52.23 112.929 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.23 -70.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 122.472 -0.429 . . . . 74.24 111.892 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -85.66 -12.72 50.6 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.185 0.439 . . . . 74.45 112.185 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 35' ' ' TRP . 52.9 p90 -158.99 169.32 24.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.728 0.27 . . . . 73.55 111.728 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -141.98 172.1 13.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.782 0.325 . . . . 73.23 111.158 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -105.39 109.83 21.96 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.281 0.475 . . . . 74.2 112.281 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 91.7 t -107.73 107.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 51.1 111.647 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.642 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 53.9 m -89.36 149.81 43.43 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.128 -0.487 . . . . 61.24 111.539 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.06 26.04 0.18 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.019 2.48 . . . . 72.31 113.136 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 45' ' ' SER . 42.9 t -158.64 -179.6 8.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.355 0.662 . . . . 61.2 109.849 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.11 -21.71 34.82 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.787 -0.721 . . . . 74.14 113.437 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -92.06 179.01 5.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.656 0.741 . . . . 75.34 112.839 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.42 111.84 10.0 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.38 -0.827 . . . . 73.45 112.012 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 p -134.48 142.69 47.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.471 -0.332 . . . . 72.23 110.964 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.7 mm? -80.19 -6.42 57.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.287 0.565 . . . . 60.21 110.968 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -82.15 8.65 10.35 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.058 -0.519 . . . . 75.52 111.341 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 45' ' ' SER . . . -66.08 114.13 6.31 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.445 -0.343 . . . . 73.52 113.593 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 m -66.83 135.8 54.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.842 0.353 . . . . 71.2 111.482 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -92.69 119.95 32.61 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.067 0.46 . . . . 71.53 112.144 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 44' ' ' VAL . 37.2 m95 -103.78 123.68 47.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.578 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.11 150.88 19.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 65.01 111.927 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -92.42 112.17 24.01 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.195 -0.457 . . . . 75.1 111.905 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 65.4 t80 -56.25 -50.12 89.36 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 112.498 0.555 . . . . 75.22 112.498 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 50.1 Cg_exo -55.75 -41.56 76.26 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.198 1.932 . . . . 61.25 113.02 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -62.03 -44.99 95.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.48 0.657 . . . . 74.3 111.628 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.486 HD12 HD21 ' A' ' 16' ' ' LEU . 87.2 mt -69.1 -47.81 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.683 -0.69 . . . . 71.51 111.776 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.3 -31.94 69.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.775 0.322 . . . . 71.53 111.365 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -42.49 91.33 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.101 0.477 . . . . 60.24 110.011 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.8 -54.99 22.45 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.424 -0.353 . . . . 74.25 111.22 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -53.39 -34.13 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 63.41 111.421 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -50.71 -31.47 16.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.844 -0.616 . . . . 74.22 111.922 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.89 -41.72 92.23 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.912 0.387 . . . . 71.04 111.479 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.562 -0.29 . . . . 64.31 111.487 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.53 -43.81 88.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.344 0.592 . . . . 74.44 110.685 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -79.97 61.19 3.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.889 -0.596 . . . . 55.41 109.927 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -48.38 106.89 0.11 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.89 -0.595 . . . . 74.22 112.497 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -133.44 131.02 39.44 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.039 0.447 . . . . 71.21 111.292 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.71 90.33 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.125 -0.489 . . . . 64.04 111.141 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -91.53 -25.03 19.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.097 -0.501 . . . . 75.2 112.124 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -107.4 117.53 34.32 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.297 -0.252 . . . . 65.11 110.91 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.3 p80 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.66 -0.686 . . . . 74.11 112.596 -178.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.06 0.457 . . . . 74.15 112.038 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.1 139.37 34.02 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.213 -0.448 . . . . 71.31 110.527 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -119.7 124.35 46.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.941 0.401 . . . . 72.34 111.484 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 7' ' ' ASN . 46.7 mm -71.64 90.59 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.288 0.566 . . . . 71.15 112.024 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -97.81 92.9 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.364 -0.38 . . . . 71.2 110.839 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 54.8 25.09 6.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.21 0.529 . . . . 61.23 111.665 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.706 ' HB3' HG23 ' A' ' 4' ' ' ILE . 4.1 t-20 -71.25 -33.64 70.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.949 -0.568 . . . . 53.44 111.486 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -78.05 87.75 4.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.182 0.515 . . . . 73.42 111.552 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 8.8 tp10 -89.45 84.95 6.43 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.932 -0.576 . . . . 74.44 110.856 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.466 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 93.7 m95 -93.57 146.09 24.06 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.074 -0.512 . . . . 71.51 111.241 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.7 ptp -160.73 159.62 30.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.937 0.399 . . . . 74.35 112.01 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.14 163.39 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.535 -0.302 . . . . 64.53 111.478 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -52.48 -47.19 66.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.326 0.491 . . . . 73.34 112.326 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -60.82 -32.05 71.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.356 -0.383 . . . . 61.4 111.31 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.61 24.83 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.034 0.445 . . . . 55.01 111.36 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -59.28 -50.61 73.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.892 -0.594 . . . . 65.44 111.05 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.6 ptp -58.27 -35.53 71.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.081 0.467 . . . . 63.41 111.481 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.4 t -72.42 -31.35 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 111.941 0.348 . . . . 65.24 111.941 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.1 -31.9 20.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.38 0.511 . . . . 73.33 112.38 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.36 -30.65 15.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.886 0.699 . . . . 70.42 112.886 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.19 4.93 62.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.887 -0.673 . . . . 53.42 113.267 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' MET . 11.0 mp -80.74 154.47 27.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.101 0.477 . . . . 75.42 111.31 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.99 165.11 25.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.053 -0.594 . . . . 55.32 112.998 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.79 -47.79 64.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.17 0.433 . . . . 74.55 112.17 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.95 -27.43 68.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.773 0.32 . . . . 70.54 111.811 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -67.91 -56.89 7.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.197 0.522 . . . . 72.42 111.099 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.36 -50.76 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.85 -0.614 . . . . 64.12 112.112 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 pt-20 -53.63 -39.76 65.23 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.852 0.316 . . . . 64.34 111.852 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -69.81 -43.45 72.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.927 0.394 . . . . 51.24 111.249 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -67.17 -28.51 68.17 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.829 0.347 . . . . 73.34 111.432 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 49.1 mtp180 -58.77 -26.8 64.38 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.192 0.441 . . . . 74.04 112.192 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -97.14 10.69 38.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.337 0.495 . . . . 52.13 112.337 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.99 -53.89 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.438 -0.887 . . . . 72.14 114.454 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.03 -23.22 31.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.311 -0.523 . . . . 73.02 112.335 -175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.436 ' HE3' ' N ' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.92 139.79 48.9 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.35 0.595 . . . . 74.2 112.151 -177.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.5 mt -134.52 125.98 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.695 -0.684 . . . . 61.3 110.305 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.21 135.88 56.44 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.0 0.429 . . . . 64.21 111.701 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -55.84 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.32 -0.4 . . . . 72.3 113.358 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.99 -46.37 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.533 0.568 . . . . 71.13 112.533 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 1.7 m-70 -110.71 -18.69 13.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.715 0.635 . . . . 70.22 112.715 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 44.1 p90 -156.74 160.85 39.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.374 0.509 . . . . 61.51 112.374 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 22.8 ptmt -148.99 150.86 33.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.847 0.356 . . . . 73.2 111.444 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -90.64 123.9 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 53.43 110.811 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -121.07 118.13 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.121 0.415 . . . . 50.45 112.121 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 47.8 t -88.87 132.45 38.27 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.459 -0.337 . . . . 72.32 110.785 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 25.8 Cg_exo -61.55 -75.9 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.759 2.306 . . . . 71.42 113.425 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -118.37 96.88 5.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.831 0.348 . . . . 61.14 111.44 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 51' ' ' THR . . . 81.57 134.17 1.67 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.218 -0.515 . . . . 72.22 112.998 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.6 11.53 2.49 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.003 -0.704 . . . . 53.14 111.936 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -82.95 -3.97 57.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.427 -0.351 . . . . 71.53 111.42 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 48' ' ' GLY . 30.2 p -79.83 164.7 23.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 55.55 112.495 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.0 mm? -101.82 3.35 39.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.009 -0.541 . . . . 72.22 110.679 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -105.22 82.63 1.86 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.13 0.49 . . . . 74.52 111.258 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.57 79.91 1.15 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.105 -0.569 . . . . 51.4 112.917 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.4 m -63.68 118.04 7.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 73.55 111.742 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -91.78 124.6 36.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.894 0.378 . . . . 73.25 111.763 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.12 148.04 25.88 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.317 -0.401 . . . . 71.23 111.075 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.48 149.51 36.23 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.506 -0.316 . . . . 75.42 111.801 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.48 114.54 25.21 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.27 0.47 . . . . 71.14 112.27 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 89.7 t80 -61.64 -48.83 88.98 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.482 0.549 . . . . 74.02 112.482 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 19.1 Cg_endo -57.59 -33.4 96.52 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.997 1.798 . . . . 63.12 112.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.44 -49.03 29.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.143 -0.481 . . . . 72.24 111.235 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 67' ' ' ILE . 72.9 mt -63.41 -32.09 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.354 -0.385 . . . . 72.12 110.937 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -58.71 -42.76 89.39 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.002 0.429 . . . . 61.51 110.515 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -60.73 -43.8 97.44 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 60.2 110.521 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -62.45 -33.21 74.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.315 -0.402 . . . . 73.13 111.708 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 63' ' ' ILE . 68.7 mt -55.39 -38.03 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.898 0.38 . . . . 64.5 110.942 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -62.24 -32.82 73.55 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.25 0.547 . . . . 74.1 110.807 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.95 -40.62 27.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.911 -0.586 . . . . 75.32 111.279 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.6 t -70.66 -22.68 62.46 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.101 -0.499 . . . . 72.12 110.862 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 71' ' ' LEU . 2.0 tm? -63.68 -41.57 98.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 63.23 109.938 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.72 138.9 44.95 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.925 -0.58 . . . . 74.45 110.189 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -127.62 115.27 18.52 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.397 0.517 . . . . 72.31 112.397 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -134.22 22.02 3.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.864 0.364 . . . . 62.12 111.631 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -160.58 102.1 1.35 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.976 0.417 . . . . 74.01 110.864 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -87.45 -1.5 57.97 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.409 0.522 . . . . 73.15 112.409 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -124.54 -62.31 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.996 -0.44 . . . . 70.34 111.469 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--O 1.257 1.468 0 CA-C-O 118.671 -0.681 . . . . 74.34 111.081 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.642 0.258 . . . . 64.41 111.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.16 97.64 8.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.842 0.353 . . . . 70.13 111.755 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -127.59 147.31 50.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.921 0.391 . . . . 74.54 111.521 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.49 86.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.452 0.644 . . . . 70.3 111.424 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.59 128.67 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.833 -0.621 . . . . 72.14 110.908 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -88.76 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 74.22 110.515 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -173.8 142.15 0.88 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.864 -0.607 . . . . 74.52 110.556 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.03 99.93 3.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.599 0.714 . . . . 55.3 110.934 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -99.32 89.77 4.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.507 . . . . 71.22 111.242 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -80.66 120.2 24.27 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.943 -0.571 . . . . 74.33 110.523 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.0 ptp -141.56 153.32 44.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 62.13 111.929 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.56 166.45 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 61.53 111.51 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -51.6 -45.37 63.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.197 0.443 . . . . 75.24 112.197 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -58.52 -50.7 72.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.831 0.348 . . . . 62.42 111.084 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -67.11 -38.03 84.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.067 0.461 . . . . 55.41 111.43 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.542 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.66 -48.56 81.26 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.974 -0.557 . . . . 72.3 111.406 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.8 ptp -59.43 -32.36 70.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.932 0.396 . . . . 53.03 111.529 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.68 -37.52 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.121 0.486 . . . . 73.24 111.306 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 31.3 mmt180 -76.33 -26.96 56.29 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.888 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.2 p -98.46 -30.85 12.3 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.305 0.483 . . . . 73.04 112.305 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.71 6.58 62.17 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.266 -0.492 . . . . 43.23 113.125 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.4 mp -85.92 160.49 19.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.194 0.521 . . . . 75.15 111.847 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.08 156.75 19.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.27 -0.491 . . . . 71.11 111.997 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.03 59.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.318 0.488 . . . . 74.42 112.318 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -21.67 66.86 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.874 0.369 . . . . 73.43 111.711 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.43 -45.42 12.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.224 0.535 . . . . 75.15 110.696 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 51.3 mt -61.11 -49.4 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.992 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.5 pt-20 -57.43 -29.98 64.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.76 0.281 . . . . 61.45 111.76 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 t -62.33 -48.1 81.32 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.182 0.515 . . . . 73.42 110.912 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -71.43 -31.03 66.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.022 -0.535 . . . . 74.41 111.774 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 27.9 mtp-105 -60.85 -19.32 59.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.067 0.395 . . . . 71.03 112.067 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.1 mm-40 -80.9 -14.86 57.63 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.501 0.556 . . . . 72.45 112.501 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.05 -48.44 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.363 -0.922 . . . . 70.41 114.313 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.25 81.34 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.286 -0.538 . . . . 75.05 112.059 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.2 104.95 5.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.069 0.461 . . . . 71.23 110.901 177.098 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -86.7 135.21 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.298 -0.41 . . . . 61.13 111.69 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.03 139.18 58.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.966 0.412 . . . . 73.32 111.613 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.03 -46.49 2.69 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.387 -0.37 . . . . 71.31 113.225 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.51 -60.1 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.35 0.5 . . . . 74.41 112.35 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -91.94 -27.37 17.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.96 0.356 . . . . 70.24 111.96 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 36.1 p90 -152.6 155.92 38.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.693 -0.231 . . . . 72.21 110.663 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.0 165.8 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.094 0.473 . . . . 74.04 112.095 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -82.54 122.24 27.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.956 -0.566 . . . . 73.03 111.525 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.19 119.29 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.094 0.473 . . . . 73.35 111.397 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.6 p -90.03 140.81 27.58 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.382 -0.372 . . . . 75.22 110.955 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.04 24.62 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.485 2.123 . . . . 63.32 113.02 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -169.5 170.78 8.05 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.235 -0.29 . . . . 72.42 111.018 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.88 -18.83 74.69 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.059 -0.591 . . . . 71.21 111.929 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.69 160.66 22.34 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.44 0.638 . . . . 71.1 111.783 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 50' ' ' LYS . 2.6 mppt? -104.0 73.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.715 -0.675 . . . . 71.24 111.047 -173.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -72.54 154.71 40.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.163 -0.472 . . . . 71.33 111.232 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.7 mm? -67.82 -9.66 46.34 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.033 0.383 . . . . 71.23 112.033 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -96.05 92.54 6.49 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.095 0.474 . . . . 74.11 110.598 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.5 107.71 3.57 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.171 -0.538 . . . . 74.53 113.099 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 m -65.86 140.42 58.37 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.696 -0.296 . . . . 71.32 110.714 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -111.67 108.49 17.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.428 0.529 . . . . 73.22 112.428 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -100.84 136.68 40.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.254 -0.43 . . . . 73.44 110.973 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.13 137.46 45.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.297 -0.41 . . . . 70.34 111.629 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 60.7 t30 -88.49 112.7 23.27 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.002 0.429 . . . . 74.13 111.05 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 68.0 t80 -51.1 -54.25 39.79 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.544 0.942 . . . . 75.44 113.544 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 78.4 Cg_exo -51.9 -38.07 67.81 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.133 1.888 . . . . 61.44 113.209 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -65.27 -25.86 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.195 0.442 . . . . 63.52 112.195 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.542 HD12 HD21 ' A' ' 16' ' ' LEU . 66.0 mt -86.52 -37.49 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.583 -0.28 . . . . 73.34 111.33 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.76 -39.77 68.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.36 0.6 . . . . 73.53 110.373 170.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -50.63 -44.48 57.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.499 -0.773 . . . . 75.14 111.016 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.42 -40.63 81.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.783 -0.644 . . . . 73.04 111.491 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 71' ' ' LEU . 62.3 mt -57.21 -36.83 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.384 -0.371 . . . . 74.14 111.778 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HD3' HH11 ' A' ' 68' ' ' ARG . 45.1 ttp180 -82.35 -36.45 26.84 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.15 -0.344 . . . . 73.15 111.248 176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.6 -56.1 26.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.214 0.45 . . . . 74.3 112.214 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.5 m -62.97 -36.21 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.642 0.608 . . . . 71.33 112.642 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 67' ' ' ILE . 8.5 mp -85.37 -24.11 27.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.145 0.424 . . . . 43.4 112.145 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 74' ' ' HIS . 48.3 mt-10 59.47 -80.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.058 0.543 . . . . 73.14 112.432 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.9 p80 45.79 -71.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.418 1.087 . . . . 64.45 113.557 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 72' ' ' GLU . 73.5 t60 -118.62 102.17 8.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.954 -0.466 . . . . 74.33 110.469 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -67.72 92.81 0.35 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.538 0.685 . . . . 53.44 111.442 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -68.95 101.14 1.32 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.53 -0.759 . . . . 63.45 112.223 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -120.48 18.22 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.255 0.55 . . . . 74.21 110.951 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 . . . . . 0 C--O 1.253 1.262 0 CA-C-N 115.995 -0.548 . . . . 74.15 110.809 171.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.538 0.209 . . . . 52.11 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.23 37.41 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.278 0.844 . . . . 74.32 113.278 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -165.39 135.62 3.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.785 -0.643 . . . . 75.41 110.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.93 97.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.294 0.568 . . . . 74.11 111.874 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.404 HG22 ' CD2' ' A' ' 6' ' ' PHE . 41.5 mm -131.02 143.41 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.836 -0.62 . . . . 62.14 110.457 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD2' HG22 ' A' ' 5' ' ' ILE . 51.6 m-85 65.21 26.32 12.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.917 0.487 . . . . 72.04 112.146 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -110.1 12.74 23.43 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.25 0.548 . . . . 72.12 110.8 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.22 104.84 15.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.053 0.454 . . . . 54.14 111.772 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 9.9 tp10 -101.45 121.53 42.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.262 -0.426 . . . . 74.14 110.882 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -122.52 140.42 52.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.608 0.242 . . . . 71.41 111.373 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 pmm? -158.47 174.42 15.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.13 0.49 . . . . 72.1 111.588 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.35 171.47 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.263 -0.426 . . . . 43.43 110.926 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -58.33 -41.98 85.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.055 0.391 . . . . 74.23 112.055 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -55.56 -48.33 74.93 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.957 0.408 . . . . 61.35 111.055 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.86 -37.53 73.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.941 0.401 . . . . 52.21 111.075 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 63' ' ' ILE . 3.2 tm? -56.97 -48.99 77.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.3 -0.409 . . . . 62.32 111.164 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.9 ptp -62.23 -36.26 81.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.658 0.266 . . . . 74.21 111.236 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' LYS . 64.6 t -69.87 -36.03 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.071 0.462 . . . . 51.34 111.309 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.5 mmt180 -74.47 -37.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.127 -0.488 . . . . 74.45 112.008 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.2 p -93.14 -30.86 15.02 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.602 0.593 . . . . 63.53 112.602 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.02 -3.2 41.04 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.162 -0.542 . . . . 51.22 113.087 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.24 -175.03 4.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.366 0.603 . . . . 64.23 112.226 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.37 169.22 23.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.96 -0.564 . . . . 73.13 112.3 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.31 -49.09 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.557 0.577 . . . . 62.41 112.557 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -63.33 -23.12 67.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.992 0.425 . . . . 74.24 111.424 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -81.74 -53.92 5.81 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.16 0.505 . . . . 75.1 111.079 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.54 -43.1 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.022 -0.535 . . . . 72.51 112.343 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 pt-20 -58.75 -29.27 66.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.997 0.369 . . . . 74.43 111.997 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -67.86 -36.84 80.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.183 0.516 . . . . 72.11 110.685 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.97 -31.22 56.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.165 -0.47 . . . . 74.23 110.897 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 55.6 mtp180 -59.96 -25.33 65.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 75.15 112.061 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -95.33 12.49 28.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 64.51 111.823 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.54 -85.77 0.06 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.95 -0.643 . . . . 71.51 114.134 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.58 65.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.8 0.667 . . . . 71.52 112.8 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.04 104.64 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.531 0.682 . . . . 73.44 111.691 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -103.61 133.34 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.384 -0.825 . . . . 75.53 110.335 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.5 142.04 58.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.917 0.389 . . . . 75.44 110.999 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 -43.62 2.79 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 121.553 -0.356 . . . . 75.44 113.11 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.13 -50.86 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.579 0.585 . . . . 62.35 112.579 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -111.49 -18.56 12.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.665 0.616 . . . . 75.03 112.665 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.63 144.33 20.43 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.441 0.163 . . . . 55.21 110.602 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -121.09 156.37 32.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.158 0.504 . . . . 74.3 111.962 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.418 HH11 HD13 ' A' ' 52' ' ' LEU . 22.3 ptt180 -95.83 143.43 27.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.266 -0.424 . . . . 53.34 111.017 176.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.82 100.62 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.868 0.366 . . . . 63.41 111.545 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.459 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 91.9 p -90.42 110.65 42.38 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.541 -0.3 . . . . 74.13 110.943 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.42 -30.52 91.04 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.796 2.33 . . . . 72.34 113.099 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.4 p -82.75 -13.7 55.83 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.434 -0.348 . . . . 72.33 111.705 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.352 -0.451 . . . . 74.32 113.395 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.48 10.43 8.92 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.598 0.592 . . . . 74.31 112.598 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 73.47 -35.02 0.3 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.597 0.759 . . . . 53.21 112.981 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -63.03 160.56 14.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.522 -0.308 . . . . 70.1 110.583 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.9 mm? -73.59 21.27 0.09 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.95 0.722 . . . . 74.21 112.95 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -77.16 81.42 3.67 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.976 -0.452 . . . . 64.4 110.741 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 45' ' ' SER . . . -177.9 -167.93 36.69 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.985 -1.102 . . . . 72.25 114.926 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.3 m -91.26 145.88 24.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.899 0.48 . . . . 63.35 111.434 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -107.3 109.34 21.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.817 0.341 . . . . 64.32 110.957 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -95.68 133.9 39.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.904 0.383 . . . . 73.43 111.594 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.7 139.11 33.25 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.076 0.465 . . . . 74.13 111.591 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.18 95.08 6.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.176 -0.465 . . . . 53.15 111.42 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.679 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 69.4 t80 -55.9 -49.9 90.34 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.65 0.611 . . . . 74.31 112.65 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.8 Cg_endo -56.82 -23.7 51.9 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.193 1.929 . . . . 63.32 112.782 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.99 -44.73 10.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.794 0.294 . . . . 73.1 111.794 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 16' ' ' LEU . 74.0 mt -66.66 -48.99 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.751 0.31 . . . . 74.24 111.153 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 53.8 t30 -56.82 -47.59 79.95 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.256 0.551 . . . . 45.23 110.39 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.19 -42.2 76.76 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.663 -0.699 . . . . 73.15 111.908 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -61.51 -47.73 84.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.009 0.433 . . . . 75.34 111.099 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.97 -52.25 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.462 . . . . 74.51 111.369 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 25.4 mmt85 -66.41 -25.3 66.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.355 -0.384 . . . . 74.12 111.686 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.16 -52.54 54.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.791 0.329 . . . . 75.12 111.633 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -83.47 -53.79 5.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.55 . . . . 74.32 112.484 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.34 -47.2 77.29 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.102 0.408 . . . . 74.13 112.102 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 61.28 16.59 7.46 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.834 0.679 . . . . 74.35 112.834 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.49 141.21 46.8 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.116 -0.365 . . . . 64.2 110.395 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -50.03 160.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.825 0.676 . . . . 75.41 112.825 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -56.79 137.14 55.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.696 -0.683 . . . . 63.22 111.721 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -95.29 146.54 24.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.848 0.356 . . . . 73.32 111.608 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -100.14 137.92 37.92 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.723 0.296 . . . . 64.25 111.551 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.884 -0.579 . . . . 64.03 111.41 177.611 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.828 0.347 . . . . 62.44 110.407 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.88 115.56 29.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.576 0.954 . . . . 74.04 113.576 -169.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -108.34 131.64 54.54 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.087 -0.708 . . . . 50.42 109.087 166.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.63 113.43 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.351 0.5 . . . . 75.52 112.351 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.75 107.54 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.884 0.373 . . . . 71.43 110.299 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -73.15 134.59 44.48 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.04 0.447 . . . . 71.51 111.594 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 9' ' ' GLU . 15.5 m120 -75.37 9.58 2.06 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.103 0.408 . . . . 74.51 112.103 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 58.57 33.84 23.41 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.174 0.435 . . . . 45.22 112.174 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 5.0 mm-40 -75.02 70.05 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.191 0.52 . . . . 74.23 110.79 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 81.9 m95 -99.21 126.53 45.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.849 -0.614 . . . . 74.02 110.537 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.502 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.3 ptp -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.021 0.438 . . . . 74.5 112.021 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.93 163.8 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.255 -0.43 . . . . 70.43 111.949 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.38 -51.08 28.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.974 0.731 . . . . 75.32 112.974 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -60.89 -40.32 92.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.676 0.274 . . . . 74.12 111.654 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.29 70.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.082 0.467 . . . . 53.43 111.098 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -60.11 -50.74 72.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.659 -0.7 . . . . 74.41 111.187 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -59.01 -33.66 70.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.948 0.404 . . . . 74.55 111.64 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' LYS . 65.2 t -71.41 -42.44 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.008 0.433 . . . . 51.12 111.513 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -85.06 -8.5 58.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.018 0.747 . . . . 73.01 113.018 -176.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.7 p -110.22 -30.34 7.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.207 0.447 . . . . 74.12 112.207 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.69 -6.69 65.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.202 -0.523 . . . . 52.4 112.846 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -73.65 157.49 36.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.031 0.443 . . . . 72.42 111.576 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.56 160.72 20.42 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.125 -0.56 . . . . 62.15 112.93 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.07 61.43 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.15 0.426 . . . . 63.22 112.15 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.93 -27.4 67.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.033 0.444 . . . . 75.35 111.712 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -76.35 -36.91 57.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.125 0.488 . . . . 62.34 110.631 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 56.6 mt -68.42 -52.53 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.422 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.8 pt-20 -54.35 -37.28 64.74 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.914 0.388 . . . . 74.45 111.405 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -57.69 -53.58 56.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.09 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -65.07 -30.99 71.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.325 -0.398 . . . . 75.34 111.948 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 18.5 mtp-105 -60.47 -23.27 64.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.605 -0.27 . . . . 72.11 111.658 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -90.76 -9.38 46.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.355 0.872 . . . . 53.31 113.355 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.49 9.36 0.33 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 119.731 -1.223 . . . . 64.31 115.666 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.96 -28.79 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.904 0.852 . . . . 52.24 111.871 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.36 133.21 44.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.591 0.71 . . . . 75.4 112.493 -177.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 60.6 mt -138.47 126.46 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.419 -0.81 . . . . 71.24 110.329 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.5 139.78 51.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.371 0.605 . . . . 43.32 110.981 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.39 -15.11 59.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.059 -0.519 . . . . 53.51 112.593 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -123.89 -73.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 122.57 -0.371 . . . . 71.11 111.655 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.447 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.5 m80 -86.34 -10.87 53.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.056 0.391 . . . . 74.35 112.056 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 44.5 p90 -170.51 179.06 3.46 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.858 -0.423 . . . . 75.53 109.858 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -157.86 149.19 21.42 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.014 0.435 . . . . 74.12 111.374 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -78.69 103.94 8.97 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.232 0.539 . . . . 72.33 111.748 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 66.0 t -100.24 144.08 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.117 -0.492 . . . . 74.53 111.047 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -74.58 143.09 78.45 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.741 0.305 . . . . 72.12 111.552 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.95 -178.18 2.47 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.752 2.302 . . . . 73.43 112.101 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -68.39 83.25 0.26 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.254 0.55 . . . . 70.54 110.737 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.62 -177.92 47.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.007 -0.542 . . . . 60.01 112.489 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.33 40.89 0.66 Allowed 'General case' 0 CA--C 1.544 0.744 0 O-C-N 122.346 -0.502 . . . . 74.21 111.487 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.03 2.48 30.82 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.455 0.539 . . . . 71.44 112.455 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.9 m -145.91 151.4 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.149 -0.344 . . . . 60.52 111.121 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -74.79 -60.24 2.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.948 0.404 . . . . 75.42 111.62 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -87.01 0.78 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.898 0.38 . . . . 63.42 111.574 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.82 -126.9 7.62 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.272 -0.422 . . . . 51.21 113.303 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 84.8 m -140.61 119.68 12.79 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 122.442 -0.446 . . . . 74.05 110.721 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -86.7 105.76 17.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.09 0.472 . . . . 75.31 112.009 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 28.7 m95 -91.23 121.75 33.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.08 -0.509 . . . . 72.55 110.006 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' ILE . 87.5 m-85 -90.32 145.07 25.25 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.918 0.71 . . . . 72.35 112.918 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.479 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 53.2 t-20 -85.36 96.88 9.69 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.735 -0.666 . . . . 73.53 110.729 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 82.9 t80 -52.4 -53.11 56.69 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 112.543 0.571 . . . . 72.1 112.543 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 82.5 Cg_exo -51.02 -50.42 13.95 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.376 2.05 . . . . 73.54 113.588 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.6 mm-40 -71.22 -28.53 64.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.143 0.423 . . . . 75.2 112.143 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 58' ' ' TYR . 46.7 mt -70.13 -42.14 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.948 -0.47 . . . . 73.0 110.547 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -34.13 72.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.051 0.453 . . . . 75.14 110.407 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.7 tppp? -59.0 -31.86 69.17 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.939 -0.573 . . . . 64.32 111.279 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -85.51 -32.22 22.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 72.24 111.232 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.4 mt -60.69 -37.39 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 122.206 -0.309 . . . . 72.44 111.467 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' LYS . 1.7 ppt_? -57.27 -33.49 67.68 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.71 0.29 . . . . 71.34 110.976 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.21 -44.22 89.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.365 0.603 . . . . 63.23 110.105 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -60.64 -23.79 65.04 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.632 -0.713 . . . . 62.33 112.162 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.26 -21.99 35.99 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.118 0.414 . . . . 60.32 112.118 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -72.9 -174.69 1.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.389 0.614 . . . . 75.13 112.359 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -79.24 115.99 19.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.109 -0.496 . . . . 72.21 111.501 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -132.99 146.2 51.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.238 -0.437 . . . . 74.54 111.625 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -125.05 86.94 2.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.38 0.609 . . . . 52.45 112.07 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -135.14 -51.91 0.77 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.473 -0.785 . . . . 62.02 109.408 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -148.21 131.29 16.32 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.324 -0.853 . . . . 73.14 110.17 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.618 -0.706 . . . . 74.11 111.535 176.737 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 111.535 0.198 . . . . 74.32 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.79 124.77 25.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.945 0.402 . . . . 35.15 111.489 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.865 0.364 . . . . 73.21 111.833 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.9 mm -77.92 85.82 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.274 0.559 . . . . 72.12 110.228 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.62 139.77 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.947 -0.569 . . . . 65.01 111.739 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.86 131.15 55.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.522 -0.308 . . . . 73.33 110.874 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -171.74 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.796 0.331 . . . . 74.52 111.848 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 116.74 1.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.462 0.912 . . . . 63.53 113.462 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 70.6 mm-40 -108.26 94.08 4.88 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.922 -0.581 . . . . 60.34 110.819 173.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.431 ' HH2' ' HE3' ' A' ' 42' ' ' LYS . 80.9 m95 -93.81 134.31 36.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.148 -0.478 . . . . 73.11 110.429 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 20.4 ptp -157.16 153.85 28.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.987 0.422 . . . . 74.31 112.035 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.27 170.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.203 -0.453 . . . . 71.45 110.865 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -57.55 -45.59 84.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.22 0.452 . . . . 74.41 112.22 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.1 tmmt? -61.54 -38.54 87.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.887 0.375 . . . . 75.43 111.14 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -72.21 -38.54 68.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.071 0.462 . . . . 74.52 111.1 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.32 -48.37 81.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.782 -0.645 . . . . 53.2 110.965 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -61.29 -28.03 68.9 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.808 0.337 . . . . 74.33 111.901 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.9 t -78.62 -49.19 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.911 0.386 . . . . 61.11 111.126 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -64.4 -26.88 68.65 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.0 p -99.05 -30.67 12.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.252 0.464 . . . . 65.22 112.252 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.5 -13.98 56.64 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.117 -0.563 . . . . 64.3 113.103 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.4 mp -66.99 159.9 27.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.219 0.533 . . . . 61.43 111.976 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.69 160.63 15.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.039 -0.528 . . . . 24.52 112.491 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.58 65.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.85 0.357 . . . . 71.53 111.591 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -59.27 -31.68 69.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.003 -0.544 . . . . 72.33 111.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' SER . 46.9 tt0 -84.37 -34.28 23.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.398 -0.365 . . . . 70.21 111.021 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 17' ' ' MET . 60.8 mt -66.24 -50.33 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.598 -0.274 . . . . 64.43 111.159 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 13.0 pt-20 -58.56 -23.25 58.02 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.986 0.422 . . . . 63.4 111.193 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 47.9 t -67.18 -56.04 11.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.224 -0.444 . . . . 73.11 110.54 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -65.72 -25.89 67.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.178 0.436 . . . . 65.1 112.178 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 78.8 mtp180 -60.37 -10.76 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 111.942 0.349 . . . . 73.23 111.942 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.17 -22.33 66.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.161 0.43 . . . . 73.45 112.161 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.67 -17.16 0.05 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.488 -0.863 . . . . 71.2 114.607 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.3 67.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.681 0.741 . . . . 55.55 111.816 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -71.94 105.07 3.71 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.065 0.46 . . . . 75.31 111.716 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -87.49 120.24 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.345 -0.389 . . . . 74.15 111.6 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.61 147.74 40.72 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.905 0.335 . . . . 73.22 111.905 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.15 -47.18 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.444 -0.344 . . . . 61.15 113.665 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.3 t -80.44 -63.65 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.468 0.307 . . . . 74.44 111.732 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.477 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 4.3 m-70 -86.88 -19.93 28.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.127 0.417 . . . . 74.22 112.127 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 12.3 p90 -165.97 143.48 5.49 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.795 -0.446 . . . . 64.03 109.795 175.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.431 ' HE3' ' HH2' ' A' ' 10' ' ' TRP . 19.1 ptpt -127.62 161.36 29.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.395 0.617 . . . . 73.55 112.488 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 43' ' ' ARG . 7.8 ptp180 -74.92 134.62 41.54 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.502 -0.772 . . . . 62.13 111.032 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.07 149.16 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.657 -0.247 . . . . 51.21 110.788 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 20.4 m -49.77 139.8 15.91 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 111.929 0.344 . . . . 51.14 111.929 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 53.2 Cg_exo -52.65 130.43 36.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.739 2.293 . . . . 63.12 113.357 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.1 m -55.73 -40.66 72.78 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.031 0.443 . . . . 70.4 110.996 174.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 170.11 32.47 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.385 -0.436 . . . . 74.21 112.072 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.31 -30.63 71.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.304 0.552 . . . . 64.32 112.19 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -140.73 39.54 1.84 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.422 0.527 . . . . 75.2 112.422 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 46' ' ' PRO . 9.4 m -68.19 144.19 55.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.686 0.279 . . . . 73.42 110.289 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.0 mm? -69.99 -61.47 1.76 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.34 0.496 . . . . 72.12 112.34 -173.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -90.94 9.59 29.91 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.342 0.497 . . . . 75.41 112.342 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.21 -134.99 34.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.035 -0.602 . . . . 31.4 113.37 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -134.22 137.74 44.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 74.35 110.791 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.1 m -123.12 120.42 33.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.932 0.396 . . . . 75.13 111.801 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -109.94 140.11 44.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.318 -0.401 . . . . 74.11 111.108 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -99.34 139.76 34.51 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.827 0.346 . . . . 74.3 111.524 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 16.7 m120 -87.66 105.49 17.39 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.303 -0.408 . . . . 72.4 111.317 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 67.4 t80 -52.06 -52.03 65.82 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.857 0.688 . . . . 71.21 112.857 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 22.4 Cg_endo -60.01 -29.42 89.27 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.877 1.718 . . . . 60.24 112.858 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HB3' ' ND1' ' A' ' 40' ' ' HIS . 74.7 mm-40 -79.9 -39.09 31.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.194 -0.457 . . . . 71.14 112.063 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -71.69 -35.76 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.768 0.318 . . . . 64.33 110.384 174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.09 -38.24 85.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.759 0.314 . . . . 72.43 110.382 172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 39.6 ttmt -53.77 -35.46 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.073 0.463 . . . . 55.41 110.974 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.66 -50.97 10.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.149 -0.478 . . . . 42.45 111.163 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 63' ' ' ILE . 54.6 mt -67.85 -22.08 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.462 0.541 . . . . 72.52 112.462 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -53.11 -32.83 49.42 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.963 0.411 . . . . 72.52 111.428 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.77 -33.61 76.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.093 0.473 . . . . 75.41 110.922 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -76.33 -24.93 54.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.264 -0.425 . . . . 75.41 111.386 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' CD2' HG22 ' A' ' 67' ' ' ILE . 4.5 mm? -68.02 -34.74 77.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.636 0.255 . . . . 62.13 110.523 171.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 53.93 37.96 27.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.926 0.393 . . . . 52.23 110.581 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -44.62 124.22 4.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.015 0.746 . . . . 73.31 113.015 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -55.95 127.77 31.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.08 -0.964 . . . . 65.53 112.265 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 77' ' ' HIS . 30.6 m-70 -72.8 106.37 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.147 -0.479 . . . . 55.32 111.28 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -69.71 -29.31 66.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.654 0.74 . . . . 71.12 109.61 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 26.2 p-80 -132.74 165.52 24.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.005 -0.998 . . . . 75.32 109.687 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.61 -0.709 . . . . 74.51 112.125 -179.194 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 112.202 0.445 . . . . 74.24 112.202 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.34 140.2 12.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.891 0.377 . . . . 74.14 111.671 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.549 HE21 ' HB ' ' A' ' 5' ' ' ILE . 24.9 tm0? -84.64 102.48 12.97 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 64.51 110.543 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.5 mm -113.23 68.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.613 0.721 . . . . 72.13 111.068 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HB ' HE21 ' A' ' 3' ' ' GLN . 4.4 mp -132.75 115.75 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.828 -0.624 . . . . 54.12 110.723 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -168.51 150.12 4.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.453 -0.34 . . . . 61.14 111.18 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 61' ' ' PRO . 61.6 t30 -162.43 159.3 24.96 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.98 0.419 . . . . 71.14 111.26 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 27.69 2.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.451 0.538 . . . . 61.11 112.451 -175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.0 mm-40 -73.87 99.18 3.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.901 0.382 . . . . 64.25 111.98 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -91.98 135.75 33.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.627 -0.26 . . . . 74.05 110.526 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.7 ptp -158.81 142.41 15.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.922 0.391 . . . . 54.34 112.045 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.09 172.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 111.795 0.295 . . . . 61.04 111.795 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -46.74 -57.51 4.78 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.896 0.702 . . . . 73.44 112.896 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -54.69 -37.52 65.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.885 0.374 . . . . 73.34 111.945 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -76.11 -42.44 47.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.097 0.475 . . . . 53.33 111.143 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -58.31 -47.72 82.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.804 -0.635 . . . . 62.31 111.209 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -58.63 -34.24 70.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.847 0.356 . . . . 63.14 111.629 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.9 t -73.49 -46.14 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.154 0.502 . . . . 52.41 111.233 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.596 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 16.8 mmt180 -69.0 -29.57 67.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.131 -0.486 . . . . 74.5 112.247 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -99.96 -30.17 12.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.538 0.57 . . . . 54.33 112.538 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 -4.64 56.12 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.025 -0.607 . . . . 41.23 112.824 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.63 -173.11 1.71 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.386 0.612 . . . . 73.01 111.767 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -146.19 169.14 27.58 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.797 -0.638 . . . . 42.24 112.266 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.12 -50.69 61.17 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.221 0.452 . . . . 72.23 112.221 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -60.95 -34.76 75.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.133 0.492 . . . . 72.15 111.736 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.67 -40.37 34.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.349 -0.387 . . . . 71.44 111.599 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 23' ' ' GLY . 73.8 mt -66.04 -44.07 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.555 0.217 . . . . 54.12 111.369 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 11.7 pt-20 -56.93 -37.92 72.17 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.812 0.339 . . . . 74.11 110.905 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 t -60.69 -49.35 77.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 43.41 110.988 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -63.07 -29.38 70.77 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.805 0.298 . . . . 74.43 111.805 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.1 mtm180 -69.71 -12.31 61.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.052 0.39 . . . . 73.13 112.052 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 45.0 mt-30 -88.74 2.76 52.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.625 0.232 . . . . 74.52 111.625 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.3 -52.29 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.177 -1.011 . . . . 64.41 114.697 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.08 -38.42 31.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.465 0.913 . . . . 71.31 113.465 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -71.55 130.67 41.82 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.015 -0.428 . . . . 72.43 111.68 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.2 mt -130.59 126.31 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 122.522 0.329 . . . . 75.13 111.094 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 42' ' ' LYS . 38.5 tt0 -68.99 150.92 47.15 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.003 0.43 . . . . 44.13 110.906 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.45 2.67 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.255 -0.498 . . . . 71.45 112.841 -174.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -97.76 -64.99 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.249 0.463 . . . . 71.44 112.249 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.4 m-70 -92.06 -11.97 34.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.75 0.648 . . . . 53.13 112.75 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 47.5 p90 -170.78 174.03 5.06 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.0 0.12 . . . . 75.02 111.012 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 18.7 ptpt -167.74 174.2 7.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.424 0.631 . . . . 75.15 112.288 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -85.4 120.86 27.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.524 -0.762 . . . . 74.44 112.002 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.8 149.98 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.007 -0.542 . . . . 62.34 110.857 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 49.5 m -58.04 141.41 81.41 Favored Pre-proline 0 N--CA 1.473 0.706 0 N-CA-C 112.318 0.488 . . . . 74.34 112.318 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 8.7 Cg_exo -72.38 163.77 37.63 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.873 2.382 . . . . 62.13 112.371 175.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.2 p -79.31 -64.29 1.22 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.403 0.52 . . . . 44.35 112.403 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.85 -58.93 3.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.22 -0.514 . . . . 72.32 114.257 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.86 147.35 50.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.285 0.564 . . . . 72.33 112.115 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.51 114.62 20.36 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.778 -0.646 . . . . 64.45 111.256 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.9 p -118.6 168.79 10.36 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.106 0.479 . . . . 62.34 111.91 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.9 mm? -80.54 -9.86 59.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.24 0.543 . . . . 75.24 110.372 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -85.92 -47.06 9.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.758 -0.655 . . . . 71.13 111.651 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 46' ' ' PRO . . . 69.69 -168.04 47.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.284 -0.484 . . . . 41.35 113.443 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 m -127.61 116.7 20.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.614 -0.345 . . . . 73.32 110.566 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.6 m -89.61 115.25 26.86 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.069 0.461 . . . . 65.11 112.171 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -102.16 133.54 46.86 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.134 -0.484 . . . . 74.55 110.848 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.38 143.31 27.54 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.018 0.437 . . . . 73.44 111.327 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.39 105.53 13.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.322 -0.399 . . . . 71.52 111.5 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 90.2 t80 -56.95 -45.15 99.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 111.822 0.305 . . . . 74.12 111.822 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.795 ' HB3' ' HB3' ' A' ' 7' ' ' ASN . 9.1 Cg_endo -50.69 -41.78 52.76 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.405 2.07 . . . . 65.32 113.109 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 40' ' ' HIS . 42.6 mm-40 -65.87 -47.27 75.44 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.136 0.493 . . . . 64.03 111.815 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 HD21 ' A' ' 16' ' ' LEU . 65.3 mt -71.79 -37.43 62.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.975 0.417 . . . . 74.23 111.183 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.6 -43.25 99.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.281 0.562 . . . . 65.22 110.177 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -55.75 -39.49 71.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.593 -0.73 . . . . 72.0 110.81 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -65.03 -48.6 73.29 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.301 -0.409 . . . . 74.51 111.468 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.4 -45.36 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.1 0.476 . . . . 71.55 111.461 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 41.3 mtp-105 -64.89 -56.75 11.47 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.241 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.68 -37.86 76.97 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.574 0.583 . . . . 75.32 112.574 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.4 p -82.45 -64.21 1.22 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.171 0.434 . . . . 71.34 112.171 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -74.42 -43.7 55.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.138 0.421 . . . . 70.31 112.138 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 1.5 mm-40 55.22 76.91 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.358 0.873 . . . . 72.44 113.358 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -79.33 106.07 11.1 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.742 -0.836 . . . . 71.4 108.742 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -57.76 89.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.028 -0.533 . . . . 72.42 112.08 -169.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -67.4 -17.17 64.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.849 0.685 . . . . 75.51 112.849 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -68.76 -3.8 13.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.018 0.437 . . . . 75.01 111.08 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -125.05 -55.46 1.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.227 -0.442 . . . . 74.04 110.473 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.255 1.383 0 CA-C-O 118.799 -0.619 . . . . 74.54 112.042 -178.239 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.4 0.143 . . . . 52.45 110.753 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.07 141.92 2.72 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.212 0.449 . . . . 64.12 112.212 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -99.4 111.27 23.67 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.075 0.464 . . . . 63.32 111.063 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -71.07 93.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.979 0.419 . . . . 74.41 110.727 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mm -94.94 102.08 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.002 0.43 . . . . 65.0 111.777 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -132.97 132.55 42.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.197 -0.456 . . . . 53.42 110.762 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -73.36 79.02 1.36 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.426 0.631 . . . . 73.41 110.794 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 8.9 pt-20 -78.02 82.05 4.39 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.758 0.79 . . . . 73.4 111.405 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -75.46 85.33 2.57 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.848 -0.614 . . . . 71.03 111.629 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -77.53 130.53 37.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.669 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.6 ptp -153.59 142.3 20.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.813 0.339 . . . . 70.33 111.779 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 15' ' ' ALA . 35.8 m -64.81 166.29 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.752 0.31 . . . . 75.52 111.819 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -52.41 -46.61 66.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.009 0.433 . . . . 70.52 111.645 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -60.13 -37.09 79.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.154 -0.475 . . . . 72.02 111.483 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -76.21 -38.97 55.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.337 0.589 . . . . 74.21 111.04 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.17 -43.11 92.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.981 -0.554 . . . . 74.43 111.299 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.519 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.1 ptp -61.06 -27.49 68.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.738 0.304 . . . . 70.35 111.35 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.4 t -67.95 -48.77 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.215 0.531 . . . . 74.22 110.805 174.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -64.82 -42.76 94.7 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.078 -0.51 . . . . 75.3 112.289 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -93.5 -30.27 15.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.048 0.758 . . . . 72.24 113.048 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.84 7.56 64.39 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.055 -0.593 . . . . 72.31 113.127 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.4 mp -79.76 160.13 26.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 63.21 111.724 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.02 153.36 16.83 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 71.32 112.002 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -41.42 62.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.203 0.501 . . . . 45.12 111.997 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.98 -27.03 69.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.412 -0.358 . . . . 72.51 111.584 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -84.9 -40.95 16.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.152 0.501 . . . . 72.14 110.755 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.71 -40.0 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.253 -0.43 . . . . 61.24 112.03 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.487 ' HB3' ' NH2' ' A' ' 31' ' ' ARG . 11.7 pt-20 -62.19 -34.32 76.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.901 0.381 . . . . 74.43 111.253 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 35.8 t -62.43 -27.6 69.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.245 0.545 . . . . 74.24 110.773 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -88.43 -31.61 18.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.274 -0.421 . . . . 72.2 111.646 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 55.2 mtm180 -64.35 -20.52 66.16 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.296 0.48 . . . . 73.35 112.296 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 29' ' ' SER . 13.6 pt20 -79.03 -8.11 58.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.435 0.531 . . . . 75.11 112.435 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.32 -49.08 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.199 -1.0 . . . . 73.25 114.642 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.33 85.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 73.54 112.463 -176.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.13 106.29 4.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.043 0.449 . . . . 75.21 111.675 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -96.87 131.71 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.529 -0.305 . . . . 72.32 111.211 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.83 147.32 53.56 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.044 0.449 . . . . 72.15 111.4 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.68 -46.03 3.01 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.254 -0.498 . . . . 62.32 112.872 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.56 -62.79 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.305 0.483 . . . . 71.14 112.305 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -93.91 -21.01 19.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.918 0.71 . . . . 50.01 112.918 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -153.24 168.22 26.72 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.862 0.301 . . . . 74.51 111.46 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -136.16 165.29 26.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.21 0.529 . . . . 64.0 111.424 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -86.79 136.71 32.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.688 -0.687 . . . . 62.03 110.173 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 78.4 t -125.14 147.77 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.216 0.531 . . . . 25.23 111.656 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 t -66.9 141.57 96.83 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.035 -0.53 . . . . 63.14 112.122 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.06 22.95 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.732 2.288 . . . . 73.11 113.123 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.0 m 66.02 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.811 0.671 . . . . 72.13 112.811 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.93 1.3 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.173 -0.537 . . . . 62.14 113.537 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 51' ' ' THR . 39.6 mt-10 -90.28 102.82 15.54 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.346 -0.503 . . . . 65.04 111.204 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.08 97.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.968 0.413 . . . . 74.35 111.716 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 49' ' ' GLU . 63.6 p -110.35 162.5 14.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.36 0.6 . . . . 72.12 111.968 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.8 mm? -96.26 14.69 23.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.823 -0.626 . . . . 72.44 110.204 173.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -122.66 102.38 8.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.606 -0.725 . . . . 64.32 110.702 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.65 113.77 6.18 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 72.21 113.048 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 26.5 m -51.45 115.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.009 0.433 . . . . 71.11 111.17 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.8 m -91.9 110.2 21.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.718 0.636 . . . . 74.24 112.718 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -104.35 128.21 52.14 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.514 . . . . 74.24 111.008 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' OH ' ' HD3' ' A' ' 31' ' ' ARG . 15.8 m-85 -90.87 157.55 17.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 74.25 112.022 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 19.1 m120 -94.77 110.19 22.07 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.277 -0.419 . . . . 74.2 110.406 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.4 t80 -52.65 -49.81 84.16 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.119 0.414 . . . . 72.25 112.119 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 55.5 Cg_exo -53.63 -41.38 74.31 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.028 1.819 . . . . 74.01 113.274 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 28.2 mm-40 -70.52 -35.66 73.32 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.735 0.642 . . . . 71.11 112.735 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.4 -41.57 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.626 0.251 . . . . 75.52 111.154 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.84 -40.96 90.27 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.26 0.552 . . . . 61.04 110.279 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -59.88 -44.67 94.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.034 -0.53 . . . . 72.42 111.118 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.15 -45.7 90.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.199 -0.455 . . . . 72.12 111.226 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' O ' HD23 ' A' ' 71' ' ' LEU . 75.0 mt -59.49 -48.49 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.067 0.46 . . . . 72.34 111.019 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -54.59 -51.9 63.85 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.278 -0.419 . . . . 74.24 111.094 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.36 -39.75 81.7 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.242 -0.435 . . . . 61.54 111.506 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -63.65 -49.96 71.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.835 0.35 . . . . 54.44 111.397 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 67' ' ' ILE . 4.5 mm? -61.49 -43.6 98.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 73.32 111.378 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.0 pt-20 -161.17 108.09 1.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.623 0.725 . . . . 74.43 112.295 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.76 52.68 2.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.473 0.654 . . . . 73.24 110.755 173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.471 ' ND1' ' HB2' ' A' ' 72' ' ' GLU . 33.1 m170 -88.75 146.26 25.13 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.229 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 91.1 3.28 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.462 0.649 . . . . 73.13 111.586 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -81.72 83.03 7.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.407 0.622 . . . . 63.52 111.483 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 178.99 -42.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.06 -0.973 . . . . 74.52 109.389 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.446 -0.788 . . . . 74.4 109.953 171.907 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.453 0.168 . . . . 74.42 111.218 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.23 130.9 0.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.245 0.461 . . . . 61.44 112.245 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -144.97 120.44 10.34 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.007 0.432 . . . . 74.24 110.277 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.02 101.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.972 0.415 . . . . 55.22 111.147 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -99.22 104.92 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.922 0.391 . . . . 74.1 111.853 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -110.92 12.12 22.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.278 0.561 . . . . 74.21 110.744 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -78.59 62.26 3.12 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.26 0.552 . . . . 64.21 111.049 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.43 118.75 23.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.156 0.503 . . . . 54.41 111.501 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.559 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 6.8 tp10 -131.83 91.01 2.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.971 -0.559 . . . . 52.55 109.737 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -94.28 130.48 40.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.864 -0.607 . . . . 60.22 110.665 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.547 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.4 ptp -144.84 160.51 41.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.074 0.464 . . . . 75.41 111.823 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 15' ' ' ALA . 33.0 m -73.67 170.31 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.133 0.492 . . . . 75.53 111.632 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.82 -48.69 80.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.237 0.458 . . . . 73.55 112.237 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . 0.8 OUTLIER -65.33 -29.7 70.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.763 0.316 . . . . 62.22 111.107 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -73.47 -41.77 62.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.994 0.426 . . . . 75.24 111.053 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -58.04 -45.88 86.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.047 -0.524 . . . . 50.33 111.207 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.7 ptp -62.28 -35.52 79.25 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.597 0.237 . . . . 74.01 111.549 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 95.8 t -72.77 -40.46 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.07 0.462 . . . . 54.34 111.433 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.547 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 15.0 mmt85 -65.55 -41.59 92.85 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.237 -0.438 . . . . 73.25 112.051 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.1 p -93.75 -30.21 14.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.97 0.73 . . . . 75.41 112.97 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.58 -4.62 47.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.198 -0.525 . . . . 75.32 112.947 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -75.82 -179.1 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 74.52 111.861 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -132.13 168.44 22.52 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.626 -0.715 . . . . 71.24 112.26 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.1 71.21 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.673 0.62 . . . . 72.05 112.673 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 87.2 mtt180 -73.99 -18.64 60.84 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.621 0.6 . . . . 54.51 112.621 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -84.57 -37.73 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.898 0.38 . . . . 71.41 110.701 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.1 mt -63.67 -50.37 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.601 -0.272 . . . . 72.53 111.126 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.7 pt-20 -59.8 -31.03 69.31 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.141 0.496 . . . . 75.1 110.935 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 40.8 t -61.5 -50.41 72.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.512 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.14 -23.68 66.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.946 0.35 . . . . 74.14 111.946 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.702 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 13.6 mtp180 -64.27 -9.79 19.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.797 0.666 . . . . 71.04 112.797 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 29' ' ' SER . 29.0 pt20 -70.9 -22.26 62.29 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.937 0.347 . . . . 74.03 111.937 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.69 -43.68 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.753 -0.737 . . . . 71.45 113.979 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.16 -49.08 78.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.095 0.405 . . . . 63.01 112.095 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.95 104.52 5.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.961 0.41 . . . . 73.22 110.241 175.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.79 127.26 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 72.41 110.848 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -58.49 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.961 0.41 . . . . 73.43 111.081 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.11 -50.22 3.35 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 64.23 113.038 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.1 t -81.35 -61.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.176 0.436 . . . . 73.15 112.176 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -89.36 -22.12 22.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 111.987 0.366 . . . . 72.31 111.987 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -160.09 127.34 4.5 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.708 0.29 . . . . 75.53 110.655 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -122.02 145.07 48.49 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.01 0.433 . . . . 71.42 111.749 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 45.3 mtm180 -73.46 103.21 4.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.03 0.443 . . . . 71.35 111.09 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.4 100.43 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.209 0.528 . . . . 72.43 111.107 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.3 p -86.93 132.22 42.61 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.318 -0.401 . . . . 71.44 110.79 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.01 -8.13 21.79 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.685 2.256 . . . . 65.21 113.093 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.1 t -127.27 158.9 35.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.118 0.485 . . . . 74.05 111.596 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.71 2.31 69.77 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.055 -0.521 . . . . 54.11 112.309 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.08 152.07 25.49 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.079 0.466 . . . . 73.45 111.911 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.74 86.17 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 62.4 111.221 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.0 p -131.91 154.29 49.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.217 -0.447 . . . . 71.03 111.489 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.4 mm? -88.88 14.9 9.35 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.014 0.435 . . . . 64.4 111.287 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -86.9 28.39 0.9 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.959 0.409 . . . . 71.3 111.98 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.12 80.25 0.2 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.147 -0.549 . . . . 65.24 113.202 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.2 m -72.97 116.7 13.8 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.579 -0.365 . . . . 74.13 110.503 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 6.9 t -81.12 138.12 35.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.276 0.56 . . . . 72.21 112.343 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -112.81 136.89 51.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.7 -0.682 . . . . 55.02 110.371 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -89.93 139.73 30.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.291 0.567 . . . . 72.42 112.126 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.547 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 39.3 t-20 -91.73 101.51 14.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.593 -0.731 . . . . 70.31 110.467 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 87.0 t80 -54.99 -52.13 73.65 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 112.627 0.603 . . . . 70.11 112.627 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 9' ' ' GLU . 80.9 Cg_exo -48.51 -49.41 14.63 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.256 1.971 . . . . 72.21 113.376 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -62.72 -41.53 99.2 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.147 0.425 . . . . 71.24 112.147 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.24 -49.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.961 0.41 . . . . 72.22 111.586 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -57.12 -38.32 73.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 61.45 110.927 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -51.33 70.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.193 -0.458 . . . . 75.55 110.091 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -55.56 -48.78 74.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.011 -0.541 . . . . 73.4 111.563 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.74 -40.86 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.17 -0.468 . . . . 62.32 111.338 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 68' ' ' ARG . 22.7 ttt180 -59.08 -32.76 70.09 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.309 0.485 . . . . 61.03 112.309 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -61.75 -49.08 77.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.937 0.399 . . . . 64.43 111.895 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.3 t -83.85 -44.68 14.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.117 0.414 . . . . 70.2 112.117 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.83 -43.68 78.97 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.924 0.342 . . . . 71.44 111.924 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 68.3 -69.56 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.168 0.587 . . . . 72.11 112.275 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -97.27 137.39 36.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.046 -0.524 . . . . 72.22 112.366 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -80.87 116.39 20.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.968 0.413 . . . . 61.4 111.45 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.3 133.33 54.97 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.381 -0.372 . . . . 71.32 111.247 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -80.15 126.81 31.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.392 . . . . 62.11 111.489 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -93.41 137.1 33.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.239 -0.437 . . . . 72.45 110.636 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.33 -0.843 . . . . 72.51 110.913 178.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.768 0.318 . . . . 65.12 111.294 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 90.64 2.06 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.39 0.515 . . . . 70.04 112.39 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -84.95 137.8 32.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.356 -0.383 . . . . 74.51 110.264 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.3 mm -70.46 78.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 121.166 0.508 . . . . 73.34 111.493 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -140.37 90.17 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.282 -0.417 . . . . 74.35 110.972 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -173.87 127.88 0.39 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.408 -0.36 . . . . 74.13 110.9 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -155.11 115.74 3.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.266 0.555 . . . . 64.23 111.915 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.581 ' HB3' ' NE1' ' A' ' 10' ' ' TRP . 50.7 mt-10 -96.14 99.96 11.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.168 -0.469 . . . . 64.42 111.065 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -88.78 88.09 7.48 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.834 0.349 . . . . 62.55 111.335 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' NE1' ' HB3' ' A' ' 8' ' ' GLU . 87.9 m95 -96.12 132.83 41.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.009 0.433 . . . . 74.24 111.647 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.39 154.45 40.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.439 -0.346 . . . . 71.31 111.072 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.25 171.33 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.429 -0.351 . . . . 72.32 111.69 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -51.64 -57.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.211 0.448 . . . . 70.44 112.211 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.2 tmmt? -53.02 -48.45 67.55 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.295 -0.412 . . . . 61.23 111.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.22 97.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.015 0.436 . . . . 70.53 111.558 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -59.65 -51.86 68.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.068 -0.515 . . . . 65.0 111.496 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -59.5 -39.45 83.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.688 0.28 . . . . 72.14 111.726 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.38 -42.68 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.829 0.347 . . . . 50.33 111.375 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -65.55 -35.33 80.55 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.391 0.515 . . . . 74.04 112.391 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.1 p -93.48 -30.24 15.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.508 0.559 . . . . 73.13 112.508 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.22 11.29 45.95 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.122 -0.561 . . . . 70.31 112.714 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.3 mp -93.39 173.14 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.137 0.494 . . . . 71.33 111.172 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.28 162.28 22.01 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.247 -0.502 . . . . 74.54 112.313 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.25 61.94 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.004 0.372 . . . . 51.43 112.004 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -60.6 -28.64 68.67 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.18 0.437 . . . . 74.02 112.18 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 9.3 tt0 -84.94 -45.16 12.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.102 0.477 . . . . 75.14 110.855 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.8 mt -64.14 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.24 -0.436 . . . . 74.42 111.99 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.71 -34.36 69.38 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.857 0.317 . . . . 60.24 111.857 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 t -64.39 -42.07 96.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.09 0.471 . . . . 61.41 111.121 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 29.0 m-85 -64.74 -33.5 76.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 75.32 111.119 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 27.9 mtm180 -62.62 -25.8 68.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.641 0.258 . . . . 70.13 111.312 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.66 -36.52 80.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.617 0.599 . . . . 70.34 112.617 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.25 35.89 0.29 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.317 -0.944 . . . . 74.22 114.506 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.25 -16.85 1.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.103 0.477 . . . . 53.53 111.917 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.499 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.03 111.91 20.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.219 0.533 . . . . 64.12 112.122 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.89 129.67 64.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.023 -0.535 . . . . 71.12 110.376 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.18 137.69 53.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.144 0.497 . . . . 43.43 110.669 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.39 2.93 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.329 -0.462 . . . . 74.52 112.372 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.25 -64.5 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.094 0.405 . . . . 72.04 112.094 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 47.4 m170 -94.24 -37.72 11.39 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.363 0.505 . . . . 73.32 112.363 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 25.6 p90 -141.74 175.7 9.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 63.24 111.121 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -144.79 133.05 21.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.897 0.379 . . . . 73.31 110.98 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -80.75 102.69 10.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.496 0.665 . . . . 74.3 110.404 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.39 125.36 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.063 -0.971 . . . . 55.15 112.175 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 75.5 m -82.79 126.35 73.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.021 -0.536 . . . . 75.14 110.704 174.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.89 -21.6 58.42 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.522 2.148 . . . . 73.22 112.859 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.7 t -136.85 105.91 5.97 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.755 0.312 . . . . 64.33 111.318 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.24 -110.13 3.24 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.159 -0.543 . . . . 64.43 113.46 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.49 169.7 17.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.029 0.442 . . . . 53.53 112.137 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 52.55 26.75 4.51 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.772 1.027 . . . . 74.23 113.772 172.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 22.8 m -71.88 160.78 31.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.122 -0.361 . . . . 73.11 110.598 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.8 mm? -82.18 20.79 0.98 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.08 0.467 . . . . 64.4 111.348 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -137.52 79.51 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.923 0.489 . . . . 72.14 110.82 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.39 82.81 0.9 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.053 -0.594 . . . . 51.13 112.985 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -69.82 113.49 7.11 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.61 -0.347 . . . . 63.32 110.679 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.432 HG23 ' CD2' ' A' ' 41' ' ' PHE . 52.2 m -86.15 115.75 23.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.01 0.744 . . . . 42.54 113.01 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -105.19 140.48 38.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.695 -0.684 . . . . 73.35 110.111 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.42 144.82 32.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.326 0.491 . . . . 70.43 112.326 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.09 111.78 18.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.379 -0.373 . . . . 64.14 110.983 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 87.7 t80 -54.85 -53.39 61.38 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 112.342 0.497 . . . . 72.32 112.342 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 55.6 Cg_endo -67.16 -20.19 50.1 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.154 1.903 . . . . 53.11 113.786 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 40' ' ' HIS . 47.1 mm-40 -83.29 -38.04 22.66 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.11 -0.369 . . . . 71.11 111.515 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 16' ' ' LEU . 58.9 mt -70.6 -42.98 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.663 0.268 . . . . 73.43 110.442 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.25 -38.2 70.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.844 0.354 . . . . 74.15 111.03 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.44 -49.61 77.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 73.15 110.798 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -58.81 -41.87 87.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.065 0.459 . . . . 71.33 111.199 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.7 mt -62.15 -53.82 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.276 -0.42 . . . . 61.11 111.232 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -66.81 -28.31 68.27 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.7 0.286 . . . . 72.03 111.675 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.32 -41.38 80.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 60.01 110.586 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -71.0 -32.06 68.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.045 0.45 . . . . 74.12 111.28 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -80.46 -56.34 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.596 0.591 . . . . 63.13 112.596 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 70.42 -35.24 0.32 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.186 0.81 . . . . 72.51 113.186 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -52.2 133.43 33.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.226 0.454 . . . . 62.41 112.226 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 77.26 12.29 2.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.914 0.886 . . . . 63.2 112.462 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -79.46 88.82 5.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.113 -0.329 . . . . 70.44 110.113 169.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -77.75 128.23 33.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.037 0.446 . . . . 71.2 111.265 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -110.22 148.98 30.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.792 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 . . . . . 0 C--O 1.249 1.051 0 O-C-N 122.29 -0.256 . . . . 74.35 111.278 175.283 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.716 0.293 . . . . 62.15 111.662 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.41 159.7 14.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.431 0.53 . . . . 64.15 112.431 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -143.89 122.28 12.37 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.005 0.431 . . . . 71.14 111.313 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.13 119.93 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.775 0.322 . . . . 64.44 111.192 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -102.46 106.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.901 0.382 . . . . 74.0 111.162 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -163.46 103.41 0.95 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.51 -0.314 . . . . 74.03 110.731 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -167.9 97.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.75 0.648 . . . . 54.24 112.75 -175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.67 132.85 49.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.021 0.438 . . . . 73.23 110.336 170.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.9 mm-40 -84.88 105.78 15.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 72.24 111.59 -176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -88.62 136.69 32.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.687 0.28 . . . . 75.41 111.014 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 ptp -157.92 153.55 26.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.949 0.404 . . . . 64.43 111.814 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.67 174.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.278 -0.419 . . . . 72.04 111.491 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 27' ' ' ILE . 35.7 tt0 -59.37 -50.66 73.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.42 . . . . 75.13 112.133 -175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -61.05 -38.13 85.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.922 0.391 . . . . 74.13 110.968 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.04 75.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.147 0.499 . . . . 74.25 111.012 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.97 -47.77 83.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.869 -0.605 . . . . 74.42 111.168 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.6 ptp -60.15 -34.99 74.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.82 0.343 . . . . 74.22 111.311 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.6 t -76.95 -27.1 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.744 0.307 . . . . 61.25 111.76 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.0 mmp_? -94.39 -14.69 25.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.672 0.619 . . . . 64.23 112.672 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.7 p -108.53 -29.86 8.55 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.496 0.554 . . . . 41.41 112.496 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.58 -0.14 58.06 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.122 -0.561 . . . . 72.13 112.578 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.1 178.52 7.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.29 0.567 . . . . 61.34 112.042 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.42 168.74 12.68 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.022 -0.535 . . . . 72.54 112.578 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 -45.14 91.35 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.602 -0.352 . . . . 60.21 111.872 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -65.21 -41.2 94.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.151 0.501 . . . . 74.04 111.123 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.59 -41.77 98.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.278 -0.419 . . . . 73.35 111.189 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG21 ' HG3' ' A' ' 13' ' ' GLU . 66.0 mt -62.39 -54.38 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.624 0.25 . . . . 42.31 111.659 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 11.8 pt-20 -59.65 -29.9 68.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.96 0.41 . . . . 72.52 111.284 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.3 t -63.04 -46.83 85.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.879 0.371 . . . . 71.51 111.093 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -68.69 -29.01 67.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.974 0.416 . . . . 61.31 111.029 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 51.9 mtp180 -61.26 -28.1 68.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.087 172.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.3 mm100 -73.08 -33.56 65.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.387 0.514 . . . . 73.21 112.387 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.82 61.19 0.3 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.169 -1.015 . . . . 54.12 114.737 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.71 -32.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.566 0.698 . . . . 63.22 110.408 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.48 130.92 41.78 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.679 -0.691 . . . . 72.24 111.581 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.458 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 70.9 mt -131.93 132.95 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.842 -0.617 . . . . 62.31 110.898 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.07 142.52 51.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.055 0.455 . . . . 71.21 111.441 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.31 -48.67 3.43 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.471 -0.395 . . . . 71.15 113.314 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.35 -60.59 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.941 0.4 . . . . 54.41 112.031 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.458 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.6 m170 -97.63 -32.19 11.9 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.282 0.475 . . . . 73.34 112.282 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 23.4 p90 -153.27 169.59 22.67 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.222 -0.299 . . . . 73.21 111.526 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.59 152.54 27.36 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.782 0.325 . . . . 73.33 110.851 174.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -78.57 131.0 36.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.237 0.542 . . . . 63.3 111.796 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 45' ' ' SER . 39.9 t -114.66 159.66 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.034 -0.53 . . . . 75.11 110.734 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.405 ' N ' HG12 ' A' ' 44' ' ' VAL . 46.6 m -51.38 131.17 33.98 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.356 -0.384 . . . . 73.55 111.713 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.3 Cg_endo -61.21 114.25 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.235 1.957 . . . . 74.2 112.361 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -82.89 9.29 10.29 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.143 0.423 . . . . 72.22 112.143 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.07 -104.51 0.21 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.255 -0.498 . . . . 64.24 112.516 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.77 122.46 19.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.016 0.436 . . . . 71.34 111.327 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -78.05 100.18 6.41 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.253 -0.431 . . . . 65.34 110.41 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -129.69 156.1 44.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.5 -0.318 . . . . 72.05 110.873 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 52' ' ' LEU . 3.1 mm? -62.66 -15.21 51.14 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.837 0.68 . . . . 65.02 112.837 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.41 -31.1 37.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.227 -0.296 . . . . 63.51 111.591 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.99 -174.45 43.49 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.33 -0.462 . . . . 54.31 113.214 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 46' ' ' PRO . 91.3 m -101.04 114.68 28.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.248 -0.56 . . . . 64.42 110.325 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m -94.42 126.23 39.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.292 0.478 . . . . 72.3 112.292 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -114.64 139.07 49.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.24 -0.437 . . . . 74.2 110.613 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 63' ' ' ILE . 55.5 m-85 -107.94 148.51 29.57 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.973 0.415 . . . . 72.12 112.015 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.1 101.36 12.38 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.997 0.427 . . . . 64.12 111.213 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.783 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 87.0 t80 -53.54 -45.24 98.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.724 0.639 . . . . 73.03 112.724 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 11.1 Cg_endo -53.65 -47.41 27.41 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.018 1.812 . . . . 75.53 112.814 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.46 -38.77 84.95 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.253 0.464 . . . . 74.11 112.253 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 58' ' ' TYR . 64.4 mt -68.06 -43.52 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.876 0.369 . . . . 55.34 110.884 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 53.1 t30 -60.28 -41.25 92.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.039 0.447 . . . . 63.25 110.269 173.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -44.43 92.29 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.902 -0.59 . . . . 55.42 111.323 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -63.35 -46.87 84.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.214 0.531 . . . . 74.14 111.432 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.27 -47.41 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.253 -0.431 . . . . 73.21 111.59 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 6.8 tpp180 -61.27 -34.61 75.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.297 -0.41 . . . . 72.1 111.164 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -28.02 65.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.966 -0.561 . . . . 74.02 111.49 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.1 t -72.95 -24.23 60.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.197 -0.456 . . . . 61.24 111.408 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.34 -40.71 15.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.402 -0.363 . . . . 64.12 111.904 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.79 16.57 3.63 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.043 0.757 . . . . 61.21 113.043 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.58 104.31 16.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.536 0.569 . . . . 52.12 112.536 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 31.11 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.902 1.445 . . . . 73.25 114.902 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -68.81 99.14 0.99 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.883 -0.599 . . . . 70.12 110.315 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -94.92 132.51 39.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.703 0.287 . . . . 70.2 111.694 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -176.36 114.93 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.997 0.427 . . . . 43.13 111.379 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.5 p80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 119.327 -0.368 . . . . 73.12 111.39 177.738 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 111.631 0.234 . . . . 75.4 111.631 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.81 -65.15 1.04 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.467 0.543 . . . . 62.22 112.467 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 59.46 55.62 4.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.416 0.627 . . . . 72.45 111.583 -175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.94 85.63 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.39 0.614 . . . . 74.33 109.848 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.6 mm -71.03 104.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 113.101 0.778 . . . . 72.33 113.101 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -134.91 107.91 7.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.869 -0.605 . . . . 75.11 110.095 170.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -153.48 43.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.782 0.801 . . . . 74.31 110.23 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 5.2 mp0 -75.35 96.26 3.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.424 -0.807 . . . . 74.33 111.705 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 11.2 mm-40 -76.43 117.0 17.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 70.11 111.42 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -99.09 123.89 43.71 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.345 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 19.8 ptp -159.79 156.71 28.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.332 0.493 . . . . 54.05 112.332 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.3 m -81.58 176.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.319 -0.4 . . . . 42.33 111.174 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -56.3 -47.05 79.46 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.645 0.609 . . . . 74.1 112.645 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -39.96 92.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.837 0.351 . . . . 72.21 111.289 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -74.79 -33.57 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.086 0.47 . . . . 62.21 111.197 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.96 -47.87 67.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.759 -0.655 . . . . 73.05 111.326 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.5 ptp -56.12 -33.71 65.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.043 0.449 . . . . 74.03 111.852 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.38 -33.98 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.102 0.477 . . . . 73.44 111.457 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -86.81 -15.33 39.57 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.425 0.528 . . . . 72.15 112.425 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' HD13 ' A' ' 22' ' ' LEU . 48.6 p -108.53 -29.1 8.95 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.774 0.657 . . . . 72.12 112.774 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.98 9.7 65.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.849 -0.691 . . . . 61.23 112.636 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.0 mp -91.77 163.1 14.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.122 0.487 . . . . 62.21 111.124 176.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.39 163.2 14.18 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.209 -0.519 . . . . 64.12 111.811 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -51.2 -41.82 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.137 0.469 . . . . 44.42 111.501 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -56.6 -37.65 70.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.348 -0.387 . . . . 72.14 112.025 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -73.92 -46.49 44.05 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 70.1 111.274 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.56 -46.82 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.462 -0.335 . . . . 72.12 111.678 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 13.1 pt-20 -59.56 -37.39 78.33 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.824 0.345 . . . . 70.41 111.027 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -56.92 -39.89 75.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.187 0.518 . . . . 74.1 110.834 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -80.67 -26.41 37.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.249 -0.432 . . . . 72.4 111.61 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 37.9 mtm180 -66.85 -17.95 65.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.798 0.333 . . . . 74.33 111.139 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.47 -23.09 65.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.311 0.485 . . . . 74.23 112.311 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.84 -52.05 0.02 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.312 -0.947 . . . . 73.23 114.276 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.76 -36.92 39.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.634 0.605 . . . . 72.5 112.634 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.33 104.39 3.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.016 0.436 . . . . 65.31 110.881 176.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -95.2 138.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.881 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.54 134.39 56.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.068 0.461 . . . . 72.41 111.899 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -35.85 1.72 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.449 -0.405 . . . . 53.25 113.894 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.5 t -84.64 -53.23 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.333 0.494 . . . . 63.21 112.333 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.38 -15.13 14.31 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.561 0.578 . . . . 72.53 112.561 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.78 152.06 35.89 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.469 -0.145 . . . . 73.01 110.637 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 8.0 mtpm? -125.69 141.29 52.09 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.094 0.473 . . . . 70.5 111.993 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -84.93 111.86 20.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.879 -0.601 . . . . 73.42 111.187 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.5 t -107.46 119.79 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.142 0.496 . . . . 70.13 111.934 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -84.32 141.56 39.83 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.089 -0.505 . . . . 63.44 111.35 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.97 -7.17 20.45 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.674 2.249 . . . . 72.33 113.149 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.5 t -136.24 -59.7 0.73 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.637 0.256 . . . . 72.43 111.323 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.01 -42.1 0.19 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.627 -0.797 . . . . 45.23 113.838 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -82.13 -177.93 6.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.207 0.527 . . . . 72.54 111.908 -177.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -64.31 120.67 12.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.037 0.446 . . . . 74.34 111.067 -178.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -120.64 157.38 29.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.827 -0.624 . . . . 72.03 111.423 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.512 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.7 mm? -82.25 -51.5 7.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.388 0.613 . . . . 74.24 110.027 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -81.25 72.9 8.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.306 0.574 . . . . 72.34 111.181 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.16 126.53 8.0 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.845 -0.616 . . . . 72.51 112.488 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.8 m -76.69 116.39 17.33 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 122.429 -0.453 . . . . 74.13 111.103 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -97.8 101.16 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.807 0.337 . . . . 73.22 111.827 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -89.15 138.47 31.39 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.574 -0.285 . . . . 72.4 110.278 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.13 134.95 43.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.063 0.459 . . . . 72.1 111.794 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 63' ' ' ILE . 1.4 m-20 -76.93 94.23 3.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.941 -0.572 . . . . 44.21 111.815 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 78.6 t80 -52.37 -48.96 87.88 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.214 0.82 . . . . 65.12 113.214 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HG3' ' HA ' ' A' ' 8' ' ' GLU . 13.1 Cg_endo -55.0 -42.15 71.98 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.985 1.79 . . . . 72.21 112.635 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 60.4 mm-40 -64.73 -41.06 96.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.019 0.438 . . . . 74.11 111.271 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.0 mt -66.54 -45.34 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.272 -0.422 . . . . 53.22 111.301 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -58.09 -44.05 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.214 0.53 . . . . 64.02 110.552 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -54.69 -38.66 67.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.793 -0.64 . . . . 75.01 111.205 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -71.62 -43.63 65.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.172 -0.467 . . . . 72.53 111.024 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 63' ' ' ILE . 77.7 mt -55.29 -46.88 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.394 -0.366 . . . . 72.41 111.25 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -50.59 -54.7 20.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.75 0.31 . . . . 62.34 111.618 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.33 -48.25 79.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.011 0.434 . . . . 73.2 111.312 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.7 t -71.38 -24.58 62.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.527 0.565 . . . . 43.51 112.527 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp -86.01 -52.25 5.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.68 0.622 . . . . 62.13 112.68 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -25.39 49.03 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.679 0.622 . . . . 74.11 112.679 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -67.14 142.13 57.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.812 0.339 . . . . 74.4 111.046 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -72.45 71.81 0.95 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.651 0.739 . . . . 62.24 112.43 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -149.82 95.7 2.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.485 -0.78 . . . . 74.54 109.789 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -97.66 124.91 42.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.874 0.369 . . . . 64.42 111.81 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -61.06 121.69 13.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.451 -0.341 . . . . 74.35 110.463 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.679 -0.677 . . . . 71.31 111.553 177.806 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 112.088 0.403 . . . . 75.42 112.088 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.33 -59.36 5.46 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.056 0.455 . . . . 64.03 111.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -129.55 141.88 50.88 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.234 -0.439 . . . . 71.43 110.395 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -80.7 94.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.001 0.429 . . . . 74.21 111.217 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.1 114.16 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.055 0.455 . . . . 65.31 110.002 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.65 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 91.5 m-85 -68.82 -52.12 33.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.935 0.717 . . . . 74.43 112.935 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 65.72 21.82 11.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.877 0.37 . . . . 72.32 111.816 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.65 ' HG3' ' HB3' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -104.22 23.67 12.7 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.415 0.626 . . . . 75.42 110.917 177.472 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 4.3 mp0 -72.06 82.58 0.97 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.668 -0.697 . . . . 71.21 110.676 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -102.69 129.82 49.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.486 -0.325 . . . . 73.55 110.968 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.2 pmm? -145.92 162.55 37.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.747 0.308 . . . . 74.1 111.266 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.4 162.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.425 -0.352 . . . . 61.13 111.512 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 42.9 tt0 -50.29 -44.92 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.284 0.476 . . . . 65.22 112.284 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -58.41 -44.54 89.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.4 -0.364 . . . . 54.35 111.263 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.21 -34.23 65.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.149 0.5 . . . . 71.2 111.336 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -49.99 75.28 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.966 -0.561 . . . . 74.43 110.871 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.02 -28.86 69.35 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.753 0.311 . . . . 74.31 111.699 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 14' ' ' LYS . 62.2 t -73.85 -38.13 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.048 0.452 . . . . 72.22 111.219 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.1 mmm180 -78.08 -24.41 47.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.986 0.365 . . . . 75.2 111.986 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 22' ' ' LEU . 67.1 p -104.67 -30.21 10.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.85 0.685 . . . . 52.25 112.85 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.78 10.0 60.58 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.258 -0.496 . . . . 62.23 113.208 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.2 mp -83.73 167.82 16.82 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.197 0.522 . . . . 70.1 112.147 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.54 159.34 14.55 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.214 -0.448 . . . . 74.23 112.787 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.1 -46.51 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.851 0.686 . . . . 63.33 112.851 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 20.8 ttm180 -75.59 -35.34 60.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.796 0.331 . . . . 75.25 111.469 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -61.92 -40.78 96.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.156 0.503 . . . . 75.41 110.562 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.56 -48.7 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.075 -0.512 . . . . 75.54 111.593 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 14.2 pt-20 -63.9 -23.19 67.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.186 -0.321 . . . . 60.23 111.324 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -67.08 -49.23 65.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.089 0.471 . . . . 72.1 110.322 172.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.161 0.505 . . . . 74.25 111.092 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 48.9 mtp180 -61.94 -13.4 24.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.822 -0.627 . . . . 70.23 111.824 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -100.53 12.27 37.67 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 111.747 0.277 . . . . 71.41 111.747 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.11 -78.2 0.03 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.461 -0.876 . . . . 61.33 114.157 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.36 67.47 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.007 0.743 . . . . 43.05 113.007 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.562 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 112.23 7.94 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.472 0.653 . . . . 73.31 112.066 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 64.8 mt -105.83 134.5 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.457 -0.792 . . . . 73.02 110.447 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.2 133.01 53.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 74.01 111.131 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.31 -32.05 3.39 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.536 -0.364 . . . . 73.1 113.648 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 47.2 t -97.18 -41.09 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.573 0.582 . . . . 62.13 112.573 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 21.8 m170 -112.18 -5.43 14.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.184 0.438 . . . . 63.51 112.184 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -170.94 164.59 7.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.606 0.225 . . . . 73.44 111.606 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -149.47 161.81 41.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.951 0.405 . . . . 72.21 111.128 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mmm-85 -87.62 118.32 27.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.311 -0.404 . . . . 75.32 111.463 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.7 t -94.24 134.52 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.768 0.318 . . . . 72.21 111.158 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -77.26 118.89 74.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 112.126 0.417 . . . . 75.43 112.126 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.515 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 70.5 Cg_endo -75.22 106.61 2.31 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.458 2.105 . . . . 71.05 111.657 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.9 t -50.41 -38.15 41.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.777 0.658 . . . . 61.33 112.777 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.29 -83.98 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.077 -0.582 . . . . 63.51 113.301 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.67 87.92 6.27 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.319 -0.518 . . . . 71.32 110.874 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -71.57 81.26 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.269 0.557 . . . . 73.23 111.662 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 p -117.64 -173.02 2.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.165 -0.47 . . . . 74.2 110.61 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.2 mm? -86.45 3.69 42.81 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.188 0.518 . . . . 74.53 111.004 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -85.63 21.58 1.8 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.309 -0.405 . . . . 74.43 111.102 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 46' ' ' PRO . . . -45.73 127.29 8.68 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.4 -0.364 . . . . 63.44 113.86 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -54.52 117.36 3.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.135 0.493 . . . . 73.5 111.702 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.8 m -83.59 105.43 14.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.191 -0.459 . . . . 62.35 111.908 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -89.35 152.69 21.38 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.485 -0.325 . . . . 71.43 110.462 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.403 ' HE2' ' HB2' ' A' ' 13' ' ' GLU . 85.5 m-85 -113.4 149.62 33.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.993 0.738 . . . . 72.31 112.993 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 63' ' ' ILE . 16.3 m120 -77.16 93.66 3.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.696 -0.684 . . . . 70.43 111.73 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.584 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.2 t80 -55.25 -47.03 99.51 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.431 0.53 . . . . 74.23 112.431 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 7.7 Cg_endo -49.07 -48.57 17.87 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.382 2.055 . . . . 63.34 113.212 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 29.0 mm-40 -74.22 -34.67 63.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.583 0.586 . . . . 64.53 112.583 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 59' ' ' ASN . 77.8 mt -67.37 -43.05 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.147 0.499 . . . . 63.14 110.54 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.78 -41.85 99.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.022 -0.536 . . . . 55.42 110.358 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -46.81 77.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.793 -0.639 . . . . 71.32 111.097 174.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.98 -51.84 68.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.056 -0.52 . . . . 65.22 111.272 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.99 -29.86 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.294 -0.412 . . . . 73.11 111.624 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.52 -49.96 75.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.823 0.344 . . . . 73.33 111.402 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.38 57.5 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.772 0.32 . . . . 74.43 111.601 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -71.5 -41.57 69.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.028 0.442 . . . . 53.25 111.752 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -56.1 6.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.21 -0.45 . . . . 73.03 110.968 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.28 -71.33 0.09 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.909 0.707 . . . . 71.11 112.909 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.26 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.706 0.403 . . . . 74.41 111.325 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -47.58 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.209 0.818 . . . . 55.42 113.209 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -97.18 129.77 44.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.709 -0.678 . . . . 75.52 111.255 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -84.6 178.02 7.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.409 0.623 . . . . 72.24 112.38 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -64.34 152.72 40.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.726 -0.67 . . . . 64.54 112.318 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.9 p80 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.486 -0.768 . . . . 74.42 111.677 176.377 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.83 0.347 . . . . 75.54 111.277 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.29 154.72 41.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.455 -0.338 . . . . 73.01 111.097 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -154.11 119.45 5.12 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 71.41 111.673 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.41 105.57 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.352 -0.386 . . . . 54.42 110.816 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -90.97 96.53 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.973 0.416 . . . . 71.23 111.463 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -149.03 152.34 36.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.208 -0.451 . . . . 72.01 111.327 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.87 124.09 16.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.953 0.406 . . . . 63.31 111.133 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -122.78 140.92 52.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.158 0.504 . . . . 71.35 111.278 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.7 mt-10 -132.28 96.56 3.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.193 -0.458 . . . . 55.2 110.637 176.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.469 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 68.2 m95 -102.26 114.38 28.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.506 -0.315 . . . . 72.12 110.909 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ptp -135.58 153.13 51.77 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.07 0.396 . . . . 53.21 112.07 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -80.58 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.321 0.489 . . . . 74.22 112.321 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -50.32 -57.25 8.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.95 0.722 . . . . 74.33 112.95 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.4 tmmt? -56.34 -40.67 74.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -38.45 68.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 64.1 111.161 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.78 -46.56 87.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.78 -0.645 . . . . 61.34 111.512 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 24.5 ptp -56.99 -36.23 70.12 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.982 0.42 . . . . 71.43 111.533 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 t -76.01 -40.56 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.123 0.487 . . . . 52.2 111.273 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.0 mmp_? -74.29 -21.4 59.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.681 0.623 . . . . 52.35 112.681 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.5 p -108.38 -30.68 8.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.72 0.637 . . . . 73.52 112.72 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.23 1.12 56.94 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.146 -0.549 . . . . 30.23 112.858 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.39 172.09 14.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.981 0.42 . . . . 73.53 111.479 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.0 161.06 12.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.335 -0.46 . . . . 44.43 112.267 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.24 62.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.01 0.374 . . . . 61.44 112.01 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -63.85 -24.87 67.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.915 0.388 . . . . 64.25 111.694 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 45.9 tt0 -84.11 -41.2 17.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.905 0.383 . . . . 75.01 110.763 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.64 -52.32 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.929 0.395 . . . . 74.33 111.405 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.01 -32.16 67.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.583 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.07 -43.76 98.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.008 0.432 . . . . 72.33 110.716 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 24.9 m-85 -70.9 -27.68 63.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.439 -0.346 . . . . 74.14 111.768 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.7 mtm180 -66.69 -10.3 45.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.798 0.332 . . . . 75.3 111.868 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -85.34 -9.59 57.42 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.077 0.399 . . . . 74.35 112.077 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.88 -48.04 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.255 -0.974 . . . . 70.0 114.497 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.409 0.522 . . . . 74.42 112.409 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 145.8 48.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.037 0.446 . . . . 73.43 111.108 177.252 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.56 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 78.6 mt -139.45 132.24 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 116.265 -0.425 . . . . 73.3 111.272 -173.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.37 134.06 53.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.1 0.476 . . . . 72.11 111.926 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.44 -55.42 4.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.464 -0.398 . . . . 51.33 113.306 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -70.08 -62.94 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.073 0.397 . . . . 72.03 112.073 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.56 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.7 m80 -95.15 -8.03 37.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.667 0.618 . . . . 74.32 112.667 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -164.61 155.78 15.18 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.694 0.283 . . . . 74.25 111.493 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -123.53 157.33 33.85 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.95 0.405 . . . . 74.11 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -104.61 116.18 31.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.986 0.422 . . . . 75.21 111.453 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -116.04 134.59 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.992 0.425 . . . . 54.31 111.615 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.3 p -83.64 154.74 65.45 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.255 -0.429 . . . . 63.42 111.347 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.17 160.9 17.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.484 2.122 . . . . 74.4 113.012 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -68.79 113.35 6.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 64.23 111.243 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.72 -69.3 2.11 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 116.31 -0.405 . . . . 43.21 113.535 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.6 110.39 6.14 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.048 0.451 . . . . 74.34 111.711 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -78.6 82.7 4.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.578 0.704 . . . . 63.52 112.186 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -94.03 155.64 17.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.697 -0.683 . . . . 72.35 110.445 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.7 mm? -63.62 -32.46 73.95 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 111.704 0.261 . . . . 64.31 111.704 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -64.09 82.14 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.298 0.57 . . . . 75.24 111.772 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.95 134.66 13.08 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.701 -0.681 . . . . 52.12 113.033 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 m -77.55 120.17 22.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.717 0.294 . . . . 72.44 111.045 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -102.41 115.01 29.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.989 0.423 . . . . 73.31 111.556 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 64.5 m95 -98.7 130.27 45.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.271 -0.422 . . . . 61.35 110.95 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 5.6 m-85 -88.29 145.01 26.08 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.963 0.411 . . . . 75.42 111.859 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t-20 -84.44 98.85 10.31 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.048 -0.523 . . . . 55.4 110.713 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 76.7 t80 -55.37 -51.61 78.43 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 112.596 0.591 . . . . 75.11 112.596 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 85.5 Cg_exo -48.45 -42.91 34.13 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.372 2.048 . . . . 52.45 113.437 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.97 -40.28 87.43 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.957 0.408 . . . . 75.22 111.517 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 58' ' ' TYR . 74.4 mt -65.99 -32.98 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.91 0.386 . . . . 71.34 110.768 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -60.47 -43.45 96.91 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.345 0.593 . . . . 64.41 110.306 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.8 -25.88 67.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.973 -0.558 . . . . 63.0 111.385 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.98 -52.86 15.04 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 72.1 110.622 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.78 -28.45 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.12 -0.491 . . . . 70.33 111.147 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.597 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 1.8 tpm_? -47.72 -57.37 5.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.964 -0.562 . . . . 71.35 111.263 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.1 -48.45 67.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.047 0.451 . . . . 74.22 111.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 66.7 m -62.28 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 74.51 111.731 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.27 -35.1 69.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.866 0.691 . . . . 74.33 112.866 -173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 16.1 mm-40 -66.57 -58.19 5.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.344 0.498 . . . . 75.13 112.344 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -97.12 18.11 15.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.371 0.508 . . . . 73.12 112.371 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' SER . 70.0 m80 -128.3 176.67 7.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.507 -0.553 . . . . 64.22 109.507 166.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -132.38 96.68 3.91 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.221 0.534 . . . . 74.01 111.341 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -79.23 77.69 5.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.904 -0.589 . . . . 74.15 110.895 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -73.48 95.58 2.27 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.916 -0.583 . . . . 75.01 111.338 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.61 -0.71 . . . . 71.53 112.705 177.678 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.855 0.317 . . . . 73.33 111.855 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.46 35.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.984 0.421 . . . . 74.14 111.91 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -162.05 132.34 4.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.445 -0.343 . . . . 63.1 111.34 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -85.72 135.87 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.894 0.378 . . . . 74.43 111.743 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.9 mp -107.73 113.59 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.021 0.439 . . . . 75.21 111.585 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 31.9 m-85 -113.42 90.17 3.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.162 0.505 . . . . 63.11 111.323 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -78.7 63.72 3.53 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.803 0.811 . . . . 63.24 110.678 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 6' ' ' PHE . 51.5 mt-10 -75.28 79.43 2.38 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.397 -0.82 . . . . 73.1 112.216 -175.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.78 78.02 9.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.027 0.441 . . . . 75.51 111.072 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -78.87 123.54 27.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.139 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.543 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.2 ptp -151.8 165.53 34.19 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.762 0.653 . . . . 44.41 112.762 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -82.77 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.088 -0.505 . . . . 75.51 110.964 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 27.2 tt0 -65.69 -39.22 91.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.839 0.311 . . . . 72.22 111.839 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -56.54 -45.67 81.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.132 0.492 . . . . 70.45 110.497 178.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -68.52 -42.21 78.85 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.191 0.519 . . . . 72.53 111.069 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.28 -47.28 78.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.931 -0.577 . . . . 64.21 111.36 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 22.8 ptp -64.61 -29.33 70.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.829 0.347 . . . . 63.2 111.483 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 14' ' ' LYS . 75.6 t -73.54 -40.43 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.015 0.436 . . . . 71.51 111.494 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.543 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.2 mmt85 -71.65 -39.74 70.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.098 0.475 . . . . 71.41 112.109 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.6 p -92.98 -30.53 15.29 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.585 0.587 . . . . 74.11 112.585 -173.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.64 -0.69 70.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.927 -0.654 . . . . 74.31 112.867 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 20' ' ' THR . 10.6 mp -73.5 156.56 38.06 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.013 0.435 . . . . 74.14 111.365 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 162.4 16.58 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.299 -0.477 . . . . 72.22 112.336 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -41.37 82.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.845 0.355 . . . . 64.2 111.363 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.87 -31.7 65.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.139 0.495 . . . . 64.52 111.483 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -83.81 -43.25 15.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.102 -0.499 . . . . 71.0 110.819 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.92 -46.73 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.213 -0.449 . . . . 64.41 111.667 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.28 -34.11 71.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.911 0.386 . . . . 63.44 111.298 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -66.67 -33.97 76.82 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.107 0.479 . . . . 74.34 110.809 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -76.79 -33.82 58.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.077 -0.511 . . . . 75.53 112.036 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 20.7 mtt180 -56.06 -34.78 66.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.269 0.557 . . . . 73.43 111.818 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -77.97 0.02 25.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.082 0.771 . . . . 74.25 113.082 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.7 -56.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.525 -0.845 . . . . 70.31 113.791 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.06 -37.69 78.66 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.81 0.67 . . . . 50.01 112.81 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.632 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.11 108.83 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.971 0.415 . . . . 75.43 111.469 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -108.38 123.42 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.138 -0.483 . . . . 75.41 110.706 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.02 152.0 44.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.82 0.343 . . . . 71.44 111.302 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -38.44 1.8 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.109 -0.567 . . . . 75.34 112.982 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 40.7 t -89.48 -65.91 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 111.87 0.322 . . . . 74.31 111.87 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.424 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 5.4 m-70 -98.29 -14.63 20.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.094 0.776 . . . . 74.12 113.094 -174.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 34.4 p90 -159.64 171.89 18.78 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.075 -0.39 . . . . 70.23 111.797 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -150.49 143.97 25.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.343 0.592 . . . . 75.01 111.556 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.8 139.48 30.41 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 70.45 111.569 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.74 118.3 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.102 0.477 . . . . 74.54 112.208 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' HD13 ' A' ' 52' ' ' LEU . 30.0 t -91.94 148.98 38.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 CA-C-N 116.156 -0.475 . . . . 55.14 111.354 174.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.39 0.88 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.468 2.112 . . . . 73.43 112.251 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 50' ' ' LYS . 89.7 p -135.14 -165.58 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.891 -0.595 . . . . 74.21 110.542 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.14 -115.91 0.07 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.141 -0.552 . . . . 55.44 113.505 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -91.13 20.67 4.82 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.461 -0.434 . . . . 73.1 111.937 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 55.6 mtpt -78.7 -172.24 2.89 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.538 0.208 . . . . 71.43 110.682 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.2 m -61.77 149.94 38.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.967 -0.458 . . . . 75.34 111.312 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.9 mm? -69.3 -81.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.227 -0.442 . . . . 73.23 112.064 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 61.85 13.89 5.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.03 0.381 . . . . 75.13 112.03 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -142.43 6.08 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.392 -0.367 . . . . 61.21 113.454 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 m -110.94 136.28 50.19 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.336 -0.508 . . . . 73.44 112.304 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 m -91.94 118.48 30.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.278 -0.419 . . . . 73.43 111.136 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -94.27 144.56 25.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.804 0.335 . . . . 74.11 111.18 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 63' ' ' ILE . 68.5 m-85 -112.13 142.07 45.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.072 0.463 . . . . 75.2 111.882 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.05 97.85 8.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.701 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 41.0 t80 -49.91 -50.9 65.58 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 112.788 0.662 . . . . 73.31 112.788 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 71.3 Cg_exo -51.46 -46.18 33.09 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.244 1.962 . . . . 72.11 112.948 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 58.4 mm-40 -64.25 -41.18 97.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.091 0.404 . . . . 72.13 112.091 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -67.93 -45.35 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.606 -0.27 . . . . 63.14 111.203 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -60.14 -35.32 75.02 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.287 0.565 . . . . 75.35 110.576 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.56 -33.65 76.4 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.796 -0.638 . . . . 73.14 111.277 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.07 -44.13 20.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.345 -0.388 . . . . 73.43 111.994 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' ILE . 75.5 mt -47.56 -40.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.235 0.457 . . . . 74.3 112.235 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -51.82 -48.56 63.85 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.989 0.423 . . . . 73.11 111.738 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 37.3 t70 -60.0 -33.31 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.259 -0.428 . . . . 73.02 111.219 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -55.24 -27.15 44.3 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.951 0.352 . . . . 74.32 111.951 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.5 mm? -86.21 -40.57 15.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.248 0.462 . . . . 73.4 112.248 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.6 6.17 19.83 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.359 0.874 . . . . 63.54 113.359 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' ASP . 67.5 t60 -53.56 118.79 4.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.817 0.303 . . . . 73.1 111.817 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -63.28 167.79 4.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.207 0.527 . . . . 44.24 112.184 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -66.82 109.65 2.99 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.395 0.617 . . . . 74.34 112.091 -176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -95.44 99.89 11.73 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.839 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -146.89 119.58 8.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.809 0.338 . . . . 72.4 111.852 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 118.617 -0.706 . . . . 71.44 110.599 175.35 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 111.735 0.272 . . . . 53.12 111.735 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.17 -65.55 0.68 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.331 0.493 . . . . 55.03 112.331 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -77.3 116.72 18.14 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.302 0.572 . . . . 62.22 111.69 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -101.51 101.01 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.997 0.427 . . . . 74.34 111.139 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -94.12 102.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.816 0.341 . . . . 70.34 110.609 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -164.4 9.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.331 -0.395 . . . . 53.43 111.818 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -80.87 56.62 2.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.775 0.798 . . . . 74.33 110.444 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.29 137.25 14.55 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.578 -0.737 . . . . 73.23 111.134 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.65 109.83 17.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 74.15 111.703 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -94.12 121.85 36.04 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.881 -0.414 . . . . 71.05 109.881 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.76 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 19.9 ptp -138.9 147.16 41.98 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.31 0.485 . . . . 74.51 112.31 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.34 165.43 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.943 0.401 . . . . 74.14 111.972 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.97 -42.73 80.69 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.239 -0.437 . . . . 73.23 111.724 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -59.15 -42.11 89.91 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.214 -0.448 . . . . 70.54 111.262 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.1 -37.55 66.69 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.191 0.519 . . . . 74.13 111.279 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.27 -47.02 84.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.84 -0.618 . . . . 72.41 111.616 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.9 ptp -59.34 -32.27 69.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.927 0.394 . . . . 64.3 111.405 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 14' ' ' LYS . 58.5 t -72.71 -32.67 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.073 0.463 . . . . 54.04 111.267 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.5 mmt85 -76.55 -43.22 40.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.463 0.542 . . . . 70.51 112.463 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.33 -27.09 16.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.981 0.734 . . . . 73.31 112.981 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.11 64.58 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.946 -0.645 . . . . 72.52 113.206 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mp -79.66 166.91 21.35 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.084 0.468 . . . . 72.42 111.514 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.92 164.18 14.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.212 -0.449 . . . . 63.24 112.421 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.48 -42.23 70.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.012 0.375 . . . . 74.33 112.012 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -62.47 -33.69 75.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.057 0.456 . . . . 72.23 111.231 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.42 -48.25 42.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.425 -0.352 . . . . 70.4 111.419 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.2 mt -57.14 -50.84 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.86 0.362 . . . . 71.34 111.313 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.764 0.316 . . . . 64.41 111.469 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.2 t -63.33 -39.21 93.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.943 0.402 . . . . 74.01 111.164 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.65 -16.74 55.22 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.976 0.417 . . . . 73.12 111.51 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.695 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 58.8 mtp180 -68.88 -10.93 59.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.781 0.324 . . . . 75.12 111.815 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -83.02 2.69 33.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 111.764 0.283 . . . . 62.11 111.764 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.01 -61.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.66 -0.781 . . . . 71.33 114.115 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.21 95.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.957 0.725 . . . . 63.13 112.957 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.695 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -71.71 104.43 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.038 -0.414 . . . . 74.41 111.073 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 62.2 mt -89.89 121.5 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.509 -0.314 . . . . 75.21 111.23 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -59.86 131.63 51.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.904 0.383 . . . . 61.42 110.34 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.752 ' HA2' ' HZ1' ' A' ' 42' ' ' LYS . . . 92.12 -31.85 5.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.541 -0.361 . . . . 43.51 113.201 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 46.4 t -101.88 -72.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.654 -0.321 . . . . 71.24 111.391 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -77.42 -7.57 56.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.958 0.355 . . . . 71.2 111.958 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 33.3 p90 -171.84 167.56 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.617 0.367 . . . . 72.01 110.773 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.752 ' HZ1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -154.02 136.54 15.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.493 0.663 . . . . 71.32 111.568 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 61.6 mtp180 -80.62 102.56 9.9 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.264 -0.88 . . . . 62.44 110.258 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.11 143.1 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.796 -0.638 . . . . 74.51 112.523 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -80.46 140.6 52.13 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 116.014 -0.539 . . . . 74.24 111.391 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.97 -35.55 76.52 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.489 2.126 . . . . 73.3 112.416 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -97.71 -46.92 5.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.225 -0.443 . . . . 52.34 111.666 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.24 -43.48 0.85 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.083 -0.579 . . . . 32.13 112.555 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 137.55 44.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.8 0.333 . . . . 73.33 110.81 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -51.56 111.7 0.63 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.734 . . . . 61.1 112.983 -171.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.4 m -83.82 155.28 23.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.487 -0.779 . . . . 74.43 110.705 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.6 mm? -65.2 -44.85 87.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.876 0.369 . . . . 54.11 111.478 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -86.82 -66.63 0.89 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.589 -0.278 . . . . 75.03 111.525 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.52 119.88 1.63 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.262 -0.494 . . . . 54.41 113.442 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.1 m -66.55 113.93 5.13 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.602 -0.352 . . . . 73.25 110.237 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -84.5 110.32 18.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.383 0.512 . . . . 65.41 112.383 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -98.59 126.87 44.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.114 -0.494 . . . . 73.44 110.272 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HB3' HD11 ' A' ' 63' ' ' ILE . 84.5 m-85 -93.33 144.75 25.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.919 0.341 . . . . 51.04 111.919 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 62' ' ' GLU . 59.1 t30 -82.64 94.47 7.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 71.04 111.049 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.523 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 70.7 t80 -51.38 -53.31 50.9 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 113.299 0.852 . . . . 73.45 113.299 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -49.66 -36.86 42.47 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.274 1.982 . . . . 74.13 113.219 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 22.2 mt-10 -81.43 -29.5 33.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.754 0.65 . . . . 73.42 112.754 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.492 ' O ' HG13 ' A' ' 67' ' ' ILE . 64.7 mt -70.46 -38.78 75.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.956 -0.465 . . . . 73.54 110.706 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -62.42 -39.08 92.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.191 0.519 . . . . 74.23 110.495 169.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 59.9 tttp -56.78 -37.16 70.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.883 -0.598 . . . . 61.31 110.877 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -72.17 -41.25 67.26 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.869 0.366 . . . . 71.25 111.031 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 63' ' ' ILE . 67.8 mt -53.29 -39.18 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.481 -0.327 . . . . 74.41 111.267 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -53.64 -36.68 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.729 0.3 . . . . 75.1 111.611 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.25 -25.77 27.07 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.04 0.448 . . . . 73.14 110.998 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.0 t -59.49 -36.35 75.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.821 0.343 . . . . 61.33 111.901 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.32 -21.28 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.018 0.377 . . . . 74.14 112.018 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -61.24 105.59 0.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.144 0.497 . . . . 74.31 111.983 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -59.38 133.0 55.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.518 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -74.51 -67.22 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.15 0.5 . . . . 64.23 110.867 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -142.55 111.18 6.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.646 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -71.81 93.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.151 0.5 . . . . 73.4 111.102 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -77.79 2.16 17.95 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.831 1.048 . . . . 62.12 113.831 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 66.6 m80 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.918 -0.563 . . . . 60.33 111.951 176.304 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.99 0.424 . . . . 70.35 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.92 101.68 12.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.969 0.414 . . . . 64.34 111.208 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -129.81 160.27 34.01 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.884 0.373 . . . . 70.51 111.365 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 7' ' ' ASN . 47.7 mm -86.91 92.71 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.923 0.392 . . . . 72.35 111.769 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.2 mp -99.27 112.44 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.931 0.396 . . . . 54.2 111.392 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.2 t80 60.05 7.77 1.28 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.629 0.974 . . . . 52.32 113.629 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.476 ' HB3' HG23 ' A' ' 4' ' ' ILE . 5.5 t30 -72.8 71.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.54 -0.725 . . . . 72.54 109.742 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.77 -170.99 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.646 -0.707 . . . . 72.44 111.386 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 60' ' ' TYR . 9.2 tp10 -151.39 111.38 4.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.775 -0.648 . . . . 70.53 110.027 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -119.83 143.2 48.01 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.272 -0.268 . . . . 75.22 111.093 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.604 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.8 ptp -164.7 171.88 13.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.657 0.614 . . . . 73.02 112.657 -176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.87 -179.99 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.977 -0.556 . . . . 34.33 111.335 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.88 -58.08 9.71 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.532 0.568 . . . . 52.43 112.532 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -61.92 -29.13 70.02 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.49 -0.323 . . . . 60.24 111.619 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.67 -37.02 42.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.238 0.542 . . . . 54.14 111.158 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.5 -49.92 74.82 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.78 -0.646 . . . . 72.31 111.019 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -55.95 -36.03 67.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.025 0.379 . . . . 74.11 112.025 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.1 t -65.75 -43.46 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.194 0.442 . . . . 75.44 112.194 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -85.23 -18.63 33.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.096 0.406 . . . . 70.24 112.096 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.9 p -100.58 -26.98 13.65 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.331 0.493 . . . . 63.13 112.331 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.81 24.8 29.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.091 -0.576 . . . . 72.13 113.176 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.6 mp -102.49 -178.86 3.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.211 0.529 . . . . 75.52 111.654 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.2 163.41 21.78 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.902 -0.59 . . . . 72.42 111.987 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.51 -46.1 77.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.096 0.448 . . . . 64.31 112.162 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 2.3 tmt_? -64.12 -34.41 77.98 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.115 0.483 . . . . 72.13 110.749 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.13 -42.4 69.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.918 0.389 . . . . 72.25 110.927 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.36 -50.48 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.357 -0.383 . . . . 74.43 111.793 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.97 -30.52 66.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.889 0.376 . . . . 74.41 111.146 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 t -62.44 -38.97 91.84 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.305 -0.407 . . . . 71.31 111.195 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -75.32 -31.11 60.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.46 -0.336 . . . . 61.45 111.67 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 21.4 mtm180 -64.88 -11.17 34.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.185 0.439 . . . . 74.31 112.185 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.23 11.01 24.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.424 -0.353 . . . . 74.14 111.926 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.53 -50.65 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.329 -0.939 . . . . 63.14 114.433 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.21 80.09 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.07 123.49 22.94 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.907 0.384 . . . . 62.03 111.145 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.84 132.67 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.37 -0.377 . . . . 74.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.23 146.63 47.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.864 0.364 . . . . 53.11 111.596 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 -53.66 2.99 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.39 -0.368 . . . . 73.13 112.638 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG12 ' ND1' ' A' ' 40' ' ' HIS . 46.3 t -70.85 -65.8 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.413 0.523 . . . . 43.41 112.413 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.412 ' ND1' HG12 ' A' ' 39' ' ' VAL . 3.1 m-70 -96.74 -16.96 20.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.932 0.716 . . . . 62.22 112.932 -175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 36.5 p90 -161.41 174.81 12.93 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.389 -0.195 . . . . 74.41 111.154 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.43 154.4 26.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.084 0.469 . . . . 72.51 112.099 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -79.43 122.9 26.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.217 -0.447 . . . . 74.13 112.173 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.37 104.15 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.204 0.526 . . . . 75.35 110.872 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.1 p -87.25 155.93 54.45 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.097 -0.501 . . . . 55.34 110.947 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.55 -49.42 6.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.205 2.604 . . . . 72.4 114.257 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -105.72 12.75 30.64 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.625 0.602 . . . . 62.5 112.625 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.08 30.78 78.82 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.639 -0.791 . . . . 70.21 112.057 -173.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.12 3.78 37.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.482 0.713 . . . . 72.04 112.029 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 65.74 2.57 2.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.122 0.786 . . . . 72.04 113.122 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.5 m -64.27 151.34 43.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.002 -0.436 . . . . 65.14 110.969 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.641 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.6 mm? -59.87 -34.24 72.89 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.487 0.551 . . . . 73.1 112.487 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -78.27 86.18 4.38 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.204 0.526 . . . . 74.55 110.973 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.43 37.08 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.785 -0.643 . . . . 73.33 112.933 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 135.99 35.45 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.94 0.4 . . . . 55.24 111.688 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -96.76 105.52 17.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.254 0.464 . . . . 73.24 112.254 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -86.0 152.03 23.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.328 -0.396 . . . . 74.2 110.905 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 41.3 m-85 -117.14 146.24 43.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.121 0.486 . . . . 75.02 111.829 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.54 108.78 19.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.986 -0.552 . . . . 54.55 110.915 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 81.9 t80 -56.79 -48.73 96.79 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.931 0.715 . . . . 65.31 112.931 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 18.0 Cg_endo -58.33 -33.45 97.74 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.9 1.733 . . . . 64.14 112.681 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -69.54 -48.2 61.18 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.155 -0.475 . . . . 62.44 111.12 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 69.7 mt -65.71 -36.86 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.023 0.44 . . . . 65.01 111.152 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.66 -37.06 82.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.585 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.6 -38.65 85.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.094 -0.503 . . . . 72.42 110.936 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -66.45 -53.53 34.36 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.008 -0.542 . . . . 74.15 111.062 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.69 -38.47 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.884 0.373 . . . . 65.4 111.451 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -57.93 -35.41 71.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.001 0.429 . . . . 73.42 111.186 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.69 -43.48 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.333 -0.394 . . . . 63.33 111.724 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.0 m -74.33 -54.13 8.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.286 0.476 . . . . 54.45 112.286 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.9 tp -75.78 -43.0 48.64 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.042 0.386 . . . . 61.53 112.042 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 70.09 -52.05 0.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.05 0.759 . . . . 75.25 113.05 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -52.47 109.47 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.272 0.558 . . . . 73.04 112.287 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -67.15 139.94 57.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.049 -0.523 . . . . 61.43 110.769 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -153.53 151.99 30.43 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.079 0.4 . . . . 53.35 112.079 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -129.42 146.88 51.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.247 -0.433 . . . . 74.14 111.194 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -78.83 -33.71 45.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 73.42 110.726 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.94 -0.552 . . . . 72.52 111.459 179.5 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.699 0.285 . . . . 74.41 111.07 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.94 157.93 36.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.664 0.269 . . . . 75.4 111.417 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -152.76 148.91 27.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.308 0.485 . . . . 63.43 112.308 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.8 mm -113.86 90.68 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.223 0.535 . . . . 74.42 109.816 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.8 mt -133.09 103.11 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.056 0.455 . . . . 71.32 111.606 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -160.84 99.69 1.25 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.941 -0.572 . . . . 72.13 110.171 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -132.63 111.84 11.53 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.999 0.428 . . . . 63.43 111.442 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 4.6 mp0 -74.49 81.26 1.95 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.176 0.512 . . . . 62.11 110.525 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.06 109.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.73 -0.668 . . . . 75.32 111.882 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.495 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 95.7 m95 -85.68 136.45 33.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.296 -0.411 . . . . 74.24 110.472 173.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.581 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.0 ptp -153.89 154.86 34.64 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.978 0.418 . . . . 75.33 111.73 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 15' ' ' ALA . 34.4 m -71.29 166.27 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.889 0.376 . . . . 73.14 111.415 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.86 -44.01 86.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.016 0.436 . . . . 75.23 111.986 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -63.71 -32.94 74.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.293 -0.412 . . . . 71.33 111.527 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -78.21 -35.94 47.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.041 0.448 . . . . 73.22 111.149 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.32 -46.21 87.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.838 -0.619 . . . . 53.24 111.003 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.501 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.2 ptp -59.87 -34.29 72.95 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.723 0.296 . . . . 72.23 111.488 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 14' ' ' LYS . 66.9 t -69.18 -40.29 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.881 0.372 . . . . 74.32 111.209 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 12.2 mmt85 -66.15 -44.66 83.48 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.996 0.427 . . . . 75.03 112.099 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 p -93.79 -25.15 17.51 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.034 0.753 . . . . 71.31 113.034 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.23 64.51 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.211 -0.518 . . . . 74.2 113.186 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' HG ' ' NE2' ' A' ' 26' ' ' GLN . 9.0 mp -74.66 173.41 10.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.367 0.603 . . . . 54.52 112.167 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.85 170.35 17.73 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.086 -0.506 . . . . 42.41 112.317 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.8 66.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.212 0.449 . . . . 50.05 112.212 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -64.82 -29.43 70.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.865 0.365 . . . . 72.53 111.961 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 47.9 tt0 -76.97 -42.67 38.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.972 0.415 . . . . 72.12 110.839 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 63.0 mt -63.72 -49.03 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.584 -0.28 . . . . 74.03 111.683 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.25 -35.03 59.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.771 0.319 . . . . 75.13 111.38 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 t -63.06 -50.7 69.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 54.41 110.69 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.72 -35.63 74.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.027 -0.533 . . . . 73.54 111.412 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 50.1 mtp180 -62.13 -19.98 63.6 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 74.2 111.44 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.97 -8.54 14.83 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.392 -0.367 . . . . 70.2 111.989 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.6 41.62 0.97 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.81 -0.71 . . . . 65.1 114.109 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.33 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.293 0.568 . . . . 71.5 111.377 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.39 141.91 48.71 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.458 0.646 . . . . 72.43 112.14 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.3 mt -138.65 135.13 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.573 -0.74 . . . . 72.54 110.236 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.47 130.62 45.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.094 0.473 . . . . 73.15 112.062 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.67 -26.68 1.64 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.352 -0.385 . . . . 63.4 113.946 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.2 t -94.91 -40.35 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.292 -0.534 . . . . 74.33 112.238 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.507 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 48.5 m80 -121.52 -9.72 8.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.425 0.528 . . . . 72.0 112.425 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -165.04 159.25 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.866 0.365 . . . . 73.21 111.831 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 55.8 pttt -153.82 153.35 31.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.029 0.443 . . . . 63.51 111.422 174.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.39 141.57 45.09 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.93 170.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t -107.93 145.06 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.797 0.332 . . . . 74.53 111.083 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -52.1 129.78 40.24 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.855 -0.611 . . . . 64.14 112.396 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.91 -32.99 49.68 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.849 2.366 . . . . 72.15 113.277 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.6 m 68.33 -5.2 0.95 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.833 1.049 . . . . 75.45 113.833 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.26 -119.07 0.86 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.639 -0.791 . . . . 54.14 114.183 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.08 -12.81 54.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.922 0.712 . . . . 64.4 112.922 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -60.54 133.74 56.39 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.9 0.381 . . . . 71.04 111.187 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -73.25 -172.06 1.05 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.129 0.49 . . . . 65.32 111.785 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.487 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.9 mm? -62.9 -13.94 40.46 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.002 0.371 . . . . 62.12 112.002 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 53' ' ' ARG . 10.8 mmt180 -60.04 -47.17 86.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.062 0.458 . . . . 71.42 111.566 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.67 -151.13 45.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.263 -0.494 . . . . 62.22 112.947 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -148.25 133.18 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 122.545 -0.385 . . . . 74.31 110.692 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.1 m -102.93 121.75 43.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.188 0.44 . . . . 73.43 112.188 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -107.85 146.53 32.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.604 176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 23.2 m-85 -106.85 154.06 21.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.791 0.663 . . . . 75.01 112.791 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.64 101.67 12.34 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.651 -0.704 . . . . 63.02 111.925 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 80.3 t80 -51.61 -50.85 74.77 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 112.762 0.653 . . . . 70.21 112.762 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.565 ' HG3' ' HA ' ' A' ' 8' ' ' GLU . 17.2 Cg_endo -56.13 -53.53 5.28 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.159 1.906 . . . . 74.42 113.273 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -64.81 -23.62 67.3 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.594 0.59 . . . . 61.13 112.594 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 75.9 mt -82.09 -46.32 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.052 -0.405 . . . . 63.41 111.379 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -58.17 -40.95 82.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.512 0.673 . . . . 65.51 109.973 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -52.81 -48.71 66.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.152 -0.931 . . . . 63.23 111.39 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.77 -37.77 79.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.457 -0.338 . . . . 65.25 111.147 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.71 -40.51 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.863 0.364 . . . . 60.13 111.0 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -57.08 -58.96 5.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.176 0.512 . . . . 62.4 110.166 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.45 -18.36 65.31 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.088 -0.505 . . . . 71.04 111.941 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.0 t -79.89 -23.08 42.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.174 0.512 . . . . 54.33 110.846 172.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.53 -61.3 1.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.263 -0.426 . . . . 72.11 111.5 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -71.86 85.44 0.95 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.648 0.261 . . . . 72.31 111.168 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -60.33 98.71 0.06 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.756 0.65 . . . . 75.53 112.756 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -148.59 -24.37 0.32 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.759 -0.655 . . . . 73.22 111.023 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -93.14 123.16 36.21 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.448 -0.342 . . . . 64.24 110.828 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -82.93 145.84 29.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.125 0.488 . . . . 74.12 111.832 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -68.6 112.36 5.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.975 -0.557 . . . . 63.54 111.762 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.2 t60 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.636 -0.697 . . . . 63.34 110.951 174.446 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.672 0.272 . . . . 70.04 111.686 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 87.88 0.73 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.385 0.513 . . . . 73.41 112.385 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -90.14 121.46 32.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.112 0.482 . . . . 73.14 110.573 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.63 88.79 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.219 0.533 . . . . 74.3 111.662 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.7 mm -87.9 64.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.94 0.876 . . . . 61.21 110.101 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -148.68 132.73 17.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 64.53 110.373 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -122.3 -177.74 3.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.882 0.372 . . . . 73.41 110.817 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 61' ' ' PRO . 50.5 mt-10 -113.75 91.15 3.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.889 0.376 . . . . 62.23 110.312 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -70.44 104.37 2.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 51.43 111.635 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 82.2 m95 -98.64 118.77 36.1 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.562 -0.29 . . . . 74.1 110.845 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.1 pmm? -133.26 172.37 12.77 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.118 0.485 . . . . 70.14 111.533 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.53 162.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.096 -0.502 . . . . 61.31 111.375 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.54 -42.5 83.03 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.179 0.437 . . . . 73.22 112.179 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -59.55 -37.87 79.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.994 0.426 . . . . 73.33 110.968 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.6 45.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.97 0.414 . . . . 72.02 111.328 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -50.61 73.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.172 -0.467 . . . . 70.34 110.603 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.404 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.6 ptp -58.39 -37.06 74.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.756 0.312 . . . . 71.41 111.803 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.5 t -69.64 -48.22 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 111.829 0.307 . . . . 75.03 111.829 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 19' ' ' ARG . 29.0 mmt180 -69.04 -28.88 66.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.286 0.476 . . . . 73.4 112.286 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.415 HG21 HG21 ' A' ' 63' ' ' ILE . 80.5 p -93.88 -29.25 15.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.489 0.552 . . . . 64.33 112.489 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.86 56.59 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 52.03 112.564 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 26' ' ' GLN . 8.3 mp -82.2 -178.17 6.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.399 0.619 . . . . 75.25 111.627 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' GLN . . . -133.27 171.09 21.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.981 -0.554 . . . . 64.13 111.909 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.83 -51.39 66.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.283 0.475 . . . . 53.51 112.283 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -66.46 -30.01 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.159 0.504 . . . . 63.3 111.504 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.542 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 5.2 tp-100 -66.98 -48.46 68.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.066 0.46 . . . . 75.22 110.918 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 64.5 mt -60.79 -52.09 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.343 -0.39 . . . . 71.42 111.296 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.2 -33.6 69.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.507 0.194 . . . . 74.24 111.409 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -61.23 -37.51 83.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.929 0.395 . . . . 50.32 110.981 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -80.26 -30.07 38.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.894 0.378 . . . . 70.45 111.808 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 67.8 mtp180 -64.13 -15.56 59.99 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.925 0.393 . . . . 75.31 111.854 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.08 -22.65 64.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.537 -0.301 . . . . 74.01 111.8 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.48 -45.07 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 120.661 -0.781 . . . . 63.32 114.342 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.75 -31.4 71.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.012 0.745 . . . . 50.25 113.012 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.513 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.18 104.69 3.72 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.455 0.645 . . . . 74.22 111.829 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.92 123.58 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.565 -0.743 . . . . 74.22 111.279 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.22 147.19 48.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.112 0.482 . . . . 72.0 111.395 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.53 -58.92 3.75 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.121 -0.49 . . . . 61.33 113.164 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.81 -56.11 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.439 0.533 . . . . 72.4 112.439 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 52.9 m80 -92.24 -23.54 19.3 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.501 0.556 . . . . 73.31 112.501 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 15.4 p90 -163.68 149.58 11.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.536 -0.172 . . . . 64.02 110.536 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -147.76 147.57 30.02 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.092 0.472 . . . . 71.22 112.264 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -79.7 117.87 21.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.853 -0.612 . . . . 74.15 111.775 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.57 128.8 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.774 0.321 . . . . 73.43 111.051 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.9 p -67.81 154.58 93.3 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 112.38 0.511 . . . . 63.34 112.38 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -58.08 -44.84 35.99 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.419 2.08 . . . . 75.44 112.517 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 t -163.97 123.14 1.98 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.08 0.4 . . . . 73.03 112.08 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.73 -94.22 0.28 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 115.151 0.82 . . . . 65.24 115.151 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -67.7 158.79 31.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.519 0.933 . . . . 75.23 113.519 -171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -76.92 86.89 3.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.431 -0.804 . . . . 74.5 111.429 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 53' ' ' ARG . 21.3 m -92.59 148.04 22.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.974 0.416 . . . . 75.11 111.477 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -70.91 -14.03 62.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.897 0.703 . . . . 70.22 112.897 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 51' ' ' THR . 16.7 mmt180 -123.77 107.28 11.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.775 0.321 . . . . 75.51 110.671 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.6 -168.96 15.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.116 -0.564 . . . . 54.03 113.606 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 m -86.36 123.7 31.9 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.859 0.361 . . . . 73.14 111.543 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -91.96 114.88 27.54 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.709 0.29 . . . . 60.43 111.418 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -100.3 144.3 29.47 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.734 -0.212 . . . . 74.41 110.856 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 94.0 m-85 -110.27 144.46 38.94 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.254 0.549 . . . . 64.55 112.135 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 40.6 t-20 -87.86 92.07 8.99 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.801 -0.636 . . . . 74.23 110.943 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 66.0 t80 -46.98 -53.04 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.972 0.73 . . . . 71.51 112.972 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.726 ' HG2' ' HA ' ' A' ' 8' ' ' GLU . 75.6 Cg_exo -52.29 -39.19 73.06 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.171 1.914 . . . . 53.32 113.399 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 52.9 mm-40 -72.03 -34.12 68.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.3 0.481 . . . . 74.51 112.3 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 20' ' ' THR . 1.8 mp -71.54 -49.94 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 75.32 110.464 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 58.5 t30 -54.1 -46.83 72.21 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.151 0.501 . . . . 63.2 110.662 176.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.87 -46.13 67.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.661 . . . . 53.05 111.536 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -57.2 -50.6 72.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.227 -0.442 . . . . 73.55 111.478 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 -57.22 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.861 0.363 . . . . 71.3 111.586 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 16.0 mmt180 -54.32 -46.16 72.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.304 0.483 . . . . 75.33 112.304 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -23.24 66.99 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 51.24 111.443 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.3 m -75.22 -30.25 60.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.522 -0.308 . . . . 74.53 111.17 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.71 -41.27 75.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.799 0.333 . . . . 63.53 110.957 175.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.6 108.66 2.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.919 0.39 . . . . 74.21 111.148 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -61.71 -35.01 76.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.401 0.62 . . . . 72.25 110.148 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -142.54 112.31 6.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.402 -0.817 . . . . 64.13 109.676 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -47.78 101.57 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.219 0.608 . . . . 73.33 112.292 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -81.85 -29.61 32.45 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.238 -0.437 . . . . 70.21 112.027 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -73.15 109.05 6.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.279 0.474 . . . . 64.13 112.279 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.226 0 N-CA-C 112.052 0.39 . . . . 72.14 112.052 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.652 0.263 . . . . 73.33 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.54 94.04 4.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.034 0.445 . . . . 60.32 112.194 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -133.51 149.51 51.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.37 -0.377 . . . . 73.24 110.983 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.02 105.0 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.511 -0.313 . . . . 72.21 110.686 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -76.42 115.65 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.475 -0.33 . . . . 73.11 110.382 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -67.85 92.8 0.37 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.309 0.576 . . . . 74.24 111.674 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.3 147.2 25.62 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.349 0.595 . . . . 72.42 111.722 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.55 110.55 11.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.464 0.649 . . . . 61.11 110.497 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 33.2 mt-10 -92.38 82.21 4.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.182 0.515 . . . . 73.3 112.355 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 76.3 m95 -94.49 149.44 21.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.778 -0.646 . . . . 65.12 110.606 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.6 ptp -159.05 151.58 21.59 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.032 0.444 . . . . 75.34 111.778 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.33 167.71 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.155 0.428 . . . . 73.44 112.155 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.21 -54.5 46.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.461 0.541 . . . . 74.41 112.461 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -35.48 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.424 -0.353 . . . . 71.45 111.551 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.81 60.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.115 0.484 . . . . 54.14 111.289 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.9 -53.59 56.53 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.812 -0.631 . . . . 44.41 111.046 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.437 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.7 ptp -54.24 -40.34 67.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.846 0.313 . . . . 62.45 111.846 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -70.4 -42.49 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.95 0.405 . . . . 73.44 112.077 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.627 0.603 . . . . 75.3 112.627 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -107.17 -28.45 9.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.929 0.395 . . . . 64.2 111.893 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.88 5.22 59.91 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.233 -0.508 . . . . 72.31 112.715 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.3 mp -82.29 160.9 22.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.197 0.522 . . . . 70.43 111.428 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.89 160.9 13.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.091 -0.576 . . . . 55.13 112.447 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.82 -41.17 61.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.938 0.369 . . . . 71.22 111.861 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 25' ' ' ARG . 8.1 ptp180 -62.56 -32.19 73.12 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.135 0.493 . . . . 73.3 111.612 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.51 -37.8 35.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.003 0.43 . . . . 72.55 111.017 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 17' ' ' MET . 59.3 mt -63.99 -49.36 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.39 -0.368 . . . . 61.33 111.095 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.75 -35.63 76.86 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.858 0.361 . . . . 74.13 110.985 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.6 t -60.75 -37.61 82.4 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 60.24 111.278 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -72.83 -37.82 67.32 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.96 0.41 . . . . 74.11 111.504 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 24.7 mtm180 -65.46 -10.41 33.88 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.228 0.455 . . . . 72.35 112.228 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -59.95 -30.95 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.759 0.281 . . . . 73.52 111.759 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.99 31.94 0.05 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.308 -0.949 . . . . 61.25 114.721 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.12 -24.86 4.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.412 0.606 . . . . 54.23 111.428 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -83.28 129.32 35.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.029 -0.532 . . . . 75.34 111.731 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.9 mt -130.87 137.27 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.697 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.69 153.17 43.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.781 0.324 . . . . 75.04 111.157 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.26 -49.95 3.89 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.487 -0.387 . . . . 53.41 112.496 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.36 -57.49 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 74.41 112.043 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -101.67 -23.76 14.2 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.094 0.776 . . . . 63.24 113.094 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -161.92 172.48 15.95 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.315 -0.24 . . . . 62.4 111.484 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -154.74 160.66 41.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.911 0.386 . . . . 74.0 111.786 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -87.48 137.09 32.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.026 0.441 . . . . 74.11 111.443 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.3 t -108.26 127.79 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.986 0.422 . . . . 73.34 111.777 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 43.2 t -90.35 115.18 63.49 Favored Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 116.23 -0.441 . . . . 61.42 111.259 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 6.4 Cg_exo -73.72 80.82 1.97 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.679 2.252 . . . . 73.43 112.516 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.7 m 55.59 33.52 21.33 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.122 0.487 . . . . 23.41 111.359 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.16 123.77 4.46 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.558 -0.617 . . . . 73.52 111.558 -173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.39 81.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.124 0.488 . . . . 71.45 112.109 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HA ' ' HE2' ' A' ' 50' ' ' LYS . 8.2 mmpt? -111.53 11.89 21.32 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.222 0.534 . . . . 63.11 110.984 171.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 p -112.15 144.92 40.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.825 -0.625 . . . . 73.1 110.562 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.84 3.71 52.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.941 0.401 . . . . 71.05 111.076 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -119.99 80.95 1.66 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.863 0.364 . . . . 72.01 111.187 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.54 131.94 12.66 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.98 -0.628 . . . . 53.3 113.16 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 m -84.16 114.74 22.0 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.63 -0.335 . . . . 73.53 110.744 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -90.44 127.25 36.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.093 0.473 . . . . 44.41 111.952 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 29.0 m95 -104.4 132.8 50.24 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.156 -0.474 . . . . 75.21 110.657 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.525 ' HB3' HD11 ' A' ' 63' ' ' ILE . 52.2 m-85 -104.36 147.01 28.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.88 -176.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -78.78 106.59 10.89 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.837 0.351 . . . . 53.15 111.422 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.1 t80 -53.49 -50.21 84.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 112.701 0.63 . . . . 53.53 112.701 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 21.0 Cg_endo -59.15 -42.82 47.01 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.11 1.873 . . . . 70.21 113.254 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -66.55 -40.12 88.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 111.892 0.33 . . . . 75.43 111.892 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' A' ' 58' ' ' TYR . 67.5 mt -67.87 -41.8 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.707 0.289 . . . . 72.13 110.786 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -60.39 -41.26 93.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.901 0.381 . . . . 72.02 110.744 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.38 -42.59 92.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.075 0.464 . . . . 72.41 110.75 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.0 -38.13 89.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.984 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' ILE . 80.7 mt -59.26 -44.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.541 -0.299 . . . . 74.24 110.728 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 68' ' ' ARG . 27.8 mmt180 -57.27 -51.13 70.6 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.238 0.542 . . . . 74.35 110.561 175.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -56.85 -34.88 68.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.385 -0.825 . . . . 64.44 111.832 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -84.14 -46.16 12.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.832 0.678 . . . . 74.22 112.832 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.5 tp -75.83 -37.65 58.84 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.02 0.748 . . . . 72.43 113.02 -170.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -57.26 99.99 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.054 0.454 . . . . 75.23 111.221 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -79.17 80.07 5.55 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.9 0.333 . . . . 73.43 111.9 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -111.22 1.04 16.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.741 0.305 . . . . 73.21 111.599 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -164.92 118.0 1.25 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.734 0.302 . . . . 71.22 111.001 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.07 132.46 45.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.37 . . . . 73.32 111.9 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -113.58 3.3 15.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.497 0.665 . . . . 73.22 109.736 170.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.46 -0.791 . . . . 72.21 110.822 175.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.281 0.562 . . . . 74.14 111.459 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -89.7 128.02 36.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.753 -0.658 . . . . 74.32 109.926 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.591 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.5 ptp -148.55 149.13 31.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.881 0.372 . . . . 53.04 111.771 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.85 176.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.249 0.462 . . . . 64.13 112.249 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.34 -57.61 11.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.547 0.573 . . . . 65.04 112.547 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.9 tmmt? -63.7 -34.41 77.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.419 -0.355 . . . . 72.33 111.79 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.5 -42.52 74.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.131 0.491 . . . . 75.04 111.128 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.08 -47.73 84.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.918 -0.583 . . . . 64.25 111.451 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.4 ptp -58.76 -32.58 69.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.781 0.324 . . . . 74.31 111.417 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' LYS . 61.4 t -74.39 -41.7 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.1 0.476 . . . . 74.45 111.391 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.591 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 13.2 mmm180 -71.28 -31.93 68.06 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.259 -0.428 . . . . 72.3 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.2 p -95.58 -30.94 13.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.47 0.544 . . . . 73.34 112.47 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.14 55.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.398 -0.43 . . . . 54.13 113.176 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' MET . 8.9 mp -90.11 174.95 7.35 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.194 0.521 . . . . 71.34 112.035 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.23 161.04 13.08 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.143 -0.48 . . . . 45.5 112.443 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.13 -42.77 63.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.528 0.566 . . . . 74.4 112.528 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -62.6 -42.78 99.77 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.098 0.475 . . . . 73.2 111.648 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.77 -36.05 77.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.006 0.431 . . . . 71.51 110.939 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.27 -43.89 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.343 -0.39 . . . . 75.34 111.404 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.25 -38.93 93.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.787 0.327 . . . . 63.41 110.489 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -60.38 -40.49 91.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 71.24 110.713 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 12.3 m-85 -66.12 -34.97 79.26 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.316 -0.402 . . . . 63.12 111.691 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.766 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 23.6 mtm180 -68.42 -21.3 64.67 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.161 0.505 . . . . 73.31 111.246 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.89 13.47 5.9 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.024 -0.535 . . . . 70.24 110.738 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.8 -81.89 0.04 OUTLIER Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.229 -0.51 . . . . 64.52 114.185 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.01 -34.52 43.94 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.145 1.165 . . . . 31.04 114.145 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.766 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -71.53 104.09 3.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.818 -0.551 . . . . 75.33 110.861 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -102.03 129.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 60.45 111.744 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -64.92 132.64 49.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.354 -0.385 . . . . 74.4 110.802 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.16 -24.86 19.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.271 -0.49 . . . . 52.23 112.929 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.23 -70.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 122.472 -0.429 . . . . 74.24 111.892 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -85.66 -12.72 50.6 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.185 0.439 . . . . 74.45 112.185 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 35' ' ' TRP . 52.9 p90 -158.99 169.32 24.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.728 0.27 . . . . 73.55 111.728 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -141.98 172.1 13.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.782 0.325 . . . . 73.23 111.158 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -105.39 109.83 21.96 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.281 0.475 . . . . 74.2 112.281 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 91.7 t . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 51.1 111.647 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.842 0.353 . . . . 71.2 111.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -92.69 119.95 32.61 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.067 0.46 . . . . 71.53 112.144 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 44' ' ' VAL . 37.2 m95 -103.78 123.68 47.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.578 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.11 150.88 19.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 65.01 111.927 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -92.42 112.17 24.01 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.195 -0.457 . . . . 75.1 111.905 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 65.4 t80 -56.25 -50.12 89.36 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 112.498 0.555 . . . . 75.22 112.498 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 50.1 Cg_exo -55.75 -41.56 76.26 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.198 1.932 . . . . 61.25 113.02 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -62.03 -44.99 95.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.48 0.657 . . . . 74.3 111.628 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.486 HD12 HD21 ' A' ' 16' ' ' LEU . 87.2 mt -69.1 -47.81 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.683 -0.69 . . . . 71.51 111.776 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.3 -31.94 69.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.775 0.322 . . . . 71.53 111.365 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -42.49 91.33 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.101 0.477 . . . . 60.24 110.011 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.8 -54.99 22.45 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.424 -0.353 . . . . 74.25 111.22 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 63.41 111.421 178.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 8.8 tp10 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 121.205 0.526 . . . . 74.44 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.466 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 93.7 m95 -93.57 146.09 24.06 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.074 -0.512 . . . . 71.51 111.241 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.7 ptp -160.73 159.62 30.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.937 0.399 . . . . 74.35 112.01 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.14 163.39 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.535 -0.302 . . . . 64.53 111.478 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -52.48 -47.19 66.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.326 0.491 . . . . 73.34 112.326 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -60.82 -32.05 71.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.356 -0.383 . . . . 61.4 111.31 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.61 24.83 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.034 0.445 . . . . 55.01 111.36 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -59.28 -50.61 73.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.892 -0.594 . . . . 65.44 111.05 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.6 ptp -58.27 -35.53 71.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.081 0.467 . . . . 63.41 111.481 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.4 t -72.42 -31.35 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 111.941 0.348 . . . . 65.24 111.941 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.1 -31.9 20.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.38 0.511 . . . . 73.33 112.38 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.36 -30.65 15.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.886 0.699 . . . . 70.42 112.886 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.19 4.93 62.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.887 -0.673 . . . . 53.42 113.267 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' MET . 11.0 mp -80.74 154.47 27.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.101 0.477 . . . . 75.42 111.31 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.99 165.11 25.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.053 -0.594 . . . . 55.32 112.998 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.79 -47.79 64.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.17 0.433 . . . . 74.55 112.17 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.95 -27.43 68.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.773 0.32 . . . . 70.54 111.811 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -67.91 -56.89 7.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.197 0.522 . . . . 72.42 111.099 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.36 -50.76 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.85 -0.614 . . . . 64.12 112.112 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 pt-20 -53.63 -39.76 65.23 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.852 0.316 . . . . 64.34 111.852 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -69.81 -43.45 72.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.927 0.394 . . . . 51.24 111.249 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -67.17 -28.51 68.17 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.829 0.347 . . . . 73.34 111.432 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 49.1 mtp180 -58.77 -26.8 64.38 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.192 0.441 . . . . 74.04 112.192 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -97.14 10.69 38.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.337 0.495 . . . . 52.13 112.337 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.99 -53.89 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.438 -0.887 . . . . 72.14 114.454 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.03 -23.22 31.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.311 -0.523 . . . . 73.02 112.335 -175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.436 ' HE3' ' N ' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.92 139.79 48.9 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.35 0.595 . . . . 74.2 112.151 -177.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.5 mt -134.52 125.98 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.695 -0.684 . . . . 61.3 110.305 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.21 135.88 56.44 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.0 0.429 . . . . 64.21 111.701 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -55.84 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.32 -0.4 . . . . 72.3 113.358 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.99 -46.37 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.533 0.568 . . . . 71.13 112.533 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 1.7 m-70 -110.71 -18.69 13.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.715 0.635 . . . . 70.22 112.715 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 44.1 p90 -156.74 160.85 39.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.374 0.509 . . . . 61.51 112.374 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 22.8 ptmt -148.99 150.86 33.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.847 0.356 . . . . 73.2 111.444 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -90.64 123.9 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 53.43 110.811 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 112.121 0.415 . . . . 50.45 112.121 -178.133 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 73.55 111.742 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -91.78 124.6 36.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.894 0.378 . . . . 73.25 111.763 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.12 148.04 25.88 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.317 -0.401 . . . . 71.23 111.075 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.48 149.51 36.23 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.506 -0.316 . . . . 75.42 111.801 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.48 114.54 25.21 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.27 0.47 . . . . 71.14 112.27 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 89.7 t80 -61.64 -48.83 88.98 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.482 0.549 . . . . 74.02 112.482 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 19.1 Cg_endo -57.59 -33.4 96.52 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.997 1.798 . . . . 63.12 112.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.44 -49.03 29.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.143 -0.481 . . . . 72.24 111.235 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 67' ' ' ILE . 72.9 mt -63.41 -32.09 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.354 -0.385 . . . . 72.12 110.937 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -58.71 -42.76 89.39 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.002 0.429 . . . . 61.51 110.515 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -60.73 -43.8 97.44 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 60.2 110.521 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -62.45 -33.21 74.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.315 -0.402 . . . . 73.13 111.708 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 63' ' ' ILE . 68.7 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.898 0.38 . . . . 64.5 110.942 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 121.092 0.473 . . . . 71.22 111.242 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -80.66 120.2 24.27 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.943 -0.571 . . . . 74.33 110.523 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.0 ptp -141.56 153.32 44.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 62.13 111.929 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.56 166.45 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 61.53 111.51 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -51.6 -45.37 63.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.197 0.443 . . . . 75.24 112.197 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -58.52 -50.7 72.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.831 0.348 . . . . 62.42 111.084 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -67.11 -38.03 84.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.067 0.461 . . . . 55.41 111.43 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.542 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.66 -48.56 81.26 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.974 -0.557 . . . . 72.3 111.406 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.8 ptp -59.43 -32.36 70.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.932 0.396 . . . . 53.03 111.529 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.68 -37.52 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.121 0.486 . . . . 73.24 111.306 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 31.3 mmt180 -76.33 -26.96 56.29 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.888 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.2 p -98.46 -30.85 12.3 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.305 0.483 . . . . 73.04 112.305 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.71 6.58 62.17 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.266 -0.492 . . . . 43.23 113.125 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.4 mp -85.92 160.49 19.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.194 0.521 . . . . 75.15 111.847 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.08 156.75 19.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.27 -0.491 . . . . 71.11 111.997 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.03 59.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.318 0.488 . . . . 74.42 112.318 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -21.67 66.86 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.874 0.369 . . . . 73.43 111.711 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.43 -45.42 12.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.224 0.535 . . . . 75.15 110.696 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 51.3 mt -61.11 -49.4 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.992 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.5 pt-20 -57.43 -29.98 64.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.76 0.281 . . . . 61.45 111.76 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 t -62.33 -48.1 81.32 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.182 0.515 . . . . 73.42 110.912 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -71.43 -31.03 66.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.022 -0.535 . . . . 74.41 111.774 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 27.9 mtp-105 -60.85 -19.32 59.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.067 0.395 . . . . 71.03 112.067 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.1 mm-40 -80.9 -14.86 57.63 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.501 0.556 . . . . 72.45 112.501 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.05 -48.44 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.363 -0.922 . . . . 70.41 114.313 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.25 81.34 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.286 -0.538 . . . . 75.05 112.059 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.2 104.95 5.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.069 0.461 . . . . 71.23 110.901 177.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -86.7 135.21 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.298 -0.41 . . . . 61.13 111.69 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.03 139.18 58.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.966 0.412 . . . . 73.32 111.613 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.03 -46.49 2.69 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.387 -0.37 . . . . 71.31 113.225 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.51 -60.1 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.35 0.5 . . . . 74.41 112.35 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -91.94 -27.37 17.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.96 0.356 . . . . 70.24 111.96 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 36.1 p90 -152.6 155.92 38.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.693 -0.231 . . . . 72.21 110.663 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.0 165.8 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.094 0.473 . . . . 74.04 112.095 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -82.54 122.24 27.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.956 -0.566 . . . . 73.03 111.525 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.094 0.473 . . . . 73.35 111.397 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 120.655 0.264 . . . . 71.32 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -111.67 108.49 17.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.428 0.529 . . . . 73.22 112.428 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -100.84 136.68 40.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.254 -0.43 . . . . 73.44 110.973 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.13 137.46 45.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.297 -0.41 . . . . 70.34 111.629 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 60.7 t30 -88.49 112.7 23.27 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.002 0.429 . . . . 74.13 111.05 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 68.0 t80 -51.1 -54.25 39.79 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.544 0.942 . . . . 75.44 113.544 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 78.4 Cg_exo -51.9 -38.07 67.81 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.133 1.888 . . . . 61.44 113.209 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -65.27 -25.86 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.195 0.442 . . . . 63.52 112.195 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.542 HD12 HD21 ' A' ' 16' ' ' LEU . 66.0 mt -86.52 -37.49 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.583 -0.28 . . . . 73.34 111.33 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.76 -39.77 68.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.36 0.6 . . . . 73.53 110.373 170.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -50.63 -44.48 57.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.499 -0.773 . . . . 75.14 111.016 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.42 -40.63 81.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.783 -0.644 . . . . 73.04 111.491 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 116.384 -0.371 . . . . 74.14 111.778 -179.352 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 9.9 tp10 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.786 0.327 . . . . 74.14 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -122.52 140.42 52.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.608 0.242 . . . . 71.41 111.373 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 pmm? -158.47 174.42 15.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.13 0.49 . . . . 72.1 111.588 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.35 171.47 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.263 -0.426 . . . . 43.43 110.926 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -58.33 -41.98 85.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.055 0.391 . . . . 74.23 112.055 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -55.56 -48.33 74.93 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.957 0.408 . . . . 61.35 111.055 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.86 -37.53 73.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.941 0.401 . . . . 52.21 111.075 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 63' ' ' ILE . 3.2 tm? -56.97 -48.99 77.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.3 -0.409 . . . . 62.32 111.164 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.9 ptp -62.23 -36.26 81.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.658 0.266 . . . . 74.21 111.236 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' LYS . 64.6 t -69.87 -36.03 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.071 0.462 . . . . 51.34 111.309 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.5 mmt180 -74.47 -37.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.127 -0.488 . . . . 74.45 112.008 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.2 p -93.14 -30.86 15.02 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.602 0.593 . . . . 63.53 112.602 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.02 -3.2 41.04 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.162 -0.542 . . . . 51.22 113.087 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.24 -175.03 4.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.366 0.603 . . . . 64.23 112.226 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.37 169.22 23.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.96 -0.564 . . . . 73.13 112.3 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.31 -49.09 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.557 0.577 . . . . 62.41 112.557 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -63.33 -23.12 67.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.992 0.425 . . . . 74.24 111.424 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -81.74 -53.92 5.81 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.16 0.505 . . . . 75.1 111.079 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.54 -43.1 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.022 -0.535 . . . . 72.51 112.343 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 pt-20 -58.75 -29.27 66.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.997 0.369 . . . . 74.43 111.997 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -67.86 -36.84 80.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.183 0.516 . . . . 72.11 110.685 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.97 -31.22 56.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.165 -0.47 . . . . 74.23 110.897 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 55.6 mtp180 -59.96 -25.33 65.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 75.15 112.061 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -95.33 12.49 28.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 64.51 111.823 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.54 -85.77 0.06 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.95 -0.643 . . . . 71.51 114.134 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.58 65.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.8 0.667 . . . . 71.52 112.8 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.04 104.64 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.531 0.682 . . . . 73.44 111.691 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -103.61 133.34 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.384 -0.825 . . . . 75.53 110.335 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.5 142.04 58.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.917 0.389 . . . . 75.44 110.999 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 -43.62 2.79 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 121.553 -0.356 . . . . 75.44 113.11 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.13 -50.86 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.579 0.585 . . . . 62.35 112.579 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -111.49 -18.56 12.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.665 0.616 . . . . 75.03 112.665 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.63 144.33 20.43 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.441 0.163 . . . . 55.21 110.602 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -121.09 156.37 32.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.158 0.504 . . . . 74.3 111.962 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -95.83 143.43 27.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.266 -0.424 . . . . 53.34 111.017 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 120.868 0.366 . . . . 63.41 111.545 178.14 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.92 0.39 . . . . 63.35 111.434 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -107.3 109.34 21.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.817 0.341 . . . . 64.32 110.957 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -95.68 133.9 39.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.904 0.383 . . . . 73.43 111.594 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.7 139.11 33.25 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.076 0.465 . . . . 74.13 111.591 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.18 95.08 6.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.176 -0.465 . . . . 53.15 111.42 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.679 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 69.4 t80 -55.9 -49.9 90.34 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.65 0.611 . . . . 74.31 112.65 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.8 Cg_endo -56.82 -23.7 51.9 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.193 1.929 . . . . 63.32 112.782 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.99 -44.73 10.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.794 0.294 . . . . 73.1 111.794 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 16' ' ' LEU . 74.0 mt -66.66 -48.99 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.751 0.31 . . . . 74.24 111.153 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -56.82 -47.59 79.95 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.256 0.551 . . . . 45.23 110.39 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.19 -42.2 76.76 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.663 -0.699 . . . . 73.15 111.908 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -61.51 -47.73 84.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.009 0.433 . . . . 75.34 111.099 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.462 . . . . 74.51 111.369 178.609 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 5.0 mm-40 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.191 0.52 . . . . 74.23 110.79 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 81.9 m95 -99.21 126.53 45.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.849 -0.614 . . . . 74.02 110.537 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.502 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.3 ptp -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.021 0.438 . . . . 74.5 112.021 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.93 163.8 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.255 -0.43 . . . . 70.43 111.949 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.38 -51.08 28.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.974 0.731 . . . . 75.32 112.974 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -60.89 -40.32 92.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.676 0.274 . . . . 74.12 111.654 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.29 70.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.082 0.467 . . . . 53.43 111.098 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -60.11 -50.74 72.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.659 -0.7 . . . . 74.41 111.187 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -59.01 -33.66 70.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.948 0.404 . . . . 74.55 111.64 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' LYS . 65.2 t -71.41 -42.44 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.008 0.433 . . . . 51.12 111.513 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -85.06 -8.5 58.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.018 0.747 . . . . 73.01 113.018 -176.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.7 p -110.22 -30.34 7.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.207 0.447 . . . . 74.12 112.207 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.69 -6.69 65.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.202 -0.523 . . . . 52.4 112.846 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -73.65 157.49 36.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.031 0.443 . . . . 72.42 111.576 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.56 160.72 20.42 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.125 -0.56 . . . . 62.15 112.93 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.07 61.43 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.15 0.426 . . . . 63.22 112.15 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.93 -27.4 67.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.033 0.444 . . . . 75.35 111.712 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -76.35 -36.91 57.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.125 0.488 . . . . 62.34 110.631 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 56.6 mt -68.42 -52.53 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.422 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.8 pt-20 -54.35 -37.28 64.74 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.914 0.388 . . . . 74.45 111.405 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -57.69 -53.58 56.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.09 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -65.07 -30.99 71.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.325 -0.398 . . . . 75.34 111.948 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 18.5 mtp-105 -60.47 -23.27 64.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.605 -0.27 . . . . 72.11 111.658 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -90.76 -9.38 46.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.355 0.872 . . . . 53.31 113.355 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.49 9.36 0.33 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 119.731 -1.223 . . . . 64.31 115.666 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.96 -28.79 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.904 0.852 . . . . 52.24 111.871 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.36 133.21 44.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.591 0.71 . . . . 75.4 112.493 -177.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 60.6 mt -138.47 126.46 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.419 -0.81 . . . . 71.24 110.329 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.5 139.78 51.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.371 0.605 . . . . 43.32 110.981 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.39 -15.11 59.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.059 -0.519 . . . . 53.51 112.593 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -123.89 -73.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 122.57 -0.371 . . . . 71.11 111.655 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.447 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.5 m80 -86.34 -10.87 53.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.056 0.391 . . . . 74.35 112.056 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 44.5 p90 -170.51 179.06 3.46 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.858 -0.423 . . . . 75.53 109.858 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -157.86 149.19 21.42 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.014 0.435 . . . . 74.12 111.374 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -78.69 103.94 8.97 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.232 0.539 . . . . 72.33 111.748 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 66.0 t . . . . . 0 N--CA 1.466 0.37 0 CA-C-N 116.117 -0.492 . . . . 74.53 111.047 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.911 0.386 . . . . 74.05 110.721 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -86.7 105.76 17.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.09 0.472 . . . . 75.31 112.009 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 28.7 m95 -91.23 121.75 33.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.08 -0.509 . . . . 72.55 110.006 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' ILE . 87.5 m-85 -90.32 145.07 25.25 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.918 0.71 . . . . 72.35 112.918 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.479 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 53.2 t-20 -85.36 96.88 9.69 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.735 -0.666 . . . . 73.53 110.729 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 82.9 t80 -52.4 -53.11 56.69 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 112.543 0.571 . . . . 72.1 112.543 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 82.5 Cg_exo -51.02 -50.42 13.95 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.376 2.05 . . . . 73.54 113.588 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.6 mm-40 -71.22 -28.53 64.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.143 0.423 . . . . 75.2 112.143 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 58' ' ' TYR . 46.7 mt -70.13 -42.14 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.948 -0.47 . . . . 73.0 110.547 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -34.13 72.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.051 0.453 . . . . 75.14 110.407 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 5.7 tppp? -59.0 -31.86 69.17 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.939 -0.573 . . . . 64.32 111.279 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -85.51 -32.22 22.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 72.24 111.232 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.4 mt . . . . . 0 CA--C 1.537 0.47 0 O-C-N 122.206 -0.309 . . . . 72.44 111.467 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 70.6 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.872 0.367 . . . . 60.34 110.819 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.431 ' HH2' ' HE3' ' A' ' 42' ' ' LYS . 80.9 m95 -93.81 134.31 36.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.148 -0.478 . . . . 73.11 110.429 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 20.4 ptp -157.16 153.85 28.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.987 0.422 . . . . 74.31 112.035 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.27 170.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.203 -0.453 . . . . 71.45 110.865 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -57.55 -45.59 84.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.22 0.452 . . . . 74.41 112.22 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.1 tmmt? -61.54 -38.54 87.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.887 0.375 . . . . 75.43 111.14 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -72.21 -38.54 68.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.071 0.462 . . . . 74.52 111.1 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.32 -48.37 81.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.782 -0.645 . . . . 53.2 110.965 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -61.29 -28.03 68.9 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.808 0.337 . . . . 74.33 111.901 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.9 t -78.62 -49.19 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.911 0.386 . . . . 61.11 111.126 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -64.4 -26.88 68.65 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.0 p -99.05 -30.67 12.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.252 0.464 . . . . 65.22 112.252 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.5 -13.98 56.64 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.117 -0.563 . . . . 64.3 113.103 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.4 mp -66.99 159.9 27.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.219 0.533 . . . . 61.43 111.976 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.69 160.63 15.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.039 -0.528 . . . . 24.52 112.491 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.58 65.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.85 0.357 . . . . 71.53 111.591 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -59.27 -31.68 69.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.003 -0.544 . . . . 72.33 111.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' SER . 46.9 tt0 -84.37 -34.28 23.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.398 -0.365 . . . . 70.21 111.021 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 17' ' ' MET . 60.8 mt -66.24 -50.33 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.598 -0.274 . . . . 64.43 111.159 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 13.0 pt-20 -58.56 -23.25 58.02 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.986 0.422 . . . . 63.4 111.193 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 47.9 t -67.18 -56.04 11.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.224 -0.444 . . . . 73.11 110.54 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -65.72 -25.89 67.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.178 0.436 . . . . 65.1 112.178 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 78.8 mtp180 -60.37 -10.76 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 111.942 0.349 . . . . 73.23 111.942 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -63.17 -22.33 66.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.161 0.43 . . . . 73.45 112.161 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.67 -17.16 0.05 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.488 -0.863 . . . . 71.2 114.607 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.3 67.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.681 0.741 . . . . 55.55 111.816 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -71.94 105.07 3.71 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.065 0.46 . . . . 75.31 111.716 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -87.49 120.24 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.345 -0.389 . . . . 74.15 111.6 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.61 147.74 40.72 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.905 0.335 . . . . 73.22 111.905 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.15 -47.18 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.444 -0.344 . . . . 61.15 113.665 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.3 t -80.44 -63.65 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.468 0.307 . . . . 74.44 111.732 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.477 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 4.3 m-70 -86.88 -19.93 28.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.127 0.417 . . . . 74.22 112.127 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 12.3 p90 -165.97 143.48 5.49 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.795 -0.446 . . . . 64.03 109.795 175.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.431 ' HE3' ' HH2' ' A' ' 10' ' ' TRP . 19.1 ptpt -127.62 161.36 29.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.395 0.617 . . . . 73.55 112.488 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 43' ' ' ARG . 7.8 ptp180 -74.92 134.62 41.54 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.502 -0.772 . . . . 62.13 111.032 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 116.657 -0.247 . . . . 51.21 110.788 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 74.35 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.1 m -123.12 120.42 33.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.932 0.396 . . . . 75.13 111.801 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -109.94 140.11 44.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.318 -0.401 . . . . 74.11 111.108 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -99.34 139.76 34.51 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.827 0.346 . . . . 74.3 111.524 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 16.7 m120 -87.66 105.49 17.39 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.303 -0.408 . . . . 72.4 111.317 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 67.4 t80 -52.06 -52.03 65.82 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.857 0.688 . . . . 71.21 112.857 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 22.4 Cg_endo -60.01 -29.42 89.27 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.877 1.718 . . . . 60.24 112.858 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HB3' ' ND1' ' A' ' 40' ' ' HIS . 74.7 mm-40 -79.9 -39.09 31.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.194 -0.457 . . . . 71.14 112.063 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -71.69 -35.76 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.768 0.318 . . . . 64.33 110.384 174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.09 -38.24 85.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.759 0.314 . . . . 72.43 110.382 172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 39.6 ttmt -53.77 -35.46 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.073 0.463 . . . . 55.41 110.974 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.66 -50.97 10.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.149 -0.478 . . . . 42.45 111.163 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 63' ' ' ILE . 54.6 mt . . . . . 0 CA--C 1.544 0.731 0 N-CA-C 112.462 0.541 . . . . 72.52 112.462 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.0 mm-40 . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 120.901 0.382 . . . . 64.25 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -91.98 135.75 33.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.627 -0.26 . . . . 74.05 110.526 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.7 ptp -158.81 142.41 15.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.922 0.391 . . . . 54.34 112.045 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.09 172.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 111.795 0.295 . . . . 61.04 111.795 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -46.74 -57.51 4.78 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.896 0.702 . . . . 73.44 112.896 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -54.69 -37.52 65.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.885 0.374 . . . . 73.34 111.945 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -76.11 -42.44 47.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.097 0.475 . . . . 53.33 111.143 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -58.31 -47.72 82.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.804 -0.635 . . . . 62.31 111.209 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -58.63 -34.24 70.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.847 0.356 . . . . 63.14 111.629 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.9 t -73.49 -46.14 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.154 0.502 . . . . 52.41 111.233 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.596 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 16.8 mmt180 -69.0 -29.57 67.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.131 -0.486 . . . . 74.5 112.247 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -99.96 -30.17 12.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.538 0.57 . . . . 54.33 112.538 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 -4.64 56.12 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.025 -0.607 . . . . 41.23 112.824 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.63 -173.11 1.71 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.386 0.612 . . . . 73.01 111.767 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -146.19 169.14 27.58 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.797 -0.638 . . . . 42.24 112.266 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.12 -50.69 61.17 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.221 0.452 . . . . 72.23 112.221 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -60.95 -34.76 75.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.133 0.492 . . . . 72.15 111.736 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -78.67 -40.37 34.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.349 -0.387 . . . . 71.44 111.599 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 23' ' ' GLY . 73.8 mt -66.04 -44.07 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.555 0.217 . . . . 54.12 111.369 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 11.7 pt-20 -56.93 -37.92 72.17 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.812 0.339 . . . . 74.11 110.905 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 t -60.69 -49.35 77.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 43.41 110.988 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -63.07 -29.38 70.77 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.805 0.298 . . . . 74.43 111.805 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.1 mtm180 -69.71 -12.31 61.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.052 0.39 . . . . 73.13 112.052 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 45.0 mt-30 -88.74 2.76 52.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.625 0.232 . . . . 74.52 111.625 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.3 -52.29 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.177 -1.011 . . . . 64.41 114.697 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.08 -38.42 31.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.465 0.913 . . . . 71.31 113.465 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -71.55 130.67 41.82 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.015 -0.428 . . . . 72.43 111.68 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.2 mt -130.59 126.31 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 122.522 0.329 . . . . 75.13 111.094 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 42' ' ' LYS . 38.5 tt0 -68.99 150.92 47.15 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.003 0.43 . . . . 44.13 110.906 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.45 2.67 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.255 -0.498 . . . . 71.45 112.841 -174.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -97.76 -64.99 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.249 0.463 . . . . 71.44 112.249 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.4 m-70 -92.06 -11.97 34.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.75 0.648 . . . . 53.13 112.75 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 47.5 p90 -170.78 174.03 5.06 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.0 0.12 . . . . 75.02 111.012 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 18.7 ptpt -167.74 174.2 7.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.424 0.631 . . . . 75.15 112.288 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -85.4 120.86 27.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.524 -0.762 . . . . 74.44 112.002 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 CA--C 1.542 0.65 0 CA-C-N 116.007 -0.542 . . . . 62.34 110.857 176.109 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.544 0.211 . . . . 73.32 110.566 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.6 m -89.61 115.25 26.86 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.069 0.461 . . . . 65.11 112.171 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -102.16 133.54 46.86 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.134 -0.484 . . . . 74.55 110.848 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.38 143.31 27.54 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.018 0.437 . . . . 73.44 111.327 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.39 105.53 13.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.322 -0.399 . . . . 71.52 111.5 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 90.2 t80 -56.95 -45.15 99.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 111.822 0.305 . . . . 74.12 111.822 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 9.1 Cg_endo -50.69 -41.78 52.76 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.405 2.07 . . . . 65.32 113.109 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 40' ' ' HIS . 42.6 mm-40 -65.87 -47.27 75.44 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.136 0.493 . . . . 64.03 111.815 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 HD21 ' A' ' 16' ' ' LEU . 65.3 mt -71.79 -37.43 62.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.975 0.417 . . . . 74.23 111.183 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.6 -43.25 99.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.281 0.562 . . . . 65.22 110.177 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -55.75 -39.49 71.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.593 -0.73 . . . . 72.0 110.81 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -65.03 -48.6 73.29 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.301 -0.409 . . . . 74.51 111.468 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 121.1 0.476 . . . . 71.55 111.461 178.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.029 0.442 . . . . 71.03 111.629 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -77.53 130.53 37.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.669 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.6 ptp -153.59 142.3 20.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.813 0.339 . . . . 70.33 111.779 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 15' ' ' ALA . 35.8 m -64.81 166.29 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.752 0.31 . . . . 75.52 111.819 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -52.41 -46.61 66.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.009 0.433 . . . . 70.52 111.645 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -60.13 -37.09 79.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.154 -0.475 . . . . 72.02 111.483 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -76.21 -38.97 55.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.337 0.589 . . . . 74.21 111.04 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.17 -43.11 92.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.981 -0.554 . . . . 74.43 111.299 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.519 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.1 ptp -61.06 -27.49 68.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.738 0.304 . . . . 70.35 111.35 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.4 t -67.95 -48.77 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.215 0.531 . . . . 74.22 110.805 174.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -64.82 -42.76 94.7 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.078 -0.51 . . . . 75.3 112.289 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -93.5 -30.27 15.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.048 0.758 . . . . 72.24 113.048 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.84 7.56 64.39 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.055 -0.593 . . . . 72.31 113.127 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.4 mp -79.76 160.13 26.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 63.21 111.724 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.02 153.36 16.83 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 71.32 112.002 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -41.42 62.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.203 0.501 . . . . 45.12 111.997 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.98 -27.03 69.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.412 -0.358 . . . . 72.51 111.584 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.443 HE21 ' HE2' ' A' ' 30' ' ' TYR . 48.8 tt0 -84.9 -40.95 16.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.152 0.501 . . . . 72.14 110.755 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.71 -40.0 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.253 -0.43 . . . . 61.24 112.03 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.487 ' HB3' ' NH2' ' A' ' 31' ' ' ARG . 11.7 pt-20 -62.19 -34.32 76.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.901 0.381 . . . . 74.43 111.253 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 35.8 t -62.43 -27.6 69.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.245 0.545 . . . . 74.24 110.773 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HE2' HE21 ' A' ' 26' ' ' GLN . 60.4 m-85 -88.43 -31.61 18.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.274 -0.421 . . . . 72.2 111.646 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 55.2 mtm180 -64.35 -20.52 66.16 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.296 0.48 . . . . 73.35 112.296 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 29' ' ' SER . 13.6 pt20 -79.03 -8.11 58.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.435 0.531 . . . . 75.11 112.435 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.32 -49.08 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.199 -1.0 . . . . 73.25 114.642 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.33 85.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 73.54 112.463 -176.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.13 106.29 4.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.043 0.449 . . . . 75.21 111.675 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -96.87 131.71 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.529 -0.305 . . . . 72.32 111.211 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.83 147.32 53.56 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.044 0.449 . . . . 72.15 111.4 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.68 -46.03 3.01 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.254 -0.498 . . . . 62.32 112.872 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.56 -62.79 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.305 0.483 . . . . 71.14 112.305 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -93.91 -21.01 19.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.918 0.71 . . . . 50.01 112.918 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -153.24 168.22 26.72 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.862 0.301 . . . . 74.51 111.46 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -136.16 165.29 26.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.21 0.529 . . . . 64.0 111.424 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -86.79 136.71 32.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.688 -0.687 . . . . 62.03 110.173 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 78.4 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.216 0.531 . . . . 25.23 111.656 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 26.5 m . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.009 0.433 . . . . 71.11 111.17 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.8 m -91.9 110.2 21.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.718 0.636 . . . . 74.24 112.718 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -104.35 128.21 52.14 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.514 . . . . 74.24 111.008 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' OH ' ' HD3' ' A' ' 31' ' ' ARG . 15.8 m-85 -90.87 157.55 17.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 74.25 112.022 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 40.8 m-80 -94.77 110.19 22.07 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.277 -0.419 . . . . 74.2 110.406 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.4 t80 -52.65 -49.81 84.16 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.119 0.414 . . . . 72.25 112.119 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 55.5 Cg_exo -53.63 -41.38 74.31 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.028 1.819 . . . . 74.01 113.274 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 28.2 mm-40 -70.52 -35.66 73.32 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.735 0.642 . . . . 71.11 112.735 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.4 -41.57 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.626 0.251 . . . . 75.52 111.154 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.84 -40.96 90.27 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.26 0.552 . . . . 61.04 110.279 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -59.88 -44.67 94.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.034 -0.53 . . . . 72.42 111.118 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.15 -45.7 90.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.199 -0.455 . . . . 72.12 111.226 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.067 0.46 . . . . 72.34 111.019 176.206 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.559 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 6.8 tp10 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.259 0.552 . . . . 52.55 109.737 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -94.28 130.48 40.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.864 -0.607 . . . . 60.22 110.665 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.547 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.4 ptp -144.84 160.51 41.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.074 0.464 . . . . 75.41 111.823 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 15' ' ' ALA . 33.0 m -73.67 170.31 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.133 0.492 . . . . 75.53 111.632 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.82 -48.69 80.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.237 0.458 . . . . 73.55 112.237 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . 0.8 OUTLIER -65.33 -29.7 70.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.763 0.316 . . . . 62.22 111.107 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -73.47 -41.77 62.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.994 0.426 . . . . 75.24 111.053 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -58.04 -45.88 86.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.047 -0.524 . . . . 50.33 111.207 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.7 ptp -62.28 -35.52 79.25 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.597 0.237 . . . . 74.01 111.549 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 95.8 t -72.77 -40.46 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.07 0.462 . . . . 54.34 111.433 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.547 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 15.0 mmt85 -65.55 -41.59 92.85 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.237 -0.438 . . . . 73.25 112.051 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.1 p -93.75 -30.21 14.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.97 0.73 . . . . 75.41 112.97 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.58 -4.62 47.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.198 -0.525 . . . . 75.32 112.947 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -75.82 -179.1 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 74.52 111.861 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -132.13 168.44 22.52 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.626 -0.715 . . . . 71.24 112.26 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.1 71.21 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.673 0.62 . . . . 72.05 112.673 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 87.2 mtt180 -73.99 -18.64 60.84 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.621 0.6 . . . . 54.51 112.621 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 10.3 tt0 -84.57 -37.73 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.898 0.38 . . . . 71.41 110.701 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.1 mt -63.67 -50.37 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.601 -0.272 . . . . 72.53 111.126 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.7 pt-20 -59.8 -31.03 69.31 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.141 0.496 . . . . 75.1 110.935 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 40.8 t -61.5 -50.41 72.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.512 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.14 -23.68 66.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.946 0.35 . . . . 74.14 111.946 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.702 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 13.6 mtp180 -64.27 -9.79 19.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.797 0.666 . . . . 71.04 112.797 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 29' ' ' SER . 29.0 pt20 -70.9 -22.26 62.29 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.937 0.347 . . . . 74.03 111.937 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.69 -43.68 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.753 -0.737 . . . . 71.45 113.979 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.16 -49.08 78.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.095 0.405 . . . . 63.01 112.095 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.95 104.52 5.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.961 0.41 . . . . 73.22 110.241 175.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.79 127.26 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 72.41 110.848 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -58.49 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.961 0.41 . . . . 73.43 111.081 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.11 -50.22 3.35 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 64.23 113.038 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.1 t -81.35 -61.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.176 0.436 . . . . 73.15 112.176 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -89.36 -22.12 22.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 111.987 0.366 . . . . 72.31 111.987 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -160.09 127.34 4.5 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.708 0.29 . . . . 75.53 110.655 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -122.02 145.07 48.49 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.01 0.433 . . . . 71.42 111.749 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 45.3 mtm180 -73.46 103.21 4.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.03 0.443 . . . . 71.35 111.09 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.209 0.528 . . . . 72.43 111.107 -179.884 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 110.503 -0.184 . . . . 74.13 110.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 6.9 t -81.12 138.12 35.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.276 0.56 . . . . 72.21 112.343 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -112.81 136.89 51.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.7 -0.682 . . . . 55.02 110.371 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -89.93 139.73 30.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.291 0.567 . . . . 72.42 112.126 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.547 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 39.3 t-20 -91.73 101.51 14.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.593 -0.731 . . . . 70.31 110.467 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 87.0 t80 -54.99 -52.13 73.65 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 112.627 0.603 . . . . 70.11 112.627 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 9' ' ' GLU . 80.9 Cg_exo -48.51 -49.41 14.63 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.256 1.971 . . . . 72.21 113.376 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -62.72 -41.53 99.2 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.147 0.425 . . . . 71.24 112.147 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.24 -49.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.961 0.41 . . . . 72.22 111.586 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -57.12 -38.32 73.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 61.45 110.927 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -51.33 70.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.193 -0.458 . . . . 75.55 110.091 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -55.56 -48.78 74.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.011 -0.541 . . . . 73.4 111.563 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.17 -0.468 . . . . 62.32 111.338 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.834 0.349 . . . . 62.55 111.335 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -96.12 132.83 41.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.009 0.433 . . . . 74.24 111.647 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.39 154.45 40.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.439 -0.346 . . . . 71.31 111.072 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.25 171.33 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.429 -0.351 . . . . 72.32 111.69 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -51.64 -57.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.211 0.448 . . . . 70.44 112.211 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.2 tmmt? -53.02 -48.45 67.55 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.295 -0.412 . . . . 61.23 111.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.22 97.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.015 0.436 . . . . 70.53 111.558 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -59.65 -51.86 68.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.068 -0.515 . . . . 65.0 111.496 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -59.5 -39.45 83.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.688 0.28 . . . . 72.14 111.726 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.38 -42.68 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.829 0.347 . . . . 50.33 111.375 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -65.55 -35.33 80.55 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.391 0.515 . . . . 74.04 112.391 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.1 p -93.48 -30.24 15.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.508 0.559 . . . . 73.13 112.508 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.22 11.29 45.95 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.122 -0.561 . . . . 70.31 112.714 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.3 mp -93.39 173.14 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.137 0.494 . . . . 71.33 111.172 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.28 162.28 22.01 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.247 -0.502 . . . . 74.54 112.313 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.25 61.94 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.004 0.372 . . . . 51.43 112.004 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -60.6 -28.64 68.67 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.18 0.437 . . . . 74.02 112.18 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 9.3 tt0 -84.94 -45.16 12.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.102 0.477 . . . . 75.14 110.855 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.8 mt -64.14 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.24 -0.436 . . . . 74.42 111.99 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.71 -34.36 69.38 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.857 0.317 . . . . 60.24 111.857 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 t -64.39 -42.07 96.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.09 0.471 . . . . 61.41 111.121 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 29.0 m-85 -64.74 -33.5 76.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 75.32 111.119 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 27.9 mtm180 -62.62 -25.8 68.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.641 0.258 . . . . 70.13 111.312 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.66 -36.52 80.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.617 0.599 . . . . 70.34 112.617 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.25 35.89 0.29 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.317 -0.944 . . . . 74.22 114.506 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.25 -16.85 1.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.103 0.477 . . . . 53.53 111.917 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.499 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.03 111.91 20.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.219 0.533 . . . . 64.12 112.122 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.89 129.67 64.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.023 -0.535 . . . . 71.12 110.376 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.18 137.69 53.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.144 0.497 . . . . 43.43 110.669 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.39 2.93 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.329 -0.462 . . . . 74.52 112.372 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.25 -64.5 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.094 0.405 . . . . 72.04 112.094 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 47.4 m170 -94.24 -37.72 11.39 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.363 0.505 . . . . 73.32 112.363 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 25.6 p90 -141.74 175.7 9.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 63.24 111.121 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -144.79 133.05 21.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.897 0.379 . . . . 73.31 110.98 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -80.75 102.69 10.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.496 0.665 . . . . 74.3 110.404 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.063 -0.971 . . . . 55.15 112.175 -174.419 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.823 0.344 . . . . 63.32 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.432 HG23 ' CD2' ' A' ' 41' ' ' PHE . 52.2 m -86.15 115.75 23.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.01 0.744 . . . . 42.54 113.01 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -105.19 140.48 38.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.695 -0.684 . . . . 73.35 110.111 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.42 144.82 32.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.326 0.491 . . . . 70.43 112.326 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.09 111.78 18.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.379 -0.373 . . . . 64.14 110.983 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 87.7 t80 -54.85 -53.39 61.38 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 112.342 0.497 . . . . 72.32 112.342 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 55.6 Cg_endo -67.16 -20.19 50.1 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.154 1.903 . . . . 53.11 113.786 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 40' ' ' HIS . 47.1 mm-40 -83.29 -38.04 22.66 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.11 -0.369 . . . . 71.11 111.515 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 16' ' ' LEU . 58.9 mt -70.6 -42.98 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.663 0.268 . . . . 73.43 110.442 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.25 -38.2 70.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.844 0.354 . . . . 74.15 111.03 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.44 -49.61 77.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 73.15 110.798 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -58.81 -41.87 87.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.065 0.459 . . . . 71.33 111.199 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.7 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 116.276 -0.42 . . . . 61.11 111.232 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.9 mm-40 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 72.24 111.59 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -88.62 136.69 32.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.687 0.28 . . . . 75.41 111.014 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 ptp -157.92 153.55 26.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.949 0.404 . . . . 64.43 111.814 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.67 174.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.278 -0.419 . . . . 72.04 111.491 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 27' ' ' ILE . 35.7 tt0 -59.37 -50.66 73.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.42 . . . . 75.13 112.133 -175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -61.05 -38.13 85.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.922 0.391 . . . . 74.13 110.968 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.04 75.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.147 0.499 . . . . 74.25 111.012 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.97 -47.77 83.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.869 -0.605 . . . . 74.42 111.168 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.6 ptp -60.15 -34.99 74.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.82 0.343 . . . . 74.22 111.311 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.6 t -76.95 -27.1 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.744 0.307 . . . . 61.25 111.76 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.0 mmp_? -94.39 -14.69 25.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.672 0.619 . . . . 64.23 112.672 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.7 p -108.53 -29.86 8.55 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.496 0.554 . . . . 41.41 112.496 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.58 -0.14 58.06 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.122 -0.561 . . . . 72.13 112.578 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.1 178.52 7.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.29 0.567 . . . . 61.34 112.042 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.42 168.74 12.68 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.022 -0.535 . . . . 72.54 112.578 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 -45.14 91.35 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.602 -0.352 . . . . 60.21 111.872 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -65.21 -41.2 94.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.151 0.501 . . . . 74.04 111.123 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.59 -41.77 98.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.278 -0.419 . . . . 73.35 111.189 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG21 ' HG3' ' A' ' 13' ' ' GLU . 66.0 mt -62.39 -54.38 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.624 0.25 . . . . 42.31 111.659 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 11.8 pt-20 -59.65 -29.9 68.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.96 0.41 . . . . 72.52 111.284 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.3 t -63.04 -46.83 85.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.879 0.371 . . . . 71.51 111.093 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -68.69 -29.01 67.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.974 0.416 . . . . 61.31 111.029 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 51.9 mtp180 -61.26 -28.1 68.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.087 172.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.3 mm100 -73.08 -33.56 65.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.387 0.514 . . . . 73.21 112.387 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.82 61.19 0.3 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.169 -1.015 . . . . 54.12 114.737 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.71 -32.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.566 0.698 . . . . 63.22 110.408 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.48 130.92 41.78 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.679 -0.691 . . . . 72.24 111.581 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.458 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 70.9 mt -131.93 132.95 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.842 -0.617 . . . . 62.31 110.898 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.07 142.52 51.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.055 0.455 . . . . 71.21 111.441 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.31 -48.67 3.43 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.471 -0.395 . . . . 71.15 113.314 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.35 -60.59 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.941 0.4 . . . . 54.41 112.031 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.458 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.6 m170 -97.63 -32.19 11.9 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.282 0.475 . . . . 73.34 112.282 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 23.4 p90 -153.27 169.59 22.67 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.222 -0.299 . . . . 73.21 111.526 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.59 152.54 27.36 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.782 0.325 . . . . 73.33 110.851 174.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -78.57 131.0 36.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.237 0.542 . . . . 63.3 111.796 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 116.034 -0.53 . . . . 75.11 110.734 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.79 0.329 . . . . 64.42 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m -94.42 126.23 39.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.292 0.478 . . . . 72.3 112.292 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -114.64 139.07 49.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.24 -0.437 . . . . 74.2 110.613 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 63' ' ' ILE . 55.5 m-85 -107.94 148.51 29.57 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.973 0.415 . . . . 72.12 112.015 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.1 101.36 12.38 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.997 0.427 . . . . 64.12 111.213 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.783 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 87.0 t80 -53.54 -45.24 98.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.724 0.639 . . . . 73.03 112.724 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 11.1 Cg_endo -53.65 -47.41 27.41 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.018 1.812 . . . . 75.53 112.814 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.46 -38.77 84.95 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.253 0.464 . . . . 74.11 112.253 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 58' ' ' TYR . 64.4 mt -68.06 -43.52 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.876 0.369 . . . . 55.34 110.884 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.28 -41.25 92.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.039 0.447 . . . . 63.25 110.269 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -44.43 92.29 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.902 -0.59 . . . . 55.42 111.323 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -63.35 -46.87 84.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.214 0.531 . . . . 74.14 111.432 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.3 mt . . . . . 0 CA--C 1.538 0.5 0 CA-C-N 116.253 -0.431 . . . . 73.21 111.59 179.494 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 11.2 mm-40 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.8 0.333 . . . . 70.11 111.42 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -99.09 123.89 43.71 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.345 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 19.8 ptp -159.79 156.71 28.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.332 0.493 . . . . 54.05 112.332 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.3 m -81.58 176.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.319 -0.4 . . . . 42.33 111.174 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -56.3 -47.05 79.46 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.645 0.609 . . . . 74.1 112.645 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -39.96 92.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.837 0.351 . . . . 72.21 111.289 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -74.79 -33.57 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.086 0.47 . . . . 62.21 111.197 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.96 -47.87 67.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.759 -0.655 . . . . 73.05 111.326 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.5 ptp -56.12 -33.71 65.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.043 0.449 . . . . 74.03 111.852 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.38 -33.98 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.102 0.477 . . . . 73.44 111.457 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -86.81 -15.33 39.57 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.425 0.528 . . . . 72.15 112.425 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' HD13 ' A' ' 22' ' ' LEU . 48.6 p -108.53 -29.1 8.95 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.774 0.657 . . . . 72.12 112.774 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.98 9.7 65.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.849 -0.691 . . . . 61.23 112.636 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.0 mp -91.77 163.1 14.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.122 0.487 . . . . 62.21 111.124 176.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.39 163.2 14.18 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.209 -0.519 . . . . 64.12 111.811 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -51.2 -41.82 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.137 0.469 . . . . 44.42 111.501 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -56.6 -37.65 70.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.348 -0.387 . . . . 72.14 112.025 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -73.92 -46.49 44.05 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 70.1 111.274 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.56 -46.82 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.462 -0.335 . . . . 72.12 111.678 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 13.1 pt-20 -59.56 -37.39 78.33 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.824 0.345 . . . . 70.41 111.027 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -56.92 -39.89 75.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.187 0.518 . . . . 74.1 110.834 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -80.67 -26.41 37.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.249 -0.432 . . . . 72.4 111.61 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 37.9 mtm180 -66.85 -17.95 65.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.798 0.333 . . . . 74.33 111.139 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.47 -23.09 65.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.311 0.485 . . . . 74.23 112.311 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.84 -52.05 0.02 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.312 -0.947 . . . . 73.23 114.276 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.76 -36.92 39.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.634 0.605 . . . . 72.5 112.634 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.33 104.39 3.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.016 0.436 . . . . 65.31 110.881 176.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -95.2 138.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.881 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.54 134.39 56.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.068 0.461 . . . . 72.41 111.899 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -35.85 1.72 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.449 -0.405 . . . . 53.25 113.894 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.5 t -84.64 -53.23 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.333 0.494 . . . . 63.21 112.333 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.38 -15.13 14.31 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.561 0.578 . . . . 72.53 112.561 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.78 152.06 35.89 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.469 -0.145 . . . . 73.01 110.637 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 8.0 mtpm? -125.69 141.29 52.09 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.094 0.473 . . . . 70.5 111.993 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -84.93 111.86 20.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.879 -0.601 . . . . 73.42 111.187 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.5 t . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.142 0.496 . . . . 70.13 111.934 -179.274 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.033 0.444 . . . . 74.13 111.103 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -97.8 101.16 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.807 0.337 . . . . 73.22 111.827 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -89.15 138.47 31.39 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.574 -0.285 . . . . 72.4 110.278 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.13 134.95 43.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.063 0.459 . . . . 72.1 111.794 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 63' ' ' ILE . 1.4 m-20 -76.93 94.23 3.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.941 -0.572 . . . . 44.21 111.815 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 78.6 t80 -52.37 -48.96 87.88 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.214 0.82 . . . . 65.12 113.214 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 13.1 Cg_endo -55.0 -42.15 71.98 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.985 1.79 . . . . 72.21 112.635 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 60.4 mm-40 -64.73 -41.06 96.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.019 0.438 . . . . 74.11 111.271 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.0 mt -66.54 -45.34 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.272 -0.422 . . . . 53.22 111.301 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -58.09 -44.05 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.214 0.53 . . . . 64.02 110.552 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -54.69 -38.66 67.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.793 -0.64 . . . . 75.01 111.205 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -71.62 -43.63 65.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.172 -0.467 . . . . 72.53 111.024 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 63' ' ' ILE . 77.7 mt . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.394 -0.366 . . . . 72.41 111.25 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 4.3 mp0 . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 120.89 0.376 . . . . 71.21 110.676 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -102.69 129.82 49.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.486 -0.325 . . . . 73.55 110.968 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.2 pmm? -145.92 162.55 37.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.747 0.308 . . . . 74.1 111.266 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.4 162.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.425 -0.352 . . . . 61.13 111.512 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 42.9 tt0 -50.29 -44.92 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.284 0.476 . . . . 65.22 112.284 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -58.41 -44.54 89.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.4 -0.364 . . . . 54.35 111.263 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.21 -34.23 65.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.149 0.5 . . . . 71.2 111.336 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -49.99 75.28 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.966 -0.561 . . . . 74.43 110.871 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.02 -28.86 69.35 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.753 0.311 . . . . 74.31 111.699 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 14' ' ' LYS . 62.2 t -73.85 -38.13 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.048 0.452 . . . . 72.22 111.219 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.1 mmm180 -78.08 -24.41 47.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.986 0.365 . . . . 75.2 111.986 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 22' ' ' LEU . 67.1 p -104.67 -30.21 10.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.85 0.685 . . . . 52.25 112.85 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.78 10.0 60.58 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.258 -0.496 . . . . 62.23 113.208 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.2 mp -83.73 167.82 16.82 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.197 0.522 . . . . 70.1 112.147 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.54 159.34 14.55 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.214 -0.448 . . . . 74.23 112.787 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.1 -46.51 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.851 0.686 . . . . 63.33 112.851 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 20.8 ttm180 -75.59 -35.34 60.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.796 0.331 . . . . 75.25 111.469 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -61.92 -40.78 96.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.156 0.503 . . . . 75.41 110.562 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.56 -48.7 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.075 -0.512 . . . . 75.54 111.593 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 14.2 pt-20 -63.9 -23.19 67.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.186 -0.321 . . . . 60.23 111.324 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -67.08 -49.23 65.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.089 0.471 . . . . 72.1 110.322 172.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.161 0.505 . . . . 74.25 111.092 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 48.9 mtp180 -61.94 -13.4 24.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.822 -0.627 . . . . 70.23 111.824 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.53 12.27 37.67 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 111.747 0.277 . . . . 71.41 111.747 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.11 -78.2 0.03 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.461 -0.876 . . . . 61.33 114.157 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.36 67.47 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.007 0.743 . . . . 43.05 113.007 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.562 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 112.23 7.94 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.472 0.653 . . . . 73.31 112.066 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 64.8 mt -105.83 134.5 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.457 -0.792 . . . . 73.02 110.447 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.2 133.01 53.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 74.01 111.131 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.31 -32.05 3.39 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.536 -0.364 . . . . 73.1 113.648 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 47.2 t -97.18 -41.09 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.573 0.582 . . . . 62.13 112.573 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 21.8 m170 -112.18 -5.43 14.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.184 0.438 . . . . 63.51 112.184 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -170.94 164.59 7.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.606 0.225 . . . . 73.44 111.606 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -149.47 161.81 41.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.951 0.405 . . . . 72.21 111.128 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mmm-85 -87.62 118.32 27.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.311 -0.404 . . . . 75.32 111.463 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.7 t . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 120.768 0.318 . . . . 72.21 111.158 177.336 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.135 0.493 . . . . 73.5 111.702 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.8 m -83.59 105.43 14.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.191 -0.459 . . . . 62.35 111.908 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -89.35 152.69 21.38 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.485 -0.325 . . . . 71.43 110.462 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.403 ' HE2' ' HB2' ' A' ' 13' ' ' GLU . 85.5 m-85 -113.4 149.62 33.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.993 0.738 . . . . 72.31 112.993 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 63' ' ' ILE . 16.3 m120 -77.16 93.66 3.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.696 -0.684 . . . . 70.43 111.73 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.584 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.2 t80 -55.25 -47.03 99.51 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.431 0.53 . . . . 74.23 112.431 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 7.7 Cg_endo -49.07 -48.57 17.87 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.382 2.055 . . . . 63.34 113.212 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 29.0 mm-40 -74.22 -34.67 63.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.583 0.586 . . . . 64.53 112.583 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 59' ' ' ASN . 77.8 mt -67.37 -43.05 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.147 0.499 . . . . 63.14 110.54 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.78 -41.85 99.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.022 -0.536 . . . . 55.42 110.358 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -46.81 77.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.793 -0.639 . . . . 71.32 111.097 174.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.98 -51.84 68.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.056 -0.52 . . . . 65.22 111.272 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 116.294 -0.412 . . . . 73.11 111.624 179.299 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.7 mt-10 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.745 0.307 . . . . 55.2 110.637 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.469 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 68.2 m95 -102.26 114.38 28.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.506 -0.315 . . . . 72.12 110.909 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ptp -135.58 153.13 51.77 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.07 0.396 . . . . 53.21 112.07 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -80.58 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.321 0.489 . . . . 74.22 112.321 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -50.32 -57.25 8.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.95 0.722 . . . . 74.33 112.95 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.4 tmmt? -56.34 -40.67 74.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -38.45 68.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 64.1 111.161 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.78 -46.56 87.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.78 -0.645 . . . . 61.34 111.512 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 24.5 ptp -56.99 -36.23 70.12 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.982 0.42 . . . . 71.43 111.533 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 t -76.01 -40.56 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.123 0.487 . . . . 52.2 111.273 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.0 mmp_? -74.29 -21.4 59.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.681 0.623 . . . . 52.35 112.681 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.5 p -108.38 -30.68 8.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.72 0.637 . . . . 73.52 112.72 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.23 1.12 56.94 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.146 -0.549 . . . . 30.23 112.858 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.39 172.09 14.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.981 0.42 . . . . 73.53 111.479 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.0 161.06 12.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.335 -0.46 . . . . 44.43 112.267 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.24 62.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.01 0.374 . . . . 61.44 112.01 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -63.85 -24.87 67.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.915 0.388 . . . . 64.25 111.694 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 45.9 tt0 -84.11 -41.2 17.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.905 0.383 . . . . 75.01 110.763 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.64 -52.32 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.929 0.395 . . . . 74.33 111.405 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.01 -32.16 67.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.583 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.07 -43.76 98.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.008 0.432 . . . . 72.33 110.716 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 24.9 m-85 -70.9 -27.68 63.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.439 -0.346 . . . . 74.14 111.768 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.7 mtm180 -66.69 -10.3 45.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.798 0.332 . . . . 75.3 111.868 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -85.34 -9.59 57.42 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.077 0.399 . . . . 74.35 112.077 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.88 -48.04 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.255 -0.974 . . . . 70.0 114.497 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.409 0.522 . . . . 74.42 112.409 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 145.8 48.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.037 0.446 . . . . 73.43 111.108 177.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.56 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 78.6 mt -139.45 132.24 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 116.265 -0.425 . . . . 73.3 111.272 -173.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.37 134.06 53.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.1 0.476 . . . . 72.11 111.926 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.44 -55.42 4.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.464 -0.398 . . . . 51.33 113.306 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -70.08 -62.94 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.073 0.397 . . . . 72.03 112.073 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.56 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.7 m80 -95.15 -8.03 37.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.667 0.618 . . . . 74.32 112.667 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -164.61 155.78 15.18 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.694 0.283 . . . . 74.25 111.493 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -123.53 157.33 33.85 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.95 0.405 . . . . 74.11 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -104.61 116.18 31.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.986 0.422 . . . . 75.21 111.453 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.992 0.425 . . . . 54.31 111.615 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 120.717 0.294 . . . . 72.44 111.045 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -102.41 115.01 29.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.989 0.423 . . . . 73.31 111.556 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 64.5 m95 -98.7 130.27 45.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.271 -0.422 . . . . 61.35 110.95 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 5.6 m-85 -88.29 145.01 26.08 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.963 0.411 . . . . 75.42 111.859 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t-20 -84.44 98.85 10.31 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.048 -0.523 . . . . 55.4 110.713 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 76.7 t80 -55.37 -51.61 78.43 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 112.596 0.591 . . . . 75.11 112.596 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 85.5 Cg_exo -48.45 -42.91 34.13 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.372 2.048 . . . . 52.45 113.437 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.97 -40.28 87.43 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.957 0.408 . . . . 75.22 111.517 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 58' ' ' TYR . 74.4 mt -65.99 -32.98 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.91 0.386 . . . . 71.34 110.768 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -60.47 -43.45 96.91 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.345 0.593 . . . . 64.41 110.306 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.8 -25.88 67.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.973 -0.558 . . . . 63.0 111.385 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.98 -52.86 15.04 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 72.1 110.622 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.472 0.644 0 CA-C-N 116.12 -0.491 . . . . 70.33 111.147 177.559 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.027 0.441 . . . . 75.51 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -78.87 123.54 27.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.139 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.543 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.2 ptp -151.8 165.53 34.19 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.762 0.653 . . . . 44.41 112.762 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -82.77 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.088 -0.505 . . . . 75.51 110.964 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 27.2 tt0 -65.69 -39.22 91.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.839 0.311 . . . . 72.22 111.839 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -56.54 -45.67 81.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.132 0.492 . . . . 70.45 110.497 178.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -68.52 -42.21 78.85 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.191 0.519 . . . . 72.53 111.069 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.28 -47.28 78.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.931 -0.577 . . . . 64.21 111.36 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 22.8 ptp -64.61 -29.33 70.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.829 0.347 . . . . 63.2 111.483 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 14' ' ' LYS . 75.6 t -73.54 -40.43 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.015 0.436 . . . . 71.51 111.494 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.543 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.2 mmt85 -71.65 -39.74 70.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.098 0.475 . . . . 71.41 112.109 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.6 p -92.98 -30.53 15.29 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.585 0.587 . . . . 74.11 112.585 -173.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.64 -0.69 70.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.927 -0.654 . . . . 74.31 112.867 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 20' ' ' THR . 10.6 mp -73.5 156.56 38.06 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.013 0.435 . . . . 74.14 111.365 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 162.4 16.58 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.299 -0.477 . . . . 72.22 112.336 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -41.37 82.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.845 0.355 . . . . 64.2 111.363 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.87 -31.7 65.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.139 0.495 . . . . 64.52 111.483 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -83.81 -43.25 15.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.102 -0.499 . . . . 71.0 110.819 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.92 -46.73 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.213 -0.449 . . . . 64.41 111.667 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.28 -34.11 71.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.911 0.386 . . . . 63.44 111.298 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -66.67 -33.97 76.82 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.107 0.479 . . . . 74.34 110.809 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -76.79 -33.82 58.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.077 -0.511 . . . . 75.53 112.036 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.632 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 20.7 mtt180 -56.06 -34.78 66.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.269 0.557 . . . . 73.43 111.818 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -77.97 0.02 25.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.082 0.771 . . . . 74.25 113.082 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.7 -56.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.525 -0.845 . . . . 70.31 113.791 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.06 -37.69 78.66 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.81 0.67 . . . . 50.01 112.81 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.632 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.11 108.83 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.971 0.415 . . . . 75.43 111.469 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -108.38 123.42 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.138 -0.483 . . . . 75.41 110.706 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.02 152.0 44.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.82 0.343 . . . . 71.44 111.302 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -38.44 1.8 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.109 -0.567 . . . . 75.34 112.982 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 40.7 t -89.48 -65.91 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 111.87 0.322 . . . . 74.31 111.87 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.424 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 5.4 m-70 -98.29 -14.63 20.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.094 0.776 . . . . 74.12 113.094 -174.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 34.4 p90 -159.64 171.89 18.78 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.075 -0.39 . . . . 70.23 111.797 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -150.49 143.97 25.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.343 0.592 . . . . 75.01 111.556 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.8 139.48 30.41 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 70.45 111.569 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.102 0.477 . . . . 74.54 112.208 -178.424 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.157 0.503 . . . . 73.44 112.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 m -91.94 118.48 30.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.278 -0.419 . . . . 73.43 111.136 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -94.27 144.56 25.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.804 0.335 . . . . 74.11 111.18 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 63' ' ' ILE . 68.5 m-85 -112.13 142.07 45.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.072 0.463 . . . . 75.2 111.882 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.05 97.85 8.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.701 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 41.0 t80 -49.91 -50.9 65.58 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 112.788 0.662 . . . . 73.31 112.788 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 71.3 Cg_exo -51.46 -46.18 33.09 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.244 1.962 . . . . 72.11 112.948 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 58.4 mm-40 -64.25 -41.18 97.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.091 0.404 . . . . 72.13 112.091 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -67.93 -45.35 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.606 -0.27 . . . . 63.14 111.203 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.14 -35.32 75.02 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.287 0.565 . . . . 75.35 110.576 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.56 -33.65 76.4 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.796 -0.638 . . . . 73.14 111.277 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.07 -44.13 20.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.345 -0.388 . . . . 73.43 111.994 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' ILE . 75.5 mt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.235 0.457 . . . . 74.3 112.235 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 74.15 111.703 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -94.12 121.85 36.04 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.881 -0.414 . . . . 71.05 109.881 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.76 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 19.9 ptp -138.9 147.16 41.98 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.31 0.485 . . . . 74.51 112.31 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.34 165.43 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.943 0.401 . . . . 74.14 111.972 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.97 -42.73 80.69 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.239 -0.437 . . . . 73.23 111.724 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -59.15 -42.11 89.91 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.214 -0.448 . . . . 70.54 111.262 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.1 -37.55 66.69 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.191 0.519 . . . . 74.13 111.279 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.27 -47.02 84.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.84 -0.618 . . . . 72.41 111.616 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.9 ptp -59.34 -32.27 69.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.927 0.394 . . . . 64.3 111.405 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 14' ' ' LYS . 58.5 t -72.71 -32.67 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.073 0.463 . . . . 54.04 111.267 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.5 mmt85 -76.55 -43.22 40.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.463 0.542 . . . . 70.51 112.463 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.33 -27.09 16.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.981 0.734 . . . . 73.31 112.981 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.11 64.58 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.946 -0.645 . . . . 72.52 113.206 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mp -79.66 166.91 21.35 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.084 0.468 . . . . 72.42 111.514 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.92 164.18 14.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.212 -0.449 . . . . 63.24 112.421 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.48 -42.23 70.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.012 0.375 . . . . 74.33 112.012 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -62.47 -33.69 75.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.057 0.456 . . . . 72.23 111.231 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.42 -48.25 42.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.425 -0.352 . . . . 70.4 111.419 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.2 mt -57.14 -50.84 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.86 0.362 . . . . 71.34 111.313 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.764 0.316 . . . . 64.41 111.469 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.2 t -63.33 -39.21 93.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.943 0.402 . . . . 74.01 111.164 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.65 -16.74 55.22 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.976 0.417 . . . . 73.12 111.51 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.695 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 58.8 mtp180 -68.88 -10.93 59.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.781 0.324 . . . . 75.12 111.815 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -83.02 2.69 33.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 111.764 0.283 . . . . 62.11 111.764 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.01 -61.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.66 -0.781 . . . . 71.33 114.115 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.21 95.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.957 0.725 . . . . 63.13 112.957 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.695 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -71.71 104.43 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.038 -0.414 . . . . 74.41 111.073 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 62.2 mt -89.89 121.5 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.509 -0.314 . . . . 75.21 111.23 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -59.86 131.63 51.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.904 0.383 . . . . 61.42 110.34 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.752 ' HA2' ' HZ1' ' A' ' 42' ' ' LYS . . . 92.12 -31.85 5.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.541 -0.361 . . . . 43.51 113.201 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 46.4 t -101.88 -72.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.654 -0.321 . . . . 71.24 111.391 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -77.42 -7.57 56.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.958 0.355 . . . . 71.2 111.958 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 33.3 p90 -171.84 167.56 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.617 0.367 . . . . 72.01 110.773 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.752 ' HZ1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -154.02 136.54 15.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.493 0.663 . . . . 71.32 111.568 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 61.6 mtp180 -80.62 102.56 9.9 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.264 -0.88 . . . . 62.44 110.258 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 115.796 -0.638 . . . . 74.51 112.523 -173.808 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 110.237 -0.283 . . . . 73.25 110.237 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -84.5 110.32 18.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.383 0.512 . . . . 65.41 112.383 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -98.59 126.87 44.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.114 -0.494 . . . . 73.44 110.272 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HB3' HD11 ' A' ' 63' ' ' ILE . 84.5 m-85 -93.33 144.75 25.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.919 0.341 . . . . 51.04 111.919 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 62' ' ' GLU . 59.1 t30 -82.64 94.47 7.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 71.04 111.049 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.523 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 70.7 t80 -51.38 -53.31 50.9 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 113.299 0.852 . . . . 73.45 113.299 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -49.66 -36.86 42.47 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.274 1.982 . . . . 74.13 113.219 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 22.2 mt-10 -81.43 -29.5 33.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.754 0.65 . . . . 73.42 112.754 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.492 ' O ' HG13 ' A' ' 67' ' ' ILE . 64.7 mt -70.46 -38.78 75.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.956 -0.465 . . . . 73.54 110.706 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -62.42 -39.08 92.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.191 0.519 . . . . 74.23 110.495 169.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 59.9 tttp -56.78 -37.16 70.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.883 -0.598 . . . . 61.31 110.877 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -72.17 -41.25 67.26 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.869 0.366 . . . . 71.25 111.031 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 63' ' ' ILE . 67.8 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-N 116.481 -0.327 . . . . 74.41 111.267 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 60' ' ' TYR . 9.2 tp10 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 110.027 -0.36 . . . . 70.53 110.027 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -119.83 143.2 48.01 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.272 -0.268 . . . . 75.22 111.093 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.604 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.8 ptp -164.7 171.88 13.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.657 0.614 . . . . 73.02 112.657 -176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.87 -179.99 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.977 -0.556 . . . . 34.33 111.335 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.88 -58.08 9.71 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.532 0.568 . . . . 52.43 112.532 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -61.92 -29.13 70.02 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.49 -0.323 . . . . 60.24 111.619 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.67 -37.02 42.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.238 0.542 . . . . 54.14 111.158 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.5 -49.92 74.82 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.78 -0.646 . . . . 72.31 111.019 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -55.95 -36.03 67.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.025 0.379 . . . . 74.11 112.025 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.1 t -65.75 -43.46 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.194 0.442 . . . . 75.44 112.194 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -85.23 -18.63 33.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.096 0.406 . . . . 70.24 112.096 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.9 p -100.58 -26.98 13.65 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.331 0.493 . . . . 63.13 112.331 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.81 24.8 29.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.091 -0.576 . . . . 72.13 113.176 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.6 mp -102.49 -178.86 3.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.211 0.529 . . . . 75.52 111.654 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.2 163.41 21.78 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.902 -0.59 . . . . 72.42 111.987 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.51 -46.1 77.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.096 0.448 . . . . 64.31 112.162 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 2.3 tmt_? -64.12 -34.41 77.98 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.115 0.483 . . . . 72.13 110.749 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.13 -42.4 69.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.918 0.389 . . . . 72.25 110.927 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.36 -50.48 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.357 -0.383 . . . . 74.43 111.793 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.97 -30.52 66.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.889 0.376 . . . . 74.41 111.146 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 t -62.44 -38.97 91.84 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.305 -0.407 . . . . 71.31 111.195 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -75.32 -31.11 60.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.46 -0.336 . . . . 61.45 111.67 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 21.4 mtm180 -64.88 -11.17 34.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.185 0.439 . . . . 74.31 112.185 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.23 11.01 24.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.424 -0.353 . . . . 74.14 111.926 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.53 -50.65 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.329 -0.939 . . . . 63.14 114.433 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.21 80.09 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.605 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.07 123.49 22.94 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.907 0.384 . . . . 62.03 111.145 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.84 132.67 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.37 -0.377 . . . . 74.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.23 146.63 47.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.864 0.364 . . . . 53.11 111.596 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 -53.66 2.99 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.39 -0.368 . . . . 73.13 112.638 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG12 ' ND1' ' A' ' 40' ' ' HIS . 46.3 t -70.85 -65.8 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.413 0.523 . . . . 43.41 112.413 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.412 ' ND1' HG12 ' A' ' 39' ' ' VAL . 3.1 m-70 -96.74 -16.96 20.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.932 0.716 . . . . 62.22 112.932 -175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 36.5 p90 -161.41 174.81 12.93 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.389 -0.195 . . . . 74.41 111.154 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.43 154.4 26.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.084 0.469 . . . . 72.51 112.099 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -79.43 122.9 26.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.217 -0.447 . . . . 74.13 112.173 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.204 0.526 . . . . 75.35 110.872 174.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.94 0.4 . . . . 55.24 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -96.76 105.52 17.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.254 0.464 . . . . 73.24 112.254 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -86.0 152.03 23.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.328 -0.396 . . . . 74.2 110.905 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 41.3 m-85 -117.14 146.24 43.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.121 0.486 . . . . 75.02 111.829 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.54 108.78 19.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.986 -0.552 . . . . 54.55 110.915 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 81.9 t80 -56.79 -48.73 96.79 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.931 0.715 . . . . 65.31 112.931 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 18.0 Cg_endo -58.33 -33.45 97.74 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.9 1.733 . . . . 64.14 112.681 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -69.54 -48.2 61.18 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.155 -0.475 . . . . 62.44 111.12 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 69.7 mt -65.71 -36.86 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.023 0.44 . . . . 65.01 111.152 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.66 -37.06 82.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.585 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.6 -38.65 85.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.094 -0.503 . . . . 72.42 110.936 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -66.45 -53.53 34.36 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.008 -0.542 . . . . 74.15 111.062 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 120.884 0.373 . . . . 65.4 111.451 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.954 0.407 . . . . 75.32 111.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.495 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 95.7 m95 -85.68 136.45 33.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.296 -0.411 . . . . 74.24 110.472 173.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.581 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.0 ptp -153.89 154.86 34.64 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.978 0.418 . . . . 75.33 111.73 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 15' ' ' ALA . 34.4 m -71.29 166.27 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.889 0.376 . . . . 73.14 111.415 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.86 -44.01 86.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.016 0.436 . . . . 75.23 111.986 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -63.71 -32.94 74.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.293 -0.412 . . . . 71.33 111.527 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -78.21 -35.94 47.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.041 0.448 . . . . 73.22 111.149 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.32 -46.21 87.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.838 -0.619 . . . . 53.24 111.003 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.501 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.2 ptp -59.87 -34.29 72.95 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.723 0.296 . . . . 72.23 111.488 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 14' ' ' LYS . 66.9 t -69.18 -40.29 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.881 0.372 . . . . 74.32 111.209 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 12.2 mmt85 -66.15 -44.66 83.48 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.996 0.427 . . . . 75.03 112.099 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 p -93.79 -25.15 17.51 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.034 0.753 . . . . 71.31 113.034 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.23 64.51 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.211 -0.518 . . . . 74.2 113.186 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' HG ' ' NE2' ' A' ' 26' ' ' GLN . 9.0 mp -74.66 173.41 10.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.367 0.603 . . . . 54.52 112.167 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.85 170.35 17.73 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.086 -0.506 . . . . 42.41 112.317 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.8 66.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.212 0.449 . . . . 50.05 112.212 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -64.82 -29.43 70.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.865 0.365 . . . . 72.53 111.961 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 47.9 tt0 -76.97 -42.67 38.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.972 0.415 . . . . 72.12 110.839 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 63.0 mt -63.72 -49.03 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.584 -0.28 . . . . 74.03 111.683 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.25 -35.03 59.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.771 0.319 . . . . 75.13 111.38 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 t -63.06 -50.7 69.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 54.41 110.69 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.72 -35.63 74.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.027 -0.533 . . . . 73.54 111.412 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 50.1 mtp180 -62.13 -19.98 63.6 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 74.2 111.44 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.97 -8.54 14.83 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.392 -0.367 . . . . 70.2 111.989 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.6 41.62 0.97 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.81 -0.71 . . . . 65.1 114.109 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.33 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.293 0.568 . . . . 71.5 111.377 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.39 141.91 48.71 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.458 0.646 . . . . 72.43 112.14 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.3 mt -138.65 135.13 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.573 -0.74 . . . . 72.54 110.236 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.47 130.62 45.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.094 0.473 . . . . 73.15 112.062 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.67 -26.68 1.64 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.352 -0.385 . . . . 63.4 113.946 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.2 t -94.91 -40.35 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.292 -0.534 . . . . 74.33 112.238 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.507 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 48.5 m80 -121.52 -9.72 8.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.425 0.528 . . . . 72.0 112.425 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -165.04 159.25 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.866 0.365 . . . . 73.21 111.831 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 55.8 pttt -153.82 153.35 31.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.029 0.443 . . . . 63.51 111.422 174.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.39 141.57 45.09 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.93 170.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 120.797 0.332 . . . . 74.53 111.083 177.637 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.35 0.119 . . . . 74.31 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.1 m -102.93 121.75 43.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.188 0.44 . . . . 73.43 112.188 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -107.85 146.53 32.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.604 176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 23.2 m-85 -106.85 154.06 21.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.791 0.663 . . . . 75.01 112.791 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.64 101.67 12.34 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.651 -0.704 . . . . 63.02 111.925 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 80.3 t80 -51.61 -50.85 74.77 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 112.762 0.653 . . . . 70.21 112.762 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.2 Cg_endo -56.13 -53.53 5.28 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.159 1.906 . . . . 74.42 113.273 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -64.81 -23.62 67.3 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.594 0.59 . . . . 61.13 112.594 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 75.9 mt -82.09 -46.32 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.052 -0.405 . . . . 63.41 111.379 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.17 -40.95 82.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.512 0.673 . . . . 65.51 109.973 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -52.81 -48.71 66.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.152 -0.931 . . . . 63.23 111.39 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.77 -37.77 79.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.457 -0.338 . . . . 65.25 111.147 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.863 0.364 . . . . 60.13 111.0 176.054 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.874 0.368 . . . . 51.43 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 82.2 m95 -98.64 118.77 36.1 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.562 -0.29 . . . . 74.1 110.845 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.1 pmm? -133.26 172.37 12.77 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.118 0.485 . . . . 70.14 111.533 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.53 162.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.096 -0.502 . . . . 61.31 111.375 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.54 -42.5 83.03 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.179 0.437 . . . . 73.22 112.179 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -59.55 -37.87 79.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.994 0.426 . . . . 73.33 110.968 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.6 45.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.97 0.414 . . . . 72.02 111.328 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -50.61 73.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.172 -0.467 . . . . 70.34 110.603 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.404 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.6 ptp -58.39 -37.06 74.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.756 0.312 . . . . 71.41 111.803 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.5 t -69.64 -48.22 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 111.829 0.307 . . . . 75.03 111.829 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 19' ' ' ARG . 29.0 mmt180 -69.04 -28.88 66.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.286 0.476 . . . . 73.4 112.286 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.415 HG21 HG21 ' A' ' 63' ' ' ILE . 80.5 p -93.88 -29.25 15.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.489 0.552 . . . . 64.33 112.489 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.86 56.59 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 52.03 112.564 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 26' ' ' GLN . 8.3 mp -82.2 -178.17 6.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.399 0.619 . . . . 75.25 111.627 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' GLN . . . -133.27 171.09 21.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.981 -0.554 . . . . 64.13 111.909 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.83 -51.39 66.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.283 0.475 . . . . 53.51 112.283 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -66.46 -30.01 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.159 0.504 . . . . 63.3 111.504 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.542 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 5.2 tp-100 -66.98 -48.46 68.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.066 0.46 . . . . 75.22 110.918 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 64.5 mt -60.79 -52.09 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.343 -0.39 . . . . 71.42 111.296 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.2 -33.6 69.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.507 0.194 . . . . 74.24 111.409 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -61.23 -37.51 83.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.929 0.395 . . . . 50.32 110.981 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -80.26 -30.07 38.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.894 0.378 . . . . 70.45 111.808 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 67.8 mtp180 -64.13 -15.56 59.99 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.925 0.393 . . . . 75.31 111.854 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -68.08 -22.65 64.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.537 -0.301 . . . . 74.01 111.8 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.48 -45.07 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 120.661 -0.781 . . . . 63.32 114.342 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.75 -31.4 71.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.012 0.745 . . . . 50.25 113.012 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.513 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.18 104.69 3.72 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.455 0.645 . . . . 74.22 111.829 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.92 123.58 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.565 -0.743 . . . . 74.22 111.279 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.22 147.19 48.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.112 0.482 . . . . 72.0 111.395 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.53 -58.92 3.75 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.121 -0.49 . . . . 61.33 113.164 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.81 -56.11 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.439 0.533 . . . . 72.4 112.439 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.461 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 52.9 m80 -92.24 -23.54 19.3 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.501 0.556 . . . . 73.31 112.501 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 15.4 p90 -163.68 149.58 11.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.536 -0.172 . . . . 64.02 110.536 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -147.76 147.57 30.02 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.092 0.472 . . . . 71.22 112.264 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -79.7 117.87 21.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.853 -0.612 . . . . 74.15 111.775 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 120.774 0.321 . . . . 73.43 111.051 176.321 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.859 0.361 . . . . 73.14 111.543 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -91.96 114.88 27.54 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.709 0.29 . . . . 60.43 111.418 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -100.3 144.3 29.47 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.734 -0.212 . . . . 74.41 110.856 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 94.0 m-85 -110.27 144.46 38.94 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.254 0.549 . . . . 64.55 112.135 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 40.6 t-20 -87.86 92.07 8.99 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.801 -0.636 . . . . 74.23 110.943 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 66.0 t80 -46.98 -53.04 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.972 0.73 . . . . 71.51 112.972 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -52.29 -39.19 73.06 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.171 1.914 . . . . 53.32 113.399 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 52.9 mm-40 -72.03 -34.12 68.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.3 0.481 . . . . 74.51 112.3 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 20' ' ' THR . 1.8 mp -71.54 -49.94 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 75.32 110.464 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -54.1 -46.83 72.21 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.151 0.501 . . . . 63.2 110.662 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.87 -46.13 67.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.661 . . . . 53.05 111.536 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -57.2 -50.6 72.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.227 -0.442 . . . . 73.55 111.478 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.861 0.363 . . . . 71.3 111.586 177.179 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 33.2 mt-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.182 0.515 . . . . 73.3 112.355 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 76.3 m95 -94.49 149.44 21.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.778 -0.646 . . . . 65.12 110.606 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.6 ptp -159.05 151.58 21.59 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.032 0.444 . . . . 75.34 111.778 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.33 167.71 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.155 0.428 . . . . 73.44 112.155 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.21 -54.5 46.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.461 0.541 . . . . 74.41 112.461 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -35.48 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.424 -0.353 . . . . 71.45 111.551 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.81 60.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.115 0.484 . . . . 54.14 111.289 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.9 -53.59 56.53 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.812 -0.631 . . . . 44.41 111.046 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.437 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.7 ptp -54.24 -40.34 67.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.846 0.313 . . . . 62.45 111.846 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -70.4 -42.49 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.95 0.405 . . . . 73.44 112.077 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.627 0.603 . . . . 75.3 112.627 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -107.17 -28.45 9.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.929 0.395 . . . . 64.2 111.893 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.88 5.22 59.91 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.233 -0.508 . . . . 72.31 112.715 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.3 mp -82.29 160.9 22.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.197 0.522 . . . . 70.43 111.428 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.89 160.9 13.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.091 -0.576 . . . . 55.13 112.447 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.82 -41.17 61.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.938 0.369 . . . . 71.22 111.861 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 25' ' ' ARG . 8.1 ptp180 -62.56 -32.19 73.12 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.135 0.493 . . . . 73.3 111.612 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.51 -37.8 35.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.003 0.43 . . . . 72.55 111.017 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 17' ' ' MET . 59.3 mt -63.99 -49.36 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.39 -0.368 . . . . 61.33 111.095 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.75 -35.63 76.86 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.858 0.361 . . . . 74.13 110.985 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.6 t -60.75 -37.61 82.4 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 60.24 111.278 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -72.83 -37.82 67.32 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.96 0.41 . . . . 74.11 111.504 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 24.7 mtm180 -65.46 -10.41 33.88 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.228 0.455 . . . . 72.35 112.228 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -59.95 -30.95 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.759 0.281 . . . . 73.52 111.759 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.99 31.94 0.05 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.308 -0.949 . . . . 61.25 114.721 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.12 -24.86 4.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.412 0.606 . . . . 54.23 111.428 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -83.28 129.32 35.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.029 -0.532 . . . . 75.34 111.731 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.9 mt -130.87 137.27 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.697 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.69 153.17 43.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.781 0.324 . . . . 75.04 111.157 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.26 -49.95 3.89 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.487 -0.387 . . . . 53.41 112.496 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.36 -57.49 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 74.41 112.043 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -101.67 -23.76 14.2 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.094 0.776 . . . . 63.24 113.094 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -161.92 172.48 15.95 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.315 -0.24 . . . . 62.4 111.484 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -154.74 160.66 41.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.911 0.386 . . . . 74.0 111.786 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -87.48 137.09 32.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.026 0.441 . . . . 74.11 111.443 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 120.986 0.422 . . . . 73.34 111.777 179.475 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 73.53 110.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -90.44 127.25 36.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.093 0.473 . . . . 44.41 111.952 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 29.0 m95 -104.4 132.8 50.24 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.156 -0.474 . . . . 75.21 110.657 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.525 ' HB3' HD11 ' A' ' 63' ' ' ILE . 52.2 m-85 -104.36 147.01 28.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.88 -176.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -78.78 106.59 10.89 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.837 0.351 . . . . 53.15 111.422 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.1 t80 -53.49 -50.21 84.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 112.701 0.63 . . . . 53.53 112.701 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 21.0 Cg_endo -59.15 -42.82 47.01 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.11 1.873 . . . . 70.21 113.254 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -66.55 -40.12 88.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 111.892 0.33 . . . . 75.43 111.892 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' A' ' 58' ' ' TYR . 67.5 mt -67.87 -41.8 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.707 0.289 . . . . 72.13 110.786 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -60.39 -41.26 93.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.901 0.381 . . . . 72.02 110.744 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.38 -42.59 92.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.075 0.464 . . . . 72.41 110.75 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.0 -38.13 89.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.984 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' ILE . 80.7 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 116.541 -0.299 . . . . 74.24 110.728 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.697 0.284 . . . . 44.14 110.982 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.8 -54.09 5.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.986 0.422 . . . . 65.22 111.03 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -165.91 135.6 3.35 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.056 -0.52 . . . . 73.11 110.829 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.7 mm -72.25 90.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.228 0.537 . . . . 62.31 111.096 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.2 mt -97.05 139.56 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.062 -0.517 . . . . 74.22 110.742 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -109.93 143.52 39.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.94 0.4 . . . . 71.55 111.885 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.68 93.99 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.935 0.397 . . . . 71.44 110.323 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -94.24 27.75 2.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.047 0.451 . . . . 64.12 112.177 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -78.14 55.09 1.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.281 0.562 . . . . 74.14 111.459 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -89.7 128.02 36.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.753 -0.658 . . . . 74.32 109.926 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.591 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.5 ptp -148.55 149.13 31.05 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.881 0.372 . . . . 53.04 111.771 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.85 176.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.249 0.462 . . . . 64.13 112.249 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.34 -57.61 11.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.547 0.573 . . . . 65.04 112.547 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.9 tmmt? -63.7 -34.41 77.81 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.419 -0.355 . . . . 72.33 111.79 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.5 -42.52 74.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.131 0.491 . . . . 75.04 111.128 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.08 -47.73 84.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.918 -0.583 . . . . 64.25 111.451 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.4 ptp -58.76 -32.58 69.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.781 0.324 . . . . 74.31 111.417 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' LYS . 61.4 t -74.39 -41.7 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.1 0.476 . . . . 74.45 111.391 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.591 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 13.2 mmm180 -71.28 -31.93 68.06 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.259 -0.428 . . . . 72.3 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.2 p -95.58 -30.94 13.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.47 0.544 . . . . 73.34 112.47 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.14 55.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.398 -0.43 . . . . 54.13 113.176 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' MET . 8.9 mp -90.11 174.95 7.35 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.194 0.521 . . . . 71.34 112.035 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.23 161.04 13.08 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.143 -0.48 . . . . 45.5 112.443 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.13 -42.77 63.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.528 0.566 . . . . 74.4 112.528 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -62.6 -42.78 99.77 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.098 0.475 . . . . 73.2 111.648 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.77 -36.05 77.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.006 0.431 . . . . 71.51 110.939 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.27 -43.89 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.343 -0.39 . . . . 75.34 111.404 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.25 -38.93 93.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.787 0.327 . . . . 63.41 110.489 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -60.38 -40.49 91.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 71.24 110.713 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 12.3 m-85 -66.12 -34.97 79.26 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.316 -0.402 . . . . 63.12 111.691 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.766 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 23.6 mtm180 -68.42 -21.3 64.67 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.161 0.505 . . . . 73.31 111.246 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.89 13.47 5.9 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.024 -0.535 . . . . 70.24 110.738 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.8 -81.89 0.04 OUTLIER Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.229 -0.51 . . . . 64.52 114.185 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.01 -34.52 43.94 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.145 1.165 . . . . 31.04 114.145 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.766 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -71.53 104.09 3.17 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.818 -0.551 . . . . 75.33 110.861 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -102.03 129.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 60.45 111.744 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -64.92 132.64 49.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.354 -0.385 . . . . 74.4 110.802 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.16 -24.86 19.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.271 -0.49 . . . . 52.23 112.929 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.23 -70.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 122.472 -0.429 . . . . 74.24 111.892 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -85.66 -12.72 50.6 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.185 0.439 . . . . 74.45 112.185 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 35' ' ' TRP . 52.9 p90 -158.99 169.32 24.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.728 0.27 . . . . 73.55 111.728 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -141.98 172.1 13.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.782 0.325 . . . . 73.23 111.158 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -105.39 109.83 21.96 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.281 0.475 . . . . 74.2 112.281 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 91.7 t -107.73 107.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 51.1 111.647 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.642 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 53.9 m -89.36 149.81 43.43 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.128 -0.487 . . . . 61.24 111.539 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.06 26.04 0.18 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.019 2.48 . . . . 72.31 113.136 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 45' ' ' SER . 42.9 t -158.64 -179.6 8.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.355 0.662 . . . . 61.2 109.849 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.11 -21.71 34.82 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.787 -0.721 . . . . 74.14 113.437 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -92.06 179.01 5.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.656 0.741 . . . . 75.34 112.839 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.42 111.84 10.0 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.38 -0.827 . . . . 73.45 112.012 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 p -134.48 142.69 47.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.471 -0.332 . . . . 72.23 110.964 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.7 mm? -80.19 -6.42 57.77 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.287 0.565 . . . . 60.21 110.968 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -82.15 8.65 10.35 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.058 -0.519 . . . . 75.52 111.341 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 45' ' ' SER . . . -66.08 114.13 6.31 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.445 -0.343 . . . . 73.52 113.593 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 m -66.83 135.8 54.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.842 0.353 . . . . 71.2 111.482 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -92.69 119.95 32.61 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.067 0.46 . . . . 71.53 112.144 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 44' ' ' VAL . 37.2 m95 -103.78 123.68 47.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.578 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.11 150.88 19.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 65.01 111.927 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -92.42 112.17 24.01 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.195 -0.457 . . . . 75.1 111.905 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 65.4 t80 -56.25 -50.12 89.36 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 112.498 0.555 . . . . 75.22 112.498 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 50.1 Cg_exo -55.75 -41.56 76.26 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.198 1.932 . . . . 61.25 113.02 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -62.03 -44.99 95.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.48 0.657 . . . . 74.3 111.628 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.486 HD12 HD21 ' A' ' 16' ' ' LEU . 87.2 mt -69.1 -47.81 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.683 -0.69 . . . . 71.51 111.776 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.3 -31.94 69.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.775 0.322 . . . . 71.53 111.365 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -42.49 91.33 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.101 0.477 . . . . 60.24 110.011 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.8 -54.99 22.45 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.424 -0.353 . . . . 74.25 111.22 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -53.39 -34.13 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 63.41 111.421 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -50.71 -31.47 16.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.844 -0.616 . . . . 74.22 111.922 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.89 -41.72 92.23 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.912 0.387 . . . . 71.04 111.479 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.562 -0.29 . . . . 64.31 111.487 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.53 -43.81 88.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.344 0.592 . . . . 74.44 110.685 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -79.97 61.19 3.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.889 -0.596 . . . . 55.41 109.927 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -48.38 106.89 0.11 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.89 -0.595 . . . . 74.22 112.497 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -133.44 131.02 39.44 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.039 0.447 . . . . 71.21 111.292 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -64.71 90.33 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.125 -0.489 . . . . 64.04 111.141 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -91.53 -25.03 19.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.097 -0.501 . . . . 75.2 112.124 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -107.4 117.53 34.32 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.297 -0.252 . . . . 65.11 110.91 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.3 p80 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.66 -0.686 . . . . 74.11 112.596 -178.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.06 0.457 . . . . 74.15 112.038 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.1 139.37 34.02 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.213 -0.448 . . . . 71.31 110.527 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -119.7 124.35 46.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.941 0.401 . . . . 72.34 111.484 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 7' ' ' ASN . 46.7 mm -71.64 90.59 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.288 0.566 . . . . 71.15 112.024 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -97.81 92.9 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 116.364 -0.38 . . . . 71.2 110.839 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 54.8 25.09 6.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.21 0.529 . . . . 61.23 111.665 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.706 ' HB3' HG23 ' A' ' 4' ' ' ILE . 4.1 t-20 -71.25 -33.64 70.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.949 -0.568 . . . . 53.44 111.486 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -78.05 87.75 4.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.182 0.515 . . . . 73.42 111.552 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 8.8 tp10 -89.45 84.95 6.43 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.932 -0.576 . . . . 74.44 110.856 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.466 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 93.7 m95 -93.57 146.09 24.06 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.074 -0.512 . . . . 71.51 111.241 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.7 ptp -160.73 159.62 30.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.937 0.399 . . . . 74.35 112.01 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.14 163.39 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.535 -0.302 . . . . 64.53 111.478 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -52.48 -47.19 66.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.326 0.491 . . . . 73.34 112.326 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -60.82 -32.05 71.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.356 -0.383 . . . . 61.4 111.31 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.61 24.83 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.034 0.445 . . . . 55.01 111.36 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -59.28 -50.61 73.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.892 -0.594 . . . . 65.44 111.05 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.6 ptp -58.27 -35.53 71.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.081 0.467 . . . . 63.41 111.481 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.4 t -72.42 -31.35 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 111.941 0.348 . . . . 65.24 111.941 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.1 -31.9 20.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.38 0.511 . . . . 73.33 112.38 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.36 -30.65 15.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.886 0.699 . . . . 70.42 112.886 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.19 4.93 62.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.887 -0.673 . . . . 53.42 113.267 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' MET . 11.0 mp -80.74 154.47 27.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.101 0.477 . . . . 75.42 111.31 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.99 165.11 25.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.053 -0.594 . . . . 55.32 112.998 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.79 -47.79 64.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.17 0.433 . . . . 74.55 112.17 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -64.95 -27.43 68.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.773 0.32 . . . . 70.54 111.811 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -67.91 -56.89 7.37 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.197 0.522 . . . . 72.42 111.099 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.36 -50.76 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.85 -0.614 . . . . 64.12 112.112 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 pt-20 -53.63 -39.76 65.23 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.852 0.316 . . . . 64.34 111.852 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -69.81 -43.45 72.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.927 0.394 . . . . 51.24 111.249 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -67.17 -28.51 68.17 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.829 0.347 . . . . 73.34 111.432 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 49.1 mtp180 -58.77 -26.8 64.38 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.192 0.441 . . . . 74.04 112.192 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -97.14 10.69 38.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.337 0.495 . . . . 52.13 112.337 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.99 -53.89 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.438 -0.887 . . . . 72.14 114.454 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.03 -23.22 31.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.311 -0.523 . . . . 73.02 112.335 -175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.436 ' HE3' ' N ' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.92 139.79 48.9 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.35 0.595 . . . . 74.2 112.151 -177.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.5 mt -134.52 125.98 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.695 -0.684 . . . . 61.3 110.305 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.21 135.88 56.44 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.0 0.429 . . . . 64.21 111.701 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -55.84 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.32 -0.4 . . . . 72.3 113.358 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.99 -46.37 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.533 0.568 . . . . 71.13 112.533 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 1.7 m-70 -110.71 -18.69 13.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.715 0.635 . . . . 70.22 112.715 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 44.1 p90 -156.74 160.85 39.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.374 0.509 . . . . 61.51 112.374 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 22.8 ptmt -148.99 150.86 33.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.847 0.356 . . . . 73.2 111.444 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -90.64 123.9 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.618 0.246 . . . . 53.43 110.811 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -121.07 118.13 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.121 0.415 . . . . 50.45 112.121 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 47.8 t -88.87 132.45 38.27 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.459 -0.337 . . . . 72.32 110.785 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 25.8 Cg_exo -61.55 -75.9 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.759 2.306 . . . . 71.42 113.425 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -118.37 96.88 5.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.831 0.348 . . . . 61.14 111.44 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 51' ' ' THR . . . 81.57 134.17 1.67 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.218 -0.515 . . . . 72.22 112.998 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.6 11.53 2.49 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.003 -0.704 . . . . 53.14 111.936 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -82.95 -3.97 57.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.427 -0.351 . . . . 71.53 111.42 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 48' ' ' GLY . 30.2 p -79.83 164.7 23.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.309 0.576 . . . . 55.55 112.495 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.0 mm? -101.82 3.35 39.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.009 -0.541 . . . . 72.22 110.679 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -105.22 82.63 1.86 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.13 0.49 . . . . 74.52 111.258 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.57 79.91 1.15 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.105 -0.569 . . . . 51.4 112.917 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.4 m -63.68 118.04 7.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.772 0.32 . . . . 73.55 111.742 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -91.78 124.6 36.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.894 0.378 . . . . 73.25 111.763 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.12 148.04 25.88 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.317 -0.401 . . . . 71.23 111.075 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.48 149.51 36.23 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.506 -0.316 . . . . 75.42 111.801 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.48 114.54 25.21 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.27 0.47 . . . . 71.14 112.27 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 89.7 t80 -61.64 -48.83 88.98 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.482 0.549 . . . . 74.02 112.482 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 19.1 Cg_endo -57.59 -33.4 96.52 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.997 1.798 . . . . 63.12 112.644 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.44 -49.03 29.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.143 -0.481 . . . . 72.24 111.235 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 67' ' ' ILE . 72.9 mt -63.41 -32.09 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.354 -0.385 . . . . 72.12 110.937 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -58.71 -42.76 89.39 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.002 0.429 . . . . 61.51 110.515 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -60.73 -43.8 97.44 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 60.2 110.521 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -62.45 -33.21 74.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.315 -0.402 . . . . 73.13 111.708 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 63' ' ' ILE . 68.7 mt -55.39 -38.03 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.898 0.38 . . . . 64.5 110.942 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -62.24 -32.82 73.55 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.25 0.547 . . . . 74.1 110.807 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.95 -40.62 27.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.911 -0.586 . . . . 75.32 111.279 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.6 t -70.66 -22.68 62.46 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.101 -0.499 . . . . 72.12 110.862 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 71' ' ' LEU . 2.0 tm? -63.68 -41.57 98.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.84 -0.618 . . . . 63.23 109.938 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.72 138.9 44.95 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.925 -0.58 . . . . 74.45 110.189 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -127.62 115.27 18.52 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.397 0.517 . . . . 72.31 112.397 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -134.22 22.02 3.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.864 0.364 . . . . 62.12 111.631 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -160.58 102.1 1.35 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.976 0.417 . . . . 74.01 110.864 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -87.45 -1.5 57.97 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.409 0.522 . . . . 73.15 112.409 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -124.54 -62.31 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.996 -0.44 . . . . 70.34 111.469 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--O 1.257 1.468 0 CA-C-O 118.671 -0.681 . . . . 74.34 111.081 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.642 0.258 . . . . 64.41 111.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.16 97.64 8.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.842 0.353 . . . . 70.13 111.755 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -127.59 147.31 50.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.921 0.391 . . . . 74.54 111.521 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.49 86.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.452 0.644 . . . . 70.3 111.424 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.59 128.67 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.833 -0.621 . . . . 72.14 110.908 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -88.76 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 74.22 110.515 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -173.8 142.15 0.88 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.864 -0.607 . . . . 74.52 110.556 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.03 99.93 3.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.599 0.714 . . . . 55.3 110.934 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -99.32 89.77 4.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.507 . . . . 71.22 111.242 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -80.66 120.2 24.27 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.943 -0.571 . . . . 74.33 110.523 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.0 ptp -141.56 153.32 44.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 62.13 111.929 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.56 166.45 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 61.53 111.51 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -51.6 -45.37 63.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.197 0.443 . . . . 75.24 112.197 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -58.52 -50.7 72.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.831 0.348 . . . . 62.42 111.084 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -67.11 -38.03 84.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.067 0.461 . . . . 55.41 111.43 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.542 HD21 HD12 ' A' ' 63' ' ' ILE . 3.3 tm? -60.66 -48.56 81.26 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.974 -0.557 . . . . 72.3 111.406 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.8 ptp -59.43 -32.36 70.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.932 0.396 . . . . 53.03 111.529 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.68 -37.52 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.121 0.486 . . . . 73.24 111.306 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 31.3 mmt180 -76.33 -26.96 56.29 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.888 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.2 p -98.46 -30.85 12.3 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.305 0.483 . . . . 73.04 112.305 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.71 6.58 62.17 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.266 -0.492 . . . . 43.23 113.125 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.4 mp -85.92 160.49 19.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.194 0.521 . . . . 75.15 111.847 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.08 156.75 19.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.27 -0.491 . . . . 71.11 111.997 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.03 59.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.318 0.488 . . . . 74.42 112.318 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -21.67 66.86 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.874 0.369 . . . . 73.43 111.711 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -84.43 -45.42 12.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.224 0.535 . . . . 75.15 110.696 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 51.3 mt -61.11 -49.4 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.992 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.5 pt-20 -57.43 -29.98 64.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.76 0.281 . . . . 61.45 111.76 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 t -62.33 -48.1 81.32 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.182 0.515 . . . . 73.42 110.912 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -71.43 -31.03 66.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.022 -0.535 . . . . 74.41 111.774 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 27.9 mtp-105 -60.85 -19.32 59.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.067 0.395 . . . . 71.03 112.067 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.1 mm-40 -80.9 -14.86 57.63 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.501 0.556 . . . . 72.45 112.501 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.05 -48.44 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.363 -0.922 . . . . 70.41 114.313 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.25 81.34 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.286 -0.538 . . . . 75.05 112.059 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.2 104.95 5.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.069 0.461 . . . . 71.23 110.901 177.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -86.7 135.21 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.298 -0.41 . . . . 61.13 111.69 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.03 139.18 58.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.966 0.412 . . . . 73.32 111.613 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.03 -46.49 2.69 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 116.387 -0.37 . . . . 71.31 113.225 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.51 -60.1 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.35 0.5 . . . . 74.41 112.35 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -91.94 -27.37 17.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.96 0.356 . . . . 70.24 111.96 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 36.1 p90 -152.6 155.92 38.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.693 -0.231 . . . . 72.21 110.663 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.0 165.8 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.094 0.473 . . . . 74.04 112.095 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -82.54 122.24 27.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.956 -0.566 . . . . 73.03 111.525 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.19 119.29 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.094 0.473 . . . . 73.35 111.397 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.6 p -90.03 140.81 27.58 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.382 -0.372 . . . . 75.22 110.955 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.04 24.62 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.485 2.123 . . . . 63.32 113.02 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -169.5 170.78 8.05 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.235 -0.29 . . . . 72.42 111.018 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.88 -18.83 74.69 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.059 -0.591 . . . . 71.21 111.929 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.69 160.66 22.34 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.44 0.638 . . . . 71.1 111.783 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 50' ' ' LYS . 2.6 mppt? -104.0 73.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.715 -0.675 . . . . 71.24 111.047 -173.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -72.54 154.71 40.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.163 -0.472 . . . . 71.33 111.232 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.7 mm? -67.82 -9.66 46.34 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.033 0.383 . . . . 71.23 112.033 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -96.05 92.54 6.49 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.095 0.474 . . . . 74.11 110.598 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.5 107.71 3.57 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.171 -0.538 . . . . 74.53 113.099 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 m -65.86 140.42 58.37 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.696 -0.296 . . . . 71.32 110.714 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -111.67 108.49 17.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.428 0.529 . . . . 73.22 112.428 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -100.84 136.68 40.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.254 -0.43 . . . . 73.44 110.973 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.13 137.46 45.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.297 -0.41 . . . . 70.34 111.629 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 60.7 t30 -88.49 112.7 23.27 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.002 0.429 . . . . 74.13 111.05 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 68.0 t80 -51.1 -54.25 39.79 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.544 0.942 . . . . 75.44 113.544 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 78.4 Cg_exo -51.9 -38.07 67.81 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.133 1.888 . . . . 61.44 113.209 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -65.27 -25.86 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.195 0.442 . . . . 63.52 112.195 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.542 HD12 HD21 ' A' ' 16' ' ' LEU . 66.0 mt -86.52 -37.49 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.583 -0.28 . . . . 73.34 111.33 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.76 -39.77 68.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.36 0.6 . . . . 73.53 110.373 170.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -50.63 -44.48 57.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.499 -0.773 . . . . 75.14 111.016 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.42 -40.63 81.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.783 -0.644 . . . . 73.04 111.491 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 71' ' ' LEU . 62.3 mt -57.21 -36.83 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.384 -0.371 . . . . 74.14 111.778 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HD3' HH11 ' A' ' 68' ' ' ARG . 45.1 ttp180 -82.35 -36.45 26.84 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.15 -0.344 . . . . 73.15 111.248 176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.6 -56.1 26.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.214 0.45 . . . . 74.3 112.214 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.5 m -62.97 -36.21 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.642 0.608 . . . . 71.33 112.642 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 67' ' ' ILE . 8.5 mp -85.37 -24.11 27.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.145 0.424 . . . . 43.4 112.145 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 74' ' ' HIS . 48.3 mt-10 59.47 -80.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.058 0.543 . . . . 73.14 112.432 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.9 p80 45.79 -71.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.418 1.087 . . . . 64.45 113.557 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 72' ' ' GLU . 73.5 t60 -118.62 102.17 8.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.954 -0.466 . . . . 74.33 110.469 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -67.72 92.81 0.35 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.538 0.685 . . . . 53.44 111.442 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -68.95 101.14 1.32 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.53 -0.759 . . . . 63.45 112.223 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -120.48 18.22 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.255 0.55 . . . . 74.21 110.951 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 . . . . . 0 C--O 1.253 1.262 0 CA-C-N 115.995 -0.548 . . . . 74.15 110.809 171.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.538 0.209 . . . . 52.11 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.23 37.41 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.278 0.844 . . . . 74.32 113.278 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -165.39 135.62 3.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.785 -0.643 . . . . 75.41 110.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.93 97.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.294 0.568 . . . . 74.11 111.874 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.404 HG22 ' CD2' ' A' ' 6' ' ' PHE . 41.5 mm -131.02 143.41 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.836 -0.62 . . . . 62.14 110.457 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD2' HG22 ' A' ' 5' ' ' ILE . 51.6 m-85 65.21 26.32 12.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.917 0.487 . . . . 72.04 112.146 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -110.1 12.74 23.43 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.25 0.548 . . . . 72.12 110.8 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.22 104.84 15.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.053 0.454 . . . . 54.14 111.772 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 9.9 tp10 -101.45 121.53 42.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.262 -0.426 . . . . 74.14 110.882 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -122.52 140.42 52.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.608 0.242 . . . . 71.41 111.373 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.679 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 pmm? -158.47 174.42 15.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.13 0.49 . . . . 72.1 111.588 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.35 171.47 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.263 -0.426 . . . . 43.43 110.926 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -58.33 -41.98 85.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.055 0.391 . . . . 74.23 112.055 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -55.56 -48.33 74.93 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.957 0.408 . . . . 61.35 111.055 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.86 -37.53 73.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.941 0.401 . . . . 52.21 111.075 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 63' ' ' ILE . 3.2 tm? -56.97 -48.99 77.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.3 -0.409 . . . . 62.32 111.164 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.9 ptp -62.23 -36.26 81.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.658 0.266 . . . . 74.21 111.236 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 14' ' ' LYS . 64.6 t -69.87 -36.03 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.071 0.462 . . . . 51.34 111.309 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.5 mmt180 -74.47 -37.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.127 -0.488 . . . . 74.45 112.008 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.2 p -93.14 -30.86 15.02 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.602 0.593 . . . . 63.53 112.602 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.02 -3.2 41.04 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.162 -0.542 . . . . 51.22 113.087 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.24 -175.03 4.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.366 0.603 . . . . 64.23 112.226 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.37 169.22 23.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.96 -0.564 . . . . 73.13 112.3 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.31 -49.09 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.557 0.577 . . . . 62.41 112.557 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -63.33 -23.12 67.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.992 0.425 . . . . 74.24 111.424 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -81.74 -53.92 5.81 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.16 0.505 . . . . 75.1 111.079 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.54 -43.1 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.022 -0.535 . . . . 72.51 112.343 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 12.9 pt-20 -58.75 -29.27 66.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.997 0.369 . . . . 74.43 111.997 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -67.86 -36.84 80.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.183 0.516 . . . . 72.11 110.685 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.97 -31.22 56.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.165 -0.47 . . . . 74.23 110.897 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 55.6 mtp180 -59.96 -25.33 65.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 75.15 112.061 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -95.33 12.49 28.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 64.51 111.823 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.54 -85.77 0.06 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.95 -0.643 . . . . 71.51 114.134 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.58 65.98 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.8 0.667 . . . . 71.52 112.8 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.04 104.64 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.531 0.682 . . . . 73.44 111.691 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -103.61 133.34 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.384 -0.825 . . . . 75.53 110.335 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.5 142.04 58.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.917 0.389 . . . . 75.44 110.999 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 -43.62 2.79 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 121.553 -0.356 . . . . 75.44 113.11 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -84.13 -50.86 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.579 0.585 . . . . 62.35 112.579 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -111.49 -18.56 12.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.665 0.616 . . . . 75.03 112.665 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.63 144.33 20.43 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.441 0.163 . . . . 55.21 110.602 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -121.09 156.37 32.42 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.158 0.504 . . . . 74.3 111.962 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.418 HH11 HD13 ' A' ' 52' ' ' LEU . 22.3 ptt180 -95.83 143.43 27.06 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.266 -0.424 . . . . 53.34 111.017 176.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.82 100.62 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.868 0.366 . . . . 63.41 111.545 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.459 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 91.9 p -90.42 110.65 42.38 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.541 -0.3 . . . . 74.13 110.943 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.42 -30.52 91.04 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.796 2.33 . . . . 72.34 113.099 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.4 p -82.75 -13.7 55.83 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.434 -0.348 . . . . 72.33 111.705 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.352 -0.451 . . . . 74.32 113.395 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.48 10.43 8.92 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.598 0.592 . . . . 74.31 112.598 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 73.47 -35.02 0.3 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.597 0.759 . . . . 53.21 112.981 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -63.03 160.56 14.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.522 -0.308 . . . . 70.1 110.583 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.9 mm? -73.59 21.27 0.09 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 112.95 0.722 . . . . 74.21 112.95 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -77.16 81.42 3.67 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.976 -0.452 . . . . 64.4 110.741 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 45' ' ' SER . . . -177.9 -167.93 36.69 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.985 -1.102 . . . . 72.25 114.926 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.3 m -91.26 145.88 24.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.899 0.48 . . . . 63.35 111.434 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -107.3 109.34 21.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.817 0.341 . . . . 64.32 110.957 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -95.68 133.9 39.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.904 0.383 . . . . 73.43 111.594 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.7 139.11 33.25 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.076 0.465 . . . . 74.13 111.591 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.18 95.08 6.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.176 -0.465 . . . . 53.15 111.42 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.679 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 69.4 t80 -55.9 -49.9 90.34 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.65 0.611 . . . . 74.31 112.65 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 17.8 Cg_endo -56.82 -23.7 51.9 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.193 1.929 . . . . 63.32 112.782 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.99 -44.73 10.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.794 0.294 . . . . 73.1 111.794 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 16' ' ' LEU . 74.0 mt -66.66 -48.99 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.751 0.31 . . . . 74.24 111.153 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 53.8 t30 -56.82 -47.59 79.95 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.256 0.551 . . . . 45.23 110.39 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.19 -42.2 76.76 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.663 -0.699 . . . . 73.15 111.908 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -61.51 -47.73 84.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.009 0.433 . . . . 75.34 111.099 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.97 -52.25 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.462 . . . . 74.51 111.369 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 25.4 mmt85 -66.41 -25.3 66.69 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.355 -0.384 . . . . 74.12 111.686 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.16 -52.54 54.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.791 0.329 . . . . 75.12 111.633 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 t -83.47 -53.79 5.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.55 . . . . 74.32 112.484 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.34 -47.2 77.29 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.102 0.408 . . . . 74.13 112.102 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 61.28 16.59 7.46 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.834 0.679 . . . . 74.35 112.834 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.49 141.21 46.8 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.116 -0.365 . . . . 64.2 110.395 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -50.03 160.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.825 0.676 . . . . 75.41 112.825 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -56.79 137.14 55.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.696 -0.683 . . . . 63.22 111.721 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -95.29 146.54 24.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.848 0.356 . . . . 73.32 111.608 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -100.14 137.92 37.92 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.723 0.296 . . . . 64.25 111.551 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.884 -0.579 . . . . 64.03 111.41 177.611 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.828 0.347 . . . . 62.44 110.407 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.88 115.56 29.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.576 0.954 . . . . 74.04 113.576 -169.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -108.34 131.64 54.54 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.087 -0.708 . . . . 50.42 109.087 166.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.63 113.43 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.351 0.5 . . . . 75.52 112.351 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.75 107.54 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.884 0.373 . . . . 71.43 110.299 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -73.15 134.59 44.48 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.04 0.447 . . . . 71.51 111.594 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 9' ' ' GLU . 15.5 m120 -75.37 9.58 2.06 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.103 0.408 . . . . 74.51 112.103 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 58.57 33.84 23.41 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.174 0.435 . . . . 45.22 112.174 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 5.0 mm-40 -75.02 70.05 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.191 0.52 . . . . 74.23 110.79 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 81.9 m95 -99.21 126.53 45.03 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.849 -0.614 . . . . 74.02 110.537 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.502 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 22.3 ptp -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.021 0.438 . . . . 74.5 112.021 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.93 163.8 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.255 -0.43 . . . . 70.43 111.949 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.38 -51.08 28.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.974 0.731 . . . . 75.32 112.974 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -60.89 -40.32 92.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.676 0.274 . . . . 74.12 111.654 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.71 -35.29 70.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.082 0.467 . . . . 53.43 111.098 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -60.11 -50.74 72.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.659 -0.7 . . . . 74.41 111.187 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -59.01 -33.66 70.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.948 0.404 . . . . 74.55 111.64 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' LYS . 65.2 t -71.41 -42.44 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.008 0.433 . . . . 51.12 111.513 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -85.06 -8.5 58.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.018 0.747 . . . . 73.01 113.018 -176.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.7 p -110.22 -30.34 7.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.207 0.447 . . . . 74.12 112.207 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.69 -6.69 65.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.202 -0.523 . . . . 52.4 112.846 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -73.65 157.49 36.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.031 0.443 . . . . 72.42 111.576 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.56 160.72 20.42 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.125 -0.56 . . . . 62.15 112.93 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.07 61.43 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.15 0.426 . . . . 63.22 112.15 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.93 -27.4 67.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.033 0.444 . . . . 75.35 111.712 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -76.35 -36.91 57.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.125 0.488 . . . . 62.34 110.631 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 56.6 mt -68.42 -52.53 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.422 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 10.8 pt-20 -54.35 -37.28 64.74 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.914 0.388 . . . . 74.45 111.405 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -57.69 -53.58 56.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.09 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -65.07 -30.99 71.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.325 -0.398 . . . . 75.34 111.948 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.583 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 18.5 mtp-105 -60.47 -23.27 64.34 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.605 -0.27 . . . . 72.11 111.658 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -90.76 -9.38 46.79 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.355 0.872 . . . . 53.31 113.355 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.49 9.36 0.33 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 119.731 -1.223 . . . . 64.31 115.666 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.96 -28.79 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.904 0.852 . . . . 52.24 111.871 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.36 133.21 44.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.591 0.71 . . . . 75.4 112.493 -177.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 60.6 mt -138.47 126.46 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.419 -0.81 . . . . 71.24 110.329 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.5 139.78 51.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.371 0.605 . . . . 43.32 110.981 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.39 -15.11 59.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.059 -0.519 . . . . 53.51 112.593 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -123.89 -73.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 122.57 -0.371 . . . . 71.11 111.655 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.447 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.5 m80 -86.34 -10.87 53.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.056 0.391 . . . . 74.35 112.056 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 44.5 p90 -170.51 179.06 3.46 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.858 -0.423 . . . . 75.53 109.858 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -157.86 149.19 21.42 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.014 0.435 . . . . 74.12 111.374 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -78.69 103.94 8.97 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.232 0.539 . . . . 72.33 111.748 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' HB ' ' CD1' ' A' ' 57' ' ' TRP . 66.0 t -100.24 144.08 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.117 -0.492 . . . . 74.53 111.047 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -74.58 143.09 78.45 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.741 0.305 . . . . 72.12 111.552 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.95 -178.18 2.47 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.752 2.302 . . . . 73.43 112.101 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -68.39 83.25 0.26 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.254 0.55 . . . . 70.54 110.737 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.62 -177.92 47.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.007 -0.542 . . . . 60.01 112.489 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -82.33 40.89 0.66 Allowed 'General case' 0 CA--C 1.544 0.744 0 O-C-N 122.346 -0.502 . . . . 74.21 111.487 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -82.03 2.48 30.82 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.455 0.539 . . . . 71.44 112.455 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.9 m -145.91 151.4 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.149 -0.344 . . . . 60.52 111.121 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -74.79 -60.24 2.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.948 0.404 . . . . 75.42 111.62 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -87.01 0.78 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.898 0.38 . . . . 63.42 111.574 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.82 -126.9 7.62 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.272 -0.422 . . . . 51.21 113.303 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 84.8 m -140.61 119.68 12.79 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 122.442 -0.446 . . . . 74.05 110.721 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -86.7 105.76 17.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.09 0.472 . . . . 75.31 112.009 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 28.7 m95 -91.23 121.75 33.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.08 -0.509 . . . . 72.55 110.006 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' ILE . 87.5 m-85 -90.32 145.07 25.25 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.918 0.71 . . . . 72.35 112.918 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.479 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 53.2 t-20 -85.36 96.88 9.69 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.735 -0.666 . . . . 73.53 110.729 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 82.9 t80 -52.4 -53.11 56.69 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 112.543 0.571 . . . . 72.1 112.543 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 82.5 Cg_exo -51.02 -50.42 13.95 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.376 2.05 . . . . 73.54 113.588 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.6 mm-40 -71.22 -28.53 64.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.143 0.423 . . . . 75.2 112.143 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 58' ' ' TYR . 46.7 mt -70.13 -42.14 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.948 -0.47 . . . . 73.0 110.547 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -34.13 72.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.051 0.453 . . . . 75.14 110.407 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.7 tppp? -59.0 -31.86 69.17 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.939 -0.573 . . . . 64.32 111.279 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -85.51 -32.22 22.33 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 72.24 111.232 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.4 mt -60.69 -37.39 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 122.206 -0.309 . . . . 72.44 111.467 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 65' ' ' LYS . 1.7 ppt_? -57.27 -33.49 67.68 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.71 0.29 . . . . 71.34 110.976 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.21 -44.22 89.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.365 0.603 . . . . 63.23 110.105 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -60.64 -23.79 65.04 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.632 -0.713 . . . . 62.33 112.162 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.26 -21.99 35.99 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.118 0.414 . . . . 60.32 112.118 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -72.9 -174.69 1.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.389 0.614 . . . . 75.13 112.359 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -79.24 115.99 19.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.109 -0.496 . . . . 72.21 111.501 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -132.99 146.2 51.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.238 -0.437 . . . . 74.54 111.625 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -125.05 86.94 2.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.38 0.609 . . . . 52.45 112.07 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -135.14 -51.91 0.77 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.473 -0.785 . . . . 62.02 109.408 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -148.21 131.29 16.32 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.324 -0.853 . . . . 73.14 110.17 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.618 -0.706 . . . . 74.11 111.535 176.737 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 111.535 0.198 . . . . 74.32 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.79 124.77 25.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.945 0.402 . . . . 35.15 111.489 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.865 0.364 . . . . 73.21 111.833 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.9 mm -77.92 85.82 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.274 0.559 . . . . 72.12 110.228 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.62 139.77 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.947 -0.569 . . . . 65.01 111.739 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.86 131.15 55.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.522 -0.308 . . . . 73.33 110.874 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -171.74 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.796 0.331 . . . . 74.52 111.848 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 116.74 1.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.462 0.912 . . . . 63.53 113.462 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 70.6 mm-40 -108.26 94.08 4.88 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.922 -0.581 . . . . 60.34 110.819 173.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.431 ' HH2' ' HE3' ' A' ' 42' ' ' LYS . 80.9 m95 -93.81 134.31 36.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.148 -0.478 . . . . 73.11 110.429 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 20.4 ptp -157.16 153.85 28.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.987 0.422 . . . . 74.31 112.035 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.27 170.56 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.203 -0.453 . . . . 71.45 110.865 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -57.55 -45.59 84.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.22 0.452 . . . . 74.41 112.22 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.1 tmmt? -61.54 -38.54 87.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.887 0.375 . . . . 75.43 111.14 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -72.21 -38.54 68.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.071 0.462 . . . . 74.52 111.1 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.32 -48.37 81.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.782 -0.645 . . . . 53.2 110.965 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -61.29 -28.03 68.9 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.808 0.337 . . . . 74.33 111.901 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.9 t -78.62 -49.19 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.911 0.386 . . . . 61.11 111.126 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -64.4 -26.88 68.65 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.0 p -99.05 -30.67 12.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.252 0.464 . . . . 65.22 112.252 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.5 -13.98 56.64 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.117 -0.563 . . . . 64.3 113.103 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.4 mp -66.99 159.9 27.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.219 0.533 . . . . 61.43 111.976 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.69 160.63 15.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.039 -0.528 . . . . 24.52 112.491 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.58 65.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.85 0.357 . . . . 71.53 111.591 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -59.27 -31.68 69.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.003 -0.544 . . . . 72.33 111.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' SER . 46.9 tt0 -84.37 -34.28 23.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.398 -0.365 . . . . 70.21 111.021 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 17' ' ' MET . 60.8 mt -66.24 -50.33 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.598 -0.274 . . . . 64.43 111.159 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 13.0 pt-20 -58.56 -23.25 58.02 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.986 0.422 . . . . 63.4 111.193 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 47.9 t -67.18 -56.04 11.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.224 -0.444 . . . . 73.11 110.54 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -65.72 -25.89 67.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.178 0.436 . . . . 65.1 112.178 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 78.8 mtp180 -60.37 -10.76 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 111.942 0.349 . . . . 73.23 111.942 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -63.17 -22.33 66.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.161 0.43 . . . . 73.45 112.161 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.67 -17.16 0.05 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.488 -0.863 . . . . 71.2 114.607 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.3 67.63 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.681 0.741 . . . . 55.55 111.816 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -71.94 105.07 3.71 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.065 0.46 . . . . 75.31 111.716 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -87.49 120.24 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.345 -0.389 . . . . 74.15 111.6 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.61 147.74 40.72 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.905 0.335 . . . . 73.22 111.905 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.15 -47.18 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.444 -0.344 . . . . 61.15 113.665 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.3 t -80.44 -63.65 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 122.468 0.307 . . . . 74.44 111.732 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.477 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 4.3 m-70 -86.88 -19.93 28.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.127 0.417 . . . . 74.22 112.127 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 12.3 p90 -165.97 143.48 5.49 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.795 -0.446 . . . . 64.03 109.795 175.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.431 ' HE3' ' HH2' ' A' ' 10' ' ' TRP . 19.1 ptpt -127.62 161.36 29.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.395 0.617 . . . . 73.55 112.488 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 43' ' ' ARG . 7.8 ptp180 -74.92 134.62 41.54 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.502 -0.772 . . . . 62.13 111.032 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.6 t -127.07 149.16 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.657 -0.247 . . . . 51.21 110.788 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 20.4 m -49.77 139.8 15.91 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 111.929 0.344 . . . . 51.14 111.929 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 53.2 Cg_exo -52.65 130.43 36.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.739 2.293 . . . . 63.12 113.357 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.1 m -55.73 -40.66 72.78 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.031 0.443 . . . . 70.4 110.996 174.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 170.11 32.47 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.385 -0.436 . . . . 74.21 112.072 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.31 -30.63 71.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.304 0.552 . . . . 64.32 112.19 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -140.73 39.54 1.84 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.422 0.527 . . . . 75.2 112.422 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 46' ' ' PRO . 9.4 m -68.19 144.19 55.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.686 0.279 . . . . 73.42 110.289 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.0 mm? -69.99 -61.47 1.76 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.34 0.496 . . . . 72.12 112.34 -173.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -90.94 9.59 29.91 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.342 0.497 . . . . 75.41 112.342 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.21 -134.99 34.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.035 -0.602 . . . . 31.4 113.37 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -134.22 137.74 44.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 74.35 110.791 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.1 m -123.12 120.42 33.18 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.932 0.396 . . . . 75.13 111.801 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -109.94 140.11 44.3 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.318 -0.401 . . . . 74.11 111.108 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -99.34 139.76 34.51 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.827 0.346 . . . . 74.3 111.524 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 16.7 m120 -87.66 105.49 17.39 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.303 -0.408 . . . . 72.4 111.317 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 67.4 t80 -52.06 -52.03 65.82 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 112.857 0.688 . . . . 71.21 112.857 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 22.4 Cg_endo -60.01 -29.42 89.27 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.877 1.718 . . . . 60.24 112.858 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HB3' ' ND1' ' A' ' 40' ' ' HIS . 74.7 mm-40 -79.9 -39.09 31.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.194 -0.457 . . . . 71.14 112.063 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -71.69 -35.76 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.768 0.318 . . . . 64.33 110.384 174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.09 -38.24 85.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.759 0.314 . . . . 72.43 110.382 172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 39.6 ttmt -53.77 -35.46 61.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.073 0.463 . . . . 55.41 110.974 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.66 -50.97 10.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.149 -0.478 . . . . 42.45 111.163 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 63' ' ' ILE . 54.6 mt -67.85 -22.08 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 112.462 0.541 . . . . 72.52 112.462 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -53.11 -32.83 49.42 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.963 0.411 . . . . 72.52 111.428 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.77 -33.61 76.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.093 0.473 . . . . 75.41 110.922 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -76.33 -24.93 54.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.264 -0.425 . . . . 75.41 111.386 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' CD2' HG22 ' A' ' 67' ' ' ILE . 4.5 mm? -68.02 -34.74 77.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.636 0.255 . . . . 62.13 110.523 171.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 53.93 37.96 27.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.926 0.393 . . . . 52.23 110.581 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -44.62 124.22 4.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.015 0.746 . . . . 73.31 113.015 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -55.95 127.77 31.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.08 -0.964 . . . . 65.53 112.265 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 77' ' ' HIS . 30.6 m-70 -72.8 106.37 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.147 -0.479 . . . . 55.32 111.28 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -69.71 -29.31 66.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.654 0.74 . . . . 71.12 109.61 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 26.2 p-80 -132.74 165.52 24.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.005 -0.998 . . . . 75.32 109.687 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.61 -0.709 . . . . 74.51 112.125 -179.194 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 112.202 0.445 . . . . 74.24 112.202 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.34 140.2 12.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.891 0.377 . . . . 74.14 111.671 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.549 HE21 ' HB ' ' A' ' 5' ' ' ILE . 24.9 tm0? -84.64 102.48 12.97 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 64.51 110.543 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.5 mm -113.23 68.24 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.613 0.721 . . . . 72.13 111.068 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HB ' HE21 ' A' ' 3' ' ' GLN . 4.4 mp -132.75 115.75 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.828 -0.624 . . . . 54.12 110.723 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -168.51 150.12 4.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.453 -0.34 . . . . 61.14 111.18 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.795 ' HB3' ' HB3' ' A' ' 61' ' ' PRO . 3.8 t-20 -162.43 159.3 24.96 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.98 0.419 . . . . 71.14 111.26 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -136.85 27.69 2.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.451 0.538 . . . . 61.11 112.451 -175.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.0 mm-40 -73.87 99.18 3.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.901 0.382 . . . . 64.25 111.98 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -91.98 135.75 33.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.627 -0.26 . . . . 74.05 110.526 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 18.7 ptp -158.81 142.41 15.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.922 0.391 . . . . 54.34 112.045 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.09 172.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 111.795 0.295 . . . . 61.04 111.795 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -46.74 -57.51 4.78 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.896 0.702 . . . . 73.44 112.896 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -54.69 -37.52 65.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.885 0.374 . . . . 73.34 111.945 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -76.11 -42.44 47.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.097 0.475 . . . . 53.33 111.143 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -58.31 -47.72 82.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.804 -0.635 . . . . 62.31 111.209 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -58.63 -34.24 70.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.847 0.356 . . . . 63.14 111.629 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.9 t -73.49 -46.14 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.154 0.502 . . . . 52.41 111.233 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.596 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 16.8 mmt180 -69.0 -29.57 67.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.131 -0.486 . . . . 74.5 112.247 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -99.96 -30.17 12.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.538 0.57 . . . . 54.33 112.538 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 -4.64 56.12 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.025 -0.607 . . . . 41.23 112.824 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.63 -173.11 1.71 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.386 0.612 . . . . 73.01 111.767 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -146.19 169.14 27.58 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.797 -0.638 . . . . 42.24 112.266 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.12 -50.69 61.17 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.221 0.452 . . . . 72.23 112.221 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -60.95 -34.76 75.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.133 0.492 . . . . 72.15 111.736 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -78.67 -40.37 34.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.349 -0.387 . . . . 71.44 111.599 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 23' ' ' GLY . 73.8 mt -66.04 -44.07 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.555 0.217 . . . . 54.12 111.369 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 11.7 pt-20 -56.93 -37.92 72.17 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.812 0.339 . . . . 74.11 110.905 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 t -60.69 -49.35 77.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 43.41 110.988 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -63.07 -29.38 70.77 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.805 0.298 . . . . 74.43 111.805 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.1 mtm180 -69.71 -12.31 61.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.052 0.39 . . . . 73.13 112.052 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 45.0 mt-30 -88.74 2.76 52.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.625 0.232 . . . . 74.52 111.625 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.3 -52.29 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.177 -1.011 . . . . 64.41 114.697 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.08 -38.42 31.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.465 0.913 . . . . 71.31 113.465 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -71.55 130.67 41.82 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.015 -0.428 . . . . 72.43 111.68 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.2 mt -130.59 126.31 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 122.522 0.329 . . . . 75.13 111.094 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 42' ' ' LYS . 38.5 tt0 -68.99 150.92 47.15 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.003 0.43 . . . . 44.13 110.906 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.52 -39.45 2.67 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.255 -0.498 . . . . 71.45 112.841 -174.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -97.76 -64.99 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.249 0.463 . . . . 71.44 112.249 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.4 m-70 -92.06 -11.97 34.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.75 0.648 . . . . 53.13 112.75 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 47.5 p90 -170.78 174.03 5.06 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.0 0.12 . . . . 75.02 111.012 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 18.7 ptpt -167.74 174.2 7.82 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.424 0.631 . . . . 75.15 112.288 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -85.4 120.86 27.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.524 -0.762 . . . . 74.44 112.002 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.8 149.98 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.007 -0.542 . . . . 62.34 110.857 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 49.5 m -58.04 141.41 81.41 Favored Pre-proline 0 N--CA 1.473 0.706 0 N-CA-C 112.318 0.488 . . . . 74.34 112.318 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 8.7 Cg_exo -72.38 163.77 37.63 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.873 2.382 . . . . 62.13 112.371 175.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.2 p -79.31 -64.29 1.22 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.403 0.52 . . . . 44.35 112.403 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.85 -58.93 3.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.22 -0.514 . . . . 72.32 114.257 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.86 147.35 50.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.285 0.564 . . . . 72.33 112.115 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.51 114.62 20.36 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.778 -0.646 . . . . 64.45 111.256 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.9 p -118.6 168.79 10.36 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.106 0.479 . . . . 62.34 111.91 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.9 mm? -80.54 -9.86 59.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.24 0.543 . . . . 75.24 110.372 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -85.92 -47.06 9.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.758 -0.655 . . . . 71.13 111.651 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 46' ' ' PRO . . . 69.69 -168.04 47.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.284 -0.484 . . . . 41.35 113.443 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.5 m -127.61 116.7 20.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.614 -0.345 . . . . 73.32 110.566 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.6 m -89.61 115.25 26.86 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.069 0.461 . . . . 65.11 112.171 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -102.16 133.54 46.86 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.134 -0.484 . . . . 74.55 110.848 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.38 143.31 27.54 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.018 0.437 . . . . 73.44 111.327 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.39 105.53 13.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.322 -0.399 . . . . 71.52 111.5 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 90.2 t80 -56.95 -45.15 99.98 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 111.822 0.305 . . . . 74.12 111.822 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.795 ' HB3' ' HB3' ' A' ' 7' ' ' ASN . 9.1 Cg_endo -50.69 -41.78 52.76 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.405 2.07 . . . . 65.32 113.109 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 40' ' ' HIS . 42.6 mm-40 -65.87 -47.27 75.44 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.136 0.493 . . . . 64.03 111.815 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 HD21 ' A' ' 16' ' ' LEU . 65.3 mt -71.79 -37.43 62.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.975 0.417 . . . . 74.23 111.183 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.6 -43.25 99.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.281 0.562 . . . . 65.22 110.177 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -55.75 -39.49 71.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.593 -0.73 . . . . 72.0 110.81 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -65.03 -48.6 73.29 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.301 -0.409 . . . . 74.51 111.468 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.4 -45.36 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.1 0.476 . . . . 71.55 111.461 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 41.3 mtp-105 -64.89 -56.75 11.47 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.241 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.68 -37.86 76.97 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.574 0.583 . . . . 75.32 112.574 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.4 p -82.45 -64.21 1.22 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.171 0.434 . . . . 71.34 112.171 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -74.42 -43.7 55.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.138 0.421 . . . . 70.31 112.138 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 1.5 mm-40 55.22 76.91 0.24 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.358 0.873 . . . . 72.44 113.358 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -79.33 106.07 11.1 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.742 -0.836 . . . . 71.4 108.742 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -57.76 89.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.028 -0.533 . . . . 72.42 112.08 -169.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -67.4 -17.17 64.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.849 0.685 . . . . 75.51 112.849 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -68.76 -3.8 13.65 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.018 0.437 . . . . 75.01 111.08 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -125.05 -55.46 1.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.227 -0.442 . . . . 74.04 110.473 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.255 1.383 0 CA-C-O 118.799 -0.619 . . . . 74.54 112.042 -178.239 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.4 0.143 . . . . 52.45 110.753 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.07 141.92 2.72 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.212 0.449 . . . . 64.12 112.212 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -99.4 111.27 23.67 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.075 0.464 . . . . 63.32 111.063 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -71.07 93.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.979 0.419 . . . . 74.41 110.727 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mm -94.94 102.08 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.002 0.43 . . . . 65.0 111.777 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -132.97 132.55 42.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.197 -0.456 . . . . 53.42 110.762 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -73.36 79.02 1.36 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.426 0.631 . . . . 73.41 110.794 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 8.9 pt-20 -78.02 82.05 4.39 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.758 0.79 . . . . 73.4 111.405 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.0 mt-10 -75.46 85.33 2.57 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.848 -0.614 . . . . 71.03 111.629 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -77.53 130.53 37.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.669 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.6 ptp -153.59 142.3 20.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.813 0.339 . . . . 70.33 111.779 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 15' ' ' ALA . 35.8 m -64.81 166.29 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.752 0.31 . . . . 75.52 111.819 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -52.41 -46.61 66.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.009 0.433 . . . . 70.52 111.645 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -60.13 -37.09 79.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.154 -0.475 . . . . 72.02 111.483 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -76.21 -38.97 55.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.337 0.589 . . . . 74.21 111.04 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.17 -43.11 92.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.981 -0.554 . . . . 74.43 111.299 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.519 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.1 ptp -61.06 -27.49 68.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.738 0.304 . . . . 70.35 111.35 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 14' ' ' LYS . 47.4 t -67.95 -48.77 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.215 0.531 . . . . 74.22 110.805 174.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -64.82 -42.76 94.7 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.078 -0.51 . . . . 75.3 112.289 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -93.5 -30.27 15.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.048 0.758 . . . . 72.24 113.048 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.84 7.56 64.39 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.055 -0.593 . . . . 72.31 113.127 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.4 mp -79.76 160.13 26.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 63.21 111.724 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.02 153.36 16.83 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 71.32 112.002 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -41.42 62.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.203 0.501 . . . . 45.12 111.997 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.98 -27.03 69.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.412 -0.358 . . . . 72.51 111.584 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.443 HE21 ' HE2' ' A' ' 30' ' ' TYR . 48.8 tt0 -84.9 -40.95 16.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.152 0.501 . . . . 72.14 110.755 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.71 -40.0 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.253 -0.43 . . . . 61.24 112.03 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.487 ' HB3' ' NH2' ' A' ' 31' ' ' ARG . 11.7 pt-20 -62.19 -34.32 76.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.901 0.381 . . . . 74.43 111.253 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 35.8 t -62.43 -27.6 69.22 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.245 0.545 . . . . 74.24 110.773 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HE2' HE21 ' A' ' 26' ' ' GLN . 60.4 m-85 -88.43 -31.61 18.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.274 -0.421 . . . . 72.2 111.646 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 55.2 mtm180 -64.35 -20.52 66.16 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.296 0.48 . . . . 73.35 112.296 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 29' ' ' SER . 13.6 pt20 -79.03 -8.11 58.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.435 0.531 . . . . 75.11 112.435 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.32 -49.08 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.199 -1.0 . . . . 73.25 114.642 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.33 85.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 73.54 112.463 -176.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.13 106.29 4.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.043 0.449 . . . . 75.21 111.675 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -96.87 131.71 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.529 -0.305 . . . . 72.32 111.211 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.83 147.32 53.56 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.044 0.449 . . . . 72.15 111.4 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.68 -46.03 3.01 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.254 -0.498 . . . . 62.32 112.872 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.56 -62.79 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.305 0.483 . . . . 71.14 112.305 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -93.91 -21.01 19.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.918 0.71 . . . . 50.01 112.918 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -153.24 168.22 26.72 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.862 0.301 . . . . 74.51 111.46 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -136.16 165.29 26.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.21 0.529 . . . . 64.0 111.424 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -86.79 136.71 32.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.688 -0.687 . . . . 62.03 110.173 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 78.4 t -125.14 147.77 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.216 0.531 . . . . 25.23 111.656 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 t -66.9 141.57 96.83 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.035 -0.53 . . . . 63.14 112.122 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.06 22.95 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.732 2.288 . . . . 73.11 113.123 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.0 m 66.02 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.811 0.671 . . . . 72.13 112.811 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.93 1.3 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.173 -0.537 . . . . 62.14 113.537 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 51' ' ' THR . 39.6 mt-10 -90.28 102.82 15.54 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.346 -0.503 . . . . 65.04 111.204 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.08 97.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.968 0.413 . . . . 74.35 111.716 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 49' ' ' GLU . 63.6 p -110.35 162.5 14.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.36 0.6 . . . . 72.12 111.968 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.8 mm? -96.26 14.69 23.32 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.823 -0.626 . . . . 72.44 110.204 173.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -122.66 102.38 8.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.606 -0.725 . . . . 64.32 110.702 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.65 113.77 6.18 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.861 -0.685 . . . . 72.21 113.048 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 26.5 m -51.45 115.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.009 0.433 . . . . 71.11 111.17 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.8 m -91.9 110.2 21.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.718 0.636 . . . . 74.24 112.718 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -104.35 128.21 52.14 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.514 . . . . 74.24 111.008 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' OH ' ' HD3' ' A' ' 31' ' ' ARG . 15.8 m-85 -90.87 157.55 17.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 74.25 112.022 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 40.8 m-80 -94.77 110.19 22.07 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.277 -0.419 . . . . 74.2 110.406 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.4 t80 -52.65 -49.81 84.16 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 112.119 0.414 . . . . 72.25 112.119 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 55.5 Cg_exo -53.63 -41.38 74.31 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.028 1.819 . . . . 74.01 113.274 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 28.2 mm-40 -70.52 -35.66 73.32 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.735 0.642 . . . . 71.11 112.735 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.4 -41.57 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.626 0.251 . . . . 75.52 111.154 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -59.84 -40.96 90.27 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.26 0.552 . . . . 61.04 110.279 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -59.88 -44.67 94.07 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.034 -0.53 . . . . 72.42 111.118 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.15 -45.7 90.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.199 -0.455 . . . . 72.12 111.226 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' O ' HD23 ' A' ' 71' ' ' LEU . 75.0 mt -59.49 -48.49 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.067 0.46 . . . . 72.34 111.019 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -54.59 -51.9 63.85 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.278 -0.419 . . . . 74.24 111.094 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.36 -39.75 81.7 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.242 -0.435 . . . . 61.54 111.506 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.6 t -63.65 -49.96 71.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.835 0.35 . . . . 54.44 111.397 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 67' ' ' ILE . 4.5 mm? -61.49 -43.6 98.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 73.32 111.378 177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.0 pt-20 -161.17 108.09 1.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.623 0.725 . . . . 74.43 112.295 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.76 52.68 2.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.473 0.654 . . . . 73.24 110.755 173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.471 ' ND1' ' HB2' ' A' ' 72' ' ' GLU . 33.1 m170 -88.75 146.26 25.13 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.229 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 91.1 3.28 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.462 0.649 . . . . 73.13 111.586 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -81.72 83.03 7.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.407 0.622 . . . . 63.52 111.483 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 178.99 -42.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.06 -0.973 . . . . 74.52 109.389 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.446 -0.788 . . . . 74.4 109.953 171.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.453 0.168 . . . . 74.42 111.218 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.23 130.9 0.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.245 0.461 . . . . 61.44 112.245 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -144.97 120.44 10.34 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.007 0.432 . . . . 74.24 110.277 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.02 101.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.972 0.415 . . . . 55.22 111.147 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -99.22 104.92 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.922 0.391 . . . . 74.1 111.853 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -110.92 12.12 22.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.278 0.561 . . . . 74.21 110.744 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.456 HD21 ' HB3' ' A' ' 61' ' ' PRO . 6.5 t30 -78.59 62.26 3.12 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.26 0.552 . . . . 64.21 111.049 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.43 118.75 23.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.156 0.503 . . . . 54.41 111.501 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.559 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 6.8 tp10 -131.83 91.01 2.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.971 -0.559 . . . . 52.55 109.737 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -94.28 130.48 40.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.864 -0.607 . . . . 60.22 110.665 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.547 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.4 ptp -144.84 160.51 41.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.074 0.464 . . . . 75.41 111.823 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 15' ' ' ALA . 33.0 m -73.67 170.31 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.133 0.492 . . . . 75.53 111.632 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.82 -48.69 80.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.237 0.458 . . . . 73.55 112.237 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . 0.8 OUTLIER -65.33 -29.7 70.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.763 0.316 . . . . 62.22 111.107 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -73.47 -41.77 62.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.994 0.426 . . . . 75.24 111.053 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.2 tm? -58.04 -45.88 86.26 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.047 -0.524 . . . . 50.33 111.207 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.7 ptp -62.28 -35.52 79.25 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.597 0.237 . . . . 74.01 111.549 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 95.8 t -72.77 -40.46 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.07 0.462 . . . . 54.34 111.433 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.547 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 15.0 mmt85 -65.55 -41.59 92.85 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.237 -0.438 . . . . 73.25 112.051 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.1 p -93.75 -30.21 14.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.97 0.73 . . . . 75.41 112.97 -174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.58 -4.62 47.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.198 -0.525 . . . . 75.32 112.947 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.9 mp -75.82 -179.1 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 74.52 111.861 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -132.13 168.44 22.52 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.626 -0.715 . . . . 71.24 112.26 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.1 71.21 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.673 0.62 . . . . 72.05 112.673 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 87.2 mtt180 -73.99 -18.64 60.84 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.621 0.6 . . . . 54.51 112.621 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 10.3 tt0 -84.57 -37.73 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.898 0.38 . . . . 71.41 110.701 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.1 mt -63.67 -50.37 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.601 -0.272 . . . . 72.53 111.126 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.7 pt-20 -59.8 -31.03 69.31 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.141 0.496 . . . . 75.1 110.935 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 40.8 t -61.5 -50.41 72.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.512 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -66.14 -23.68 66.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.946 0.35 . . . . 74.14 111.946 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.702 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 13.6 mtp180 -64.27 -9.79 19.71 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.797 0.666 . . . . 71.04 112.797 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 29' ' ' SER . 29.0 pt20 -70.9 -22.26 62.29 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.937 0.347 . . . . 74.03 111.937 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.69 -43.68 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.753 -0.737 . . . . 71.45 113.979 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.16 -49.08 78.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.095 0.405 . . . . 63.01 112.095 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -74.95 104.52 5.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.961 0.41 . . . . 73.22 110.241 175.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.79 127.26 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 72.41 110.848 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -58.49 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.961 0.41 . . . . 73.43 111.081 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.11 -50.22 3.35 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.163 -0.541 . . . . 64.23 113.038 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.1 t -81.35 -61.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.176 0.436 . . . . 73.15 112.176 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -89.36 -22.12 22.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 111.987 0.366 . . . . 72.31 111.987 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -160.09 127.34 4.5 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.708 0.29 . . . . 75.53 110.655 172.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -122.02 145.07 48.49 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.01 0.433 . . . . 71.42 111.749 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 45.3 mtm180 -73.46 103.21 4.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.03 0.443 . . . . 71.35 111.09 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.4 100.43 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.209 0.528 . . . . 72.43 111.107 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.3 p -86.93 132.22 42.61 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.318 -0.401 . . . . 71.44 110.79 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.01 -8.13 21.79 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.685 2.256 . . . . 65.21 113.093 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.1 t -127.27 158.9 35.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.118 0.485 . . . . 74.05 111.596 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.71 2.31 69.77 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.055 -0.521 . . . . 54.11 112.309 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.08 152.07 25.49 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.079 0.466 . . . . 73.45 111.911 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.74 86.17 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 62.4 111.221 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.0 p -131.91 154.29 49.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.217 -0.447 . . . . 71.03 111.489 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.4 mm? -88.88 14.9 9.35 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.014 0.435 . . . . 64.4 111.287 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -86.9 28.39 0.9 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.959 0.409 . . . . 71.3 111.98 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.12 80.25 0.2 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.147 -0.549 . . . . 65.24 113.202 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.2 m -72.97 116.7 13.8 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.579 -0.365 . . . . 74.13 110.503 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 6.9 t -81.12 138.12 35.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.276 0.56 . . . . 72.21 112.343 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -112.81 136.89 51.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.7 -0.682 . . . . 55.02 110.371 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -89.93 139.73 30.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.291 0.567 . . . . 72.42 112.126 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.547 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 39.3 t-20 -91.73 101.51 14.12 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.593 -0.731 . . . . 70.31 110.467 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 87.0 t80 -54.99 -52.13 73.65 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 112.627 0.603 . . . . 70.11 112.627 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 9' ' ' GLU . 80.9 Cg_exo -48.51 -49.41 14.63 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.256 1.971 . . . . 72.21 113.376 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -62.72 -41.53 99.2 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.147 0.425 . . . . 71.24 112.147 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.24 -49.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.961 0.41 . . . . 72.22 111.586 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -57.12 -38.32 73.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 61.45 110.927 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -51.33 70.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.193 -0.458 . . . . 75.55 110.091 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -55.56 -48.78 74.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.011 -0.541 . . . . 73.4 111.563 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.74 -40.86 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.17 -0.468 . . . . 62.32 111.338 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 68' ' ' ARG . 22.7 ttt180 -59.08 -32.76 70.09 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.309 0.485 . . . . 61.03 112.309 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -61.75 -49.08 77.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.937 0.399 . . . . 64.43 111.895 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.3 t -83.85 -44.68 14.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.117 0.414 . . . . 70.2 112.117 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.83 -43.68 78.97 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.924 0.342 . . . . 71.44 111.924 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 68.3 -69.56 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.168 0.587 . . . . 72.11 112.275 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -97.27 137.39 36.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.046 -0.524 . . . . 72.22 112.366 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -80.87 116.39 20.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.968 0.413 . . . . 61.4 111.45 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.3 133.33 54.97 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.381 -0.372 . . . . 71.32 111.247 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -80.15 126.81 31.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.392 . . . . 62.11 111.489 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -93.41 137.1 33.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.239 -0.437 . . . . 72.45 110.636 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.33 -0.843 . . . . 72.51 110.913 178.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.768 0.318 . . . . 65.12 111.294 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 90.64 2.06 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.39 0.515 . . . . 70.04 112.39 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -84.95 137.8 32.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.356 -0.383 . . . . 74.51 110.264 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.3 mm -70.46 78.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 121.166 0.508 . . . . 73.34 111.493 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -140.37 90.17 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.282 -0.417 . . . . 74.35 110.972 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -173.87 127.88 0.39 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.408 -0.36 . . . . 74.13 110.9 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -155.11 115.74 3.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.266 0.555 . . . . 64.23 111.915 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.581 ' HB3' ' NE1' ' A' ' 10' ' ' TRP . 50.7 mt-10 -96.14 99.96 11.65 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.168 -0.469 . . . . 64.42 111.065 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -88.78 88.09 7.48 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.834 0.349 . . . . 62.55 111.335 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' NE1' ' HB3' ' A' ' 8' ' ' GLU . 87.9 m95 -96.12 132.83 41.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.009 0.433 . . . . 74.24 111.647 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.39 154.45 40.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.439 -0.346 . . . . 71.31 111.072 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.25 171.33 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.429 -0.351 . . . . 72.32 111.69 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -51.64 -57.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.211 0.448 . . . . 70.44 112.211 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.2 tmmt? -53.02 -48.45 67.55 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.295 -0.412 . . . . 61.23 111.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.22 97.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.015 0.436 . . . . 70.53 111.558 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD21 HD12 ' A' ' 63' ' ' ILE . 3.2 tm? -59.65 -51.86 68.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.068 -0.515 . . . . 65.0 111.496 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.9 ptp -59.5 -39.45 83.84 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.688 0.28 . . . . 72.14 111.726 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.38 -42.68 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.829 0.347 . . . . 50.33 111.375 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -65.55 -35.33 80.55 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.391 0.515 . . . . 74.04 112.391 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.1 p -93.48 -30.24 15.13 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.508 0.559 . . . . 73.13 112.508 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.22 11.29 45.95 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.122 -0.561 . . . . 70.31 112.714 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.3 mp -93.39 173.14 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.137 0.494 . . . . 71.33 111.172 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.28 162.28 22.01 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.247 -0.502 . . . . 74.54 112.313 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.25 61.94 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.004 0.372 . . . . 51.43 112.004 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -60.6 -28.64 68.67 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.18 0.437 . . . . 74.02 112.18 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 9.3 tt0 -84.94 -45.16 12.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.102 0.477 . . . . 75.14 110.855 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.8 mt -64.14 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.24 -0.436 . . . . 74.42 111.99 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.71 -34.36 69.38 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.857 0.317 . . . . 60.24 111.857 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 t -64.39 -42.07 96.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.09 0.471 . . . . 61.41 111.121 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 29.0 m-85 -64.74 -33.5 76.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 75.32 111.119 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 27.9 mtm180 -62.62 -25.8 68.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.641 0.258 . . . . 70.13 111.312 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.66 -36.52 80.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.617 0.599 . . . . 70.34 112.617 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.25 35.89 0.29 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.317 -0.944 . . . . 74.22 114.506 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.25 -16.85 1.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.103 0.477 . . . . 53.53 111.917 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.499 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.03 111.91 20.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.219 0.533 . . . . 64.12 112.122 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.89 129.67 64.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.023 -0.535 . . . . 71.12 110.376 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.18 137.69 53.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.144 0.497 . . . . 43.43 110.669 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.39 2.93 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.329 -0.462 . . . . 74.52 112.372 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.25 -64.5 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.094 0.405 . . . . 72.04 112.094 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 47.4 m170 -94.24 -37.72 11.39 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.363 0.505 . . . . 73.32 112.363 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 25.6 p90 -141.74 175.7 9.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 63.24 111.121 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -144.79 133.05 21.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.897 0.379 . . . . 73.31 110.98 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -80.75 102.69 10.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.496 0.665 . . . . 74.3 110.404 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.39 125.36 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.063 -0.971 . . . . 55.15 112.175 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 75.5 m -82.79 126.35 73.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.021 -0.536 . . . . 75.14 110.704 174.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.89 -21.6 58.42 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.522 2.148 . . . . 73.22 112.859 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.7 t -136.85 105.91 5.97 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.755 0.312 . . . . 64.33 111.318 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.24 -110.13 3.24 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.159 -0.543 . . . . 64.43 113.46 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.49 169.7 17.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.029 0.442 . . . . 53.53 112.137 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 52.55 26.75 4.51 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.772 1.027 . . . . 74.23 113.772 172.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 22.8 m -71.88 160.78 31.96 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.122 -0.361 . . . . 73.11 110.598 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.8 mm? -82.18 20.79 0.98 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.08 0.467 . . . . 64.4 111.348 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -137.52 79.51 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.923 0.489 . . . . 72.14 110.82 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.39 82.81 0.9 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.053 -0.594 . . . . 51.13 112.985 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.0 m -69.82 113.49 7.11 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.61 -0.347 . . . . 63.32 110.679 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.432 HG23 ' CD2' ' A' ' 41' ' ' PHE . 52.2 m -86.15 115.75 23.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.01 0.744 . . . . 42.54 113.01 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -105.19 140.48 38.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.695 -0.684 . . . . 73.35 110.111 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.42 144.82 32.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.326 0.491 . . . . 70.43 112.326 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.09 111.78 18.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.379 -0.373 . . . . 64.14 110.983 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 87.7 t80 -54.85 -53.39 61.38 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 112.342 0.497 . . . . 72.32 112.342 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 55.6 Cg_endo -67.16 -20.19 50.1 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.154 1.903 . . . . 53.11 113.786 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 40' ' ' HIS . 47.1 mm-40 -83.29 -38.04 22.66 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.11 -0.369 . . . . 71.11 111.515 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 16' ' ' LEU . 58.9 mt -70.6 -42.98 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.663 0.268 . . . . 73.43 110.442 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -56.25 -38.2 70.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.844 0.354 . . . . 74.15 111.03 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.44 -49.61 77.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 73.15 110.798 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -58.81 -41.87 87.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.065 0.459 . . . . 71.33 111.199 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' ILE . 79.7 mt -62.15 -53.82 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.276 -0.42 . . . . 61.11 111.232 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -66.81 -28.31 68.27 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.7 0.286 . . . . 72.03 111.675 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.32 -41.38 80.92 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.148 0.499 . . . . 60.01 110.586 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -71.0 -32.06 68.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.045 0.45 . . . . 74.12 111.28 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -80.46 -56.34 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.596 0.591 . . . . 63.13 112.596 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 70.42 -35.24 0.32 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.186 0.81 . . . . 72.51 113.186 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -52.2 133.43 33.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.226 0.454 . . . . 62.41 112.226 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 77.26 12.29 2.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.914 0.886 . . . . 63.2 112.462 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -79.46 88.82 5.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.113 -0.329 . . . . 70.44 110.113 169.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -77.75 128.23 33.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.037 0.446 . . . . 71.2 111.265 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -110.22 148.98 30.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.792 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 . . . . . 0 C--O 1.249 1.051 0 O-C-N 122.29 -0.256 . . . . 74.35 111.278 175.283 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.716 0.293 . . . . 62.15 111.662 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.41 159.7 14.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.431 0.53 . . . . 64.15 112.431 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -143.89 122.28 12.37 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.005 0.431 . . . . 71.14 111.313 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.13 119.93 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.775 0.322 . . . . 64.44 111.192 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -102.46 106.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.901 0.382 . . . . 74.0 111.162 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -163.46 103.41 0.95 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.51 -0.314 . . . . 74.03 110.731 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -167.9 97.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.75 0.648 . . . . 54.24 112.75 -175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.67 132.85 49.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.021 0.438 . . . . 73.23 110.336 170.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 32.9 mm-40 -84.88 105.78 15.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 72.24 111.59 -176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -88.62 136.69 32.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.687 0.28 . . . . 75.41 111.014 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.7 ptp -157.92 153.55 26.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.949 0.404 . . . . 64.43 111.814 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.67 174.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.278 -0.419 . . . . 72.04 111.491 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 27' ' ' ILE . 35.7 tt0 -59.37 -50.66 73.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.42 . . . . 75.13 112.133 -175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 17' ' ' MET . 1.2 tmmt? -61.05 -38.13 85.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.922 0.391 . . . . 74.13 110.968 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.17 -39.04 75.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.147 0.499 . . . . 74.25 111.012 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.97 -47.77 83.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.869 -0.605 . . . . 74.42 111.168 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 23.6 ptp -60.15 -34.99 74.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.82 0.343 . . . . 74.22 111.311 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.6 t -76.95 -27.1 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.744 0.307 . . . . 61.25 111.76 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.0 mmp_? -94.39 -14.69 25.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.672 0.619 . . . . 64.23 112.672 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.7 p -108.53 -29.86 8.55 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.496 0.554 . . . . 41.41 112.496 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.58 -0.14 58.06 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.122 -0.561 . . . . 72.13 112.578 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.1 178.52 7.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.29 0.567 . . . . 61.34 112.042 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.42 168.74 12.68 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.022 -0.535 . . . . 72.54 112.578 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 -45.14 91.35 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.602 -0.352 . . . . 60.21 111.872 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -65.21 -41.2 94.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.151 0.501 . . . . 74.04 111.123 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.59 -41.77 98.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.278 -0.419 . . . . 73.35 111.189 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG21 ' HG3' ' A' ' 13' ' ' GLU . 66.0 mt -62.39 -54.38 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.624 0.25 . . . . 42.31 111.659 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 11.8 pt-20 -59.65 -29.9 68.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.96 0.41 . . . . 72.52 111.284 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.3 t -63.04 -46.83 85.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.879 0.371 . . . . 71.51 111.093 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -68.69 -29.01 67.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.974 0.416 . . . . 61.31 111.029 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 51.9 mtp180 -61.26 -28.1 68.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.087 172.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 28' ' ' GLU . 15.3 mm100 -73.08 -33.56 65.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.387 0.514 . . . . 73.21 112.387 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.82 61.19 0.3 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.169 -1.015 . . . . 54.12 114.737 -176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.71 -32.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.566 0.698 . . . . 63.22 110.408 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -72.48 130.92 41.78 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.679 -0.691 . . . . 72.24 111.581 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.458 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 70.9 mt -131.93 132.95 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.842 -0.617 . . . . 62.31 110.898 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.07 142.52 51.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.055 0.455 . . . . 71.21 111.441 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.31 -48.67 3.43 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.471 -0.395 . . . . 71.15 113.314 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.35 -60.59 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.941 0.4 . . . . 54.41 112.031 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.458 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.6 m170 -97.63 -32.19 11.9 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.282 0.475 . . . . 73.34 112.282 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 23.4 p90 -153.27 169.59 22.67 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.222 -0.299 . . . . 73.21 111.526 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.59 152.54 27.36 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.782 0.325 . . . . 73.33 110.851 174.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -78.57 131.0 36.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.237 0.542 . . . . 63.3 111.796 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 45' ' ' SER . 39.9 t -114.66 159.66 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.034 -0.53 . . . . 75.11 110.734 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.405 ' N ' HG12 ' A' ' 44' ' ' VAL . 46.6 m -51.38 131.17 33.98 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.356 -0.384 . . . . 73.55 111.713 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.3 Cg_endo -61.21 114.25 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.235 1.957 . . . . 74.2 112.361 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -82.89 9.29 10.29 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.143 0.423 . . . . 72.22 112.143 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.07 -104.51 0.21 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.255 -0.498 . . . . 64.24 112.516 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.77 122.46 19.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.016 0.436 . . . . 71.34 111.327 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -78.05 100.18 6.41 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.253 -0.431 . . . . 65.34 110.41 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -129.69 156.1 44.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.5 -0.318 . . . . 72.05 110.873 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 52' ' ' LEU . 3.1 mm? -62.66 -15.21 51.14 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.837 0.68 . . . . 65.02 112.837 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.41 -31.1 37.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.227 -0.296 . . . . 63.51 111.591 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.99 -174.45 43.49 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.33 -0.462 . . . . 54.31 113.214 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 46' ' ' PRO . 91.3 m -101.04 114.68 28.84 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.248 -0.56 . . . . 64.42 110.325 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m -94.42 126.23 39.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.292 0.478 . . . . 72.3 112.292 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -114.64 139.07 49.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.24 -0.437 . . . . 74.2 110.613 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 63' ' ' ILE . 55.5 m-85 -107.94 148.51 29.57 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.973 0.415 . . . . 72.12 112.015 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -85.1 101.36 12.38 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.997 0.427 . . . . 64.12 111.213 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.783 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 87.0 t80 -53.54 -45.24 98.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.724 0.639 . . . . 73.03 112.724 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 11.1 Cg_endo -53.65 -47.41 27.41 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.018 1.812 . . . . 75.53 112.814 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.46 -38.77 84.95 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.253 0.464 . . . . 74.11 112.253 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 58' ' ' TYR . 64.4 mt -68.06 -43.52 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.876 0.369 . . . . 55.34 110.884 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 53.1 t30 -60.28 -41.25 92.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.039 0.447 . . . . 63.25 110.269 173.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -44.43 92.29 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.902 -0.59 . . . . 55.42 111.323 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -63.35 -46.87 84.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.214 0.531 . . . . 74.14 111.432 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.27 -47.41 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.253 -0.431 . . . . 73.21 111.59 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 6.8 tpp180 -61.27 -34.61 75.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.297 -0.41 . . . . 72.1 111.164 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -28.02 65.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.966 -0.561 . . . . 74.02 111.49 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.1 t -72.95 -24.23 60.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.197 -0.456 . . . . 61.24 111.408 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.34 -40.71 15.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.402 -0.363 . . . . 64.12 111.904 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.79 16.57 3.63 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.043 0.757 . . . . 61.21 113.043 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.58 104.31 16.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.536 0.569 . . . . 52.12 112.536 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 31.11 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.902 1.445 . . . . 73.25 114.902 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -68.81 99.14 0.99 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.883 -0.599 . . . . 70.12 110.315 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -94.92 132.51 39.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.703 0.287 . . . . 70.2 111.694 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -176.36 114.93 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.997 0.427 . . . . 43.13 111.379 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.5 p80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 119.327 -0.368 . . . . 73.12 111.39 177.738 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 111.631 0.234 . . . . 75.4 111.631 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.81 -65.15 1.04 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.467 0.543 . . . . 62.22 112.467 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 59.46 55.62 4.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.416 0.627 . . . . 72.45 111.583 -175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.94 85.63 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.39 0.614 . . . . 74.33 109.848 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.6 mm -71.03 104.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 113.101 0.778 . . . . 72.33 113.101 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -134.91 107.91 7.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.869 -0.605 . . . . 75.11 110.095 170.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -153.48 43.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.782 0.801 . . . . 74.31 110.23 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 5.2 mp0 -75.35 96.26 3.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.424 -0.807 . . . . 74.33 111.705 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 60' ' ' TYR . 11.2 mm-40 -76.43 117.0 17.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 70.11 111.42 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -99.09 123.89 43.71 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.345 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 19.8 ptp -159.79 156.71 28.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.332 0.493 . . . . 54.05 112.332 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.3 m -81.58 176.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.319 -0.4 . . . . 42.33 111.174 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -56.3 -47.05 79.46 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.645 0.609 . . . . 74.1 112.645 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -39.96 92.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.837 0.351 . . . . 72.21 111.289 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -74.79 -33.57 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.086 0.47 . . . . 62.21 111.197 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.96 -47.87 67.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.759 -0.655 . . . . 73.05 111.326 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 23.5 ptp -56.12 -33.71 65.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.043 0.449 . . . . 74.03 111.852 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.38 -33.98 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.102 0.477 . . . . 73.44 111.457 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -86.81 -15.33 39.57 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.425 0.528 . . . . 72.15 112.425 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HB ' HD13 ' A' ' 22' ' ' LEU . 48.6 p -108.53 -29.1 8.95 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.774 0.657 . . . . 72.12 112.774 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.98 9.7 65.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.849 -0.691 . . . . 61.23 112.636 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.0 mp -91.77 163.1 14.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.122 0.487 . . . . 62.21 111.124 176.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.39 163.2 14.18 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.209 -0.519 . . . . 64.12 111.811 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -51.2 -41.82 60.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.137 0.469 . . . . 44.42 111.501 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -56.6 -37.65 70.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.348 -0.387 . . . . 72.14 112.025 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -73.92 -46.49 44.05 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 70.1 111.274 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.56 -46.82 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.462 -0.335 . . . . 72.12 111.678 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 13.1 pt-20 -59.56 -37.39 78.33 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.824 0.345 . . . . 70.41 111.027 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -56.92 -39.89 75.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.187 0.518 . . . . 74.1 110.834 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -80.67 -26.41 37.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.249 -0.432 . . . . 72.4 111.61 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 37.9 mtm180 -66.85 -17.95 65.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.798 0.333 . . . . 74.33 111.139 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.47 -23.09 65.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.311 0.485 . . . . 74.23 112.311 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.84 -52.05 0.02 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.312 -0.947 . . . . 73.23 114.276 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.76 -36.92 39.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.634 0.605 . . . . 72.5 112.634 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.33 104.39 3.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.016 0.436 . . . . 65.31 110.881 176.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -95.2 138.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.881 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.54 134.39 56.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.068 0.461 . . . . 72.41 111.899 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -35.85 1.72 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.449 -0.405 . . . . 53.25 113.894 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.5 t -84.64 -53.23 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.333 0.494 . . . . 63.21 112.333 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.38 -15.13 14.31 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.561 0.578 . . . . 72.53 112.561 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.78 152.06 35.89 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.469 -0.145 . . . . 73.01 110.637 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 8.0 mtpm? -125.69 141.29 52.09 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.094 0.473 . . . . 70.5 111.993 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -84.93 111.86 20.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.879 -0.601 . . . . 73.42 111.187 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.5 t -107.46 119.79 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.142 0.496 . . . . 70.13 111.934 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -84.32 141.56 39.83 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.089 -0.505 . . . . 63.44 111.35 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.97 -7.17 20.45 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.674 2.249 . . . . 72.33 113.149 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.5 t -136.24 -59.7 0.73 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.637 0.256 . . . . 72.43 111.323 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.01 -42.1 0.19 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.627 -0.797 . . . . 45.23 113.838 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -82.13 -177.93 6.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.207 0.527 . . . . 72.54 111.908 -177.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -64.31 120.67 12.63 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.037 0.446 . . . . 74.34 111.067 -178.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.1 m -120.64 157.38 29.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.827 -0.624 . . . . 72.03 111.423 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.512 ' N ' HD22 ' A' ' 52' ' ' LEU . 2.7 mm? -82.25 -51.5 7.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.388 0.613 . . . . 74.24 110.027 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -81.25 72.9 8.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.306 0.574 . . . . 72.34 111.181 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.16 126.53 8.0 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.845 -0.616 . . . . 72.51 112.488 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.8 m -76.69 116.39 17.33 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 122.429 -0.453 . . . . 74.13 111.103 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.6 m -97.8 101.16 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.807 0.337 . . . . 73.22 111.827 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -89.15 138.47 31.39 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.574 -0.285 . . . . 72.4 110.278 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.13 134.95 43.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.063 0.459 . . . . 72.1 111.794 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 63' ' ' ILE . 1.4 m-20 -76.93 94.23 3.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.941 -0.572 . . . . 44.21 111.815 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 78.6 t80 -52.37 -48.96 87.88 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 113.214 0.82 . . . . 65.12 113.214 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HG3' ' HA ' ' A' ' 8' ' ' GLU . 13.1 Cg_endo -55.0 -42.15 71.98 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.985 1.79 . . . . 72.21 112.635 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 60.4 mm-40 -64.73 -41.06 96.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.019 0.438 . . . . 74.11 111.271 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.0 mt -66.54 -45.34 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.272 -0.422 . . . . 53.22 111.301 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -58.09 -44.05 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.214 0.53 . . . . 64.02 110.552 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -54.69 -38.66 67.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.793 -0.64 . . . . 75.01 111.205 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -71.62 -43.63 65.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.172 -0.467 . . . . 72.53 111.024 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 63' ' ' ILE . 77.7 mt -55.29 -46.88 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 116.394 -0.366 . . . . 72.41 111.25 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -50.59 -54.7 20.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.75 0.31 . . . . 62.34 111.618 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.33 -48.25 79.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.011 0.434 . . . . 73.2 111.312 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.7 t -71.38 -24.58 62.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.527 0.565 . . . . 43.51 112.527 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp -86.01 -52.25 5.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.68 0.622 . . . . 62.13 112.68 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -25.39 49.03 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.679 0.622 . . . . 74.11 112.679 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -67.14 142.13 57.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.812 0.339 . . . . 74.4 111.046 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -72.45 71.81 0.95 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.651 0.739 . . . . 62.24 112.43 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -149.82 95.7 2.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.485 -0.78 . . . . 74.54 109.789 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -97.66 124.91 42.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.874 0.369 . . . . 64.42 111.81 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -61.06 121.69 13.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.451 -0.341 . . . . 74.35 110.463 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.679 -0.677 . . . . 71.31 111.553 177.806 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 112.088 0.403 . . . . 75.42 112.088 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.33 -59.36 5.46 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.056 0.455 . . . . 64.03 111.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -129.55 141.88 50.88 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.234 -0.439 . . . . 71.43 110.395 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -80.7 94.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.001 0.429 . . . . 74.21 111.217 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.1 114.16 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.055 0.455 . . . . 65.31 110.002 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.65 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 91.5 m-85 -68.82 -52.12 33.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.935 0.717 . . . . 74.43 112.935 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 65.72 21.82 11.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.877 0.37 . . . . 72.32 111.816 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.65 ' HG3' ' HB3' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -104.22 23.67 12.7 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.415 0.626 . . . . 75.42 110.917 177.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 4.3 mp0 -72.06 82.58 0.97 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.668 -0.697 . . . . 71.21 110.676 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -102.69 129.82 49.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.486 -0.325 . . . . 73.55 110.968 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.2 pmm? -145.92 162.55 37.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.747 0.308 . . . . 74.1 111.266 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.4 162.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.425 -0.352 . . . . 61.13 111.512 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 42.9 tt0 -50.29 -44.92 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.284 0.476 . . . . 65.22 112.284 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -58.41 -44.54 89.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.4 -0.364 . . . . 54.35 111.263 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.21 -34.23 65.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.149 0.5 . . . . 71.2 111.336 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.74 -49.99 75.28 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.966 -0.561 . . . . 74.43 110.871 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.02 -28.86 69.35 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.753 0.311 . . . . 74.31 111.699 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 14' ' ' LYS . 62.2 t -73.85 -38.13 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.048 0.452 . . . . 72.22 111.219 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.1 mmm180 -78.08 -24.41 47.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.986 0.365 . . . . 75.2 111.986 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 22' ' ' LEU . 67.1 p -104.67 -30.21 10.1 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.85 0.685 . . . . 52.25 112.85 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.78 10.0 60.58 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.258 -0.496 . . . . 62.23 113.208 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD13 ' HB ' ' A' ' 20' ' ' THR . 9.2 mp -83.73 167.82 16.82 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.197 0.522 . . . . 70.1 112.147 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.54 159.34 14.55 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.214 -0.448 . . . . 74.23 112.787 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.1 -46.51 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.851 0.686 . . . . 63.33 112.851 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 20.8 ttm180 -75.59 -35.34 60.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.796 0.331 . . . . 75.25 111.469 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -61.92 -40.78 96.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.156 0.503 . . . . 75.41 110.562 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.56 -48.7 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.075 -0.512 . . . . 75.54 111.593 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 14.2 pt-20 -63.9 -23.19 67.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.186 -0.321 . . . . 60.23 111.324 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -67.08 -49.23 65.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.089 0.471 . . . . 72.1 110.322 172.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.161 0.505 . . . . 74.25 111.092 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 48.9 mtp180 -61.94 -13.4 24.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.822 -0.627 . . . . 70.23 111.824 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.53 12.27 37.67 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 111.747 0.277 . . . . 71.41 111.747 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.11 -78.2 0.03 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.461 -0.876 . . . . 61.33 114.157 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.36 67.47 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.007 0.743 . . . . 43.05 113.007 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.562 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 112.23 7.94 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.472 0.653 . . . . 73.31 112.066 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 64.8 mt -105.83 134.5 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.457 -0.792 . . . . 73.02 110.447 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.2 133.01 53.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 74.01 111.131 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.31 -32.05 3.39 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.536 -0.364 . . . . 73.1 113.648 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 47.2 t -97.18 -41.09 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.573 0.582 . . . . 62.13 112.573 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 21.8 m170 -112.18 -5.43 14.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.184 0.438 . . . . 63.51 112.184 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -170.94 164.59 7.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.606 0.225 . . . . 73.44 111.606 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -149.47 161.81 41.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.951 0.405 . . . . 72.21 111.128 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.4 mmm-85 -87.62 118.32 27.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.311 -0.404 . . . . 75.32 111.463 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.7 t -94.24 134.52 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.768 0.318 . . . . 72.21 111.158 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -77.26 118.89 74.94 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 112.126 0.417 . . . . 75.43 112.126 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.515 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 70.5 Cg_endo -75.22 106.61 2.31 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.458 2.105 . . . . 71.05 111.657 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.9 t -50.41 -38.15 41.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.777 0.658 . . . . 61.33 112.777 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.29 -83.98 0.33 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.077 -0.582 . . . . 63.51 113.301 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.67 87.92 6.27 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.319 -0.518 . . . . 71.32 110.874 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -71.57 81.26 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.269 0.557 . . . . 73.23 111.662 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 p -117.64 -173.02 2.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.165 -0.47 . . . . 74.2 110.61 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.2 mm? -86.45 3.69 42.81 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.188 0.518 . . . . 74.53 111.004 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -85.63 21.58 1.8 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.309 -0.405 . . . . 74.43 111.102 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 46' ' ' PRO . . . -45.73 127.29 8.68 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.4 -0.364 . . . . 63.44 113.86 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -54.52 117.36 3.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.135 0.493 . . . . 73.5 111.702 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.8 m -83.59 105.43 14.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.191 -0.459 . . . . 62.35 111.908 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -89.35 152.69 21.38 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.485 -0.325 . . . . 71.43 110.462 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.403 ' HE2' ' HB2' ' A' ' 13' ' ' GLU . 85.5 m-85 -113.4 149.62 33.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.993 0.738 . . . . 72.31 112.993 -171.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 63' ' ' ILE . 16.3 m120 -77.16 93.66 3.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.696 -0.684 . . . . 70.43 111.73 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.584 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.2 t80 -55.25 -47.03 99.51 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.431 0.53 . . . . 74.23 112.431 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 7.7 Cg_endo -49.07 -48.57 17.87 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.382 2.055 . . . . 63.34 113.212 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 29.0 mm-40 -74.22 -34.67 63.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.583 0.586 . . . . 64.53 112.583 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 59' ' ' ASN . 77.8 mt -67.37 -43.05 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.147 0.499 . . . . 63.14 110.54 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.78 -41.85 99.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.022 -0.536 . . . . 55.42 110.358 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -46.81 77.62 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.793 -0.639 . . . . 71.32 111.097 174.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -58.98 -51.84 68.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.056 -0.52 . . . . 65.22 111.272 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.99 -29.86 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.294 -0.412 . . . . 73.11 111.624 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.52 -49.96 75.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.823 0.344 . . . . 73.33 111.402 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.38 57.5 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.772 0.32 . . . . 74.43 111.601 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -71.5 -41.57 69.11 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.028 0.442 . . . . 53.25 111.752 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -56.1 6.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.21 -0.45 . . . . 73.03 110.968 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.28 -71.33 0.09 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.909 0.707 . . . . 71.11 112.909 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.26 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.706 0.403 . . . . 74.41 111.325 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -47.58 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.209 0.818 . . . . 55.42 113.209 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -97.18 129.77 44.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.709 -0.678 . . . . 75.52 111.255 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -84.6 178.02 7.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.409 0.623 . . . . 72.24 112.38 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -64.34 152.72 40.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.726 -0.67 . . . . 64.54 112.318 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.9 p80 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.486 -0.768 . . . . 74.42 111.677 176.377 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.83 0.347 . . . . 75.54 111.277 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.29 154.72 41.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.455 -0.338 . . . . 73.01 111.097 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -154.11 119.45 5.12 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 71.41 111.673 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.41 105.57 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.352 -0.386 . . . . 54.42 110.816 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -90.97 96.53 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.973 0.416 . . . . 71.23 111.463 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -149.03 152.34 36.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.208 -0.451 . . . . 72.01 111.327 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.87 124.09 16.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.953 0.406 . . . . 63.31 111.133 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -122.78 140.92 52.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.158 0.504 . . . . 71.35 111.278 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 44.7 mt-10 -132.28 96.56 3.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.193 -0.458 . . . . 55.2 110.637 176.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.469 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 68.2 m95 -102.26 114.38 28.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.506 -0.315 . . . . 72.12 110.909 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ptp -135.58 153.13 51.77 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.07 0.396 . . . . 53.21 112.07 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.8 m -80.58 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.321 0.489 . . . . 74.22 112.321 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -50.32 -57.25 8.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.95 0.722 . . . . 74.33 112.95 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 1.4 tmmt? -56.34 -40.67 74.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -38.45 68.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 64.1 111.161 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.78 -46.56 87.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.78 -0.645 . . . . 61.34 111.512 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' LYS . 24.5 ptp -56.99 -36.23 70.12 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.982 0.42 . . . . 71.43 111.533 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 t -76.01 -40.56 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.123 0.487 . . . . 52.2 111.273 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.0 mmp_? -74.29 -21.4 59.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.681 0.623 . . . . 52.35 112.681 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.5 p -108.38 -30.68 8.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.72 0.637 . . . . 73.52 112.72 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.23 1.12 56.94 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.146 -0.549 . . . . 30.23 112.858 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.39 172.09 14.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.981 0.42 . . . . 73.53 111.479 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.0 161.06 12.8 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.335 -0.46 . . . . 44.43 112.267 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.24 62.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.01 0.374 . . . . 61.44 112.01 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -63.85 -24.87 67.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.915 0.388 . . . . 64.25 111.694 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HG2' ' CE2' ' A' ' 30' ' ' TYR . 45.9 tt0 -84.11 -41.2 17.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.905 0.383 . . . . 75.01 110.763 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.64 -52.32 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.929 0.395 . . . . 74.33 111.405 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.01 -32.16 67.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.583 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.07 -43.76 98.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.008 0.432 . . . . 72.33 110.716 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE2' ' HG2' ' A' ' 26' ' ' GLN . 24.9 m-85 -70.9 -27.68 63.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.439 -0.346 . . . . 74.14 111.768 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 22.7 mtm180 -66.69 -10.3 45.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.798 0.332 . . . . 75.3 111.868 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -85.34 -9.59 57.42 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.077 0.399 . . . . 74.35 112.077 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.88 -48.04 0.02 OUTLIER Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.255 -0.974 . . . . 70.0 114.497 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.409 0.522 . . . . 74.42 112.409 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.03 145.8 48.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.037 0.446 . . . . 73.43 111.108 177.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.56 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 78.6 mt -139.45 132.24 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 116.265 -0.425 . . . . 73.3 111.272 -173.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.37 134.06 53.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.1 0.476 . . . . 72.11 111.926 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.44 -55.42 4.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.464 -0.398 . . . . 51.33 113.306 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -70.08 -62.94 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.073 0.397 . . . . 72.03 112.073 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.56 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 36.7 m80 -95.15 -8.03 37.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.667 0.618 . . . . 74.32 112.667 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -164.61 155.78 15.18 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.694 0.283 . . . . 74.25 111.493 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -123.53 157.33 33.85 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.95 0.405 . . . . 74.11 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -104.61 116.18 31.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.986 0.422 . . . . 75.21 111.453 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -116.04 134.59 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.992 0.425 . . . . 54.31 111.615 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.3 p -83.64 154.74 65.45 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.255 -0.429 . . . . 63.42 111.347 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.17 160.9 17.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.484 2.122 . . . . 74.4 113.012 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -68.79 113.35 6.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 64.23 111.243 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.72 -69.3 2.11 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 116.31 -0.405 . . . . 43.21 113.535 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.6 110.39 6.14 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.048 0.451 . . . . 74.34 111.711 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -78.6 82.7 4.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.578 0.704 . . . . 63.52 112.186 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -94.03 155.64 17.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.697 -0.683 . . . . 72.35 110.445 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.7 mm? -63.62 -32.46 73.95 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 111.704 0.261 . . . . 64.31 111.704 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -64.09 82.14 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.298 0.57 . . . . 75.24 111.772 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.95 134.66 13.08 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.701 -0.681 . . . . 52.12 113.033 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.9 m -77.55 120.17 22.14 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.717 0.294 . . . . 72.44 111.045 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -102.41 115.01 29.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.989 0.423 . . . . 73.31 111.556 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 64.5 m95 -98.7 130.27 45.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.271 -0.422 . . . . 61.35 110.95 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 5.6 m-85 -88.29 145.01 26.08 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.963 0.411 . . . . 75.42 111.859 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t-20 -84.44 98.85 10.31 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.048 -0.523 . . . . 55.4 110.713 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 76.7 t80 -55.37 -51.61 78.43 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 112.596 0.591 . . . . 75.11 112.596 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 85.5 Cg_exo -48.45 -42.91 34.13 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.372 2.048 . . . . 52.45 113.437 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.97 -40.28 87.43 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.957 0.408 . . . . 75.22 111.517 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 58' ' ' TYR . 74.4 mt -65.99 -32.98 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.91 0.386 . . . . 71.34 110.768 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -60.47 -43.45 96.91 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.345 0.593 . . . . 64.41 110.306 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.8 -25.88 67.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.973 -0.558 . . . . 63.0 111.385 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.98 -52.86 15.04 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 72.1 110.622 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.78 -28.45 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 116.12 -0.491 . . . . 70.33 111.147 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.597 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 1.8 tpm_? -47.72 -57.37 5.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.964 -0.562 . . . . 71.35 111.263 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.1 -48.45 67.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.047 0.451 . . . . 74.22 111.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 66.7 m -62.28 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 74.51 111.731 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.27 -35.1 69.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.866 0.691 . . . . 74.33 112.866 -173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 16.1 mm-40 -66.57 -58.19 5.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.344 0.498 . . . . 75.13 112.344 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -97.12 18.11 15.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.371 0.508 . . . . 73.12 112.371 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' SER . 93.3 m-70 -128.3 176.67 7.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.507 -0.553 . . . . 64.22 109.507 166.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -132.38 96.68 3.91 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.221 0.534 . . . . 74.01 111.341 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -79.23 77.69 5.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.904 -0.589 . . . . 74.15 110.895 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -73.48 95.58 2.27 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.916 -0.583 . . . . 75.01 111.338 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.61 -0.71 . . . . 71.53 112.705 177.678 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.855 0.317 . . . . 73.33 111.855 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.46 35.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.984 0.421 . . . . 74.14 111.91 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -162.05 132.34 4.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.445 -0.343 . . . . 63.1 111.34 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm -85.72 135.87 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.894 0.378 . . . . 74.43 111.743 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.9 mp -107.73 113.59 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.021 0.439 . . . . 75.21 111.585 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 31.9 m-85 -113.42 90.17 3.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.162 0.505 . . . . 63.11 111.323 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -78.7 63.72 3.53 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.803 0.811 . . . . 63.24 110.678 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 6' ' ' PHE . 51.5 mt-10 -75.28 79.43 2.38 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.397 -0.82 . . . . 73.1 112.216 -175.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.78 78.02 9.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.027 0.441 . . . . 75.51 111.072 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -78.87 123.54 27.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.139 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.543 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.2 ptp -151.8 165.53 34.19 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.762 0.653 . . . . 44.41 112.762 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -82.77 177.38 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.088 -0.505 . . . . 75.51 110.964 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 58' ' ' TYR . 27.2 tt0 -65.69 -39.22 91.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.839 0.311 . . . . 72.22 111.839 -176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -56.54 -45.67 81.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.132 0.492 . . . . 70.45 110.497 178.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -68.52 -42.21 78.85 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.191 0.519 . . . . 72.53 111.069 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.28 -47.28 78.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.931 -0.577 . . . . 64.21 111.36 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 22.8 ptp -64.61 -29.33 70.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.829 0.347 . . . . 63.2 111.483 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 14' ' ' LYS . 75.6 t -73.54 -40.43 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.015 0.436 . . . . 71.51 111.494 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.543 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.2 mmt85 -71.65 -39.74 70.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.098 0.475 . . . . 71.41 112.109 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' HD13 ' A' ' 22' ' ' LEU . 66.6 p -92.98 -30.53 15.29 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.585 0.587 . . . . 74.11 112.585 -173.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.64 -0.69 70.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.927 -0.654 . . . . 74.31 112.867 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 20' ' ' THR . 10.6 mp -73.5 156.56 38.06 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.013 0.435 . . . . 74.14 111.365 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 162.4 16.58 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.299 -0.477 . . . . 72.22 112.336 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -41.37 82.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.845 0.355 . . . . 64.2 111.363 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.87 -31.7 65.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.139 0.495 . . . . 64.52 111.483 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -83.81 -43.25 15.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.102 -0.499 . . . . 71.0 110.819 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.92 -46.73 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.213 -0.449 . . . . 64.41 111.667 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.28 -34.11 71.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.911 0.386 . . . . 63.44 111.298 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -66.67 -33.97 76.82 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.107 0.479 . . . . 74.34 110.809 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -76.79 -33.82 58.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.077 -0.511 . . . . 75.53 112.036 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 20.7 mtt180 -56.06 -34.78 66.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.269 0.557 . . . . 73.43 111.818 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -77.97 0.02 25.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.082 0.771 . . . . 74.25 113.082 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.7 -56.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.525 -0.845 . . . . 70.31 113.791 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.06 -37.69 78.66 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.81 0.67 . . . . 50.01 112.81 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.632 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.11 108.83 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.971 0.415 . . . . 75.43 111.469 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -108.38 123.42 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.138 -0.483 . . . . 75.41 110.706 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.02 152.0 44.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.82 0.343 . . . . 71.44 111.302 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.15 -38.44 1.8 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.109 -0.567 . . . . 75.34 112.982 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 40.7 t -89.48 -65.91 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 111.87 0.322 . . . . 74.31 111.87 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.424 ' ND1' ' HB3' ' A' ' 62' ' ' GLU . 5.4 m-70 -98.29 -14.63 20.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.094 0.776 . . . . 74.12 113.094 -174.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 34.4 p90 -159.64 171.89 18.78 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 122.075 -0.39 . . . . 70.23 111.797 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -150.49 143.97 25.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.343 0.592 . . . . 75.01 111.556 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.8 139.48 30.41 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.134 -0.484 . . . . 70.45 111.569 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.74 118.3 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.102 0.477 . . . . 74.54 112.208 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' HD13 ' A' ' 52' ' ' LEU . 30.0 t -91.94 148.98 38.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 CA-C-N 116.156 -0.475 . . . . 55.14 111.354 174.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.39 0.88 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.468 2.112 . . . . 73.43 112.251 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 50' ' ' LYS . 89.7 p -135.14 -165.58 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.891 -0.595 . . . . 74.21 110.542 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.14 -115.91 0.07 OUTLIER Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.141 -0.552 . . . . 55.44 113.505 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -91.13 20.67 4.82 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.461 -0.434 . . . . 73.1 111.937 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 55.6 mtpt -78.7 -172.24 2.89 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.538 0.208 . . . . 71.43 110.682 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.2 m -61.77 149.94 38.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.967 -0.458 . . . . 75.34 111.312 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.9 mm? -69.3 -81.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.227 -0.442 . . . . 73.23 112.064 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 61.85 13.89 5.85 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.03 0.381 . . . . 75.13 112.03 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -142.43 6.08 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.392 -0.367 . . . . 61.21 113.454 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.9 m -110.94 136.28 50.19 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.336 -0.508 . . . . 73.44 112.304 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 m -91.94 118.48 30.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.278 -0.419 . . . . 73.43 111.136 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -94.27 144.56 25.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.804 0.335 . . . . 74.11 111.18 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 63' ' ' ILE . 68.5 m-85 -112.13 142.07 45.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.072 0.463 . . . . 75.2 111.882 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -82.05 97.85 8.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.701 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 41.0 t80 -49.91 -50.9 65.58 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 112.788 0.662 . . . . 73.31 112.788 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 71.3 Cg_exo -51.46 -46.18 33.09 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.244 1.962 . . . . 72.11 112.948 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 58.4 mm-40 -64.25 -41.18 97.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.091 0.404 . . . . 72.13 112.091 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 67' ' ' ILE . 60.4 mt -67.93 -45.35 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.606 -0.27 . . . . 63.14 111.203 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.14 -35.32 75.02 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.287 0.565 . . . . 75.35 110.576 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.56 -33.65 76.4 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.796 -0.638 . . . . 73.14 111.277 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -80.07 -44.13 20.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.345 -0.388 . . . . 73.43 111.994 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' ILE . 75.5 mt -47.56 -40.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.235 0.457 . . . . 74.3 112.235 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -51.82 -48.56 63.85 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.989 0.423 . . . . 73.11 111.738 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 37.3 t70 -60.0 -33.31 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.259 -0.428 . . . . 73.02 111.219 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -55.24 -27.15 44.3 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.951 0.352 . . . . 74.32 111.951 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.5 mm? -86.21 -40.57 15.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.248 0.462 . . . . 73.4 112.248 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.6 6.17 19.83 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.359 0.874 . . . . 63.54 113.359 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' ASP . 67.5 t60 -53.56 118.79 4.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.817 0.303 . . . . 73.1 111.817 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -63.28 167.79 4.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.207 0.527 . . . . 44.24 112.184 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -66.82 109.65 2.99 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.395 0.617 . . . . 74.34 112.091 -176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -95.44 99.89 11.73 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.839 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -146.89 119.58 8.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.809 0.338 . . . . 72.4 111.852 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 118.617 -0.706 . . . . 71.44 110.599 175.35 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 111.735 0.272 . . . . 53.12 111.735 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.17 -65.55 0.68 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.331 0.493 . . . . 55.03 112.331 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -77.3 116.72 18.14 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.302 0.572 . . . . 62.22 111.69 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -101.51 101.01 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.997 0.427 . . . . 74.34 111.139 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -94.12 102.93 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.816 0.341 . . . . 70.34 110.609 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -164.4 9.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.331 -0.395 . . . . 53.43 111.818 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -80.87 56.62 2.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.775 0.798 . . . . 74.33 110.444 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.29 137.25 14.55 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.578 -0.737 . . . . 73.23 111.134 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.65 109.83 17.71 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 74.15 111.703 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -94.12 121.85 36.04 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.881 -0.414 . . . . 71.05 109.881 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.76 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 19.9 ptp -138.9 147.16 41.98 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.31 0.485 . . . . 74.51 112.31 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.34 165.43 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.943 0.401 . . . . 74.14 111.972 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.97 -42.73 80.69 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.239 -0.437 . . . . 73.23 111.724 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 tmmt? -59.15 -42.11 89.91 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.214 -0.448 . . . . 70.54 111.262 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.1 -37.55 66.69 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.191 0.519 . . . . 74.13 111.279 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.27 -47.02 84.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.84 -0.618 . . . . 72.41 111.616 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.9 ptp -59.34 -32.27 69.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.927 0.394 . . . . 64.3 111.405 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 14' ' ' LYS . 58.5 t -72.71 -32.67 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.073 0.463 . . . . 54.04 111.267 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 14.5 mmt85 -76.55 -43.22 40.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.463 0.542 . . . . 70.51 112.463 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -93.33 -27.09 16.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.981 0.734 . . . . 73.31 112.981 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.81 -0.11 64.58 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.946 -0.645 . . . . 72.52 113.206 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 mp -79.66 166.91 21.35 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.084 0.468 . . . . 72.42 111.514 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.92 164.18 14.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.212 -0.449 . . . . 63.24 112.421 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.48 -42.23 70.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.012 0.375 . . . . 74.33 112.012 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -62.47 -33.69 75.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.057 0.456 . . . . 72.23 111.231 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.42 -48.25 42.67 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.425 -0.352 . . . . 70.4 111.419 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.2 mt -57.14 -50.84 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.86 0.362 . . . . 71.34 111.313 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.764 0.316 . . . . 64.41 111.469 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.2 t -63.33 -39.21 93.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.943 0.402 . . . . 74.01 111.164 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.65 -16.74 55.22 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.976 0.417 . . . . 73.12 111.51 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.695 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 58.8 mtp180 -68.88 -10.93 59.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.781 0.324 . . . . 75.12 111.815 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -83.02 2.69 33.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 111.764 0.283 . . . . 62.11 111.764 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.01 -61.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.66 -0.781 . . . . 71.33 114.115 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.21 95.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.957 0.725 . . . . 63.13 112.957 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.695 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -71.71 104.43 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.038 -0.414 . . . . 74.41 111.073 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 62.2 mt -89.89 121.5 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.509 -0.314 . . . . 75.21 111.23 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -59.86 131.63 51.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.904 0.383 . . . . 61.42 110.34 178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.752 ' HA2' ' HZ1' ' A' ' 42' ' ' LYS . . . 92.12 -31.85 5.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.541 -0.361 . . . . 43.51 113.201 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 36' ' ' ILE . 46.4 t -101.88 -72.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.654 -0.321 . . . . 71.24 111.391 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -77.42 -7.57 56.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.958 0.355 . . . . 71.2 111.958 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 33.3 p90 -171.84 167.56 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.617 0.367 . . . . 72.01 110.773 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.752 ' HZ1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -154.02 136.54 15.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.493 0.663 . . . . 71.32 111.568 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 61.6 mtp180 -80.62 102.56 9.9 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.264 -0.88 . . . . 62.44 110.258 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.11 143.1 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.796 -0.638 . . . . 74.51 112.523 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -80.46 140.6 52.13 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 116.014 -0.539 . . . . 74.24 111.391 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.97 -35.55 76.52 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.489 2.126 . . . . 73.3 112.416 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -97.71 -46.92 5.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.225 -0.443 . . . . 52.34 111.666 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.24 -43.48 0.85 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.083 -0.579 . . . . 32.13 112.555 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 137.55 44.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.8 0.333 . . . . 73.33 110.81 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -51.56 111.7 0.63 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.734 . . . . 61.1 112.983 -171.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.4 m -83.82 155.28 23.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.487 -0.779 . . . . 74.43 110.705 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.6 mm? -65.2 -44.85 87.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.876 0.369 . . . . 54.11 111.478 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -86.82 -66.63 0.89 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.589 -0.278 . . . . 75.03 111.525 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.52 119.88 1.63 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.262 -0.494 . . . . 54.41 113.442 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.1 m -66.55 113.93 5.13 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.602 -0.352 . . . . 73.25 110.237 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -84.5 110.32 18.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.383 0.512 . . . . 65.41 112.383 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -98.59 126.87 44.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.114 -0.494 . . . . 73.44 110.272 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HB3' HD11 ' A' ' 63' ' ' ILE . 84.5 m-85 -93.33 144.75 25.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.919 0.341 . . . . 51.04 111.919 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 62' ' ' GLU . 59.1 t30 -82.64 94.47 7.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 71.04 111.049 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.523 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 70.7 t80 -51.38 -53.31 50.9 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 113.299 0.852 . . . . 73.45 113.299 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 60' ' ' TYR . 75.6 Cg_exo -49.66 -36.86 42.47 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.274 1.982 . . . . 74.13 113.219 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 22.2 mt-10 -81.43 -29.5 33.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.754 0.65 . . . . 73.42 112.754 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.492 ' O ' HG13 ' A' ' 67' ' ' ILE . 64.7 mt -70.46 -38.78 75.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.956 -0.465 . . . . 73.54 110.706 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -62.42 -39.08 92.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.191 0.519 . . . . 74.23 110.495 169.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' GLU . 59.9 tttp -56.78 -37.16 70.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.883 -0.598 . . . . 61.31 110.877 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -72.17 -41.25 67.26 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.869 0.366 . . . . 71.25 111.031 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 63' ' ' ILE . 67.8 mt -53.29 -39.18 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.481 -0.327 . . . . 74.41 111.267 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -53.64 -36.68 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.729 0.3 . . . . 75.1 111.611 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.25 -25.77 27.07 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.04 0.448 . . . . 73.14 110.998 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.0 t -59.49 -36.35 75.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.821 0.343 . . . . 61.33 111.901 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.32 -21.28 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.018 0.377 . . . . 74.14 112.018 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -61.24 105.59 0.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.144 0.497 . . . . 74.31 111.983 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -59.38 133.0 55.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.518 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -74.51 -67.22 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.15 0.5 . . . . 64.23 110.867 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -142.55 111.18 6.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.646 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -71.81 93.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.151 0.5 . . . . 73.4 111.102 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -77.79 2.16 17.95 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.831 1.048 . . . . 62.12 113.831 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 66.6 m80 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.918 -0.563 . . . . 60.33 111.951 176.304 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.99 0.424 . . . . 70.35 111.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.92 101.68 12.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.969 0.414 . . . . 64.34 111.208 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -129.81 160.27 34.01 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.884 0.373 . . . . 70.51 111.365 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 7' ' ' ASN . 47.7 mm -86.91 92.71 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.923 0.392 . . . . 72.35 111.769 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.2 mp -99.27 112.44 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.931 0.396 . . . . 54.2 111.392 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.2 t80 60.05 7.77 1.28 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.629 0.974 . . . . 52.32 113.629 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.476 ' HB3' HG23 ' A' ' 4' ' ' ILE . 5.5 t30 -72.8 71.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.54 -0.725 . . . . 72.54 109.742 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.77 -170.99 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.646 -0.707 . . . . 72.44 111.386 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 60' ' ' TYR . 9.2 tp10 -151.39 111.38 4.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.775 -0.648 . . . . 70.53 110.027 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -119.83 143.2 48.01 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.272 -0.268 . . . . 75.22 111.093 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.604 ' SD ' ' HA ' ' A' ' 16' ' ' LEU . 17.8 ptp -164.7 171.88 13.78 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.657 0.614 . . . . 73.02 112.657 -176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.87 -179.99 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.977 -0.556 . . . . 34.33 111.335 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.88 -58.08 9.71 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.532 0.568 . . . . 52.43 112.532 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.4 tmmt? -61.92 -29.13 70.02 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.49 -0.323 . . . . 60.24 111.619 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.67 -37.02 42.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.238 0.542 . . . . 54.14 111.158 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' HA ' ' SD ' ' A' ' 11' ' ' MET . 3.3 tm? -61.5 -49.92 74.82 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.78 -0.646 . . . . 72.31 111.019 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 24.0 ptp -55.95 -36.03 67.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.025 0.379 . . . . 74.11 112.025 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.1 t -65.75 -43.46 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.194 0.442 . . . . 75.44 112.194 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -85.23 -18.63 33.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.096 0.406 . . . . 70.24 112.096 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.9 p -100.58 -26.98 13.65 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.331 0.493 . . . . 63.13 112.331 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.81 24.8 29.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.091 -0.576 . . . . 72.13 113.176 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' MET . 10.6 mp -102.49 -178.86 3.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.211 0.529 . . . . 75.52 111.654 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.2 163.41 21.78 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.902 -0.59 . . . . 72.42 111.987 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.51 -46.1 77.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.096 0.448 . . . . 64.31 112.162 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 2.3 tmt_? -64.12 -34.41 77.98 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.115 0.483 . . . . 72.13 110.749 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.13 -42.4 69.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.918 0.389 . . . . 72.25 110.927 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.36 -50.48 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.357 -0.383 . . . . 74.43 111.793 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.97 -30.52 66.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.889 0.376 . . . . 74.41 111.146 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 t -62.44 -38.97 91.84 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.305 -0.407 . . . . 71.31 111.195 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -75.32 -31.11 60.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.46 -0.336 . . . . 61.45 111.67 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 21.4 mtm180 -64.88 -11.17 34.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.185 0.439 . . . . 74.31 112.185 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.23 11.01 24.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.424 -0.353 . . . . 74.14 111.926 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.53 -50.65 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.329 -0.939 . . . . 63.14 114.433 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.56 -41.21 80.09 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.234 0.457 . . . . 74.13 112.234 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.07 123.49 22.94 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.907 0.384 . . . . 62.03 111.145 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.84 132.67 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.37 -0.377 . . . . 74.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.23 146.63 47.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.864 0.364 . . . . 53.11 111.596 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 -53.66 2.99 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.39 -0.368 . . . . 73.13 112.638 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG12 ' ND1' ' A' ' 40' ' ' HIS . 46.3 t -70.85 -65.8 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.413 0.523 . . . . 43.41 112.413 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.412 ' ND1' HG12 ' A' ' 39' ' ' VAL . 3.1 m-70 -96.74 -16.96 20.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.932 0.716 . . . . 62.22 112.932 -175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 35' ' ' TRP . 36.5 p90 -161.41 174.81 12.93 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.389 -0.195 . . . . 74.41 111.154 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.43 154.4 26.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.084 0.469 . . . . 72.51 112.099 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -79.43 122.9 26.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.217 -0.447 . . . . 74.13 112.173 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.37 104.15 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.204 0.526 . . . . 75.35 110.872 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.1 p -87.25 155.93 54.45 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.097 -0.501 . . . . 55.34 110.947 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.55 -49.42 6.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.205 2.604 . . . . 72.4 114.257 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.9 m -105.72 12.75 30.64 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.625 0.602 . . . . 62.5 112.625 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.08 30.78 78.82 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.639 -0.791 . . . . 70.21 112.057 -173.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.12 3.78 37.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.482 0.713 . . . . 72.04 112.029 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 65.74 2.57 2.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.122 0.786 . . . . 72.04 113.122 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.5 m -64.27 151.34 43.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.002 -0.436 . . . . 65.14 110.969 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.641 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.6 mm? -59.87 -34.24 72.89 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.487 0.551 . . . . 73.1 112.487 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -78.27 86.18 4.38 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.204 0.526 . . . . 74.55 110.973 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.43 37.08 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.785 -0.643 . . . . 73.33 112.933 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 135.99 35.45 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.94 0.4 . . . . 55.24 111.688 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -96.76 105.52 17.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.254 0.464 . . . . 73.24 112.254 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -86.0 152.03 23.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.328 -0.396 . . . . 74.2 110.905 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 41.3 m-85 -117.14 146.24 43.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.121 0.486 . . . . 75.02 111.829 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.54 108.78 19.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.986 -0.552 . . . . 54.55 110.915 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 81.9 t80 -56.79 -48.73 96.79 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.931 0.715 . . . . 65.31 112.931 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 18.0 Cg_endo -58.33 -33.45 97.74 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.9 1.733 . . . . 64.14 112.681 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -69.54 -48.2 61.18 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.155 -0.475 . . . . 62.44 111.12 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 69.7 mt -65.71 -36.86 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.023 0.44 . . . . 65.01 111.152 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.66 -37.06 82.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.585 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.6 -38.65 85.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.094 -0.503 . . . . 72.42 110.936 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -66.45 -53.53 34.36 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.008 -0.542 . . . . 74.15 111.062 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.69 -38.47 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.884 0.373 . . . . 65.4 111.451 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -57.93 -35.41 71.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.001 0.429 . . . . 73.42 111.186 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.69 -43.48 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.333 -0.394 . . . . 63.33 111.724 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.0 m -74.33 -54.13 8.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.286 0.476 . . . . 54.45 112.286 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.9 tp -75.78 -43.0 48.64 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.042 0.386 . . . . 61.53 112.042 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 70.09 -52.05 0.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.05 0.759 . . . . 75.25 113.05 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -52.47 109.47 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.272 0.558 . . . . 73.04 112.287 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -67.15 139.94 57.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.049 -0.523 . . . . 61.43 110.769 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -153.53 151.99 30.43 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.079 0.4 . . . . 53.35 112.079 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -129.42 146.88 51.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.247 -0.433 . . . . 74.14 111.194 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -78.83 -33.71 45.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 73.42 110.726 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.94 -0.552 . . . . 72.52 111.459 179.5 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.699 0.285 . . . . 74.41 111.07 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.94 157.93 36.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.664 0.269 . . . . 75.4 111.417 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -152.76 148.91 27.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.308 0.485 . . . . 63.43 112.308 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.8 mm -113.86 90.68 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.223 0.535 . . . . 74.42 109.816 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.8 mt -133.09 103.11 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.056 0.455 . . . . 71.32 111.606 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -160.84 99.69 1.25 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.941 -0.572 . . . . 72.13 110.171 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -132.63 111.84 11.53 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.999 0.428 . . . . 63.43 111.442 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 4.6 mp0 -74.49 81.26 1.95 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.176 0.512 . . . . 62.11 110.525 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.06 109.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.73 -0.668 . . . . 75.32 111.882 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.495 ' CZ3' ' HG2' ' A' ' 42' ' ' LYS . 95.7 m95 -85.68 136.45 33.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.296 -0.411 . . . . 74.24 110.472 173.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.581 ' SD ' ' HG3' ' A' ' 19' ' ' ARG . 21.0 ptp -153.89 154.86 34.64 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.978 0.418 . . . . 75.33 111.73 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 15' ' ' ALA . 34.4 m -71.29 166.27 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.889 0.376 . . . . 73.14 111.415 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.86 -44.01 86.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.016 0.436 . . . . 75.23 111.986 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 tmmt? -63.71 -32.94 74.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.293 -0.412 . . . . 71.33 111.527 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -78.21 -35.94 47.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.041 0.448 . . . . 73.22 111.149 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.32 -46.21 87.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.838 -0.619 . . . . 53.24 111.003 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.501 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.2 ptp -59.87 -34.29 72.95 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.723 0.296 . . . . 72.23 111.488 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 14' ' ' LYS . 66.9 t -69.18 -40.29 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.881 0.372 . . . . 74.32 111.209 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' SD ' ' A' ' 11' ' ' MET . 12.2 mmt85 -66.15 -44.66 83.48 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.996 0.427 . . . . 75.03 112.099 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.0 p -93.79 -25.15 17.51 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.034 0.753 . . . . 71.31 113.034 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.23 64.51 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.211 -0.518 . . . . 74.2 113.186 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' HG ' ' NE2' ' A' ' 26' ' ' GLN . 9.0 mp -74.66 173.41 10.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.367 0.603 . . . . 54.52 112.167 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.85 170.35 17.73 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.086 -0.506 . . . . 42.41 112.317 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.8 66.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.212 0.449 . . . . 50.05 112.212 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -64.82 -29.43 70.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.865 0.365 . . . . 72.53 111.961 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.427 ' NE2' ' HG ' ' A' ' 22' ' ' LEU . 47.9 tt0 -76.97 -42.67 38.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.972 0.415 . . . . 72.12 110.839 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 63.0 mt -63.72 -49.03 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.584 -0.28 . . . . 74.03 111.683 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.25 -35.03 59.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.771 0.319 . . . . 75.13 111.38 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 t -63.06 -50.7 69.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 54.41 110.69 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -59.72 -35.63 74.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.027 -0.533 . . . . 73.54 111.412 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 50.1 mtp180 -62.13 -19.98 63.6 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.852 0.358 . . . . 74.2 111.44 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.97 -8.54 14.83 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.392 -0.367 . . . . 70.2 111.989 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.6 41.62 0.97 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.81 -0.71 . . . . 65.1 114.109 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.33 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.293 0.568 . . . . 71.5 111.377 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.448 ' CG ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -72.39 141.91 48.71 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.458 0.646 . . . . 72.43 112.14 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' H ' ' HB2' ' A' ' 40' ' ' HIS . 65.3 mt -138.65 135.13 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.573 -0.74 . . . . 72.54 110.236 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.47 130.62 45.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.094 0.473 . . . . 73.15 112.062 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.67 -26.68 1.64 Allowed Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.352 -0.385 . . . . 63.4 113.946 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.2 t -94.91 -40.35 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.292 -0.534 . . . . 74.33 112.238 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.507 ' HB2' ' H ' ' A' ' 36' ' ' ILE . 48.5 m80 -121.52 -9.72 8.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.425 0.528 . . . . 72.0 112.425 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -165.04 159.25 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.866 0.365 . . . . 73.21 111.831 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HG2' ' CZ3' ' A' ' 10' ' ' TRP . 55.8 pttt -153.82 153.35 31.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.029 0.443 . . . . 63.51 111.422 174.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.39 141.57 45.09 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.93 170.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t -107.93 145.06 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.797 0.332 . . . . 74.53 111.083 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -52.1 129.78 40.24 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 115.855 -0.611 . . . . 64.14 112.396 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.91 -32.99 49.68 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.849 2.366 . . . . 72.15 113.277 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.6 m 68.33 -5.2 0.95 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.833 1.049 . . . . 75.45 113.833 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.26 -119.07 0.86 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.639 -0.791 . . . . 54.14 114.183 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.08 -12.81 54.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.922 0.712 . . . . 64.4 112.922 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -60.54 133.74 56.39 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.9 0.381 . . . . 71.04 111.187 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -73.25 -172.06 1.05 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.129 0.49 . . . . 65.32 111.785 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.487 HD22 ' H ' ' A' ' 52' ' ' LEU . 2.9 mm? -62.9 -13.94 40.46 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.002 0.371 . . . . 62.12 112.002 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 53' ' ' ARG . 10.8 mmt180 -60.04 -47.17 86.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.062 0.458 . . . . 71.42 111.566 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.67 -151.13 45.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.263 -0.494 . . . . 62.22 112.947 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -148.25 133.18 18.1 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 122.545 -0.385 . . . . 74.31 110.692 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.1 m -102.93 121.75 43.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.188 0.44 . . . . 73.43 112.188 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -107.85 146.53 32.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.604 176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' HD11 ' A' ' 63' ' ' ILE . 23.2 m-85 -106.85 154.06 21.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.791 0.663 . . . . 75.01 112.791 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.64 101.67 12.34 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.651 -0.704 . . . . 63.02 111.925 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 80.3 t80 -51.61 -50.85 74.77 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 112.762 0.653 . . . . 70.21 112.762 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.565 ' HG3' ' HA ' ' A' ' 8' ' ' GLU . 17.2 Cg_endo -56.13 -53.53 5.28 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.159 1.906 . . . . 74.42 113.273 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -64.81 -23.62 67.3 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.594 0.59 . . . . 61.13 112.594 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 58' ' ' TYR . 75.9 mt -82.09 -46.32 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.052 -0.405 . . . . 63.41 111.379 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.17 -40.95 82.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.512 0.673 . . . . 65.51 109.973 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -52.81 -48.71 66.75 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.152 -0.931 . . . . 63.23 111.39 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.77 -37.77 79.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.457 -0.338 . . . . 65.25 111.147 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.71 -40.51 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.863 0.364 . . . . 60.13 111.0 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -57.08 -58.96 5.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.176 0.512 . . . . 62.4 110.166 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.45 -18.36 65.31 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.088 -0.505 . . . . 71.04 111.941 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.0 t -79.89 -23.08 42.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.174 0.512 . . . . 54.33 110.846 172.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.53 -61.3 1.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.263 -0.426 . . . . 72.11 111.5 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -71.86 85.44 0.95 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.648 0.261 . . . . 72.31 111.168 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -60.33 98.71 0.06 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.756 0.65 . . . . 75.53 112.756 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -148.59 -24.37 0.32 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.759 -0.655 . . . . 73.22 111.023 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -93.14 123.16 36.21 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.448 -0.342 . . . . 64.24 110.828 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -82.93 145.84 29.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.125 0.488 . . . . 74.12 111.832 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -68.6 112.36 5.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.975 -0.557 . . . . 63.54 111.762 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.2 t60 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.636 -0.697 . . . . 63.34 110.951 174.446 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.672 0.272 . . . . 70.04 111.686 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 87.88 0.73 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.385 0.513 . . . . 73.41 112.385 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -90.14 121.46 32.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.112 0.482 . . . . 73.14 110.573 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.63 88.79 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.219 0.533 . . . . 74.3 111.662 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.7 mm -87.9 64.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.94 0.876 . . . . 61.21 110.101 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -148.68 132.73 17.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 64.53 110.373 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -122.3 -177.74 3.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.882 0.372 . . . . 73.41 110.817 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 61' ' ' PRO . 50.5 mt-10 -113.75 91.15 3.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.889 0.376 . . . . 62.23 110.312 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -70.44 104.37 2.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 51.43 111.635 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' TYR . 82.2 m95 -98.64 118.77 36.1 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.562 -0.29 . . . . 74.1 110.845 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 60' ' ' TYR . 1.1 pmm? -133.26 172.37 12.77 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.118 0.485 . . . . 70.14 111.533 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.53 162.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.096 -0.502 . . . . 61.31 111.375 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.54 -42.5 83.03 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.179 0.437 . . . . 73.22 112.179 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -59.55 -37.87 79.57 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.994 0.426 . . . . 73.33 110.968 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.6 45.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.97 0.414 . . . . 72.02 111.328 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.93 -50.61 73.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.172 -0.467 . . . . 70.34 110.603 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.404 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.6 ptp -58.39 -37.06 74.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.756 0.312 . . . . 71.41 111.803 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 14' ' ' LYS . 59.5 t -69.64 -48.22 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 111.829 0.307 . . . . 75.03 111.829 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 19' ' ' ARG . 29.0 mmt180 -69.04 -28.88 66.94 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.286 0.476 . . . . 73.4 112.286 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.415 HG21 HG21 ' A' ' 63' ' ' ILE . 80.5 p -93.88 -29.25 15.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.489 0.552 . . . . 64.33 112.489 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.86 56.59 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 52.03 112.564 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 26' ' ' GLN . 8.3 mp -82.2 -178.17 6.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.399 0.619 . . . . 75.25 111.627 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' GLN . . . -133.27 171.09 21.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.981 -0.554 . . . . 64.13 111.909 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.83 -51.39 66.03 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.283 0.475 . . . . 53.51 112.283 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -66.46 -30.01 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.159 0.504 . . . . 63.3 111.504 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.542 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 5.2 tp-100 -66.98 -48.46 68.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.066 0.46 . . . . 75.22 110.918 174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 64.5 mt -60.79 -52.09 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.343 -0.39 . . . . 71.42 111.296 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.2 -33.6 69.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.507 0.194 . . . . 74.24 111.409 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.4 t -61.23 -37.51 83.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.929 0.395 . . . . 50.32 110.981 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -80.26 -30.07 38.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.894 0.378 . . . . 70.45 111.808 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HG2' ' CD1' ' A' ' 35' ' ' TRP . 67.8 mtp180 -64.13 -15.56 59.99 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.925 0.393 . . . . 75.31 111.854 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -68.08 -22.65 64.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.537 -0.301 . . . . 74.01 111.8 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.48 -45.07 0.02 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 120.661 -0.781 . . . . 63.32 114.342 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.75 -31.4 71.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.012 0.745 . . . . 50.25 113.012 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.513 ' CD1' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -72.18 104.69 3.72 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.455 0.645 . . . . 74.22 111.829 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.92 123.58 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.565 -0.743 . . . . 74.22 111.279 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.22 147.19 48.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.112 0.482 . . . . 72.0 111.395 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.53 -58.92 3.75 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.121 -0.49 . . . . 61.33 113.164 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.81 -56.11 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.439 0.533 . . . . 72.4 112.439 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 52.9 m80 -92.24 -23.54 19.3 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.501 0.556 . . . . 73.31 112.501 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 35' ' ' TRP . 15.4 p90 -163.68 149.58 11.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.536 -0.172 . . . . 64.02 110.536 177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -147.76 147.57 30.02 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.092 0.472 . . . . 71.22 112.264 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -79.7 117.87 21.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.853 -0.612 . . . . 74.15 111.775 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.57 128.8 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.774 0.321 . . . . 73.43 111.051 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.9 p -67.81 154.58 93.3 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 112.38 0.511 . . . . 63.34 112.38 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -58.08 -44.84 35.99 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.419 2.08 . . . . 75.44 112.517 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 t -163.97 123.14 1.98 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.08 0.4 . . . . 73.03 112.08 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.73 -94.22 0.28 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 115.151 0.82 . . . . 65.24 115.151 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -67.7 158.79 31.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.519 0.933 . . . . 75.23 113.519 -171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -76.92 86.89 3.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.431 -0.804 . . . . 74.5 111.429 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 53' ' ' ARG . 21.3 m -92.59 148.04 22.4 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.974 0.416 . . . . 75.11 111.477 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -70.91 -14.03 62.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.897 0.703 . . . . 70.22 112.897 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 51' ' ' THR . 16.7 mmt180 -123.77 107.28 11.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.775 0.321 . . . . 75.51 110.671 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.6 -168.96 15.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.116 -0.564 . . . . 54.03 113.606 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 m -86.36 123.7 31.9 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.859 0.361 . . . . 73.14 111.543 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -91.96 114.88 27.54 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.709 0.29 . . . . 60.43 111.418 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -100.3 144.3 29.47 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.734 -0.212 . . . . 74.41 110.856 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 94.0 m-85 -110.27 144.46 38.94 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.254 0.549 . . . . 64.55 112.135 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 40.6 t-20 -87.86 92.07 8.99 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.801 -0.636 . . . . 74.23 110.943 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 66.0 t80 -46.98 -53.04 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.972 0.73 . . . . 71.51 112.972 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.726 ' HG2' ' HA ' ' A' ' 8' ' ' GLU . 75.6 Cg_exo -52.29 -39.19 73.06 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.171 1.914 . . . . 53.32 113.399 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 52.9 mm-40 -72.03 -34.12 68.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.3 0.481 . . . . 74.51 112.3 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 20' ' ' THR . 1.8 mp -71.54 -49.94 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 75.32 110.464 174.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 58.5 t30 -54.1 -46.83 72.21 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.151 0.501 . . . . 63.2 110.662 176.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -52.87 -46.13 67.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.661 . . . . 53.05 111.536 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -57.2 -50.6 72.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.227 -0.442 . . . . 73.55 111.478 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.97 -57.22 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.861 0.363 . . . . 71.3 111.586 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 16.0 mmt180 -54.32 -46.16 72.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.304 0.483 . . . . 75.33 112.304 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -23.24 66.99 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 51.24 111.443 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.3 m -75.22 -30.25 60.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.522 -0.308 . . . . 74.53 111.17 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.71 -41.27 75.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.799 0.333 . . . . 63.53 110.957 175.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.6 108.66 2.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.919 0.39 . . . . 74.21 111.148 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -61.71 -35.01 76.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.401 0.62 . . . . 72.25 110.148 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -142.54 112.31 6.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.402 -0.817 . . . . 64.13 109.676 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -47.78 101.57 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.219 0.608 . . . . 73.33 112.292 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -81.85 -29.61 32.45 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.238 -0.437 . . . . 70.21 112.027 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -73.15 109.05 6.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.279 0.474 . . . . 64.13 112.279 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.226 0 N-CA-C 112.052 0.39 . . . . 72.14 112.052 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.652 0.263 . . . . 73.33 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.54 94.04 4.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.034 0.445 . . . . 60.32 112.194 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -133.51 149.51 51.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.37 -0.377 . . . . 73.24 110.983 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.02 105.0 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.511 -0.313 . . . . 72.21 110.686 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -76.42 115.65 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.475 -0.33 . . . . 73.11 110.382 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -67.85 92.8 0.37 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.309 0.576 . . . . 74.24 111.674 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.3 147.2 25.62 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.349 0.595 . . . . 72.42 111.722 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.55 110.55 11.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.464 0.649 . . . . 61.11 110.497 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 33.2 mt-10 -92.38 82.21 4.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.182 0.515 . . . . 73.3 112.355 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 76.3 m95 -94.49 149.44 21.24 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.778 -0.646 . . . . 65.12 110.606 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.6 ptp -159.05 151.58 21.59 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.032 0.444 . . . . 75.34 111.778 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.33 167.71 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.155 0.428 . . . . 73.44 112.155 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.21 -54.5 46.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.461 0.541 . . . . 74.41 112.461 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -35.48 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.424 -0.353 . . . . 71.45 111.551 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.81 -40.81 60.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.115 0.484 . . . . 54.14 111.289 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.9 -53.59 56.53 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.812 -0.631 . . . . 44.41 111.046 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.437 ' HB3' HD11 ' A' ' 27' ' ' ILE . 23.7 ptp -54.24 -40.34 67.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.846 0.313 . . . . 62.45 111.846 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -70.4 -42.49 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.95 0.405 . . . . 73.44 112.077 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.627 0.603 . . . . 75.3 112.627 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -107.17 -28.45 9.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.929 0.395 . . . . 64.2 111.893 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.88 5.22 59.91 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.233 -0.508 . . . . 72.31 112.715 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' MET . 9.3 mp -82.29 160.9 22.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.197 0.522 . . . . 70.43 111.428 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.89 160.9 13.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.091 -0.576 . . . . 55.13 112.447 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.82 -41.17 61.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.938 0.369 . . . . 71.22 111.861 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 25' ' ' ARG . 8.1 ptp180 -62.56 -32.19 73.12 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.135 0.493 . . . . 73.3 111.612 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.51 -37.8 35.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.003 0.43 . . . . 72.55 111.017 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 17' ' ' MET . 59.3 mt -63.99 -49.36 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.39 -0.368 . . . . 61.33 111.095 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.75 -35.63 76.86 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.858 0.361 . . . . 74.13 110.985 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.6 t -60.75 -37.61 82.4 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.916 0.389 . . . . 60.24 111.278 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -72.83 -37.82 67.32 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.96 0.41 . . . . 74.11 111.504 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 24.7 mtm180 -65.46 -10.41 33.88 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.228 0.455 . . . . 72.35 112.228 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -59.95 -30.95 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.759 0.281 . . . . 73.52 111.759 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.99 31.94 0.05 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.308 -0.949 . . . . 61.25 114.721 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.12 -24.86 4.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.412 0.606 . . . . 54.23 111.428 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -83.28 129.32 35.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.029 -0.532 . . . . 75.34 111.731 -178.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.9 mt -130.87 137.27 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.697 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.69 153.17 43.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.781 0.324 . . . . 75.04 111.157 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.26 -49.95 3.89 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.487 -0.387 . . . . 53.41 112.496 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.36 -57.49 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 74.41 112.043 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -101.67 -23.76 14.2 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.094 0.776 . . . . 63.24 113.094 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -161.92 172.48 15.95 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.315 -0.24 . . . . 62.4 111.484 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -154.74 160.66 41.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.911 0.386 . . . . 74.0 111.786 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -87.48 137.09 32.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.026 0.441 . . . . 74.11 111.443 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.3 t -108.26 127.79 64.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.986 0.422 . . . . 73.34 111.777 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 43.2 t -90.35 115.18 63.49 Favored Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 116.23 -0.441 . . . . 61.42 111.259 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 6.4 Cg_exo -73.72 80.82 1.97 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.679 2.252 . . . . 73.43 112.516 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.7 m 55.59 33.52 21.33 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.122 0.487 . . . . 23.41 111.359 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.16 123.77 4.46 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.558 -0.617 . . . . 73.52 111.558 -173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.39 81.65 1.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.124 0.488 . . . . 71.45 112.109 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HA ' ' HE2' ' A' ' 50' ' ' LYS . 8.2 mmpt? -111.53 11.89 21.32 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.222 0.534 . . . . 63.11 110.984 171.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 p -112.15 144.92 40.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.825 -0.625 . . . . 73.1 110.562 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.84 3.71 52.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.941 0.401 . . . . 71.05 111.076 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -119.99 80.95 1.66 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.863 0.364 . . . . 72.01 111.187 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.54 131.94 12.66 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.98 -0.628 . . . . 53.3 113.16 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 m -84.16 114.74 22.0 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.63 -0.335 . . . . 73.53 110.744 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -90.44 127.25 36.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.093 0.473 . . . . 44.41 111.952 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 10' ' ' TRP . 29.0 m95 -104.4 132.8 50.24 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.156 -0.474 . . . . 75.21 110.657 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.525 ' HB3' HD11 ' A' ' 63' ' ' ILE . 52.2 m-85 -104.36 147.01 28.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.88 -176.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -78.78 106.59 10.89 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.837 0.351 . . . . 53.15 111.422 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 93.1 t80 -53.49 -50.21 84.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 112.701 0.63 . . . . 53.53 112.701 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 60' ' ' TYR . 21.0 Cg_endo -59.15 -42.82 47.01 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.11 1.873 . . . . 70.21 113.254 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -66.55 -40.12 88.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 111.892 0.33 . . . . 75.43 111.892 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' A' ' 58' ' ' TYR . 67.5 mt -67.87 -41.8 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.707 0.289 . . . . 72.13 110.786 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -60.39 -41.26 93.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.901 0.381 . . . . 72.02 110.744 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.38 -42.59 92.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.075 0.464 . . . . 72.41 110.75 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.0 -38.13 89.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.984 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' ILE . 80.7 mt -59.26 -44.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.541 -0.299 . . . . 74.24 110.728 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 68' ' ' ARG . 27.8 mmt180 -57.27 -51.13 70.6 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.238 0.542 . . . . 74.35 110.561 175.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -56.85 -34.88 68.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.385 -0.825 . . . . 64.44 111.832 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -84.14 -46.16 12.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.832 0.678 . . . . 74.22 112.832 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.5 tp -75.83 -37.65 58.84 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.02 0.748 . . . . 72.43 113.02 -170.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -57.26 99.99 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.054 0.454 . . . . 75.23 111.221 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -79.17 80.07 5.55 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.9 0.333 . . . . 73.43 111.9 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -111.22 1.04 16.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.741 0.305 . . . . 73.21 111.599 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -164.92 118.0 1.25 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.734 0.302 . . . . 71.22 111.001 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.07 132.46 45.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.37 . . . . 73.32 111.9 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -113.58 3.3 15.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.497 0.665 . . . . 73.22 109.736 170.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.46 -0.791 . . . . 72.21 110.822 175.834 . . . . . . . . 0 0 . 1 stop_ save_